Asymmetric transformations under chiral bronsted acid catalysis: (4+3) cycloaddition and allylboration of imines by Villar Arango, Laura
UPV/EHU 
FACULTY OF SCIENCE AND TECHNOLOGY 
DEPARTMENT OF ORGANIC CHEMISTRY II 
Asymmetric Transformations under 
Chiral Brønsted Acid Catalysis: 
(4+3) Cycloaddition and Allylboration of Imines 
MEMORIA PRESENTADA POR 
Laura Villar Arango 
PARA OPTAR AL GRADO DE DOCTOR 
CON MENCIÓN “DOCTOR INTERNACIONAL” 
Leioa, 2017 
(c)2017 LAURA VILLAR ARANGO
  
 
 
  
Quiero expresar mi agradecimiento a los Profesores Dr. Jose L. Vicario y 
Dra. Uxue Uria por la dirección y supervisión de este trabajo. Igualmente 
agradezco a los Profesores Dr. Efraím Reyes, Dra. Marisa Carrillo y al Dr. Jose 
I. Martínez por su apoyo durante este periodo. También quiero agradecer a las 
personas que de una u otra forma han contribuido a la realización de este 
trabajo. 
I must also mention Professor Andrei V. Malkov. I would like to thank him 
for the opportunity he gave to me to work in his group, as well as for all the time 
he dedicated to me during my stay in Loughborough University. 
Agradezco también al Ministerio de Economía y Competitividad la 
concesión de una ayuda de “Formación del Personal Investigador” (BES-2012-
051856). Del mismo modo agradezco al MINECO (CTQ2011-22790 y CTQ2014-
52107), el Gobierno Vasco por la Subvención General a Grupos de Investigación 
(IT328-10 t IT908-16) y la UPV/EHU (EHUA12/09 y UFI QOSYC 11/22) por la 
financiación otorgada, al apoyo técnico y humano del servicio SGIKer de la 
UPV/EHU y su financiació europea (FEDER, FSE). 
  
Summary 
The use of catalysts able to engage in hydrogen bonding interactions with a given 
reagent opens up as a useful strategy in the area of organocatalysis. Chiral BINOL-based 
phosphoric acids and derivatives have demonstrated their proficiency as versatile 
catalysts for a wide range of synthetic transformations. In this context, our group has 
started to use those strong Brønsted acids to catalyze different organocatalytic reactions. 
The present manuscript compiles the study and development of diverse 
enantioselective organocatalytic reactions. In this context, investigations were directed 
to the use of allenamides as oxyallyl cation precursors in the (4+3) cycloaddition with a 
wide range of electron-rich dienes, catalyzed by BINOL-based chiral Brønsted acids. 
Under the optimal conditions a complete regioselective reaction furnishes 8-
oxabicyclo[3.2.1]octane scaffold with four new stereogenic centers in high yields and 
excellent stereoselectivities. 
Additionally, as a part of a short stay in the laboratories of Prof. Andrei V. 
Malkov in Loughborough University and a later collaboration between both research 
groups, the optimization of the kinetic resolution of racemic secondary allyl boronates 
has been studied with the aim to use these enantiopure allyl boronates in the allylation 
reaction of primary imines via chirality transfer. This leads to the formation of chiral 
homoallylic primary amines which are very interesting chiral building blocks. 
  
  
Resumen 
El uso de catalizadores capaces de involucrarse en interacciones mediante enlaces 
de hidrógeno con un determinado reactivo abre una nueva y útil estrategia en el área de 
la organocatálisis. Los ácidos fosfóricos quirales derivados de BINOL han demostrado 
su gran capacidad versátil en un gran número de transformaciones sintéticas. En este 
contexto, nuestro grupo se ha iniciado en la utilización de este tipo de ácidos de 
Brønsted fuertes para catalizar diferentes reacciones organocatalíticas. 
El presente manucrito compila el estudio y desarrollo de diversas reacciones 
organocatalíticas enantioselectivas. En este contexto, las investigaciones fueron 
dirigidas al uso de alenamidas como precursores de cationes oxaalílicos en la 
cicloadición (4+3) con una gran variedad de dienos ricos en electrones catalizado por 
ácidos de Brønsted quirales derivados del BINOL. Bajo las condiciones óptimas se 
consigue una reacción completamente regioselectiva para dar estructuras tipo 8-
oxabiciclo[3.2.1]octano con cuatro nuevos centros estereogénicos con altos 
rendimientos y excelentes estereoselectividades. 
Adicionalmente, como parte de una estancia breve en los laboratorios del Prof. 
Andrei V. Malkov en la Universidad de Loughborough y una posterior colaboración 
entre ambos grupos de investigación, se estudió la optimización de la resolución cinética 
de alilboronatos secundarios racémicos con el fin de utilizar los alilboronatos 
enantiopuros en la reacción de alilación con iminas mediante transferencia de quiralidad 
para obtener aminas primarias homoalílicas quirales como estructuras interesantes. 
  
  
Laburpena 
Hidrogeno-loturen bidez nahasteko gai diren katalizatzaileak erreaktibo jakin 
batekin estrategia berri eta baliagarri bati hasiera eman diote organotakalisi arloan. 
Transformazio sintetiko askotarako eraginkor eta erabilera anitzeko katalizatzaileak 
direla egiaztatu dute azido fosforiko kiralak. Testuinguru honetan, gure taldea Brønsted 
azido gogor hauekin hasi da lanean erreakzio organokatalitiko ezberdinak katalizatu ahal 
izateko. 
Eskuidatzi honek erreakzio enantioselektibo organokatalitiko ezberdinen ikasketa 
eta garapena biltzen ditu. Testuinguru honetan, alenamiden erabilerara bideratu zen 
ikerketa katioi oxalilikoen aurrendari bezala lan dezakete elektroi aberatsak diren dieno 
ugariekin BINOL deribatuen Brønsted azido kiralengandik katalizatuta den (4+3) 
zikloadizio erreakzioa. Erreakzioa guztiz erregioselektiboki funtzionatzen du lau zentru 
estereogeniko berri dituzten 8-oxabiziklo[3.2.1]oktano estrukturak etekin altuekin eta 
estereoselektibitate bikainekin lortzeko. 
Bestela ere, egonaldi motz baten emaitzaz Prof. Andrei V. Malkoven laborategian 
Loughborough Unibertsitatean eta ikerketa talde bien artean ondorengo kolaborazio 
baten emaitzaz, alilboronato sekundario razemikoen erresoluzio zinetiko baten 
optimizazioan lan egin zen. Geroago, alilboronato enantiopuruak eta iminak alilazio 
erreakzioan erabili ziren kiralitate-transferentziaren bidez interesgarriak diren amina 
primario homoaliliko kiralak lortu ahal izateko. 
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1. ASYMMETRIC ORGANOCATALYSIS 
Asymmetric catalysis is one of the most important and efficient methodologies in organic 
synthesis for the preparation of chiral compounds in a stereoselective manner. Control over the 
stereochemical outcome of organic reactions has long been recognized by multiple sectors of 
synthetic chemistry and proof of this is the Nobel Prize to Knowles, Sharpless and Noyori in 
2001 for their work on the use of chiral catalysts for highly enantioselective transformations.  
Organocatalysis is one of the three general subfields that, along with enzymatic-1 and 
metal-catalysis,2 comprises the whole area of asymmetric catalysis. It is based on the use of 
substoichiometric amounts of small organic molecules that do not contain any metal atom in their 
active site to catalyze a wide range of organic transformations. Although asymmetric catalysis 
has been governed by bio- and metal-catalysis, organocatalysis3 has gathered importance as it is 
indicated by the large number of publications during the last two decades.4 
Although the first examples that illustrate the ability of small organic molecules to 
catalyze an enantioselective organic reaction were reported several decades ago with the works 
of Marckwald (1904),5 Bredig and Fiske (1912)6 and Pracejus (1960),7 the area of 
enantioselective organocatalysis has became a main focus of research only recently. In fact, 
                                                           
1
  Enzymatic catalysis: (a) Enzyme Catalysis in Organic Chemistry, 3rd ed.; .Drauz, K., Gröger, H., May, O., Eds.; 
Wiley-VCH: Weinheim, 2012. (b) Tao, J.; Zhao, L.; Ran, N. Org. Process. Res. Dev. 2007, 11, 259. (c) Benkovic, S. 
J.; Hammes-Schiffer, S. Science 2003, 301, 1196. (d) Bruice, T. C. Acc. Chem. Res. 2002, 35, 139. 
2
  Metal-catalysis: (a) Metal Catalyzed Reactions in Water; Dixneuf, P. H., Cadierno, V., Eds.; Wiley-VCH: Weinheim, 
2013. (b) Homogeneus Catalysis with Metal Complexes; Temkin, O. N., Ed.; Springer: Berlin, 2012. (c) Transition 
Metals for Organic Synthesis, 2nd ed.; Beller, M., Bolm, C., Eds.; Wiley-VCH: Weinheim, 2004. (d) Catalytic 
Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York, 2000. 
3
  For the first-time introduction of the term “organic catalysis” see: (a) Langebeck, W. Angew. Chem. 1928, 41, 740. 
(b) Langebeck, W. Angew. Chem. 1932, 45, 97. (c) Die Organiche Katalysatoren und ihre Beziehungen zu den 
Fermenten; Langebeck, W., Ed.; Springer-Verlag: Berlin, 1949. 
4
  General reviews in organocatalysis: (a) Donslund, B. S.; Johansen, T. K.; Poulsen, P. H.; Halskov, K. S.; Jørgensen, 
K. A. Angew. Chem. Int. Ed. 2015, 54, 13860. (b) Akiyama, T.; Mori, K. Chem. Rev. 2015, 115, 9277. (c) Flanigan, 
D. M.; Romanov-Michailidis, F.; White, N. A.; Rovis, T. Chem. Rev. 2015, 115, 9307. (d) Marson, C. M. Chem. Rev. 
2012, 41, 7712. (e) Jacobsen, E. N.; MacMillan, D. W. C. Proc. Natl. Acad. Sci. USA 2010, 107, 20618. (f) 
Asymmetric Organocatalysis:From Biomimetic Concepts to Applications in Asymmetric Synthesis; Berkessel, A., 
Groger, H., MacMillan, D. W. C., Eds.; Wiley-VCH: Weinheim, 2005. (h) MacMillan, D. W. C. Nature, 2008, 455, 
304. (i) Yang, J. W.; List, B. Science 2006, 313, 1584. (j) Stereoselective Organocatalysis. Bond Formation and 
Activation Modes; Rios Torres, R., Ed.; Wiley-VCH: Weinheim, 2013. (k) Asymmetric Organocatalysis in Natural 
Product Syntheses; Waser, M., Ed.; Springer: Heidelberg, 2012. (l) Organocatalytic Enantioselective Conjugate 
Addition Reactions: A Powerful Tool for the Stereocontrolled Synthesis of Complex Molecules; Vicario, J. L., Badía, 
D., Carrillo, L., Reyes, E., Eds.; RSC Publishing: Cambridge, 2010. 
5
  Marckwald, W. Ber. Dtsch. Chem. Ges. 1904, 37, 349. 
6
  (a) Bredig, G.; Fiske, P. S. Biochem. Z. 1913, 46, 7. (b) Bredig, G.; Fiske, P. S. Chem- Ztg. 1912, 35, 324. 
7
  Pracejus, H. Justus Liebigs Ann. Chem. 1960, 634, 9. 
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between 1968 and 1997, there were only a few reports showing the use of small organic 
molecules as catalysts for asymmetric reactions; probably being the most famous the Hajos-
Parrish-Eder-Sauer-Wiechert reaction8 that was established in the context of the intramolecular 
aldol reaction catalyzed by L-proline, that was used in the preparation of chiral precursors 
required for the synthesis of steroids (see Scheme 1.1). 
 
Scheme 1.1 
In these early publications there was not a strong emphasis on the potential benefits of 
using these small organic molecules as catalysts and were focused only on individual 
transformations. This situation began to change with important contributions to this field such as 
the enantioselective epoxidation of simple alkenes catalyzed by enantioenriched ketones realized 
by Shi and Yang,9 and by the first examples of hydrogen-bonding catalysis in the asymmetric 
Strecker reaction by Jacobsen and Corey between 1998 and 1999.10 However, it was not until 
2000 when chemists realized that the use of organic molecules as chiral catalysts could become a 
whole field of research within the area of asymmetric synthesis that occurred with the publication 
of the key seminal examples by List, Lerner and Barbas III11 on the L-proline catalyzed aldol 
reaction and by Ahrendt, Borths and MacMillan12 on the imidazolidinone-catalyzed Diels-Alder 
reaction.13 
                                                           
8
  (a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615. (b) Hajos, Z. G.; Parrish, D. R. German Patent DE 
2102623, 1971. (c) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem. Int. Ed. 1971, 10, 496. (d) Eder, U.; Sauer, G.; 
Wiechert, R. German Patent DE 2014757, 1971. 
9
  (a) Tu, Y.; Wang, Z.; Shi, Y. J. Am. Chem. Soc. 1996, 118, 9806. (b) Yang, D.; Yip, Y.-C.; Tang, M.-W.; Wong, M.-
K.; Zheng, J.-H.; Cheung, K.-K. J. Am. Chem. Soc. 1996, 118, 491. 
10
  (a) Sigman, M.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901. (b) Corey, E. J.; Grogan, M. J. Org. Lett. 1999, 
1, 157. 
11
  List, B.; Lerner, R. A.; Barbas III, C. F. J. Am. Chem. Soc. 2000, 122, 2395. 
12
  Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243. 
13
  MacMillan, D. W. C. Nature 2008, 455, 304. 
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The contribution of List, Lerner and Barbas III was significant because they reported the 
first enantioselective intermolecular aldol reaction between acetone and a variety of aldehydes 
catalyzed by L-proline supporting that the mechanism of Hajos-Parrish reaction could be 
extended to other transformations with higher applications. Mechanistic studies demonstrated 
that enamine intermediates were present as nucleophiles in the reaction (see Scheme 1.2). At the 
same year, MacMillan introduced the iminium activation concept in the first enantioselective 
organocatalytic Diels-Alder reaction catalyzed by a chiral imidazolidinone salt. He reported that 
the imidazolidinone catalyst would activate α,β-unsaturated carbonyl compounds through 
condensation furnishing the corresponding iminium ion, which consequently lowered the energy 
of its LUMO, becoming activated as dienophile towards the Diels-Alder cycloaddition with 
electron-rich dienes (see Scheme 1.2). 
Scheme 1.2 
After these seminal works, the field has experienced an impressive growth with the 
emergence of new activation mechanisms and their application to multiple organic 
transformations. The number of publications on the topic has impressively increased and 
organocatalysis is nowadays commonly viewed as the third pillar of asymmetric catalysis, with 
the other two being biocatalysis and metal catalysis. Other important contributions to this field 
also took place between the last decades of the 20th century and the first one of the 21st, in which 
other activation manifolds were also reported such as phase-transfer catalysis,14 H-bonding 
catalysis,15 NHC16 and the use of chiral Brønsted acids to catalyze asymmetric transformations.17 
                                                           
14
  (a) Dolling, U.-H.; Davis, P.; Grabowski, E. J. J. J. Am. Chem. Soc. 1984, 106, 446. (b) Hughes, D. L.; Dolling, U.-
H.; Ryan, K. M.; Schoenewaldt, E. F.; Grabowski, E. J. J. J. Org. Chem. 1987, 52, 4745. 
15
  (a) Sigman, M. S.; Jacobsen, E. M. J. Am. Chem. Soc. 1998, 120, 4901. (b) Tanaka, K.; Mori, A.; Inoue, S. J. Org. 
Chem. 1990, 55, 181. (c) Sigman, M. S.; Jacobsen, E. M. J. Am. Chem. Soc. 1998, 120, 4901. (d) Hiemstra, H.; 
Wynberg, H. J. Am. Chem. Soc. 1981, 103, 417. 
16
  Selected reviews on NHC: (a) Flanigan, D. M.; Romanov-Michailidis, F.; White, N. A.; Rovis, T. Chem. Rev. 2015, 
115, 9307. (b) Dwivedi, S.; Gupta, S.; Das, S. Curr. Organocatal. 2014, 1, 13. (c) Bugaut, X.; Glorius, F.; Chem. 
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The most important progress for the success of organocatalysis has been the classification 
of the generic modes of catalyst activation, induction and reactivity. These models can be further 
used as templates in new synthetic transformations due to their simplicity and broad scope of 
application. Moreover, this has lead to the development of new catalysts that are useful in a wide 
range of asymmetric reactions. 
There are two main ways to classify organocatalysts; depending on the interaction 
between substrate and catalyst in the transition state (named covalent and non-covalent 
catalysis);3c or according to their acid/base reactivity (see Figure 1.1). 
Covalent catalysis represents those reactions in which the catalysts activate the substrate 
forming a covalent bond. This method of activation implies that reversible chemical reactions 
have to be available for the attaching and detaching of the catalyst to the substrate/final product 
in order to allow activation and catalyst turnover. Chiral amines or aminocatalysts belong to this 
group participating in many reactions by the formation of azomethine compound (enamine, 
iminium ion or iminium-radical cation, also known as SOMO catalysis).18 N-heterocyclic 
carbene16 or those involving the formation of ylides and phosphinium salts19 are other important 
catalysts. On the other hand, non-covalent catalysis, is based on weaker interactions between the 
catalyst and the substrate. One of the most important activation mechanism is that involving the 
formation of catalyst-substrate complexes by the formation of hydrogen bonds.20 The formation 
of chiral ion pairs21 and the use of tertiary amines as chiral Brønsted base catalysts22 are also 
other important methodologies included in this group. 
                                                                                                                                                 
Soc. Rev. 2012, 41, 3511. (d) Enders, D.; Henseler, A. Chem. Rev. 2007, 107, 5606. (e) Marion, N.; Díez-González, 
S.; Nolan, S. P. Angew. Chem. Int. Ed. 2007, 46, 2988. (f) Enders, D.; Balensiefer, T. Acc. Chem. Res. 2004, 37, 534. 
17
  (a) Rueping, M.; Parmar, D.; Sugiono, E. Asymmetric Brønsted Acid Catalysis; Wiley-VCH: Weinheim, 2016. (b) 
Akiyama, T. Hydrogen-Bond Catalysis or Brønsted-Acid Catalysis? General Considerations. In Hydrogen Bonding 
in Organic Synthesis; Pihko, P. M., Ed.; Wiley-VCH: Weinheim, 2009. 
18
  For reviews in aminocatalysis: (a) Nielsen, M.; Worgull, D.; Zweifel, T.; Gschwend, B.; Bertelsen, S.; JØrgensen, K. 
A. Chem. Commun. 2011, 47, 632. (b) Bertelsen, S.; JØrgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178. (c) 
Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem. Int. Ed. 2008, 47, 6138. (d) List, B. Chem. 
Commun. 2006, 819. 
19
  Selected reviews on chiral phosphine catalysis: (a) Xiao, Y.; Sun, Z.; Kwon, O. Beilstein, J. Org. Chem. 2014, 10, 
2089. (b) Wei, Y.; Shi, M. Chem. Asian J. 2014, 10, 2720. (c) Xu, L.-W. ChemCatChem 2013, 5, 2775. (d) Wei, Y.; 
Shi, M. Acc. Chem. Res. 2010, 43, 1005. 
20
  (a) Hydrogen Bonding in Organic Synthesis; Pihko, P. M., Ed.; Wiley-VCH: Weinheim, 2009. (b)Yu, X.; Wang, W. 
Chem. Asian J. 2008, 3, 516. (c) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713. (d) Taylor, M. S.; 
Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520. (e) Schreiner, P. R. Chem. Soc. Rev. 2003, 32, 289. 
21
  (a) Brak, K.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2013, 52, 534. (b) Kaneko, S.; Kumatabara, Y.; Shirakawa, S. 
Org. Biomol. Chem. 2016, 14, 5367. (c) Shirakawa, S.; Maruoka, K. Angew. Chem. Int. Ed. 2013, 52, 4312. (d) Jew, 
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Figure 1.1 
Another way to categorize organocatalysts is according to their acid/base reactivity.23 In 
this sense, organocatalysts can be classified as Lewis acids, Lewis bases, Brønsted bases and 
Brønsted acids. Although Lewis acid catalysts are commonly associated to metal catalysis, these 
are also organic catalysts used to activate electrophiles under this type of acid/base interactions.24 
Electrostatic coordination of the metal-free Lewis acid through Coulomb and dispersion forces to 
a lone pair of electrons results in the withdrawal of electron density and thereby in the activation 
of the electrophile toward nucleophilic attack.25 The most important ones are phase-transfer 
catalysts (PTC) in which tipically chiral cation-directed catalysts, such as quaternary ammonium 
                                                                                                                                                 
S.; Park, H. Chem. Commun. 2009, 7090. (e) Asymmetric Phase Transfer Catalysis; Maruoka, K., Ed.; Wiley-VCH: 
Weinheim, 2008. (f) Ooi, T.; Maruoka, K. Angew. Chem. Int. Ed. 2007, 46, 4222. (g) Hashimoto, T.; Maruoka, K. 
Chem. Rev. 2007, 107, 5656. For ACDC: (h) Mahlau, M.; List, B. Angew. Chem. Int. Ed. 2013, 52, 518. 
22
  Palomo, C.; Oiarbide, M.; López, R. Chem. Soc. Rev. 2009, 38, 632. 
23
  Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3, 719. 
24
  For reviews on Lewis acid organocatalysis: (a) Maruoka, K.; Ooi, T. Chem. Rev. 2003, 103, 3013. (b) O´Donnell, M. 
J. Acc. Chem. Res. 2004, 37, 506. (c), Shi, Y. Chem Res. 2004, 37, 488. (d) Yang, D. Acc. Chem. Res. 2004, 37, 497. 
(e) Ooi, T.; Maruoka, K. Angew. Chem. Int. Ed. 2007, 46, 4222. (f) Sereda, O.; Tabassum, S.; Wilhelm, R. Topics 
Current Chem. 2009, 291, 86. (g) Wang, X.; Lan, Q.; Shirakawa, S.; Maruoka, K. Chem. Commun. 2010, 46, 321. 
25
  Cooperative Catalysis: Designing Efficient Catalysts for Synthesis; Peters, R. Ed.; Wiley-VCH: Weinheim, 2015. 
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or phosphonium salts, have been used in reaction between two substances located in different 
immiscible phases where a hydrophobic conterion assist the transport phenomenon.26 
Analogously, Lewis base catalysts can be use to enhance the nucleophilicity or the 
electrophilicity of a reagent. These activate the substrate via nucleophilic addition which 
undergoes a reaction and then releases the product and the catalyst for further turnover. Different 
modes of activation depend on the selected Lewis base converting the substrates either into 
activated nucleophiles (e.g. enamine catalysis) or electrophiles (e.g. iminium catalysis).18 The 
crucial effect of Lewis acids and Lewis bases on the reactivity is associated with changes in 
frontier orbital energies of the reaction components and consists of a lowering of the energy of 
the LUMO of the electrophile and an increase of the energy of the HOMO of a nucleophile, 
respectively. On the other hand, Brønsted bases operate through a partial deprotonation of a 
pronucleophile substrate providing new species with improved nucleophilicity due to the 
formation of an ion-pair that maintains the chiral environment during the reaction.22 Finally, 
Brønsted acid activation takes place through the protonation of the substrate or via H-bonding 
interactions for the activation of the electrophile.27 The weak nature of these interactions is 
capable to decrease the electronic density of the electrophile favouring the nucleophilic attack. 
In the following section methodologies involving Brønsted acid activation will be 
presented due to their direct relationship with the research presented in this manuscpript. 
                                                           
26
  (a) Kaneko, S.; Kumatabara, Y.; Shirakawa, S. Org. Biomol. Chem. 2016, 14, 5367. (b) Shirakawa, S.; Maruoka, K. 
Angew. Chem. Int. Ed. 2013, 52, 4312. (c) Jew, S.; Park, H. Chem. Commun. 2009, 7090. 
27
  Akiyama, T.; Itoh, J.; Fuchibe, K. Adv. Synth. Catal. 2006, 348, 999. 
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2. BRØNSTED ACID CATALYSIS: BINOL-DERIVED CHIRAL BRØNSTED 
CATALYSTS 
As mentioned, Brønsted acids interact with the substrates (a Lewis base) releasing 
electronic density and favouring the activation towards nucleophilic attack. These have 
demonstrated that are highly efficient and versatile catalysts for relevant synthetic 
transformations.28 Brønsted acids are classified into two categories; weak Brønsted acids, such as 
ureas,29 thioureas30 and diol derivatives,31 which are also called H-bonding catalysts; and on the 
other hand, stronger Brønsted acids, such as phosphoric acids, sulfonic acids and related 
derivatives. 
The use of catalysts incorporating multiple hydrogen bond donors opens up as a useful 
strategy resulting in an increase of enthalpic binding affinities between the catalyst and the 
substrate which provide better organization in the transition states and as a consequence, better 
stereoselectivities. Thioureas have emerged as one of the most efficient classes of catalysts 
working under H-bonding activation, with a superior ability than ureas due to the higher N-H 
acidity and lower tendency to self aggregation. 
The first example of chiral Brønsted acid catalysis was reported by Jacobsen in the 
enantioselective Strecker reaction catalyzed by a chiral thiourea and represented a real 
breakthrough in the field, demonstrating the enormous power of H-bonding activation.32 
Computational studies showed that the thiourea catalyst was able to interact with the imine 
electrophile by formation of a double H-bonded network, which resulted in a rigid transition state 
that in the presence of bulky substituents at both the amino acid position and the 3-position of the 
salicylimine moiety accounted for the high enantioselectivity observed (see Scheme 1.3). This 
seminal work indicated that a chiral Brønsted acid enables discrimination between the 
enantiotopic faces of an imine substrate via hydrogen bonds, opening a new way in 
                                                           
28
  Parmar, D.; Sugiono, E.; Raja, S.; Rueping, M. Chem. Rev. 2014, 114, 9047. 
29
  Wenzel, A. G.; Lalonde, M. P.; Jacobsen, E. N. Synlett 2003, 12, 1919. 
30
  For reviews on chiral thiourea catalysts: (a) Takemoto, Y. Org. Biomol. Chem. 2005, 3, 4299. (b) Connon, S. J. 
Chem. Eur. J. 2006, 12, 5418. 
31
  Seebach, D.; Beck, A. K.; Heckel, A. Angew. Chem. Int. Ed. 2001, 40, 92. 
32
  (a) Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901. (b) Sigman, M. S.; Vachal, P.; Jacobsen, E. 
N. Angew. Chem. Int. Ed. 2000, 39, 1279. (c) Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10012. 
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enatioselective catalysis without the use of chiral metal catalysts. Later in 2003 Schreiner used 
thioureas as catalysts for diastereoselective Diels-Alder reactions.33 
 
Scheme 1.3 
Rawal reported the use of TADDOL as chiral Brønsted acid catalyst on the 
enantioselective hetero-Diels-Alder reaction.34 He showed that a simple chiral diol uses H-
bonding to catalyze an important family of [4+2] cycloaddition reactions between aminosilyloxy 
dienes and different aldehydes. Diols functions in the same way as Lewis acids, by activating the 
carbonyl group through hydrogen bonding. After treatment with acetyl chloride to remove the 
TBS group and the dimethylamino groups, dihydropyrones were obtained in excellent 
enantioselectivities and yields (see Scheme 1.4). 
 
Scheme 1.4 
The use of BINOL as chiral Brønsted acids in the enantioselective asymmetric Morita-
Baylis-Hillman reaction between cyclohexenone and aldehydes has been demonstrated by 
Schaus.35 The catalyst serves to promote the conjugate addition step of the reaction, and then 
remain hydrogen-bonded to the resulting enolate in the enanioselectivity-determining aldehyde 
                                                           
33
  (a) Schreiner, P. R.; Wittkopp, A. Chem. Eur. J. 2003, 9, 407. (b) Schreiner, P. R.; Wittkopp, A. Org. Lett. 2002, 4, 
217. 
34
  Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146. 
35
  McDougal, N. T.; Schaus, S. E. J. Am. Chem. Soc. 2003, 125, 12094. 
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addition step. Presumably, the chiral Brønsted-acid-stabilized enolate formed after addition of the 
trialkylphosphine would act as the nucleophile in the addition reaction. 
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Scheme 1.5 
These landmark works have strongly influenced on the development of chiral Brønsted 
acid catalysis. However, the acidity of the thiourea and alcohol functionalities is rather weak; and 
consequently, the activation capacity of these catalysts is low.36 Due to the necessity of stronger 
Brønsted acids for activating wider range of substrates and compensate this limitation, Terada 
and Akiyama have evaluated different organic acids that are shown in Figure 1.2, which 
incorporated strong acidic functionalities. 
 
Figure 1.2 
Initially, sulfonic acids were surveyed but due to their too strong acidity they probably 
could not keep H-bonding interactions between a protonated substrate and the conjugated base. 
These would generate non stable ionic pairs, which would lead to diastereomeric TS and low 
enantioselectivities. Carboxylic and sulfinic acids have appropriate acidity; however, it would be 
                                                           
36
  Thiourea and urea: Bordwell, F. G.; Algrim, D. J.; Harrelson Jr., J. A. J. Am. Chem. Soc. 1988, 110, 5903. Aliphatic 
alcohols: (a) Bordwell, F. G.; McCallum, R. J.; Olmstead, W. N. J. Org. Chem. 1984, 49, 1424. (b) Olmstead, W. N.; 
Margolin, Z.; Bordwell, F. G. J. Org. Chem. 1980, 45, 3295. pKa values: For (thio)urea: (c) Li, X.; Deng, H.; Zhang, 
B.; Li, J. Y.; Zhang, L.; Luo, S. Z.; Cheng, J.-P. Chem. Eur. J. 2010, 16, 450. (d) Jakab, G.; Tancon, C.; Zhang, Z. 
G.; Lippert, K. M.; Schreiner, P. R. Org. Lett. 2012, 14, 1724. For squaramides: Ni, X.; Li, X.; Wang, Z.; Cheng, J.-
P. Org. Lett. 2014, 16, 1786. For DIOL derivatives: Ni, X.; Li, X.; Li, Z.; Cheng, J.-P. Org. Chem. Front. 2016, 3, 
1154. For TADDOL derivatives: (e) Seebach, D.; Beck, A. K.; Bichsel, H.-U.; Pichota, A.; Sparr, C.; Wünsch, R.; 
Schweizer, W. B. Helv. Chim. Acta 2012, 95, 1303. (f) Christ, P.; Lindsay, A. G.; Vormittag, S. S.; Neudörfl, J.-M.; 
Berkessel, A.; O´Donoghue, A. C. Chem. Eur. J. 2011, 17, 8524. 
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difficult to provide and efficient chiral environment due to their free rotation around the single 
bond. Phosphoric acids were found to be interesting due to the possibility to introduce two 
substituents at the phosphorous atom three atoms away from the acidic proton. This means that a 
chiral environment can be design closer than in the case of sulfonic, carboxylic or sulfinic acids. 
Under these premises, Akiyama and Terada put their attention on phosphoric acids due to their 
structural and chemical features and in 2004 independently presented BINOL-derived phosphoric 
acids in Mannich reactions.37 They were selected as chiral sources due to their axially chiral 
molecule having C2-symmetry which is crucial in the catalytic design because it supposes that the 
same catalyst molecule is generated when the acidic proton migrates to the phosphoryl oxygen. 
They showed an adequate acidity to generate stable electrostatic interactions and due to their 
chiral environment, the acidic group is more restricted (see Figure 1.3). A chiral pocket is formed 
and free rotation is avoided when the phosphorous atom and the BINOL framework are 
connected by two P-O bonds. There is also the possibility to change stereoelectronic effects 
introducing diverse subtituents (G) on the ring system conferring different chiral environments as 
necessity. However, the most innovative characteristic is probably its bifunctionality; the 
phosphoryl oxygen (P=O) contains two free electron pairs giving to the molecule Brønsted base 
functions making phosphate group with acid and base properties. 
 
Figure 1.3 
There is an important relationship between the catalytic activity and the acidity of the 
phosphoric acid and surprisingly, pKa studies are relatively scarce. A general study was published 
by O´Donoghue and Berkessel with some pKa´s in DMSO of chiral phosphoric acids and N-
triflylphosphoramides.37f They concluded that the differences in acidity between the different 
catalysts were not large and that the relative acidity of the catalyst may not be the only factor that 
influences their catalytic performance. However, it has to be pointed out that measurements of 
                                                           
37
  (a) Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem. Int. Ed. 2004, 43, 1566. (b) Uraguchi, D.; Terada, 
M. J. Am. Chem. Soc. 2004, 126, 5356. 
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pKa values of highly acidic acids in DMSO can provide almost indentical pKa values (near zero) 
depending on the experimental procedure employed.38 A solution came from Rueping and Leito 
in 2013 when they reported a full study on establishing an acidity scale for the most widely used 
Brønsted acids which were conducted by using UV/Vis spectrophotometric methods in MeCN.39 
In addition, Cheng and Li reported a theoretical study on the acidities of BINOL phosphoric 
acids and other related derivatives.40 From the measurements that were conducted in MeCN it 
was found that these type of BINOL-based Brønsted acids could be classified on three distinct 
groups of varying acidity depending on their structure, namely phosphoric acids, N-sulfonyl 
phosphoramides and sulfonyl imides (Figure 1.4). Hydrogenated versions of parent catalysts are 
also commonly used and it is usual to find several transformations with these catalysts. 
 
Figure 1.4 pKa values in MeCN 
The mechanism involved in the activation of the electrophile by this type of BINOL-based 
strong Brønsted acids is a subject of intense debate and in many cases it has not clearly 
established. In principle, there are three possible ways for the Brønsted acid to interact with the 
substrate through Brønsted acid/Brønsted base interactions identified as mono-, dual- and 
bifunctional activation (see Figure 1.5). For mechanisms including the monoactivation manifold 
the reaction proceeds through a single H-bonding interaction between the catalyst and the 
substrate. In the case of dual activation, there are additional interactions with the electrophilic 
substrate that offer higher stabilization of the intermediates. This can imply the formation of a 
Brønsted acid-substrate complex involving the participation of the phosphoryl oxygen of the 
catalyst as H-bonding acceptor, forming a second hydrogen bond with a Brønsted-acid site at the 
                                                           
38
  Koppel, I. A.; Koppel, J.; Pihl, V.; Leito, I.; Mishima, M.; Vlasov, V. M.; Yagupolskii, R. W.; Taft, R. W. J. Chem. 
Soc. Perkin Trans. 2 2000, 1125. 
39
  Kaupmees, K.; Tolstoluzhsky, N.; Raja, S.; Rueping, M.; Leito, I. Angew. Chem. Int. Ed. 2013, 52, 11569. 
40
  Yang, C.; Xue, X.-S.; Jin, J.-L.; Li, X.; Cheng, J.-P. J. Org. Chem. 2013, 78, 7076. 
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substrate, establishing a network of two H-bonding interactions between the catalyst and the 
electrophilic reagent or the exclusive participation of the proton and two Brønsted basic sites of 
the substrate in a bidentate fashion. Finally, bifuncional activation is probably the mechanistic 
pathway that covers the largest proportion of this catalysis and implies the activation of both the 
electrophile and the nucleophile by the catalyst. 
 
Figure 1.5 
A good example of a phosphoric acid-catalyzed reaction in which the catalyst operated 
through the monoactivation manifold is the report by Terada in the context of aza-Friedel-Crafts 
reaction between N-Boc imines and methoxyfuran (see Scheme 1.6).41 The mechanistic proposal 
involves the formation of the substrate-catalyst complex through the aforementioned single H-
bonding interaction followed by nucleophilic attack of furan. According to the model proposed 
by Goodman,42 configuration of E imine is maintained in the transition state and the geometry of 
the complex would try to avoid steric clashing between the Boc group and the large 3,3´-
substituents of the BINOL moiety. Addition of 2-methoxyfuran will take place through the less 
hindered Re-face affording the major enantiomer shown in Scheme 1.6. 
 
Scheme 1.6 
                                                           
41
  Uraguchi, D.; Sorimachi, K.; Terada, M. J. Am. Chem. Soc. 2004, 126, 11804. 
42
  Reid, J. P.; Simón, L.; Goodman, J. M. Acc. Chem. Res. 2016, 49, 1029. 
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Motivated by the desire to activate a wider range of substrates, Yamamoto developed a 
new type of catalysts which are more acidic than phosphoric acids.43 They introduced the 
strongly electron-withdrawing group triflylamide into the phosphate moiety becoming very 
powerful catalysts due to their higher acidity (see Figure 1.5) and therefore being able to activate 
unreactive substrates in the presence of phosphoric acids.44 In this context, an example of a N-
triflyl phosphoramide catalyzed activation of electrophiles through the monoactivation approach 
is the conjugate addition of indoles to β,γ-unsaturated-α-ketoesters reported by Rueping.45 The 
investigation was started with the use of weak acids such as carbonic acids or diphenyl 
phosphate, but no reaction was observed resulting in the use of catalytic amounts of N-
triflylphosphoramide crucial for the formation of the final product (see Scheme 1.7). 
 
Scheme 1.7 
A good example of a chiral phosphoric acid activating the substrate through dual 
activation can be seen in enantioselective Mannich-type reaction reported by Akiyama and co-
workers.37a In this report, 2-hydroxyphenyl imines reacted enantioselectively with silyl ketene 
acetals in the presence of a catalytic amount of a BINOL-based chiral phosphoric acid to give 
syn-Mannich products (see Scheme 1.8). It was found that the N-2-hydroxyphenyl substituent of 
the aldimine was essential to fix its geometry giving the reaction in order to obtain a range of 
syn-diastereoisomers generally in high yields and enantioselectivities. The proposed dual 
                                                           
43
  Nakashima, D.; Yamamoto, H. J. Am. Chem. Soc. 2006, 128, 9626. 
44
  (a) Kaupmees, K.; Tolstoluzhsky, N.; Raja, S.; Rueping, M.; Leito, I. Angew. Chem. Int. Ed. 2013, 125, 11783. (b) 
Johnston, J. N. Angew. Chem. Int. Ed. 2011, 50, 2890. (c) Rueping, M.; Nachtsheim, B. J.; Ieawsuwan, W.; 
Atodiresei, I. Angew. Chem. Int. Ed. 2011, 50, 6706. (d) Cheon, C.-H.; Yamamoto, H. Chem. Commun. 2011, 47, 
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  Rueping, M.; Nachtsheim, B. J.; Moreth, S. A.; Bolte, M. Angew. Chem. Int. Ed. 2008, 47, 593. 
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activation manifold involved the participation of the acidic proton of the catalyst by protonation 
of the imines nitrogen and the 2-hydroxy group would form a hydrogen bond with the 
phosphoryl oxygen to generate a zwitteronic nine-membered cyclic transition state which is 
attacked by the silyl enol ether. It was also reported that the transition state corresponding to the 
si-facial attack is sterically less favoured than the re-facial alternative due to sterically repulsive 
interaction between 3,3´-aryl substituents and approaching nucleophile. 
 
Scheme 1.8 
In a similar approach, Terada demonstrated that glyoxylates can also undergo an anti-
selective hetero-Diels-Alder reaction with dienes to give dihydropyrans.46 The glyoxylate 
aldehyde participates in a dual activation mannifold where the aldehyde proton is proposed to be 
acidic enough to interact with the Lewis basic site of the catalyst and, at the same time, an 
interaction between the oxygen atom of the aldehyde and the acidic proton on the catalyst would 
occur generating a rigid substrate-catalyst complex. On one hand, different 3,3´-substituents on 
the catalyst demonstrated that the reaction proceeded via exo-alignment depending on the steric 
demand of the catalyst leading to syn selectivity (see Scheme 1.9). The use of non-bulky groups 
such as phenyl groups at the 3 and 3´ positions of the catalyst and the steric repulsion between 
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  Momiyama, N.; Tabuse, H.; Terada, M. J. Am. Chem. Soc. 2009, 131, 12882. 
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the diene substituents and glyoxylate in the endo transition state allow the diene to occupy an exo 
orientation. On the other hand, facial selectivity is determined by the steric hindrance between 
the diene substituents and the phenyl group of the catalyst, thus lead the attack of the diene 
through the Si-face of the glyoxylate. 
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The dual activation by bidentate H-bonding interaction is exemplified with the 
enantioselective Nazarov cyclization with α-alkoxyketones catalyzed by chiral Brønsted acids to 
generate cyclopentenones reported by Rueping.47 In this work, the necessity of N-triflyl 
phosphoramides as more acidic Brønsted acids was observed; the acidic proton of the catalyst is 
involved in a bidentate interaction between the alkoxy and the carbonyl group of the substrate as 
it is shown in Scheme 1.10. Subsequent conrotatory 4π electrocyclization leads to an oxyallyl 
cation intermediate which forms an enolate through the elimination of a proton. Successive 
protonation of this enolate should results in the formation of the final product and regenerates the 
catalyst. 
 
Scheme 1.10 
In spite of these previous selected examples of mono- and dual activation manifolds, 
bifunctional activation covers the largest proportion of BINOL-derived Brønsted acid-catalyzed 
transformations. As it is mentioned before, this involves the participation of the phosphate 
moiety as a bifunctional entity that interacts with the electrophile by donating the acidic proton 
and simultaneously activates the pronucleophile by the participation of the phosphoryl oxygen as 
Brønsted basic site. A good example of this behaviour is shown in Scheme 1.11. Terada and co-
workers showed their results simultaneously with Akiyama in the presence of Brønsted acids in a 
Mannich reaction between acetyl acetone with N-Boc proteceted imines (see Scheme 1.11).37b 
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Thus, the phosphoric acid catalyst electrophilically activates the imine through the acidic proton, 
and the Brønsted basic phosphoryl oxygen interacts with the O-H proton of the enol tautomer 
leading to secondary amine products enantioselectively in high yields. The protective group of 
the imine was found to be crucial to achieve a high enantioselectivity observing that with a low 
steric demand of the protecting group the ee was reduced. Later, Goodman and Simón48 
explained the final stereochemistry of the reaction reporting a model for the enantioselectivity of 
reactions with imines catalyzed by BINOL-phosphoric acids catalysts which is applicable for 
other reactions. The model appears to work in all 40 cases evaluated and requires only of the 
transition state E/Z configuration and the choice between type I and type II pathways. For the 
lowest energy transition structure of reactions with many nucleophiles, the nitrogen substituents 
of the imine is directed toward the empty side of the oxygen to which it is H-bonded (type I). 
Type II pathway has a higher energy as a consequence of additional steric interactions due to 
imine substituent is directed toward the bulky group of the catalyst. This model explains the 
enantioselectivity obtained for many nucleophilic addition to imines. 
 
Scheme 1.11 
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Another representative reaction that shows this excellent performance of phosphoric acids 
as bifunctional catalyst is the transfer hydrogenation49 of imines or imine equivalents in the 
presence of Hantzsch esters as hydride sources.50 In this sense, the first enantioselective chiral 
phosphoric acid-catalyzed hydrogen transfer reaction of imines with a Hantzsch ester was 
reported by Rueping in 2005 (see Scheme 1.12).51 Activation of ketimine by protonation through 
the catalyst was proposed to take place, leading to the formation of an iminium/phosphate ion 
pair intermediate; and subsequent activation of the hydride donor would occur via H-bonding 
interaction with the acidic N-H moiety of the dihydropyridine substrate. Goodman52 and Himo53 
have investigated the origin of the enantiocontrol with generic transition state that can also be 
used to explain other BINOL-derived phosphoric acid-catalyzed reductions of imines with 
Hantzsch esters (see Scheme 1.12). Calculations revealed that the less stable (Z)-iminium 
intermediate proceeded to react through the lowest energy transition state due to shortest H-bond 
distance between the iminium cation and the phosphate anion, and that the (Z) geometry confers 
more compactness to the former, which is crucial to enter into the binding pocket of the catalyst. 
The most favourable attack takes place on the Re face of the iminium ion, while other posibilities 
present important steric repulsions between catalyst and reactants. 
 
Scheme 1.12 
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  (a) Rueping, M.; Dufour, J.; Schoepke, F. R. Green Chem. 2011, 13, 1084. (b) Wang, C.; Wu, X.; Xiao, J. Chem. 
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  (a) Rueping, M.; Sugiono, E.; Azap, C.; Theissmann, T.; Bolte, M. Org. Lett. 2005, 7, 3781. (b) Rueping, M.; Azap, 
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The bifunctional activation manifold can also operate in other mechanistically different 
reactions such as in the enantioselective allylation of aldehydes with allylboronates shown in 
Scheme 1.13 reported by Antilla.54 These reactions proceed via cyclic, six-membered ring 
chairlike transition states involving the interaction of the carbonyl group with the boron atom. 
Mechanistic insights suggested that the reaction involves both H-bonding interaction from the P-
O-H group to the pseudoaxial oxygen of the cyclic boronate (the nucleophile) and a stabilizing 
interaction from the phosphoryl oxygen to the formyl hydrogen of the aldehyde (the 
electrophile).55 This second stabilizing interaction provides rigidity in the transition state that 
could be responsible for the high levels of enantioselectivity observed. The reaction is favoured 
by Re face over Si face due to the unfavorable steric interaction between the pinacol ester methyl 
groups and the large aromatic group of the catalyst which disfavors the TSSi coffering the (R)-
homoallylic alcohols. 
 
Scheme 1.13 
However, it has to be pointed out that in addition to these three possible ways for a 
Brønsted acid to activate the electrophile discussed before, there is a fourth possibility that has 
been more recently proposed and developed. This implies the possibility for the formation of an 
ion pair after the catalytst protonates the electrophilic substrate. This additional mode of 
activation is defined as counterion catalysis and involves the capacity of the chiral phosphate 
counteranion to exert stereoinduction of the reaction occurring at the protonated substrate. In this 
sense, it must be taken into account that the formation of a chiral contact ion pair between the 
chiral acid and the substrate will depend on the difference in pKa between the chiral Brønsted 
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acid catalyst and the substrate during the activation of the electrophile and that this will 
determine the equilibrium between the formation of a hydrogen-bonded or an ion-pair species.56 
In particular, Rueping and Gschwind have been able to demonstrate that NMR spectroscopy is 
the method of choice to distinguish between both activation modes of hydrogen bonding and ion 
pairing in Brønsted acid catalysis.57 The study was performed with diphenyl phosphate and 15N-
labeled imines observing the variations in 1H-NMR spectra under different reaction conditions. It 
was found that the ratio between hydrogen bonding and ion pairing can be manipulated readily 
by simply introducing substituents with different electronic properties. 
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A good example of this activation pattern is the intramolecular allylic alkylation of 
substrate phenols reported by Rueping that leads to the formation of chromenes under N-triflyl 
phosphoramide catalyst.58 The process exhibits high compatibility with the presence of a wide 
range of substituents at the aromatic rings in the substrate. The transformation was proposed to 
proceed via protonation of the allylic alcohol which subsequently dehydrates to yield a 
carbocation which is associated with the phosphoramide anion in a chiral contact ion pair assisted 
by hydrogen-bonding interaction with the phenol moiety. The allyl carbocation is formed in a 
preferred anti,anti configuration, stabilized by intramolecular π-π stacking interactions as well as 
by intermolecular electrostatic interactions with the catalyst. 
 
Scheme 1.14 
N-acyl iminium ions are another class of reactive electrophiles that have been used under 
the counterion activation manifold. In particular, γ-lactams were used by Huang as N-
acyliminium precursors in the enantioselective N-H functionalization of indoles (see Scheme 
1.15).59 The chiral phosphoric acid was involved in the generation of a chiral conjugate base/N-
acyl iminium ion pair by protonation of the γ-lactam in a reversible process which has 
demonstrated by Deuterium-labelling experiment. Better understanding of the mechanism was  
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obtained from in situ FTIR experiments observing that the enol-type N-acyiliminium ion was 
most likely involved in the contact ion pair which subsequently the free hydroxy group will 
capture the conjugate Bronsted base by intermolecular H-bonding. Assisted by the conjugate 
base, the acidic N-H group of the indole will react with the cyclic N-acyliminium ion through Re-
face nucleophilic addition. 
 
Scheme 1.15 
An alternative, yet analogous approach to this type of activation is the strategy kwon as 
Asymmetric Counteranion Directed Catalysis (ACDC).21h This methodology refers to “the 
induction of enantioselectivity in a reaction proceeding through a cationic intermediate by means 
of ion pairing with a chiral, enantiomerically pure anion provided by the catalyst”. A good 
example of this strategy is reported by List who established the first steps on the field in a 
enantioselective epoxidation of α,β-unsaturated enals catalyzed by phosphate amine salt derived 
from a trifluoromethyl-substituted dibenzylamine and phosphate with tert-butyl hydroperoxide as 
oxidant observing high yields, and stereoselectivities (see Scheme 1.16).60 The reaction is 
thought to proceed through the conjugate addition of tert-butyl hydroperoxide to the iminium-ion 
intermediate, and therefore the formation of the β stereocenter can be assumed as a case of 
ACDC without significant stabilization. The effect of TRIP in the formation of the α stereocenter 
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is proven by the high enantioselectivities obtained with β,β-disubstituted enal bearing two 
identical substituents. In this case, the initial addition of the hydroperoxide to the chiral iminium-
TRIP ion pair will not generate a stereocenter, and the departure of tert-butanol from 
intermediate II and formation of the C-O bond will become the enantiodetermining step leading 
to the formation of chiral iminium-TRIP ion pair III. Enantioselectivities are only possible if the 
achiral intermediate II is generated in a chiral conformation through the influence of phosphate 
anion but chirality must be induced via H-bonding interaction due to the neutral nature of the II 
intermediate.61 The potential of the reaction was proved with the improvement on the obtained 
results compared with those achieved with diarylprolinol silyl ether catalyst,62 so this system 
provided the proof of principle for the feasibility of ACDC. 
 
Scheme 1.16 
In summary, BINOL-derived chiral Brønsted acids have shown to be highly efficient for a 
wide range of transformations forming C-C, C-H and even C-X bonds in enantioselective 
fashion. Their utility is not only limited to their acidic character, they have become powerful 
counterions for an increasing list of reactions. However, we are far from understading of how the 
catalysts function, for that reason experimental and computational studies are required for further 
progress in the field. 
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  Merten, C.; Pollok, C. H.; Liao, S.; List, B. Angew. Chem. Int. Ed. 2015, 54, 8841. 
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  Marigo, M.; Franzén, J.; Poulsen, T. B.; Zhuang, W.; Jørgensen, K. A. J. Am. Chem. Soc. 2005, 127, 6964. 
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3. BACKGROUND: PREVIOUS REPORTS OF THE GROUP 
Our research group has been focussed in the development of new methodologies in 
asymmetric synthesis. Originally, the chiral auxiliary strategy was widely used to obtain the 
required stereochemical control in a number of contributions to enolate chemistry,63 and 
conjugate addition reactions.64 
More recently, the interest of the group moved forward to asymmetric organocatalysis, 
especially in aminocatalysis, which suppose the activation of the corresponding substrate via 
condensation with a primary or secondary amine generating an azomethine intermediate 
(enamine, iminium salt or their vinylogous versions). First steps in this field were taken in the 
context of enamine activation with one example of a Michael reactions between aldehydes and β-
nitroacrolein dimethyl acetal (see Scheme 1.17).65 The obtained Michael adducts were directly 
transformed into highly functionalized enantioenriched pyrrolidines through simple 
transformations.66 
 
Scheme 1.17 
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  Latest aldol reaction: (a) Ocejo, M.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E. J. Org. Chem. 2011, 76, 460. 
Latest Mannich reaction: (b) Iza, A.; Vicario, J. L.; Carrillo, L.; Badía, D. Synthesis 2006, 4065. Latest electrophilic 
amination reaction: (c) Vicario, J. L.; Badía, D.; Carrillo, L.; Anakabe, E. Tetrahedron: Asymmetry 2002, 13, 745. 
Aziridine ring opening reaction: (d) Vicario, J. L.; Badía, D.; Carrillo, L. J. Org. Chem. 2001, 66, 5801. 
64
  Conjugated additions: (a) Ocejo, M.; Carrillo, L.; Badía, D.; Vicario, J. L.; Fernández, N.; Reyes, E. J. Org. Chem. 
2009, 74, 4404. (b) Reyes, E.; Vicario, J. L.; Carrillo, L.; Badía, D.; Uria, U.; Iza, A. J. Org. Chem. 2006, 71, 7763. 
Aza-Michael reactions: (c) Etxebarria, J.; Vicario, J. L.; Badía, D.; Carrillo, L.; Ruiz, N. J. Org. Chem. 2005, 70, 
8790. (d) Etxebarria, J.; Vicario, J. L.; Badía, D.; Carrillo, L. J. Org. Chem. 2004, 69, 2588. 1,4-Addition/α-
alkylation tándem reaction: (e) Reyes, E.; Vicario, J. L.; Carrillo, L.; Badía, D.; Iza, A.; Uria, U. Org. Lett. 2006, 8, 
2535. 
65
  Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L. Org. Lett. 2006, 8, 6135. 
66
  Ruiz, N.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; Uria, U. Chem. Eur. J. 2008, 14, 9357. 
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Simultaneously, the iminium activation approach has been applied using chiral secondary 
amines as catalysts in a wide range of transformations comprising the β-functionalization of 
aldehydes and α,β-unsaturated ketones (see Scheme 1.18). In this sense, the group started 
developing organocatalytic enantioselective aza-Michael-type reactions using tetrazoles and 
tetrazolothiones as N-donors.67 The group also worked in enantioselective conjugate additions 
employing hydrazones as umpolung acyl anion equivalents, providing a direct access to 1,4-
dicarbonyl compounds, or alternatively, using N-nitromethylphthalimides as masked 
hydroxymoyl anion equivalents to get enantioenriched γ-hydroxyiminoaldehydes.68 In other 
cases, bis-nucleophilic substrates have been used in cascade processes involving sequential 
1,4/1,2-addition that finishes in the isolation of hemiaminal-type products.69 
 
Scheme 1.18 
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  (a) Uria, U.; Vicario, J. L.; Badía, D.; Carrillo, L. Chem. Commun. 2007, 2509. (b) Uria, U.; Reyes, E.; Vicario, J. L.; 
Badía, D.; Carrillo, L. Org. Lett. 2011, 13, 336. 
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  (a) Fernández, M.; Uria, U.; Vicario, J. L.; Reyes, E.; Carrillo, L. J. Am. Chem. Soc. 2012, 134, 11872. (b) Alonso, 
B.; Reyes, E.; Carrillo, L.; Vicario, J. L.; Badía, D. Chem. Eur. J. 2011, 17, 6048. 
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  Fernández, M.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L. Adv. Synth. Catal. 2012, 354, 371. (b) Talavera, G.; 
Reyes, E.; Vicario, J. L.; Carrillo, D.; Uria, U. Adv. Synth. Catal. 2013, 355, 653. (c) Riaño, I.; Díaz, E.; Uria, U.; 
Reyes, E.; Carrillo, L.; Vicario, J. L. Chem. Commun. 2016, 52, 2330. 
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The LUMO-lowering effect associated with the formation of an α,β-unsaturated iminium 
ions (iminium catalysis) has also been applied to cycloaddition chemistry where the group 
developed a (3+2) cycloaddition with azomethine ylides as 1,3-dipoles (see Scheme 1.19).70 This 
reaction has demonstrated a great ability to support different substitution patterns on the 
substrates allowing to report different variants of the initial reaction,71 and in the application to 
the synthesis of diverse heterocyclic structures.72 Accordingly, after a extensive computational 
study73 it was established that the process follows a stepwise Michael/Mannich mechanism, 
initiated by the conjugate additions of the 1,3-dipole over the α,β-unsaturated iminium ion, 
followed by the generation of a nucleophilic enamine intermediate, which reacts intramolecularly 
with the azomethine moiety. In a similar way, the combination of iminium ion/enamine cascade 
activation has been applied to promote different transformations, such as oxa-
Michael/Aldol/hemiacetalization,74 Michael/Aldol/dehydration,75 Michael/Michael,76 Michael/α-
alkyaltion77 and oxa-Michael-Michael reactions.78 
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  Vicario, J. L.; Reboredo, S.; Badía, D.; Carrillo, L. Angew. Chem. Int. Ed. 2007, 46, 5168. 
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  (a) Fernández, M.; Vicario, J. L.; Reyes, E.; Carrillo, L.; Badía, D. Chem. Commun. 2012, 48, 2092. (b) Sánchez-
Díez, E.; Vesga, D. L.; Reyes, E.; Uria, U.; Carrillo, L.; Vicario, J. L. Org. Lett. 2016, 18, 1270. 
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  Riaño, I.; Uria, U.; Carrillo, L.; Reyes, E.; Vicario, J. L. Org. Chem. Front. 2015, 2, 206. 
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Reyes, E.; Uria, U.; Carrillo, L.; Vicario, J. L. ChemCatChem 2013, 5, 2240. 
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Scheme 1.19 
On the other hand, the remote functionalization of unsaturated carbonyl systems has been 
achieved making use of the combination of enamine and iminium activation modes with the 
principle of vinilogy. In this sense, our research group has employed the dienamine activation 
manifold to the (2+2) cycloaddition with nitroalkenes79 and to the (5+2) cycloaddition with 
oxidopyrylium ylides80 (see Scheme 1.20). Additionaly, dienamine activation was applied to a 
cascade Diels-Alder cycloaddition/elimination sequence between enolizable enals and 
acetoxyhydropyran-5-ones yielding 8-oxabicyclo[3.2.1]octane adducts in excellent yield and 
stereocontrol.81 Finally, trienamine activation has also been explored using dienals with 
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interrupted conjugation which are more reactive than the standard ones in the presence of 
nitroalkenes for a Diels-Alder cycloaddition.82 
 
Scheme 1.20 
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On the other hand, other different activation modes have been more recenrly explored in 
our group. In particular, N-heterocyclic carbene catalysis has been used in the formation of 
tertiary propargylic alcohols via cross-benzoin reaction between aldehydes and ynones,83 or in 
the hetero-Diels-Alder reactions between catalytically generated acyl azolium enolated and 
alkylideneoxindoles using formyl cyclopropanes as unconventional starting materials undergoing 
activation by the NHC (see Scheme 1.21).84 
 
Scheme 1.21 
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Alternatively, non-covalent activation mode was also explored in a diastereosivergent 
Michael/Henry cascade process under bifunctional Brønsted base/H-bonding catalysis 
employing squaramide/tertiary amine-type catalysts (see Scheme 1.22).85 
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Scheme 1.22 
As it is shown, the diverse research activity of the group allows achieving stereocontrol on 
different reactions using carbonyl compounds as substrates through varied organocatalysis under 
covalent and non-covalent activation. Despite the progress, in our group there is no previous 
experience in the use of strong Brønsted acids as organocatalysts which is the central subject of 
this research work. 
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4. GENERAL OBJECTIVES OF THE PRESENT WORK 
The work presented in this manuscript was developed as a new field in the research of the 
group with a common objective, the development of new organocatalytic reactions applied to the 
enantioselective synthesis of functionalized products. In particular with this project, we wished to 
explore the possibility of using BINOL-based chiral Brønsted acids as organocatalysts to 
promote new transformations. The research was divided into two different part, including a 
chapter detailing the work performed in the context of a short stay at University of 
Loughborough under the supervision of Prof. A. V. Malkov. 
1. Brønsted Acid Catalysis: Enantioselective Oxidative (4+3) Cycloaddition between 
allenamides and furans. As part of our ongoing program dedicated to the development of 
organocatalytic cycloaddition reactions we direct our efforts in a (4+3) cycloaddition reaction. In 
particular, it is known that oxyallyl cations react with electron rich dienes under this type of 
reactivity pattern, providing a direct access to seven-membered carbocyclic structures. Thus, we 
decided to apply this reactivity under Brønsted acid catalysis as it is shown in Scheme 1.23. 
 
Scheme 1.23 
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2. Brønsted Acid Catalysis and Chirality Transfer: Enantioselective allylation of imines 
with allyl boronates. Prof. Andrei V. Malkov has developed a kinetic resolution of chiral 
racemic secondary allyl boronates in the allylation of aldehydes catalyzed by chiral phosphoric 
acids (see Scheme 1.24).86 
 
Scheme 1.24 
The objective of the present work is the use of the chiral secondary allylboronates 
obtained by resolution in the reaction mentioned before as chiral reagents in the 1,2-addition to 
imines to obtain enantiopure homoallylic amines (see Scheme 1.24). In particular, we will also 
focus in the use of primary imines as challenging reagents that lead directly to N-unprotected 
products. This project was started at Malkov´s group in Loughborough University and followed 
in the University of the Basque Country in a context of collaboration between both research 
groups. 
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1. INTRODUCTION: (4+3) CYCLOADDITIONS WITH OXYALLYL CATIONS 
The development of efficient new methodologies for the synthesis of complex carbo- or 
heterocyclic molecules has become a very important goal in organic synthesis. Cycloaddition 
reactions can be especially useful for this purpose as they provide access to the cyclic scaffolds in 
one step and typically provide products with high functionalization and stereoselectivity. These 
reactions represent one of the most powerful methods for the synthesis of five and six-membered 
rings,1 which are usually prepared by the well-known 1,3-dipolar2 and Diels-Alder reactions.3 
However, seven-membered rings are more difficult to prepare due to the increased ring strain 
associated to the formation of the cycloheptene core. The use of cycloaddition reactions to 
construct seven-membered rings in a straightforward way, from acyclic precursors would allow 
access to these types of rings.4 The more common approaches to seven-membered carbo- or 
heterocyclic compounds through cycloaddition chemistry are based on (5+2)5 and (4+3)6 
strategies. In the particular case of the (4+3) cycloaddition reaction, it involves the interaction 
between an allylic cation and a diene, producing the seven-membered ring carbocyclic product 
after evolution of the carbocationic intermediate (see Scheme 2.1).  
 
Scheme 2.1 General (4+3) cycloaddition reaction 
Allyl cations cover many structural types and variations. Generally, they are stabilized by 
an atom or group which has the ability to stabilize the positive charge in the final cationic 
product. In particular, oxygen-stabilized allyl cations are very common cations in (4+3) 
cycloadditions which allows adding a new function in the final product. In the following section 
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 Cycloaddition Reactions in Organic Syntheses; Nishiwaki, N. Ed.; Wiley-VCH: Hoboken, 2014. 
2
 For recent reviews in 1,3-dipolar cycloadditions, see: (a) Hashimoto, T.; Maruoka, K. Chem. Rev. 2015, 115, 5366. 
(b) Narayan, R.; Potowski, M.; Jia, Z. J.; Antonchick, A. P.; Andrey, P.; Waldmann, H. Acc. Chem. Res. 2014, 47, 
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 For recent reviews in asymmetric Diels-Alder cycloaddition, see: (a) Masson, G.; Lalli, C.; Benohoud, M.; 
Dagousset, G. Chem. Soc. Rev. 2013, 42, 902. (b) Handbook of Cyclization Reactions; Ma, S. Ed.; Wiley-VCH: 
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Cycloaddition Reactions in Organic Syntheses; Nishiwaki, N., Ed.; John Wiley & Sons: Hoboken, 2014. (b) Ylijoki, 
K. E. O.; Stryker, J. M. Chem. Rev. 2013, 113, 2244. (c) Pellissier, H. Adv. Synth. Catal. 2011, 353, 189. 
6
 Mascareñas, J. L.; Gulías, M.; López, F. (4+3) Cycloadditions. In Comprehensive Organic Synthesis II; Knochel, P., 
Molander, G. A. Eds.; Elsevier: Amsterdam, 2014, Vol. 5, pp 595-655. 
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(4+3) cycloadditions using oxyallyl cations will be discussed due to the relationship with the 
research project. 
 
Scheme 2.2 
The success of the (4+3) cycloaddition reaction depends on the facility to generate the 
oxyallyl cation which is going to react with a four-carbon partner. They have been demonstrated 
to be reactive dienophiles and when those are used, we are able to obtain the interesting 
cycloheptenone scaffold (see Scheme 2.2) belong to the core of numerous natural products (see 
Figure 2.1). 
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The (4+3) cyloaddition is isoelectronic to the Diels-Alder (DA) reaction involving two 
electrons from the allyl cation and 4 electrons from the diene in a [4πs+2πs] suprafacial approach. 
The reactions are symmetry allowed by Woodward-Hoffmann rules and can be explained as an 
interaction between the highest occupied molecular orbital (HOMO) of the diene and the lowest 
unoccupied molecular orbital (LUMO) of the oxyallyl cation (see Figure 2.2). 
 
Figure 2.2 
In 1984 Hoffmann8 proposed three types of possible mechanisms for the reaction between 
a electron rich diene and an oxyallyl cation. Class A pathway belongs to a (4+3) cycloaddition 
through concerted mechanism; class B is a (4+3) cycloaddition through stepwise bond-formation 
mechanism; and class C, an electrophilic addition which could be followed by loss of a proton 
with overall electrophilic substitution at the diene by the intramolecular-nucleophilic capture of 
the intermediate (see Scheme 2.3). 
 
Scheme 2.3 
                                                                                                                                                 
(4+3) cycloaddition strategy: Hansson, T.; Wickberg, B. J. Org. Chem. 1992, 57, 5370. Cortistatin J: Nilson, M. G.; 
Funk, R. L. J. Am. Chem. Soc. 2011, 133, 12453. 
8
  Hoffmann, H. M. R. Angew. Chem. Int. Ed. 1984, 23, 1. 
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Type A cyloaddition belongs to a concerted mechanism where the two σ bonds are formed 
simultaneously. The configuration of the cation remains unalterable during the course of the 
reaction and therefore, the configuration of the cycloadducts reflects the configuration of the 
oxyallyl cations.9 Type B cycloadditions follow a stepwise pathway, in which the first σ bond is 
formed between the most nuclephilic site of the diene and the most electrophilic site of the 
dienophile. In this case, the intermediate may lose the configuration during the course of the 
reaction, thus the configuration of the cycloadduct depends on the stability and lifetime of the 
intermediate: if the second step is fast, the second σ bond will be formed maintaining the 
configuration of the cation (B1) but if it is slow, bond rotation following path B2. Type C 
reactions take place via the same intermediate but it suffers an electrophilic alkylation leading to 
the formation of a (3+2)-type of cycloaddition product or alternatively, the diene recovers 
conjugation by elimination, resulting in the formation of a Friedel-Crafts type adduct. Hoffmann 
stated that “the reaction of any structurally defined cation can only belong to at most two reaction 
types” (type A/B or B/C). That excludes the possibility of the reaction taking place by type A 
mechanism if we observe type C products and vice versa. Later on, Cramer10 investigated the 
mechanism using computational methods and suggests that the mechanism depends on the 
nucleophilicity of the dienes, the electrophilicity of the oxyallyl cations and the electronic 
properties of oxygen on the allylic moiety. 
Oxyallyl cations can adopt different geometries but it is generally considered that there 
are three types of structures namely W-type, S-type and the least stable U-shaped (seeFigure 2.3). 
The W-type form represents the lowest energy due to its less sterically congested nature and it is 
usually proposed for acyclic substrates. The U-shaped conformation is the only one possible in 
case of cyclic oxyallyl cations. 
 
Figure 2.3 
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The accepted mechanism for the approach of the oxyallyl cation to the diene in the 
concerted pathway (class A) involves two topologically distinct transition states; a compact endo 
mode (boat-like) or an extended transition state in an exo approach (chair-like) (see Figure 2.4). 
Reactions through compact transition state tend to the formation of diequatorial products; while 
reactions through extended TS give products with the R1 and R2 in diaxial orientation. 
 
Figure 2.4 
A good example of a (4+3) cycloaddition through concerted pathway (class A 
mechanism) is the one presented by Noyori in 197811 in which 2,4-dibromo-3-pentanone reacted 
with cyclopentadiene in the presence of diiron nonacarbonyl, Fe2(CO)9. These reductive 
conditions involve the reaction of α,α´-dihaloketones with the metal-based reducing agent to give 
a metal enolate, which evolved by loss of the second halide to generate a metal-bound oxyallyl 
cation. Next, the oxyallyl cation react with cyclopentadiene to yield a mixture of endo and exo 
diastereoisomers but confirming that the reaction proceeded through the retention of the 
particular W-shaped configuration of the oxyallyl cation (see Scheme 2.4). 
 
Scheme 2.4 
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 Takaya, H.; Makino, S.; Hayakawa, Y.; Noyori, R. J. Am. Chem. Soc. 1978, 100, 1765. 
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Noyori also presented a similar reaction undergoing the stepwise path (class B) as it is 
shown in Scheme 2.3.11 When 2,4-dibromo-3-pentanone reacted with Fe2(CO)9 in the presence of 
furan, a mixture in which the two substituents of the oxyallyl cation were arranged in a 1,3-cis 
and 1,3-anti relative configuration cycloadducts were obtained. Noyori proposed that the oxyallyl 
cation adopts a W-configuration at the beginning which is lost once the initial intermediate of the 
stepwise process is generated. The observed differences with the previously mentioned reaction 
in which cyclopentadiene was employed as the 4C reagent suggests that furan is less reactive 
towards iron oxyallyls and therefore the formation of the second bond is slow enough to lead to 
the formation of a 1,3-cis and 1,3-anti mixture of cycloadducts. 
 
Scheme 2.5 
Finally, an example of class C reaction was also reported by Noyori using the same 
pentanone in the presence of Fe2(CO)9 and N-methylpyrrole obtaining a mixture of regioisomers 
arising from standard Friedel-Crafts-type reactivity (see Scheme 2.6).11 The formed intermediate 
cation after the initial C-C bond formation is so stable that no bond closure steps are energetically 
favourable. 
 
Scheme 2.6 
These initial reports together with other key contributions by Hoffmann and Mann could 
provide the evidence that the electrophilicity of the oxyallyl cation plays an important role, with 
its configuration determining the stereochemical outcome of the cycloproducts.12 This high 
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dependence of the reaction mechanism with the nature of the oxyallyl cation is shown in Scheme 
2.7, only the least electrophilic N-based oxyallyl cation gave cycloaddition products with N-
methylpyrrole due to the ionic nature of Na-O bond. The preferentially obtained endo product is 
consistent with a concerted mechanism through compact TS. The more electrophilic dienophiles 
generated by the presence of Zn/Cu and Fe2(CO)4 respectively are more susceptible to Friedel-
Crafts-type reactivity. When furan was used as diene a similar behaviour was observed 
demonstrating that more electrophilic oxyallyl cations are more likely to react in a stepwise path 
to give the axial-equatorial product. 
 
Scheme 2.7 
Observing these results, it is also irrefutable the influence of the diene in the outcome of 
the reaction. Pyrroles behave as poor dienes in cycloadditions due to competing 
retrocycloaddition to recover aromaticity13 and resulting in few satisfactory examples in the 
literature.14 Furans and cyclopentadienes are the most reactive dienes; cyclohexadienes, 
anthracenes15 or fulvenes have also been used resulting in less effective and selective reactions. 
Acyclic dienes generally provide low yields of cycloaddition products due to the low 
concentration of s-cis conformers. 
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  (a) Donnini, C. P.; Just, G. J. Heterocyclic Chem. 1977, 14, 1423. (b) Lee, C. K.; Hahn, C. S.; Noland, W. E. J. Org. 
Chem. 1978, 43, 3727. (c) Noland, W. E.; Lee, C. K. J. Org. Chem. 1980, 45, 4573. 
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  (a) Noyori, R. Acc. Chem. Res. 1979, 12, 61. (b) Davies, H. M. L.; Young, W. B.; Smith, D. H. Tetrahedron Lett. 
1989, 35, 4653. (c) Davies, H. M. L.; Matasi, J. J.; Hodges, L. M.; Huby, N. J. S.; Thornley, C.; Kong, N.; Houser, J. 
H. J. Org. Chem. 1997, 62, 1095. (d) Davies, H. M. L.; Huby, N. J. S. Tetrahedron Lett. 1992, 46, 6935. (e) 
Ravisekhara, R. P.; Davies, H. M. L. J. Am. Chem. Soc. 2007, 129, 10313. (f) Fuchigami, R.; Namba, K.; Tanino, K. 
Tetrahedron Lett. 2012, 53, 5725. 
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  Ivanova, O. A.; Budynina, E. M.; Grishin, Y. K.; Trushkov, I. V.; Verteletskii, P. V. Eur. J. Org. Chem. 2008, 31, 
5329. 
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As seen from the previous examples, oxyallyl cations are unstable reagents that have to be 
generated in situ from the convenient precursor. In addition to α-haloketones shown before,6 
epoxy enolsilanes are alternative starting materials to generate oxyallyl cations through acid-
mediated ring opening of the oxirane moiety. The first use of epoxy enolsilanes as oxyallyl cation 
precursors for (4+3) cycloaddition was reported by Eguchi and coworkers16 in the reaction with 
furan and cyclopentadiene under Lewis acid catalysis (see Scheme 2.8). Although the 
cycloadducts were produced in low yields and low diastereoselectivities, the reaction could be 
carried out using a catalytic amount of TESOTf as catalyst. In a later work, Chiu and coworkers17 
demonstrated that the (4+3) cycloadducts could be obtained in good yields performing the 
reaction at a lower temperature, although without any diastereoselectivity. Slightly better results 
were obtained using were possible to obtain using epoxy enolsilanes containing bulkier silyl 
groups. 
 
Scheme 2.8 
In constrast to the results obtained in intermolecular cycloadditions with epoxy 
enolsilanes, intramolecular versions afford good yields of the corresponding cycloadducts, and 
provided as single diastereoisomer in a stereospecific manner. Using a single enantiomer of the 
epoxy enolsilyl ether optically pure cycloadduct shown in Scheme 2.9 was obtained under the 
same reactivity as used in Scheme 2.8.17a The diastereoselectivity is explained on the basis of a 
compact transition state adopting preferentially a W-type configuration, thus the cycloaddition is 
initiated with furan asynchronously with furan through a compact-endo transition state in which 
the tether adopts a chairlike conformation to afford the observed diastereoisomer. This pathway 
is preferred over the alternative unfavoured endo transition state in which the siloxyallyl cation is 
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  (a) Chung, W. K.; Lam, S. K.; Lo, B.; Liu, L. L.; Wong, W.-T.; Chiu, P. J. Am. Chem. Soc. 2009, 131, 4556. (b) Lo, 
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in S-type configuration resulting in the isomeric product. This strategy has been applied to the 
asymmetric synthesis of the pentacyclic framework of stereoidal alkaloid Cortistatins by Chiu.18 
 
Scheme 2.9 
In 2012, an intermolecular asymmetric version of this (4+3) cycloaddition has reported in 
which the authors confirmed that starting from an enantiopure epoxide the chiral information was 
directly translated to the absolute stereochemistry of the final product.19 This result was 
explained by proposing that the diene intercepts the oxyallyl cation before the cation dissociates 
to the achiral oxyallyl cation. Computational studies were carried out afterwards which 
confirmed that the activation energies of the reaction between the chiral oxyallyl cation 
intermediate and the diene were lower than the barrier required for epoxide ring opening.20 
O
OTES
X
TESOTf (10 mol%)
CH2Cl2, -91 ºC
X
O
OH
X
O
OH
(endo) (exo)
X= O, Yield 75%, d.r. 54:46 92% ee 97% ee
X=CH2, Yield 69%, d.r. 42:58 98% ee 99% ee  
Scheme 1.1 
Cyclopropanone diacetals have also been used as oxyallyl cation precursors. These 
strained carbocyclic reagents undergo spontaneous ring-opening in the presence of a Brønsted 
acid in order to release ring strain, generating an alkylidene oxyallyl cation-type intermediate. In 
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 Liu, L. L.; Chiu, P. Chem. Commun. 2011, 47, 3416. 
19
  Lo, B.; Lam, S.; Wong, W.-T.; Chiu, P. Angew. Chem. Int. Ed. 2012, 51, 12120. 
20
  Krenske, E. H.; Lam, S.; Ng, J. P. L.; Lo, B.; Lam, S. K.; Chiu, P. Angew. Chem. Int. Ed. 2015, 54, 7422. 
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particular, Fujita and coworkers21 showed that these alkylidenecyclopropanone acetals could 
react with furan in the presence of HCl, producing (4+3) cycloadducts in good yields (see 
Scheme 2.10). 
 
Scheme 2.10 
Alternatively, Albizati and coworkers22 reported that α,α-dialkoxy trialkylsilylenol ethers 
are also excellent precursors of O-stabilized oxyallyl cations through Lewis acid mediated 
dealkoxylation. In their initial report, they showed the possibility to promote the (4+3) reaction 
with furans in a regio- and diastereoselective fashion using using substoichiometric amounts of 
TMSOTf as Lewis acid promoter (see Scheme 2.11). 
 
Scheme 2.11 
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  Fujita, M.; Oshima, M.; Okuno, S.; Sugimura, T.; Okuyama, T. Org. Lett. 2006, 8, 4113. 
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  Murray, D. H.; Albizati, K. F. Tetrahedron Lett. 1990, 31, 4109. 
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Hoffmann extended this work through the use of a chiral allyl acetal as the oxyallyl cation 
precursor developing an asymmetric variant (see Scheme 2.12).23 These chiral allyl acetals in the 
presence of TESOTf as Lewis acid promoter, generate a chiral oxyallyl cation intermediate 
which reacts diastereoselectively with furan providing the final product in good yields. 
Cycloaddition takes place with high leves of diastereoselectivity through an endo transition state. 
In addition, facial selectivity levels depend on the choice of aryl group at the acetal stereogenic 
center. When a 2-naphthyl group was chosen, the (4+3) cycloadduct was formed as single 
diastereoisomer. Houk and Harmata24 examined the reaction using density functional theory 
calculations and they predicted that these cycloadditions take place via stepwise fashion due to 
electrostatic stabilization after the formation of the first σ bond. In addition, stereoselectivity is 
controlled by two main factors: minimization of steric repulsion between the allyl group of the 
cation and the methyl group of the chiral auxiliary; and by stabilizing CH-π interaction between 
furan and the aryl group. This model could also predict the differences in selectivity observed 
when a phenyl and 2-naphthyl substituents were placed at the chiral auxiliary. 
 
Scheme 2.12 
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  (a) Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem. Int. Ed. 1998, 37, 1266. (b) Stark, C. B. W.; 
Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. Chem. Eur. J. 2000, 6, 684. 
24
  Krenske, E. H.; Houk, K. N.; Harmata, M. Org. Lett. 2010, 12, 444. 
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Vinyl oxocarbenium species25 are also available from other precursors like α-silyloxy-α,β-
unsaturated carbonyls. Harmata26 demonstrated that 2-(triisopropylsilyloxy)propenal reacts with 
different dienes in the presence of catalytic amounts of Sc(OTf)3 to afford the corresponding 
cycloadducts in good to excellent yields and in some cases with full diastereoselectivity (see 
Scheme 2.13). The potential of this type of precursors was demonstrated by Funk27 who reported 
the total synthesis of (±)-cortistatin J using α-silyloxy-α,β-unsaturated carbonyl derivatives in an 
intramolecular version. 
 
Scheme 2.13 
Allenamides are also other effective precursors for the preparation of nitrogen-stabilized 
oxyallyl cations. These are converted into the key oxyallyl cations through regioselective 
epoxidation that generates an alkylidenepoxide intermediate that undergoes subsequent ring 
opening in the presence of a Lewis acid. This methodology has been extensively studied by 
Hsung reporting the first use of 1-amidoallenes as source of N-substituted oxyallyl cations in 
(4+3) cycloadditions with a variety of furans (see Scheme 2.14).28 Hsung incorporated a chiral 
oxazolidinone as chiral auxiliary in the allene moiety which evolved to the N-substituted oxyallyl 
cation after a regioselective epoxidation of the most electron-rich alkene. This intermediate could 
be readily trapped by the presence of a high excess of furan leading to the final cycloadduct 
diastereoselectively and with completely endo selectivity in the presence of ZnCl2 as Lewis acid 
promoter. Dimethyldioxirane (DMDO) was found to be the most useful protocol in epoxidizing 
chiral allenamide at low temperatures. When the reaction was promoted with cyclopentadiene, 
the final product was obtained endo and diastereoselectively but with an important loss on the 
reaction yield. Based on experimental data, Hsung and Houk have reported a mechanistic model 
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  For review on cycloadditions of vinyl oxocarbenium ions: Harmata, M.; Rashatasakhon, P. Tetrahedron 2003, 59, 
2371. 
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  Harmata, M.; Sharma, U. Org. Lett. 2000, 2, 2703. 
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  Nilson, M. G.; Funk, R. L. J. Am. Chem. Soc. 2011, 133, 12451. 
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based on DFT-theoretical calculations to explain the stereoselectivities of this cycloaddition.29 
Authors revealed that the most stable oxyallyl cation intermediate presents (E) configuration in 
order to minimize electronic repulsions between the oxazolidinone carbonyl and the oxyallyl 
oxygen. The study reported that this arrangement in maintained in the TS and that the 
incorporation of the Lewis acid decreases the activation barrier of the cycloaddition but does not 
change the conformation of the intermediate. The facial selectivity was explained by the presence 
of a stabilized C-H-π interaction between the phenyl ring of the chiral auxiliary and the hydrogen 
atom at C-3 position of the furan. As a consequence, the addition of the furan takes place through 
the most hindered face of the oxyallyl cation. 
 
Scheme 2.14 
Houk and Hsung also performed the reaction with 2- and 3-substituted furans observing 
that when 2-substituted furans were used syn cycloadducts were formed. However, in the 
presence of 3-substituted furans, the final product was formed selectively as the anti product (see 
Scheme 2.15).29 In the same work, they also reported that the aforementioned C-H-π interactions 
also aid to understand the stereoselectivity of the reaction. In both cases, the major 
diastereoisomer is derived from the attack of the furan to the more hindered face of the cation, 
favored by C-H-π interactions. For 2-substituted furans, syn cycloadducts are formed selectively, 
because this arrangement enables the stronger bonding interaction in the TS to involve the less-
hindered (C-5) carbon and the more nucleophilic site of the oxyallyl cation. 3-substituted furans 
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52   Chapter 2 
undergo cycloaddition preferentially in the anti geometry, in order to avoid steric clash between 
the 3-substituent and the phenyl ring. 
 
Scheme 2.15 
The group of Hsung has also reported an efficient intramolecular version of these (4+3) 
cycloadditions with allenamides as oxyallyl cation precursors.30 They reported the first 
intramolecular (4+3) cycloaddition using nitrogen-stabilized chiral oxyallyl cations via 
epoxidation of N-tethered allenamides (see Scheme 2.16).30b The epoxidation became very 
selective at low temperatures for the allenic double bond leading to the formation of the 
corresponding oxyallyl cation, the subsequent intramolecular reaction gave the desired final 
products as single diastereomers. The reaction was also tested under Lewis acid catalyst but it did 
not have any influence on the stereochemical outcome. On the basis of stereochemical 
assignments, Hsung proposed an approach to intramolecular (4+3) cycloaddition where the 
cation adopts the most stable W-conformation and proceeds through exo transition state. Both 
oxygen atoms are proposed to be unaligned in view of the fact that Lewis acids did not have any 
influence on the reaction. 
 
Scheme 2.16 
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Finally, heteroaromatic betaines such as those used in dipolar (5+2) cycloadditions, can 
also participate in (4+3) cycloadditions with a suitable diene.31 Cha and coworkers32 applied this 
methodology to generate a cyclic N-stabilized oxyallyl cation which reacted with 
cyclopentadiene at room temperature providing the corresponding endo cycloadducts in moderate 
yield. Cha could perform the reaction on large scale and applied it in a sequence of 
transformation applied towards the synthesis of to prepare the tricyclic core of Sarain A, a 
molecule which is reported to display modest antibacterial, insecticidal and antitumor activities.33 
 
Scheme 2.17 
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There is a lack of catalytic (4+3) cycloadditions in the literature and even rarer 
enantioselective versions; in fact, only two examples of catalytic enantioselective (4+3) 
cycloadditions have been reported up to date. One of these reports made use of the iminium 
activation approach to activate the oxyallyl cation reagent and the other realied on a Cu(II)/bis-
oxazoline chiral Lewis acid as catalyst. Next, these are presented in-depth. 
In 2003, Harmata34 presented the first enantioselective version of (4+3) cycloaddition 
using silyloxy pentadienals as oxyallyl cation precursors. Silyloxy pentadienals react with the 
MacMillan catalyst to generate an iminium ion intermediate shown in Scheme 2.18. The addition 
of 2,5-disubstituted furans lead to the final cycloadduct as a single endo diastereomer in 
moderate to good yields and good enantioselectivities. The reaction performed well with methyl, 
ethyl and propyl substituents at this position of the furan ring but the complete 
diastereoselectivity and enantioselectivity was lost when phenyl groups were used. The reaction 
with 2-substituted furans did not take place observing only the Friedel-Crafts type alkylation 
product which could suggest a stepwise process. 
 
Scheme 2.18 
Prior to the determination of the absolute configuration, Harmata assumed that the 
mechanism that explains the enantioselectivity would follow the earlier proposed model by 
MacMillan for imidazolidinone-catalyzed enantioselective Diels-Alder and Michael reactions 
with α,β-unsaturated aldehydes and ketones. However, Sun and Xu applied this methodology in 
the synthesis of (+)-englerin A and (–)-orientalol F and they deduced the absolute configuration 
comparing the optical rotations to their final products to those of authentic samples.35 They 
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realized that Harmata had anticipated a mechanism that explains the formation of the opposite 
enantiomer. The addition should take place through syn face of the iminium ion. For that reason, 
in 2014 Harmata and Krenske investigated the mechanism under DFT calculations.36 The most 
stable conformation for the iminium ion was reported to be (E) isomer; however, some 
involvement of Z transition states may occur, and this would slightly reduce the 
enantioselectivity.37 The addition through the syn face of the first step is understood trough 
conformational changes within the iminium cation that occur upon interaction with the diene. In 
the proposed TS, diene is far enough from the benzyl group and tert-butyl group of the catalyst 
that creates no steric clashes with these groups. To accommodate syn-face approach by the furan, 
SiR3 group would accommodate in the anti face of the iminium intermediate. They demonstrated 
that the role of SiR3 is crucial in transmitting chiral information from the catalyst to the bond-
forming site. 
 
Figure 2.5 
Later on, Hsung reported an enantioselective version using chiral Lewis acid catalysis (see 
Scheme 2.19).38 The cycloaddition was performed with achiral oxazolidinone-derived 
allenamides in the presence of a Cu(II)/bis-oxazoline chiral Lewis acid, that promoted the in situ 
formation of the oxyallyl cation which, by oxidation with dimethyldioxirane (DMDO) reacted 
with dienes with endo selectivity and with modest to good enantioselectivities. The use of 
molecular sieves in the reaction led to higher yields. The use of furan led to endo product with 
excellent yield and enantioselectivity (see Scheme 2.19). The reaction was also carried out with 
cyclopentadiene but lower enantioselectivities were achieved due to a more reactive diene that 
                                                                                                                                                 
Chen, S.-G.; Ding, R.; Lin, G.-Q.; Xu, J.-Y.; Shang, Y.-J. Synlett 2012, 23, 1266. (d) Wang, J.; Chen, S.-G.; Sun, B.-
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contributes to a great amount of background reaction.39 Hsung proposed a working model to 
explain the obtained stereoselectivity based on mechanistic analysis for asymmetric catalysis 
employing C2-symmetric ligands. In this model, it could be observed that the attack through the 
Si face of the oxyallyl cation would be sterically unfavoured due to the interaction between the 
furan and the phenyl rings, while the Re face would predominate. 
 
Scheme 2.19 
The reaction with 2,5-dimethylfuran provided low enantioselectivities but, in contrast, the 
use of both 2-methylfuran and methyl furylcarboxylic ester provided excellent regioselectivities 
in favor of the syn isomer with moderate to high enantioselectivities. Reactions with 3-substituted 
furans were successful, leading to cycloadducts with high enantioselectivities in favor of the anti 
regioisomer as major product (see Scheme 2.20). 
 
Scheme 2.20 
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The selected examples illustrate the different research activity to get oxyallyl cations and 
to involve these in (4+3) cycloadditions. It is evident that there is a lack of examples of catalytic 
(4+3) cycloadditions and when speaking about catalytic enantioselective versions, the literature is 
limited to the two examples disclosed previously. This encouraged us to confront this challenge. 
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2. SPECIFIC OBJECTIVES AND WORK PLAN 
As stated in the previous section, despite the fact that the (4+3) cycloaddition reaction 
using oxyallyl cation as the 3C component is a powerful tool to assemble seven-membered rings; 
there is an evident lack of catalytic and enantioselective versions that enable the access to 
enantiopure adducts through this highly useful approach. In consequence, we decided to direct 
our efforts to the development of an organocatalytic enantioselective version of the (4+3) 
cycloaddition between oxyallyl cations and electron rich dienes employing Brønsted acid 
catalysis as the methodological approach to activate the reagents and to achieve stereocontrol 
(see Scheme 2.21). 
 
Scheme 2.21 
Our hypothesis is shown in Scheme 2.22 and relies on the ability of chiral Brønsted acids 
to favour the formation of the oxyallyl cation intermediate through ring-opening of an 
alkylideneoxirane intermediate that is generated upon regioselective epoxidation of an 
allenamide. Moreover, the chiral Brønsted acid should also be able to transfer its stereochemical 
influence during the (4+3) cycloaddition process. In particular, BINOL-based Brønsted acids will 
be surveyed to catalyze this (4+3) cycloaddition. 
 
Scheme 2.22 
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Considering all this aspects, the following work plan was designed: 
1. Proof of concept 
Firstly, we need to evaluate the ability of postulated Brønsted acids to catalyze the process 
and to induce enantioselectivity in the (4+3) cycloaddition between allenamide and furan in the 
presence of an oxidant that should be compatible with the catalytic system (see Scheme 2.23). 
 
Scheme 2.23 
2. Optimization of the reaction conditions 
Once the viability of the reaction has been established, structural requirements to be met 
by the allenamides give the best performance under these Brønsted acid-catalyzed conditions will 
have to be identified. In particular, R1 and R2 will be modified with electronically different 
groups until the allenamide that performs best is indetified (see Scheme 2.23). Next, the reaction 
between furan and the most suitable allenamide will be chosen as model system, with the aim to 
identify the chiral Brønsted acid that provides the best performing one in terms of yield and 
enantiocontrol. Some catalyst will be tested and once the best performance is identified, other 
experimental variables like solvent, additives, concentration or temperature will be evaluated (see 
Scheme 2.24). 
 
Scheme 2.24 
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3. Scope of the reaction 
With the optimal conditions in hand, several allenes with different substitution patterns as 
well as different dienes will be evaluated in order to explore the scope and limitations of the 
reaction (see Scheme 2.25). 
 
Scheme 2.25 
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3. RESULTS AND DISCUSSION 
Once the synthetic methodologies and literature examples on this topic have been 
presented and after establishing the specific objectives and a work plan, the most relevant results 
obtained will be presented and subsequent discussed. 
3.1 Proof of concept 
We began our work applying the conditions reported previously by Hsung38 that involved 
the use of allene 1a containing a 2-oxazolidinone moiety in the presence of dimethyldioxirane 
(DMDO) as the oxidant and an excess of furan 2a. An achiral acid such as diphenyl phosphate 
was incorporated as catalyst and the reaction was evaluated at two different temperatures (see 
Scheme 2.26). Initially the reaction was carried out at room temperature observing a very poor 
conversion into the final products. When the reaction was carried out at -78 ºC a promising 
reaction yield was achieved. These results indicated the necessity of working at low temperatures 
probably due to the volatility and unstable properties of DMDO at temperatures over -20 ºC. It 
has to be highlighted that when the reaction was performed without catalyst at -78 ºC, the 
reaction underwent with a 27% yield indicating that we had to deal with a high degree of 
background reaction. 
 
Scheme 2.26 
The use of DMDO as oxidant presents some disadvantages that we wanted to overcome.40 
In particular, DMDO has to be freshly prepared previous to its use which would be in solution in 
available solvents; it must be storage at temperatures below -20 ºC away from light and its 
lifetime is around 2-6 days at these temperatures. Thus, other different types of oxidants were 
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evaluated such as hydroperoxides (tBuOOH, H2O2), peracetic acid or m-chloroperbenzoic acid. 
However, none of the oxidants gave the desired cycloadduct. In fact, in all cases the starting 
allene was recovered. 
3.2 Optimization of reaction conditions 
Once the possibility of carrying out the reaction in the presence of a Brønsted acid catalyst 
by using DMDO as the oxidant to generate the key oxyallyl cation intermediate from an 
allenamide-type substrate, we evaluated the effect of different BINOL-based chiral Brønsted 
acids on the reaction. In particular, several commercially available chiral phosphoric acids (3a-e) 
and N-triflyl phosphoramide-based chiral acids (3f-g) were surveyed with the results shown in 
Table 2.1. 
Table 2.1 Variations on the reaction under DMDO and different CBA 
 
Entry Catalyst Yielda eeb 
1 3a 69 8 
2 3b 53 5 
3 3c 45 <5 
4 3d 65 16 
5 3e 51 <5 
6 3f 38 45 
7 3g 44 20 
aYield of pure product isolated after flash chromatography. bDetermined by HPLC analysis of the pure product. 
When chiral phosphoric acids 3a-e were used as catalysts (entries 1-5) adduct 4a was 
formed in moderate yield but with very poor enantiocontrol. With the most acidic BINOL-based 
phosphoric acid 3d we were able to raise the enantiocontrol to a promising 16% ee. Thus, these 
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results suggested that more acidic catalysts were necessary in the reaction to get better results. In 
this sense, geometrically different but the most acidic catalyst in the series of phosphoric acids 3e 
(entry 5) was evaluated obtaining adduct 4a in a promising yield but very low enantioselectivity. 
However, two different BINOL-derived N-triflyl phosphoramides were evaluated (entries 6-7) 
which provided higher enantioselectivities (45% and 20% respectively). 
These promising preliminary results encouraged us to carry on further efforts in order to 
achieve the highest possible yield and stereoselectivity. In this sense, we decided first to evaluate 
allenamides with different substitution patterns employing catalysts 3f and 3g which had 
provided the best results in our preliminary survey. The reactions were carried out at -78 ºC 
under 5 mol% of catalyst loading with excess of furan (3 eq) and DMDO (2 eq) and the obtained 
results are shown in Table 2.2. 
Table 2.2 Evaluation of the structure of the allenamide precursor 
 
Entry allene R1 R2 Product Yield (%)a ee (%)b 
1 1b Me Ts 4b 34 48 
2 1c Ph Ts 4c 17 74 
3 1d p-BrC6H4 Ts 4d 23 39 
4c 1e 2,4,6-(Me)3C6H2 Ts 4e 18 50 
5d  1f p-MeOC6H4 Ts 4f 50 60 
6 1g p-MeOC6H4 Ac 4g 50 22 
7 1h Ph Boc 4h 37 64 
8 1i p-BrC6H4 Boc 4i 29 71 
9 1j p-MeOC6H4 Boc 4j 63 68 
10 1k 3,4,5-(MeO)3C6H2 Boc 4k 38 73 
11 - p-(N-(Me)2)C6H4 Boc - n.r.e - 
aYield of pure product isolated after flash chromatography. bDetermined by HPLC analysis of the pure product. cThe 
reaction was carried out with 3f catalyst. dAbsolute configuration was determined by X-ray analysis (see Experimental 
section). eNo reaction. 
We started the evaluation of different allenamides by studying different R1 groups while 
keeping an electron withdrawing group as the other R2 substituent. Initially, we tested alkyl 
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(entry 1) and aromatic substituents (entries 2-5). Allenamide 1b containing a methyl and tosyl 
group did not afford good results in terms of yield and enantioselectivity and when a phenyl 
group was placed (entry 2) the enantiocontrol increased to a promising 74% ee, albeit in very low 
yield. The use of an electron withdrawing aryl substituent (entry 3) afforded lower 
enantioselectivities than a simple phenyl group, thus allenamides containing an electron-donating 
aryl substituent together with the tosyl group were subsequently evaluated (entries 4-5). In 
particular, allenamide 1e with a mesityl group (entry 4) and 1f with a p-methoxyphenyl 
substituent (entry 5) were evaluated obtaining the best result with the latter. Alternatively, we 
tested the performance of p-methoxyphenyl substituted allenamides in combination with other 
different electron withdrawing substituents such as an acetyl group (entry 6) performing the 
reaction in a very low enantiocontrol. On the other hand, tert-butoxycarbonyl-substituted 
allenamide 1h performed much better with an increased 67% ee. Finally, other N-Boc protected 
allenamides were surveyed trying to obtain a fine tuning of the electronic properties of the N-aryl 
moiety (entries 8-11). As it happened before, the best results were obtained with the use of the 
electron donating p-methoxyphenyl substituent (entry 9). This push-pull effect on the nitrogen 
atom seems to be the most suitable system. However, when the more electron-donating 3,4,5-
trimethoxyphenyl substituent was incorporated as the aryl substituent (entry 10) the reaction 
performed poorly in terms of yield and the use of p-dimethylaminophenyl substituent in the 
allenamide moiety resulted in a sluggish reaction presumably because of overoxidation (entry 
11). 
We could grow a crystal of the obtained cycloadduct 4f which allowed to establish the 
absolute configuration which was established by X-ray analysis (see Figure 2.6). The 
crystallographic analysis showed an (1R,2S,5R) absolute configuration which was extended to 
the other cycloadducts 4a-k based on a mechanistic analogy for all reactions. 
 
Figure 2.6 
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Once the structure of the allenamide reagent had been optimized and with catalyst 3g as 
the best performing one, we proceeded to study the effect of other parameters on the reaction like 
solvent, stoichiometric ratio between the different reagents or the incorporation of additives (see 
Table 2.3). We started by surveying the effect of using more excess of furan (entries 2-3) 
observing a significant improvement in the yield when 13 equivalents were used. Higher excess 
of furan did not improve this result. It has to be pointed out that the use of a large excess of diene 
is usual to find in the previous reports about (4+3) cycloadditions using oxyallyl cations due to 
the probable oxidation of furan. Finally, we also evaluated the effect of the temperature, 
demonstrating that when the temperature was higher than -78 ºC (entry 4), poorer enantiocontrol 
was obtained. However, when we carried out the reaction at -90 ºC (entry 5) the 
enantioselectivity was not higher compared to the same reaction at -78 ºC. 
Table 2.3 Study of the effect of the furan equivalents and temperature on the reaction. 
 
Entry Furan eq T /ºC Yielda eeb 
1 3 -78 63 68 
2 13 -78 74 73 
3 24 -78 70d 65 
4 13 -40 50 56 
5 13 -90 62 67 
aYield of pure product isolated after flash chromatography. bDetermined by HPLC analysis of the pure product. c10 mol% 
catalyst. dYield was measured by 1H NMR in the crude with TMB as IS. 
We next proceeded to study the influence of the solvent in the reaction as it can be seen in 
Table 2.4. Initially, we tested the reaction in the presence of polar solvents (entries 2-3). The use 
of a chlorinated solvent such as dichloromethane (entry 2) did not afford better results than those 
obtained in the original reaction in toluene. Propionitrile was also evaluated obtaining good 
results in terms of yield and enantioselectivities but not better than in toluene (entry 3 vs 1). An 
apolar solvent like hexane was also evaluated with no improvement in yield and enantiocontrol. 
In all these cases we were also able to prepare solutions of DMDO in each of the solvent tested, 
which means that all these reactions were carried out in a single solvent system. For the 
evaluation of other solvents in which DMDO solutions can not be prepared, the oxidant was 
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employed as a solution in toluene in view of the results presented in entry 1. As a consequence, 
the following experiments were carried out in binary solvent mixtures. In the presence of ethers, 
the yield of the reaction resulted significantly affected, while maintaining similar 
enantioselectivities (entries 5-8). The use of nitroethane in the reaction led to similar results to 
those provided by ethereal solvents (entry 9). However, when we performed the reaction in the 
presence of ethyl acetate as co-solvent we observed that the enantioselectivity improved 
significantly (entry 10). We were also able to improve the yield of the reaction using higher 
excess of DMDO (2.5 equivalents, entry 11) maintaining the enantiocontrol. The reaction was 
also tested with 3 equivalents of DMDO with no improvement in the yield (entry 12). Moreover, 
in these cases the reaction could be carried out using furan as the limiting reagent in the presence 
of a 3-fold excess of allenamide (entry 12) which represents a remarkable improvement 
compared with 13 equivalents of diene previously required. The use of isopropyl acetate (entry 
13) or ethyl formate (entry 14) as co-solvents did not improve the enantiocontrol and led to an 
important loss in the reaction yield. 
Table 2.4 Effect of the solvents and co-solvents on the reaction 
 
Entry Solvent Co-solvent Yielda eeb 
1 Toluene - 74 75 
2 CH2Cl2 - 60 65 
3 EtCN - 68 63 
4 hexane - 60 66 
5 toluene MTBE 21 65 
6 toluene Et2O 58 68 
7 toluene CpMeO 58 60 
8 toluene THF 39 69 
9 toluene EtNO2 52 63 
10 toluene EtOAc 75 80 
11d toluene EtOAc 78 82 
12f toluene EtOAc 71 82 
13d toluene iPrOAc 72e 66 
14d toluene Ethyl formate 35e 70 
aYield of pure product isolated after flash chromatography. bDetermined by HPLC analysis of the pure product. cReaction 
was carried out at -40 ºC. d2.5 equivalents of DMDO were used. eYield was measured by 1H NMR in the crude with TMB 
as IS. fThe reaction was carried out using 1 eq of furan, 3 eq of allenamide and 6.3 eq of DMDO. 
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These results agree with some publications41 by Shimizu and Hoffmann where it was 
indicated that apolar solvents may induce type B/C mechanisms instead of a concerted A 
pathway which is the main mechanism operating when polar solvents are used.41a Authors 
explained this change on mechanism by the power of the solvent to stabilize and dissociate the 
cation/counterion pair. The more polar solvent can fully dissociate the cations making it more 
electrophilic, while in apolar solvents the cation forms tightly bonded ion-pair with the phosphate 
ion. The full dissociation favours a concerted pathway while a partial dissociation favours a 
stepwise manifold starting by the electrophilic addition to the oxyallyl cation/phosphate anion 
pair. 
Finally and with these improved reaction conditions on hand, we decided to reevaluate 
other catalysts trying to obtain a better performance in terms of enantiocontrol. We prepared 
electronically structurally different BINOL-based phosphoramides as phosphoric acids and their 
behavior as catalysts on the (4+3) cycloaddition between 1j and 2a was evaluated. 
  
                                                           
41
  (a) Shimizu, N.; Tanaka, M.; Tsuno, Y. J. Am. Chem. Soc. 1982, 104, 1330. (b) Hoffmann, H. M. R.; Chidgey, R. 
Tetrahedron Lett. 1978, 1, 85. 
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Table 2.5 Evaluation of a series of catalysts 
 
Entry Catalyst Yielda eeb 
1 3g 78 82 
2 3h 33 65 
3 3i 70 49 
4 3j 27 <5 
5 3k 69 -56 
6 3l 20 25 
7 3m 40 14 
8 3n 19 12 
9 3o 45 70 
10 3p 28 26 
aYield of pure product isolated after flash chromatography. bDetermined by HPLC analysis of the pure product. 
As shown in Table 2.5, we started by modulating the acidity of the original catalyst 3g 
(entry 1 shown for comparison purposes) with the presence of thiophosphate group (entry 2) that 
led to an important loss of yield and a slight drop in the enantiocontrol. The less acidic partially 
reduced catalyst 3i (entry 3) was able to promote the reaction with good yield but with an 
important loss of enantioselectivity. Next, we decided to evaluate steric effects on 3,3´-positions, 
starting with catalyst 3j incorporating the bulky tert-butyl dimethyl silyl group (entry 4), that led 
to an important loss of enantioselectivity. Chiral phosphoric acid 3k containing a spirobiindane 
scaffold which is very similar in acidity to 3i but with different geometrical features afforded the 
contrary enantiomer of 4j with poor enantioselectivity (entry 5). Next, BINOL-based 
phosphoramides with aryl substituents at the 3,3´positions were evaluated. In this sense, catalyst 
3l, 3m and 3n with a phenanthrenyl group (entry 6), biphenyl group (entry 7) and p-
methoxyphenyl group (entry 8) in 3,3´positions respectively supposed a dramatic loss in the 
reaction yield and enantiocontrol. The bulky 2,4,6-triisopropylphenyl group known as TRIP 
catalyst 3o (entry 9) provided 4j with a good enantiocontrol but with an important drop in the 
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yield of the reaction. Finally, bisphosphoric acid catalyst 3p (entry 10) was evaluated but the 
results indicate that probably higher acidity was necessary. 
Therefore, 3g remained as the best catalyst to perform the (4+3) cycloaddition reaction. 
Thus, after a wide range of experimental variables had been explored, we concluded that the 
optimal conditions for the reaction involved the use of 5 mol% of the chiral Brønsted acid 3g 
catalyst, DMDO in toluene as oxidant to generate the oxyallyl cation and 13 equivalents of furan, 
working in EtOAc as co-solvent in a 0.05M reaction concentration at -78 ºC (see Scheme 2.27). 
 
Scheme 2.27 
3.3 Scope of the reaction 
Once the best reaction conditions for carrying out the (4+3) cycloaddition reaction 
between allenamide 1j and furan had been established, we decided to extend the methodology to 
other dienes with different substitution patterns. Initially, we performed the reaction between 
allenamide 1j and 3-methylfuran 2b using the optimized conditions but we obtained the 
corresponding cycloadduct in a poor 53% yield. However, when the reaction was carried out 
using furan as the limiting reagent in the presence 3-fold excess of allenamide and 6.3 
equivalents of oxidant added portionwise lead to better a reaction yield in a high regioselectivity 
as it is shown in Scheme 2.28. 
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Scheme 2.28 
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These last conditions were extended to the reaction between allenamide 1j and a variety of 
furans (Table 2.6). When 3-methylfuran was used (entry 1) very high enantioselectivity was 
obtained; while the 3-ethyl derivative (entry 2) slightly drops the reaction yield and 
enantiocontrol. Furans with longer or bulkier alkyl substituents at this position provides the 
corresponding adducts with better enantioselectivity, although in low to moderate yield (entries 
3-5). Furan 2g incorporating an olefinic side chain did not give good results in terms of yield 
very likely because of a competitive oxidation side reaction (entry 6). Finally, when aryl 
substituents with different electronic properties were introduced at the furan scaffold the reaction 
performed very poorly (entries 7-9). The same happened when a halogen group or an ester group 
were incorporated at this position (entries10-11), in which cycloaddition did not take place. In all 
cases the reaction proceeded diastereoselectively obtaining the endo product and also the syn 
regioisomer was obtained as major isomer out of two possible ones. 
Table 2.6 Scope of the reaction with 3-substituted furansa 
 
Entry R Product Yield regioisomer 
ratiob ee
c 
1 Me (2b) 5a 72 14:1 83 
2 Et (2c) 5b 66 10:1 71 
3 o-MeC6H4CH2 (2d) 5c 45 10:1 85 
4d iC5H11 (2e) 5d 40 15:1 76 
5 CH2CH2Ph (2f) 5e 30 18:1 62 
6 (Z)-PhCH=CH (2g) 5f 12 >20:1 86 
7 Ph (2h) 5g 34 >20:1 76 
8 p-MeOC6H4 (2i) 5h 17 >20:1 63 
9 p-FC6H4 (2j) 5i 34 >20:1 57 
10 Br - n.r.e - - 
11 CO2CH3 - n.r.e - - 
aReaction carried out in a 0.05 mmol scale of 2b-j, using 3.0 eq. of allenamide 1j, 6.3 eq. of DMDO (as solution in 
toluene) and 5 mol% of 3g in AcOEt at -78ºC. bDetermined by 1H NMR analysis of the crude reaction mixture. 
cDetermined by HPLC analysis of the pure product. d1 eq of allene, 2.5 eq. of DMDO and 2 eq. of furan were used. eNo 
reaction. 
Other functionalized furans were also prepared and evaluated in the (4+3) cycloaddition 
reaction (see Table 2.7). The use of O-protected 2-(hydroxymethyl)furan derivatives lead to the 
formation of endo-syn products with high yields and enantioselectivities. Remarkably, the use of 
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O-silyl protected furans, 2m and 2n resulted into a highly efficient reaction in terms of both yield 
and stereocontrol (adducts 5l and 5m). We evaluated the use of 3-(hydroxymethyl)furan 2o but 
the reaction did not work. We also studied the performance of the reaction using N-(p-
methoxyphenyl)-protected 2-aminomethyl substituted furans (2p-s). In this case, using a Boc-
protected substrate 2p provided adduct 5n in a moderate yield and poor enantioselectivity but 
changing to an amide as the protecting group led to an important improvement in the 
performance of the reaction obtaining 5p with a good 71% ee with N-propionamide derived 
substrate 2r. When moving to the more bulky pivaloyl derivative 5q, enantioselectivity was 
lower and no reaction was observed with N-unprotected aminomethyl substituted furan 2t. 
Table 2.7 Scope of the reaction with functionalized furansa 
 
aReaction carried out in a 0.05 mmol scale of 2k-t, using 3.0 eq. of allenamide 1j, 6.3 eq. of 
DMDO (as solution in toluene) and 5 mol% of 3g in AcOEt at -78ºC. b1 eq of allene, 2.5 eq. of 
DMDO and 2 eq. of furan. Yield of pure product isolated after flash chromatography. ee 
determined by HPLC analysis of the pure product. n.r. refers to no reaction. 
Next we proceeded to evaluate the possibility of carrying out the reaction with 2-
substituted furans (see Scheme 2.29). However, none of them provided any (4+3) cycloaddition 
product. In the case of 2-methylfuran 2u the Friedel-Crafts type alkylation product was observed, 
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while for 2,5-dimethylfuran 2v the starting material was recovered unaltered. The formation of 
the alkylation product in the reaction with 2-methylfuran might suggest a possible stepwise 
pathway for this cycloaddition reaction. 
 
Scheme 2.29 
Finally, the reaction was also carried out with more nucleophilic cyclopentadiene 2w and 
the more reactive 6,6-dimethylfulvene 2x. In both cases some cycloaddition product could be 
isolated in low yields and with complete lack of enantiocontrol (see Scheme 2.30). It has to be 
mentioned that several pyrroles, tiophenes and acyclic dienes such as Danishefsky´s diene were 
evaluated with no success. 
 
Scheme 2.30 
Next, we turned our attention to the use of substituted allenamides as potential substrates 
in this reaction (see Table 2.8). It has to be highlighted that there are no precedents in catalytical 
enantioselective (4+3) cycloadditions using substituted allenes in terminal position. 
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Table 2.8 Scope of the reaction with γ-substituted allenamides and 3-substituted furansa 
 
Entry R1 (allene) R2 (furan) Prod. Yield regioisomer 
ratiob ee
c 
1d Me (1l) H (2a) 6a 67 - 35 
2 Me (1l) Me (2b) 6b 86 15:1 81 
3 Me (1l) o-MeC6H4CH2 (2d) 6c 53 >20:1 73 
4 Me (1l) CH2OSiPh3 (2m) 6d 64 >20:1 90 
5 Me (1l) CH2OSiiPr3 (2n) 6e 75 >20:1 85 
6d,e Et (1m) H (2a) 6f 64 - 35 
7e Et (1m) Me (2b) 6g 76 10:1 92 
8 Et (1m) o-MeC6H4CH2 (2d) 6h 60 >20:1 87 
9 Et (1m) CH2OSiiPr3 (2n) 6i 82 >20:1 93 
10 Et (1m) CH2CH2Ph (2f) 6j 73 >20:1 77 
11 Et (1m) CH2CH2CO2Et (2y) 6k 70 >20:1 85 
12e,f Et (1m) CH2N-(p-OMeC6H4)(COEt) (2r) 6l 60 >20:1 68 
aReaction carried out in a 0.05 mmol scale of 2, using 3.0 eq. of allenamide 1l-m, 6.3 eq. of DMDO (as solution in 
toluene) and 5 mol% of 3g in AcOEt at -78ºC. bDetermined by 1H NMR analysis of the crude reaction mixture. 
cDetermined by HPLC analysis of the pure product. d1 eq allene, 2.5 eq of DMDO in toluene and EtOAc, 13 eq furan. e1 
eq allene, 2.5 eq of DMDO in toluene and EtOAc, 2 eq diene. eThe enantiomer of catalyst 3e was used under the same 
reaction conditions. f5 eq. of allene, 12.5 eq. of DMDO, 1 eq. diene. 
We first tested methyl-substituted allenamides 1m in combination with furan 2a but 
despite the fact that cycloadduct 6a was isolated in good yield and as a single diastereoisomer, 
the enantioselectivity was very poor (entry 1). However, other 3-substituted furans performed 
much better, starting with 3-methylfuran (2b, entry 2), 3-benzylsubstituted derivative (2d, entry 
3) and two O-protected hydroxymethyl substituted furans (2m and 2n, entry 4 and 5 
respectively). In all these cases the reaction provided moderate to high yields, excellent 
diastereoselectivities and high ee. Moreover, the reaction also proceeded with high regiocontrol, 
only observing minor amounts of the other possible regioisomer in the case of 3-methylfuran 
(entry 2). When we moved to the use of ethyl substituted allenamides 1n the reaction behaved 
similarly (entries 6-12). In fact, while the cycloaddition with furan proceeded with poor ee, other 
substituted furans behaved excellently, furnishing the corresponding adducts with high yields 
diastereoselectively with high enantiocontrol and regioselectively. Moreover, in this case the 
reaction also tolerated well the incorporation of other different substitution patterns such as 2-
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phenethyl (entry 10), 2-ethoxycarbonylethyl (entry 11) and protected N-(p-
methoxyphenyl)aminomethyl (entry 12) that also performed well in the reaction. 
Remarkably, allenamides 1n incorporating a more bulky cyclohexyl substituent performed 
much better in all cases as shown in Table 2.9 including the possibility of using the simple furan 
2a as diene (entry 1). The reaction with a variety of 3-substituted furans proceeded in all cases 
with the highest degree of enantiocontrol observed in all the series and also with good yield and 
complete endo selectivity (entries 1-6). We finally moved to evaluate allenamides 1o and 1p 
(entries 7-13) that incorporate an aryl and a protected hydroxyl group at the lateral chain 
observing similar results of those observed before. 
Table 2.9 Scope of the reaction with γ-substituted allenamides and 3-substituted furans 
 
Entry R1 (allene) R2 (furan) Prod. Yield r.r.b eec 
1d cC6H11 (1n) H (2a) 6m 44 - 80 
2 cC6H11 (1n) Me (2b) 6n 40 >20:1 94 
3 cC6H11 (1n) o-MeC6H4CH2 (2d) 6o 76 >20:1 97 
4 cC6H11 (1n) CH2OSiiPr3 (2n) 6p 87 >20:1 99 
5 cC6H11 (1n) CH2CH2Ph (2f) 6q 70 >20:1 95 
6e cC6H11 (1n) CH2N-(p-OMeC6H4(COEt))(2r) 6r 51 >20:1 96 
7d CH2CH2Ph (1o) H (2a) 6s 30 - 13 
8e CH2CH2Ph (1o) Me (2b) 6t 60 10:1 84 
9f CH2CH2Ph (1o) CH2OSiiPr3 (2n) 6u 62 >20:1 82 
10d CH2CH2OTBS (1p) H (2a) 6v 37 - 10 
11f,g CH2CH2OTBS (1p) Me (2b) 6w 82 15:1 79 
12f CH2CH2OTBS (1p) CH2OSiiPr3 (2n) 6x 34 >20:1 83 
13f,g CH2CH2OTBS (1p) CH2OSiPh3 (2m) 6y 73 >20:1 85 
aReaction carried out in a 0.05 mmol scale of 2, using 3.0 eq. of allenamide 1o-q, 6.3 eq. of DMDO (as solution in 
toluene) and 5 mol% of 3g in AcOEt at -78ºC. bRegioisomer ratio determined by 1H NMR analysis of the crude reaction 
mixture. cDetermined by HPLC analysis of the pure product. d1 eq allene, 2.5 eq of DMDO in toluene and EtOAc, 13 eq 
furan. e1 eq allene, 2.5 eq of DMDO in toluene and EtOAc, 2 eq diene. f5 eq. of allene, 12.5 eq. of DMDO, 1 eq. diene. 
gThe enantiomer of catalyst 3e was used obtaining the opposite enantiomer as major isomer under the same reaction 
conditions. 
At this point, the absolute configuration of the cycloadducts obtained by this protocol was 
established by single-crystal X-ray analysis of an enantiopure sample of compound 6t, for which 
a monocrystalline sample could be obtained (see Figure 2.7). Accordingly to the stereostructure 
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obtained for this compound, the configuration of all other adducts 6a-y, was established by 
assuming the same stereochemical outcome for all reactions between allenamides 1m-q and 
furans 2 based on mechanistic analogy. 
 
Figure 2.7 
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3.4 Mechanistic proposal 
Based on the obtained stereochemical outcome of the reaction, we present herein a 
mechanistic proposal that can explain the regio- and stereoselective outcome of the process. 
*
 
Scheme 2.31 Mechanistic proposal 
The reaction would start with the regioselective epoxidation of the more electron rich 
alkene moiety of the allene in the presence of DMDO, forming the oxirane intermediate I which 
in the presence of chiral Brønsted acid 3g would lead to the key oxyallyl cation II. Once the 
oxyallyl cation is formed the catalyst would interact via H-bonding with the OH moiety and it is 
also proposed that the phosphate anion would remain close to the iminium cation through ion-
pairing interactions, lowering the LUMO of the oxyallyl cation to favour the reaction with the 
nucleophile. Our proposal relies on a more plausible stepwise mechanism base both in the 
literature precedent regarding computational studies carried out by Houk and Harmata on related 
Lewis-acid catalyzed processes36 and also on the fact that side products arising from Friedel-
Crafts type reactivity has been observed in some cases. In this sense, the first σ bond will be 
formed between the most nucleophilic site on the diene and the most electrophilic site on the 
cation assisted by the chiral phosphoramide anion forming intermediate III which should have a 
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long enough lifetime to undergo bond rotation before generating the second σ bond to lead to the 
formation of the final cycloadduct with the observed relative configuration between the two 
substitution of the oxyallyl cation. 
According to the experimental results, a major syn regioisomer is obtained in all cases. As 
it is shown in Figure 2.8, the approximation of the furan to the oxyallyl cation is proposed to be 
controlled by electronic effects with the most nucleophilic site of the furan and the most 
electrophilic site of the oxyallyl cation reacting between each other in the first step. The minor 
regioisomer it is thought to be formed through the background side background reaction because 
this minor regioisomer has always been obtained as racemic material. 
 
Figure 2.8 
On the basis of the experimental results and as it is mentioned before, the catalyst would 
form a H bond with the dipole and an electrostatic interaction through an ion pair with the 
iminium cation which lead to a rigid transition state allowing to the furan an approach from the 
less hindered face (Si-face) because of the chiral environment created by the bulky triphenylsilyl 
substituents of the catalyst (see Figure 2.9). This proposal is agree with the obtained absolute 
configuration detected experimentally. Finally, it is proposed that endo selectivity is favoured 
due to the preferred alignment of the dipole moments of the furan and the oxyallyl cation which 
are in opposite directions as proposed by other authors.42 
                                                           
42
  (a) See Ref. 35. (b) Du, Y.; Krenske, E. H.; Antoline, J. E.; Lohse, A. G.; Houk, K. N.; Hsung, R. P. J. Org. Chem. 
2013, 78, 1753. (c) See Ref. 30. 
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Figure 2.9 Major diastereoisomer 
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4. CONCLUSION 
Given the results presented in this chapter, the following conclusions can be settled: 
 The in situ generated oxyallyl cations participate in the organocatalyzed asymmetric (4+3) 
cycloaddition with furans under Brønsted acid catalysis promoted by substoichiometric 
amounts of 3g as the most efficient catalyst. 
 The non-stable oxyallyl cations are formed in situ after a regioselective epoxidation in the 
presence of a strong oxidant which epoxidize the most electron-rich alkene. 
 The described method provides excellent results with high yields and enantioselectivities 
with a wide range of allenes and furans containing electron-withdrawing or electron-
donating groups. 
 Especially mentioned is the applicability of the methodology to γ-substituted allenes, 
where no precedents are in the literature. 
 The cycloadducts are formed with four new stereogenic centers totally endo selectively, 
diastereoselectively, highly regioselectively and enantioselectively. 
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1. INTRODUCTION 
The allylation of carbonyl or azomethine compounds is a reaction of great synthetic 
interest because it enables the direct access to homoallylic alcohols and amines (see Scheme 3.1), 
which are useful building blocks widely used in the synthesis of natural products and commercial 
drugs.1 Stereoselective allylation has attracted a wide interest being the asymmetric addition of 
allylmetal reagents to aldehydes and imines one of the most used approaches to this type of 
products. 
 
Scheme 3.1 
In 1983, Denmark and Webber classified the asymmetric addition for different allylation 
reagents to C=X bonds into three major types, named Type I, II and III.2 In the Type I class, 
allyl-metal reagents undergo reaction through the activation of the carbonyl or imine electrophile 
involving a closed six-membered chair-like transition state (see Scheme 3.2).3 The metal acts as a 
Lewis acid to activate the aldehyde or imine and transfers the allyl fragment to the final product 
diastereospecificaly, where the (E)-allyl fragment provides the anti-product and the (Z)-allyl 
fragment affords the syn product. Such complete transfer of stereochemical information is 
explained by a highly organized transition state and theoretical calculations have demonstrated 
that a Zimmerman-Traxler chair-like transition state pathway is the lowest energy one relative to 
other possibilities.4 However, this methodology presents some limitations such as the necessity to 
isolate diastereomerically pure (E) and (Z) allylmetal reagents.5 Allylboron, allyllithium, 
                                                           
1
  For recent reviews: (a) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774. (b) Yus, M.; 
González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595. (c) Huo, H.-X.; Duvall, J. R.; Huang, M.-Y.; Hong, 
R. Org. Chem. Front. 2014, 1, 303. (d) Hall, D. G.; Rybak, T.; Verdelet, T. Acc. Chem. Res. 2016, 49, 2489. (d) 
Diner, C.; Szabó, K. J. J. Am. Chem. Soc. 2017, 139, 2. 
2
  Denmark, S. E.; Weber, E. J. Hel. Chim. Acta 1983, 66, 1655. 
3
  (a) Li, Y.; Houk, K. N. J. Am. Chem. Soc. 1989, 111, 1236. (b) Vulpetti, A.; Gardner, M.; Gennari, C.; Bernardi, A.; 
Goodman, J. M.; Paterson, I. J. Org. Chem. 1993, 58, 1711. (c) Gennari, C.; Fioravanzo, E.; Bernardi, A.; Vulpetti, 
A. Tetrahedron 1994, 50, 8815. (d) Omoto, K.; Fujimoto, H. J. Org. Chem. 1998, 63, 8331. (e) Gajewski, J. J.; 
Bocian, W.; Brichford, N. L.; Henderson, J. L. J. Org. Chem. 2002, 67, 4236. 
4
   Li, Y.; Houk, K. N. J. Am. Chem. Soc. 1989, 111, 1236. 
5
  (a) Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092. (b) Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; 
Brown, H. C. J. Org. Chem. 1986, 51, 432. (c) Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919. 
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allylaluminate and allyltrihalosilane are reagents that are classified to typically undergo reactions 
with aldehydes or imines through Type I pathway. 
 
Scheme 3.2 
On the other hand, Type II allylations involve the use of non-Lewis acidic metal-allyl 
nucleophiles (generally allyl trialkylsilanes or allyl trialkylstannanes), which react with the 
electrophile under the activation of an external Lewis acid, and proceed through an open 
transition state (see Scheme 3.3). The open transition state leads to the most favorable syn 
product due to minimized destabilizing gauche interactions regardless the geometry of the C=C 
bond of the allylmetal reagent.6 
 
Scheme 3.3 
Finally, Type III class allylation involves the use of a Lewis acidic metal-allyl fragment 
which is able to undergo fast E-Z isomerization before undergoing addition to the carbonyl or 
azomethine electrophile, which takes place preferentially via the (E) isomer (see Scheme 3.4). 
The reaction takes place through closed six-membered chair-like transition state, similar to Type 
                                                           
6
   Hayashi, T.; Konishi, M.; Ito, H.; Kumada, M. J. Am. Chem. Soc. 1982, 104, 4962. 
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I reagents, resulting in the anti diastereoisomer.7 Allylchromium reagents are the most used ones 
under this reactivity scheme. 
 
Scheme 3.4 
Several excellent methodologies have been reported for carbonyl allylation using a wide 
range of allylmetal reagents. Among the huge variety of such reagents, allylboron compounds 
have dominated the field across the years, together with allyltrichlorosilanes.8 One of the main 
advantages associated to the use of allylboron reagents is their ease of preparation, broad 
functional group tolerance, high stability, low toxicity and in overall the excellent operational 
simplicity associated to their use as nucleophilic reagents.9 
The allylboration of aldehydes was originally documented in 1964 by Mikhailov and 
Bubnov, who observed the formation of a homoallylic alcohol product from the reaction with 
triallylborane with aldehydes.10 However, it was not until the late 1970s when Hoffmann 
reported the regio- and diastereospecific nature of the additions of the two isomers of 
crotylboronate to aldehydes, resulting in the beginnings of this chemistry.11 Allylic boron 
reagents react with different carbonyl compounds and derivatives such as imines and other 
azomethine derivatives. However, their most common use is in nucleophilic additions to 
aldehydes to produce homoallylic secondary alcohols. In the first 20 years of development, 
                                                           
7
  Hafner, A.; Duthaler, R. O.; Marti, R.; Rihs, G.; Rothe-Streit, P.; Schwarzenbach, F. J. Am. Chem. Soc. 1992, 114, 
2321. 
8
  (a) Denmark, S. E.; Almstead, N. G. In Modern Carbonyl Chemistry, Otera, J., Ed.; Wiley-VCH: Weinheim, 2000; 
pp 299-402. (b) Chemler, S. R.; Roush, W. R. In Modern Carbonyl Chemistry, Otera, J., Ed.; Wiley-VCH: 
Weinheim, 2000; pp 403-490. (c) Denmark, S. E.; Fu, J. Chem. Rev. 2003, 103, 2763. 
9
  Hall, D. G. Pure Appl. Chem. 2008, 80, 913. 
10
  Mikhailov, B. M.; Bubnov, Y. N. Izv. Akad. Nauk. SSSR, Ser. Khim. 1964, 1874. 
11
  (a) Hoffmann, R. W.; Zeiss, H.-J. Angew. Chem. Int. Ed. 1979, 18, 306. (b) Hoffmann, R. W.; Zeiss, H.-J. J. Org. 
Chem. 1981, 46, 1309. 
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works of Brown,12 Roush,13 Masamune14 and Corey15 were determinant in the chemistry of 
carbonyl allylboration to become one of the primary methodological tools in stereoselective 
synthesis (see Figure 3.1). All of those key contributions were based on the use of chiral 
auxiliaries attached to the boronate to achieve stereocontrol on the final product.16 
 
Figure 3.1 
In addition to these chiral reagent-based methodologies, asymmetric catalysis also arises 
as a useful approach to achieve stereocontrol. In fact, one highly explored approach to optically 
enriched homoallyl alcohols or amines is based on the use of an achiral allyl boronate in the 
presence of chiral catalyst. A third possible approach to achieve stereocontrol in this reaction is 
the use of a chiral boron reagent in which the stereochemical information is already placed at the 
allyl residue that is transferred to the electrophilic carbonyl compound or imine and relies on the 
capacity to transfer the chirality to the new formed stereocenter (see Scheme 3.5).17 
 
Scheme 3.5 
                                                           
12
  (a) Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092. (b) Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 
1986, 108, 293. (c) Ramachandran, P. V. Aldrichimica Acta 2002, 35, 23. 
13
  (a) Roush, W. R.; Walts, A. E.; Hoong, L. K. J. Am. Chem. Soc. 1985, 107, 8186. (b) Roush, W. R.; Ando, K.; 
Powers, D. B.; Palkowitz, A. D.; Halterman, R. L. J. Am. Chem. Soc. 1990, 112, 6339. 
14
  (a) García, J.; Kim, B.; Masamune, S. J. Org. Chem. 1987, 52, 4831. (b) Short, R. P.; Masamune, S. J. Am. Chem. 
Soc. 1989, 111, 1892. 
15
  (a) Corey, E. J.; Yu, C.-M.; Kim, S. S. J. Am. Chem. Soc. 1989, 111, 5495. (b) Corey, E. J.; Yu, C.-M.; Lee, D.-H. J. 
Am. Chem. Soc. 1990, 112, 878. 
16
  (a) Ishiyama, T.; Ahiko, T.-A.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 12414. (b) Rauniyar, V.; Hall, D. G. J. Am. 
Chem. Soc. 2004, 126, 4518. 
17
  (a) Lachance, H.; Hall, D. G. Allylboration of Carbonyl Compounds. Organic Reactions; John Wiley & Sons, Inc.: 
New York, 2004. (b) Mikhailov, B. M.; Bubnov, Y. N. Organoboron Compounds in Organic Synthesis, OPA, 
Amsterdam B. V., 1984, 571. (c) Hoffmann, R. W. Pure Appl. Chem. 1988, 60, 123. (d) Hoffmann, R. W.; Niel, G.; 
Schlapbach, A. Pure Appl. Chem. 1990, 62, 1993. 
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In the following pages, relevant examples of this third approach will be discussed due to 
their direct relationship with this research. 
A good example on the capacity of chiral α-substituted allylic boronates to transfer 
stereochemical information to the final product was reported by Hoffmann for the synthesis of 
enantioenriched homoallylic alcohols by addition to achiral aldehydes.17c A chirally modified 
allyl boronate was able to differentiate the two enantiotopic faces of the aldehyde and allow an 
enantioselective formation of the homoallylic alcohols. These reagent-controlled additions 
proceed with near perfect transfer of chirality to provide two diastereomeric products (see 
Scheme 3.6). The obtained (Z) and (E) homoallylic alcohols were geometrical isomers with 
opposite stereochemistry at the new stereocentre. Remarkably, the Z/E ratio could be tuned 
through the rational selectivity of the substituents at the boronate moiety. 
 
Scheme 3.6 
In fact, Hoffmann,18 Pietruszka and Schone19 illustrated that the E/Z ratio of the 
homoallylic alcohol products in the allylation with secondary alkyl allylboronates was 
determined by the steric hindrance of the boronate fragment (see Figure 3.2). The Z-isomer was 
more likely generated with larger groups, such as pinacolate or benzopinacolate in the boronate 
moiety (R3), due to destabilization of the transition structure (TS2) by a (dominant) gauche steric 
interaction between the boronic ester and the pseudo-equatorial α-substituent (R2).18,20 However, 
                                                           
18
  (a) See Ref. 14c and 14d. (b) Hoffmann, R. W.; Weidmann, U. J. Organomet. Chem. 1985, 195, 137. 
19
  Pietruszka, J.; Schone, N. Eur. J. Org. Chem. 2004, 5011. 
20
  Hesse, M. J.; Butts, C. P.; Willis, C. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2012, 51, 12444. 
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TS1 is also destabilized by 1,3-diaxial interactions when R2 substituent is oriented in the axial 
position.21 This is the reason of poor selectivity observed; the use of Lewis acids to modify the 
geometry of these transition states, and thus the stereoselectivity, has been studied by the groups 
of Hall and later Roush.22 Dipolar effects also influence in the stabilization of the transition state 
TS1, thus when polar substituents were used (R2) such as halogen or alkoxy groups, dipolar 
effects tend to dominate and further favor the transition structure TS1 with the pseudoaxial C-R2 
bond oriented anti to the axial B-O bond leading to the formation of Z and E homoallylic alcohol 
in modest selectivities.18b 
 
Figure 3.2 
  
                                                           
21
  Carosi, L.; Hall, D. G. Angew. Chem. Int. Ed. 2007, 46, 5913. 
22
  (a) Carosi, L.; Lachance, H.; Hall, D. G. Tetrahedron Lett. 2005, 46, 8981. (b) Chen, M.; Roush, W. R. Org. Lett. 
2010, 12, 2706. 
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The group of Aggarwal has disclosed two different and diastereodivergent methodologies 
for overcoming this issue with aldehydes, providing densely functionalized homoallylic alcohols 
in high yields with almost complete diastereo- and enantioselectivity.23 The first method relies on 
transforming chiral α-substituted crotylBpin reagents into their corresponding borinic esters via 
sequential treatment with nBuLi and trapping the alkoxyde intermediate with TFAA, and 
subsequently showing high reactivity and selectivity with a range of representative aldehydes 
(see Scheme 3.7). The reaction is initiated by the addition of nBuli to the boronic ester at low 
temperatures generating the ate complex which might be in equilibrium with the ring opened and 
coordinately unsaturated borinic ester. Although the equilibrium would lie on the side of the ate 
complex, the higher reactivity of the borinic ester was expected to be trapped by the addition of 
TFAA. Addition of aldehyde led to a six-membered chair-transition state obtaining almost 
complete E-selectivity for homoallylic alcohols due to a less sterically environment around boron 
avoiding clashes between the equatorial α-substituent at the transition state. Evidences of the 
intermediates were obtained following the course of the allylation reaction by 11B NMR. This 
strategy has been applied in total synthesis for the preparation of natural products such as (–)-
Clavosolide A developed by Aggarwal.24 
 
Scheme 3.7 
The second approach by this group involves the use of chiral α,α-disubstituted allylic 
pinacol boronic esters bearing an alkyl group in β-position with a range of different aldehydes.25 
In this case, a bulkier aryl group prefers the axial position of the transition state in order to avoid 
                                                           
23
  Chen, J. L.-Y.; Scott, H. K.; Hesse, M. J.; Willis, C. L.; Aggarwal, V. K. J. Am. Chem. Soc. 2013, 135, 5316. 
24
  Millán, A.; Smith, J. R.; Chen, J. L.-Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2016, 55, 2498. 
25
  Hesse, M.; Essafi, S.; Watson, C.; Harvey, J.; Hirst, D.; Willis, C.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2014, 53, 
6145. 
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steric clash between both the bulky pinacolate moiety and the adjacent methyl group, giving 
access to (Z)-homoallylic alcohols in complete diastereoselectivity (see Scheme 3.8). Notably, 
this methodology allows access to enantioenriched homoallylic alcohols with adjacent 
stereocenters and a tetrasubstituted olefin. 
 
Scheme 3.8 
Imines can also undergo allylation reactions with chiral boron reagents which are very 
attractive way in that they provide a route to homoallylic amines, which as mentioned before, are 
useful synthetic intermediates in natural product synthesis and drug discovery.26 However, the 
addition of allylic boronates to imines is much slower than the additions to the corresponding 
aldehyde and can often be less selective. This is due to the decreased polarization of the C=N 
double bond and to the fact that imines are not always configurationally stable and may undergo 
E/Z isomerization or even tautomerization to the corresponding enamine in the case of enolizable 
imines. Nevertheless, and due to the preference of imines to exist in an E-geometry, they are 
expected to have higher activation barriers compared with carbonyl analogues expecting different 
stereoselectivity due to unfavorable 1,3-diaxial interactions that can occur in the transition state 
(see Figure 3.3).27 
 
Figure 3.3 
                                                           
26
  (a) Bloch, R. Chem. Rev. 1998, 98, 1407. (b) Ding, H.; Friestad, G. K. Synthesis 2005, 2815. (c) Kobayashi, S.; Mori, 
Y.; Fossey, J. S.; Salter, M. M. Chem. Rev. 2011, 111, 2626. 
27
  Yamamoto, Y.; Komatsu, T.; Maruyama, K. J. Org. Chem. 1985, 50, 3115. 
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Due to the relation with the present project, allylboration reactions with imines via 
chirality transfer from C-chiral allylboronates will be only discusses in the following pages.28 
An example to accessing homoallylic amines in enantioselective fashion through chiral 
allylboronate chemistry is shown in Scheme 3.9 and relies on the use of prochiral allenes which 
in the presence of a palladium catalyst and a chiral ligand form a chiral diboron intermediate that 
contains both allylboronate and vinylboronate functional groups that subsequently undergo 
addition to imines, observing excellent levels of chirality transfer.29 Morken developed a one-pot 
tandem allene diboration/imine allylation process with in situ generated primary imines through 
reaction of an aldehyde and ammonium acetate. Considering the selectivity achieved in the allene 
diboration reaction step, the level of chirality transfer in the subsequent allylation reaction often 
approaches 99%. It has to be highlighted that the enantiomer of the ligand used in the diboration 
reaction led to (S) configuration of the intermediate (R2=Ph) and the final product was isolated 
with the (R) configuration. As a consequence, it is likely that the allylation reaction proceeds 
through a transition state structure similar to the one expected for Type I allylmetal compounds.30 
In this model, R1 group would place in a pseudo-axial position due to the destabilizated 1,2-strain 
present in the diastereomeric transition structure B. 
 
Scheme 3.9 
  
                                                           
28
  For some examples of allylborations with imines through B-chiral allylic boronates: (a) Chataigner, I.; Zammatio, F.; 
Lebreton, J.; Villiéras, J. Synlett 1998, 275. (b) Chen, G.-M.; Ramachandran, P. V.; Brown, H. C. Angew. Chem. Int. 
Ed. 1999, 38, 825. (c) Wu, T. R.; Chong, J. M. J. Am. Chem. Soc. 2006, 128, 9646. 
29
  Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2006, 128, 74. 
30
  (a) See Ref. 16e and 16d. (b) Roush, W. R. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon: 
Oxford, 1991. 
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A direct application of chiral allylboration of imines towards the synthesis of relevant 
heterocyclic structures was reported by Aggarwal,31 by combining the use of C-chiral allyl 
boronates with the amination of tertiary potassium trifluoroborates with alkyl azides for the 
application towards cyclic substrates particularly with certain 2,2-disubstituted piperidines which 
have emerged as promising neurokinin 1 antagonists that possesses unique antidepressant, 
anxiolytic and antiemetic properties (see Scheme 3.10).32 
 
Scheme 3.10 
Aggarwal has also reported the possibility of using the traditionally unreactive 3,3-
disubstituted allylic pinacol boronic esters33 in the allylation of imines.34 As mentioned, this type 
of boronic esters are not sufficiently reactive to react with ketones and imines by themselves. 
However, Aggarwal demonstrated the enhanced reactivity of borinic esters in the allylation of 
aldehydes obtaining high diastereo- and enantioselectivities. Aggarwal showed the versatility of 
the methodology in the use of challenging imines as electrophiles for the unprecedented 
construction of two adjacent quaternary stereogenic centers (see Scheme 3.11). 
 
Scheme 3.11 
The borinic ester was prepared in situ after the sequential addition of nBuli to the 
corresponding boronic ester followed by quenching with TFAA. Next, these boronic esters can 
                                                           
31
  Bagutski, V.; Elford, T. G.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2011, 50, 1080. 
32
  Xiao, D.; Lavey, B. J.; Palani, A.; Wang, C.; Aslanian, R. G.; Kozlowski, N.-Y.; Shih, A. T. Tetrahedron Lett. 2005, 
46, 7653. 
33
  Hoffmann, R. W.; Sander, T. Chem. Ber. 1990, 123, 145. 
34
  Chen, J. L.-Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2014, 53, 10992. 
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react smoothly with different aldimines and ketimines to give E-homoallylic amines exclusively 
in good yields and complete enantiospecificity (see Scheme 3.11). The reaction proceeded better 
with aldimines than with ketimines in terms of reaction yield. A clear advantage of this 
methodology is that it is completely stereodivergent allowing the preparation of the four possible 
stereoisomers by simply changing the E/Z geometry of the allylboronate and the absolute 
configuration of its α-stereocenter. 
In summary, despite the long history of allylic boronates being used as nucleophiles in the 
addition reactions to carbonyl compounds and derivatives, it is only in the past few years that 
their full potential has begun to be fully realized. In particular, the use of enantiopure 
allylboronates to obtain homoallylic amines through enantiospecific addition has not been very 
extensively investigated. As it is shown in the different examples presented from the literature, 
allylation of imines with the α-chiral allylboronates performs with high or excellent chirality 
transfer as it happens with aldehydes, making this methodology a powerful approach.35 Despite 
these significant advances in imine allylboration, some challenges in terms of substrate generality 
and control of stereoselectivity still remain unexplored. 
  
                                                           
35
  (a) Pietruszka, J.; Schöne, N.; Frey, W.; Grundl, L. Chem. Eur. J. 2008, 14, 5178. (b) Hoffmann, R. W.; Landmann, 
B.; Tetrahedron Lett. 1983, 24, 3209. (c) Hoffmann, R. W.; Landmann, B. Angew. Chem. Int. Ed. 1984, 23, 437. (d) 
Hoffmann, R. W.; Landmann, B. Angew Chem. Int. Ed. 1986, 25, 189. (e) Hoffmann, R. W.; Wolff, J. J. Chem. Ber. 
1991, 124, 563. 
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2. SPECIFIC OBJECTIVES AND PRECEDENTS IN THE GROUP 
The group of Prof. A. Malkov in Loughborough University, where I incorporated in a 
context of a short stay, had recently reported a novel method for the allylation of aldehydes that 
involves an efficient kinetic resolution of chiral racemic allyl boronates under chiral Brønsted 
acid-catalysis.36 The reaction proceeded through high face- and Z-selective fashion, leading to Z-
homoallylic alcohols as major products (see Scheme 3.12). The reaction tolerated a wide range of 
aldehydes with a very high Z-selectivity (>25:1). In this initial report, emphasis was placed on 
the synthesis of the homoallylic alcohols as products, but the potential applicability of this 
approach to resolve the starting allylboronate reagents had not been covered at that moment. 
 
Scheme 3.12 
In this context, the aim of the present project is to establish the conditions for the 
efficient kinetic resolution of chiral racemic secondary allylboronates through 1,2-addition to 
benzaldehyde employing chiral Brønsted acids as catalyst and to use the resolved chiral 
allylboronates reagents in the allylation of primary imines for the synthesis of 
enantioenriched N-unsusbtituted homoallylic amines (see Scheme 3.13). 
 
Scheme 3.13 
  
                                                           
36
  Incerti-Pradillos, C. A.; Kabeshov, M. A.; Malkov, A. V. Angew. Chem. Int. Ed. 2013, 52, 5338. 
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Considering all this aspects, the following work plan was designed: 
1. Optimization of the Kinetic Resolution step: Enantioselective synthesis of allylboronates 
As it was mentioned, the previous report by the group of Prof. Malkov was not focused in 
the potential of the methodology to achieve an efficient resolution of the racemic allylboronates 
that would lead to the isolation of these reagents as enantiopure materials. For that reason, 
conditions to obtain this enantiopure boronates would be first needed to be optimized working on 
the allylation of benzaldehyde with boronate 7b under Brønsted acid catalysis conditions 
reported initially (see Scheme 3.14). 
 
Scheme 3.14 
2. Allylation of primary imines: Reaction optimization 
Once the optimal reaction conditions for the resolution of the starting boronates are 
established, we will proceed to explore the use of these chiral substituted allylboronates for the 
allylation reaction of imines (see Scheme 3.15). In particular, we decided to face the challenge of 
using primary imines as substrates that would allow the direct obtention of N-unprotected 
homoallyl amines without the need for deprotection. 
 
Scheme 3.15 
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3. Scope of the reaction: Enantiospecific allylation of imines 
Once the optimal conditions for the allylation process using the enantiopure boronate had 
been established with the model reaction, a variety of imines with different substitution patterns 
will be evaluated in combination with the enantiopure allylboronate obtained before in order to 
explore the scope of the reaction (see Scheme 3.16). 
 
Scheme 3.16 
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3. RESULTS AND DISCUSSION 
Having reviewed the representative examples found in the literature on this topic and after 
establishing the specific objectives of the project and a suitable work plan, we will proceed with 
the discussion of the most relevant results obtained in this part of our research. 
3.1 Optimization of the Kinetic Resolution step: Enantioselective synthesis of 
allylboronates 
The starting allylboronates are prepared in a racemic form from the corresponding diol 
through a one-pot reaction which starts with the formation of the dialkoxyborane intermediate 
followed by a transmetallation step with crotyl magnesium bromide. The starting diols are either 
commercially available or prepared following a known procedure that involves the pinacol 
coupling of 3-pentenone in the presence of samarium iodide (see Scheme 3.17). 
 
Scheme 3.17 
Once the starting materials were prepared, we proceeded to study their kinetic resolution 
using the conditions reported previously (see Scheme 3.12). Under these reaction conditions and 
adjusting the number of equivalents of boronate and benzaldehyde to an accurate 2:1 
boronate/benzaldehyde relationship, allylboronate (S)-7b was isolated in 97% ee and in 45% 
yield out of a maximum of 50% (see Scheme 3.18). The lower reactivity of the the (S) 
enantiomer of the starting material towards the 1,2-addition with benzaldehyde in the presence of 
(R)-TRIP prhosphoric acid catalyst is in accordance with the mechanistic studies carried out by 
Malkov.36 
 
Scheme 3.18 
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It must be highlighted that the enantiomeric excess of the boronate could not be directly 
determined at this point. This was carried out by utilizing this enantiopure boronate in a 
subsequent allylation reaction with benzaldehyde under the conditions reported by Hoffmann that 
are known to proceed with complete chirality transfer (see Scheme 3.19).17c 
 
Scheme 3.19 
3.2 Allylation of primary imines: Reaction optimization 
Once we had optimized the reaction conditions for the kinetic resolution of the racemic 
secondary allyl boronate, we started with the optimization of the allylation of imines. As model 
reaction we combined benzaldehyde with ethanolic NH3 and next, (±)-7a as the allylboronate 
reagent has added (see Table 3.1).37 The reaction involves the in situ formation of the primary 
imine by condensation of the aldehyde with ammonia and once this reaction is completed the 
boronate had to be added to the reaction mixture. In an initial prospective study to optimize the 
yield of the reaction we employed racemic starting materials and in particular, we decided to 
employ boronate (±)-7a because it is much more easily accessible from commercially available 
starting materials. 
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Table 3.1 Optimization of the reactiona 
 
Entry Boronate eq  Aldehyde eq NH3 eq Z/E ratiob Yield (%) 
1 1.0 1.2 10 5.3:1 47 
2 1.0 1.2 20 5.9:1 52 
3 1.0 1.2 30 5.9:1 60 
4 1.2 1.0 30 6.1:1 65 
5c 1.2 1.0 30 6.5:1 75 
6c 1.2 1.0 40 6.5:1 74 
aAldehyde in ammonia solution in EtOH (2M) was stirred at -10 ºC for 2h. To the solution allylboronate was added 
dropwise. The mixture was stirred at -10 ºC for 3h and then at rt for 1h before workup. bMeasured after column 
chromatography in the 1H-NMR Spectra. cAldehyde in 30 wt% aqueous ammonia and EtOH was stirred at room 
temperature for 30 min. To the solution was added allylboronate (see Experimental Section for more details). 
In our first experiment, the reaction was carried out using a slight excess of benzaldehyde 
with respect to the boronate reagent, together with 10 equivalents of ammonia (entry 1). Under 
these conditions the corresponding homoallylic amine (±)-9a was isolated in moderate yield but 
in a very promising 5.3:1 Z:E ratio (entry 1). It should be mentioned that some homoallylic 
alcohol byproduct was also identified in the crude reaction mixture due to a non-complete 
condensation of the aldehyde with NH3. We next carried out the reaction by increasing the 
amount of ammonia, observing progressively better yields and also a slight increase in the Z/E 
ratio (entries 2-3). We finally proceeded to carry out the same set of experiments but working in 
the presence of a slight excess of boronate reagent with respect to benzaldehyde, observing that 
adduct (±)-9a was obtained in 65% yield and a 6.1:1 Z/E ratio (entry 4). In a subsequent 
experiment using aqueous ammonia instead of the ethanolic solution of NH3, and also working at 
room temperature, we were able to obtain a better yield and a slightly higher Z/E ratio in shorter 
reaction times (entry 5). Increasing the amount of ammonia under these conditions did not end in 
better results (entry 6). 
With these results in hand, we decided to evaluate the reaction using enantiopure boronate 
(S)-7b under these optimized conditions (see Scheme 3.20). The reaction proceeded with similar 
levels of efficiency, providing adduct 9a in 76% yield, a 8.3:1 Z/E ratio and with an excellent 
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97% enantiomeric excess, which also indicated a complete chirality transfer from the boronate to 
the final product. It should be mentioned that the enantiomeric excess of 9a had to be analyzed in 
the acetylated product because conditions could not be found for the separation of both 
enantiomers under all HPLC columns available. 
 
Scheme 3.20 
3.3 Scope of the reaction 
Once the best conditions for carrying out the allylation of benzaldehyde-derived primary 
imine and boronate had been established, we decided to extend the methodology to other 
aldehydes with different substitution patterns as shown in Table 3.2 
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Table 3.2 Scope of the reaction with substituted aldehydesa 
 
Entry R Compound Z/E ratiob Yieldc (%) ee (Z/E)d (%) 
1 p-MeC6H4 9b 6.0:1 62 >99/95 
2 p-OMeC6H4 9c 6.4:1 74 98/95 
3 o-OMeC6H4 9d 9.0:1 61 85/73 
4 m-OMeC6H4 9e 5.6:1 59 >99/96 
5 p-BrC6H4 9f 6.0:1 73 98/98 
6 p-ClC6H4 9g 5.5:1 82 99/99 
7 p-FC6H4 9h 5.4:1 61 99/99 
8 2-furyl - n.d. <10 - 
9 3-furyl - n.d. <5 - 
10 CH2CH2C6H5 9i n.d. 73 93/93 
11 n-heptyl 9j 5.6:1 60 96/99 
12 c-C6H11 9k 6.3:1 34 91/94 
13 trans-CH=CHC6H5 9l 6.0:1 66 99/n.d. 
aThe reaction was carried out with 1 equivalent of aldehyde, 1.2 eq of boronate (S)-7b and 30 equivalents of aqueous 
solution of ammonia and EtOH. bMeasured after column chromatography in the 1H-NMR Spectra. cCombined yield of the 
diastereomeric mixture isolated after flash chromatography. dEnantiomeric excess of 9b-l determined by HPLC analysis 
of the pure product after acetylation or benzoylation to the corresponding product 10b-l. 
As it is shown in Table 3.2, the reaction tolerated well the use of benzaldehyde derivatives 
with both electron-donating substituents (entries 1-4) and electron withdrawing substituents 
(entries 5-7) with an important increment in the E/Z ratio when ortho-substituted aryl groups at 
the starting aldehyde are applied; although, the enantioselectivity was slightly lower on that case. 
However, aldehyde derivatives with heteroaromatic substituents (entries 8-9) did not afford the 
homoallylic amine product. Aldehydes containing alkyl substituents were also tested in the 
reaction with success (entries 10-12); 3-phenylpropanal lead to high yields and excellent 
enantiocontrol (entry 10) while the use of an aliphatic aldehyde with a longer alkyl chain  
suppose a slightly lower yield but still obtaining a high enantiocontrol (entry 11). On the 
contrary, the utilization of cyclohexanecarboxaldehyde (entry 12) provided adduct 9k in low 
yield but with high Z/E ratio and excellent enantioselectivity. Cinnamaldehyde also performed 
well in the reaction with good yields and enantiocontrol (entry 13). In general, it can be seen that 
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the reaction proceeded with good diastereoselectivity and with an absolute transfer of chirality 
from the enantiopure boronate to the homoallylic primary amine products with high yields. 
As it has mentioned before, the enantiomeric excess of the primary homoallylic amines 
was not possible to analyze under all HPLC columns available, thus we had to acetylate the final 
products, and in the case of 9i and 9k it was necessary to benzoylate them with a high conversion 
(see Scheme 3.21). 
 
Scheme 3.21 
Finally, the absolute configuration of the obtained major diastereoisomer was established 
by X-Ray analysis of compound 10h. We could grow a crystal from compound 10h after 
acetylation of primary amine 9h. The crystallographic analysis showed an absolute configuration 
of (S,Z) which was extended to other amines (see Figure 3.4). 
 
Figure 3.4 
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3.4 Mechanistic proposal 
Based on the obtained stereochemical outcome of the reaction, we present herein a 
mechanistic proposal that can explain the stereoselective outcome of the reaction. The allylation 
of imines is thought to proceed via cyclic six-membered transition state with a complete transfer 
of chirality from chiral allylboronate to the newly formed stereogenic center of the amine (see 
Scheme 3.22). There are four competing transition states for this process and the energy 
difference will determine the asymmetric induction. When α-substituted group (methyl) is in 
equatorial position gauche destabilizing interactions are present in the transition states TSII and 
TSIV which favour the formation of Z-homoallylic amines.38 The spatial disposition of the 
methyl group with respect to the π-bond will determine the energy and coefficients of the π-
orbital, being the most reactive conformation the one in which there is no π-σ* delocalisation as 
it happens with axial conformation where the dihedral angle between the π-orbital and σ*-orbital 
belongs to 90º. For transition states TSI and TSII there are also 1,3-diaxial interactions which 
favour the formation of (S) enantiomer as major Z-amine which is in accordance with 
experimental results. It was assumed that the major enantiomer of E-homoallylic amine would be 
(R)-enantiomer due to a more hindered and destabilizing transition state TSII which is also in 
accordance with literature precedents using aldehydes as electrophiles.17c When bulky boronic 
esters are used an increase in geometrical selectivity is expected as it has be mentioned in the 
introduction of the present Chapter. This is also in agreement with the observed experimental 
work, when bulkier group like ethyl glycol boronate was used the diastereoselectivity increased 
with respect to less bulkier group derived from pinacol boronate. 
 
Scheme 3.22 
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4. CONCLUSIONS 
Given the results presented in this chapter, the following conclusions can be advanced: 
 The kinetic resolution of racemic secondary allylboronates through allylation reaction 
with benzaldehyde under TRIP catalyst has been accomplished with high yield. 
 This enantiopure allylboronate has been used in the allylation reaction with primary 
imines to get enantiopure homoallylic primary amines, which are interesting scaffolds in 
the synthesis of many natural products. 
 The reaction proceeds through in situ formation of imines by condensation of the 
aldehyde with ammonia in ethanol solution. The allylation reaction with enantiopure 
boronates proceeds with a complete transfer of chirality to give Z homoallylic primary 
amines as major diastereoisomers. 
 The allylation reaction with enantiopure boronates proceeds with an absolute transfer of 
chirality through a six-membered transition state to give Z homoallylic amines as major 
diastereoisomer. 
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FINAL CONCLUSIONS 
The present work gathers different synthetic transformations in which the common feature 
is the use of BINOL-based Brønsted acid catalysts with the aim to obtain enantiopure products. 
Experimental results collected during the accomplishment of this work led to the following 
conclusions. 
Enantioselective (4+3) cycloadditions between allenamides and furans. It has been 
demonstrated that the use of catalytic amounts of a chiral Brønsted acid could promote the 
enantioselective (4+3) cycloaddition between oxyallyl cations which are in situ formed after a 
regioselective epoxidation of allenamides in the presence of a strong oxidant, and furans as 
electron-rich diene. Described method provided the endo oxabicyclo[3.2.1]octane scaffold in 
excellent results diastereoselectively and highly regioselective with high yields and 
enantioselectivities with a wide range of allenes and furans containing different electron-
withdrawing or electron-donating groups. 
Allylation of imines using enantiopure boronates. The work verified that chiral 
Brønsted acid could catalyze the kinetic resolution of racemic allylboronates through allylation 
reaction with benzaldehyde which takes place via six-membered chair-like transition state to 
obtain enantiopure allylboronates that can be used in the allylation reaction with primary imines 
to get enantiopure homoallylic primary amines. (Z)-Homoallylic amines has proven to be the 
major diastereoisomer after the allylation reaction via transfer of chirality with in situ formed 
imines by condensation of the aldehyde with ammonia in ethanol solution and enantiopure 
boronates. 
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1. GENERAL METHODS AND MATERIALS 
NMR: Monodimensional and/or bidimensional nuclear magnetic resonance proton and carbon 
spectra (1H NMR and 13C NMR) were acquired at 25 ºC on a Bruker AC-300 spectrometer (300 
MHZ for 1H and 75.5 MHz for 13C) and a Bruker AC-500 spectrometer (500 MHz for1H and 
125.7 MHz for 13C) at indicated temperature. Chemical shifts (δ) are reported in ppm relative to 
residual solvent signals (CHCl3, 7.26 ppm for 1H NMR, CDCl3, 77.16 ppm for 13C NMR; 
CH3OH, 4.87 ppm and 3.31 ppm for 1H NMR, CD3OD, 49.1 ppm for 13C NMR; DMSO-d6, 2.50 
ppm for 1H NMR and 39.5 ppm for 13C NMR) and coupling constants (J) in hertz (Hz). The 
following abbreviations are used to indicate the multiplicity in NMR Spectra: s, singlet; d, 
doublet; t, triplet; q, quartet; app s, apparent singlet; app d, apparent doublet; dd, doublet of 
doublets; ddd, doublet of doublets of doublets; dq, doublet of quartets; m, multiplet; bs, broad 
signal. 13C NMR spectra were acquired on a broad band decoupled mode using DEPT 
experiments (Distorsionless Enhancement by Polarization Transfer) for assigning different types 
of carbon environment. Selective n.O.e., NOESY, COSY, HSQC and HMBC experiments were 
acquired to confirm precise molecular conformation and to assist in deconvoluting complex 
multiplet signals.1 
IR: Infrared spectra (IR) were measured in a Jasco FT/IR 4100 in the interval between 4000 and 
400 cm-1 with a 4 cm-1 resolution. Only characteristic bands are given in each case. 
MS: Mass spectra (MS) were recorded on an Agilent 7890A gas chromatograph coupled to an 
Agilent 5975C quadrupole mass spectrometer under electronic impact ionization (EI) 70 eV. The 
obtained data is presented in mass units (m/z) and the values found in brackets belong to the 
relative intensities comparing to the base peak (100%). 
HRMS: High-resolution mass spectra on an Acquity UPLC coupled to a QTOF mass 
spectrometer (SYNAPT G2 HDMS) using electrospray ionization (ESI+ or ESI-) or on a 
Micromass GCT spectrometer using chemical ionization (CI). 
HPLC: The enantiomeric excess (ee) of the products was determined by High Performance 
Liquid Chromatography on a chiral stationary phase in a Waters 2695 chromatograph coupled to 
                                                           
1
  Kinss, M.; Sanders, J. K. M. J. Mag. Res. 1984, 56, 518. 
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a Waters 2998 photodiode array detector. Daicel Chiralpak AD-H, IA, IC, AY-3 and Chiralcel 
OD-3 and OZ-3 columns (0.46 × 25 cm) were used; specific conditions are indicated for each 
case. 
M.p.: Melting points were measured in a Buchi B-540 apparatus in open capillary tubes and are 
uncorrected. 
Optical rotations [α]D20: were measured at 20 ºC on a Jasco P-2000 polarimeter with sodium 
lamp at 589 nm and a path of length of 1 dm. Solvent and concentration are specified in each 
case. 
X-ray: Data collections were performed in an Agilent Supernova diffractometer equipped with 
an Atlas CCD area detector, and a CuKα micro-focus source with multilayer optics (λ = 
1.54184Å, 250µm FWHM beam size). The sample was kept at 120 K with a Oxford 
Cryosystems Cryostream 700 cooler. The quality of the crystals was checked under a polarizing 
microscope, and a suitable crystal or fragment was mounted on a Mitegen MicromountTM using 
Paratone N inert oil and transferred to the diffractometer. 
Miscellaneous: Analytical grade solvents and commercially available reagents were used 
without further purification. Anhydrous solvents were purified and dried with activated 
molecular sieves prior to use.2 EtCN was distilled over CaH2 prior to use. For reactions carried 
out under inert conditions, the argon was previously dried through a column of P2O5 and a 
column of KOH and CaCl2. All the glassware was dried for 12 hours prior to use in an oven at 
140 ºC, and allowed to cool under a dehumidified atmosphere.3 Reactions at reduced 
temperatures were carried out using a Termo Haake EK90 refrigerator. Reactions were 
monitored using analytical thin layer chromatography (TLC), in pre-coated silica-backed plates 
(Merck Kiesegel 60 F254). These were visualized by ultraviolet irradiation, p-anisaldehyde, 
phosphomolybdic acid or potassium permanganate dips.4 For flash chromatography Silicycle 40-
63, 230-400 mesh silica gel was used.5 For the removal of the solvents under reduced pressure 
Büchi R-210 rotatory evaporators were used. 
                                                           
2
  Armarego, W. L. F.; Chai, C. L. L. Purification of Laboratory Chemicals, 7th ed.; Elsevier: Oxford, 2012. 
3
  Kramer, G. W.; Levy, A. B.; Midland, M. M. Organic Synthesis via Boranes, John Wiley & Sons, New York, 1975. 
4
  Stahl, E. Thin Layer Chromatography, Springer Verlag: Berlin, 1969. 
5
  Still, W. C.; Kahn, H.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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2. ENANTIOSELECTIVE (4+3) CYCLOADDITIONS BETWEEN 
ALLENAMIDES AND FURANS 
2.1 Synthesis of allenes 1a-p 
Scheme SI-1. General Overview of the Synthesis of Allenes 1a-p 
Synthesis of Protected Amines SIa-k. Lactam SI1a was obtained from commercial sources. 
SIb-f,6 SI1g7 and SIh-k8 were prepared following the procedure described in the literature. 
Spectroscopic data were consistent with those reported in the literature. 
General Procedure A (GP-A) for the Synthesis of Propargyl Amides, Tosylamides or 
Carbamates SI2a-k. Products SI2a-k were prepared following the procedure described in the 
literature9 with some modifications: Corresponding nitrogen derivative SI1a-k (10 mmol, 1 eq) 
was dissolved in dry DMF (0.33 M) and cooled to 0ºC and NaH (12 mmol, 60 wt. % in mineral 
oil, 1.2 eq) was added in one portion. After stirring for 30 min at 0ºC, the corresponding 
propargyl bromide (14 mmol, 1.4 eq) was added and the mixture was stirred at room temperature 
for 16 h. The resulting mixture was quenched with a saturated aqueous solution off NH4Cl and 
extracted with Et2O (3 × 20 mL). The combined organic phases were washed with brine or 5% 
                                                           
6
 Kamal, A.; Reddy, J. S.; Bharathi, E. V.; Dastagiri, D. Tetrahedron Lett. 2008, 49, 348. 
7
  González-Gómez, A.; Añorbe, L.; Poblador, A.; Domínguez, G.; Pérez-Castells, J. Eur. J. Org. Chem. 2008, 1370. 
8
 Kumar, K. S.; Iqbal, J.; Pal, M. Tetrahedron Lett. 2009, 50, 6244. 
9
 Tayama, E.; Sugai, S. Tetrahedron Lett. 2007, 48, 6163. 
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aq. solution of LiCl. Products SI2a-k was used without further purification in the next step. 
Spectroscopic data of SI2a10 and SIb-k9 were in agreement with those reported in the literature. 
Products SI2l-p were purified by FC on silica gel (petroleum ether/EtOAc). Spectroscopic data 
for SI2l11 were in agreement with those reported in the literature. 
tert-Butyl (4-methoxyphenyl)(pent-2-yn-1-yl)carbamate, SI2m. Following 
GP-A, SI2m (330 mg, 1.14 mmol, 52%) was isolated by FC (petroleum 
ether/AcOEt, 19:1 to 8:2) on silica gel as colorless oil, starting from tert-butyl 
(4-methoxyphenyl)carbamate (500 mg, 2.2 mmol, 1 eq) in DMF (11 mL, 
0.2M), NaH 60 wt. % in mineral oil (100 mg, 2.6 mmol, 1.2 eq) and 1-bromo-2-pentyne (0.32 
mL, 3.1 mmol, 1.4 eq). Rf= 0.8 (petroleum ether/AcOEt, 8:2). 1H NMR (300 MHz, CDCl3) δ 
7.20 (d, J = 8.9 Hz, 2H, Carom-H), 6.84 (d, J = 8.9 Hz, 2H, Carom-H), 4.27 (t, J = 2.0 Hz, 2H, 
NCH2), 3.78 (s, 3H, OCH3), 2.15 (qt, J = 7.5, 2.2 Hz, 2H, CH2), 1.42 (s, 9H, 3×CH3), 1.08 (t, J = 
7.5 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ 157.8 (Carom-O), 154.6 (C=O), 135.3 (Carom), 
128.0 (Carom-H), 113.8 (Carom-H), 85.4 (C≡C), 80.5 (C(CH3)3), 75.6 (C≡C), 55.4 (OCH3), 40.3 
(NCH2), 28.4 (C(CH3)3), 13.9 (CH3), 12.5 (CH2). IR (neat): 2976 (C-H st), 1698 (C=O st), 1249 
(C-O-C st as), 1026 (C-O-C st sy) cm-1. MS (EI) m/z (%): 289 (3, M+), 233 (46), 189 (90), 122 
(100). HRMS: Calculated for [C17H23NO3Na]+: 312.1576 [M+Na]+; found: 312.1582. 
tert-Butyl (3-cyclohexylprop-2-yn-1-yl)(4-methoxyphenyl)carbamate, 
SI2n. Following GP-A, SI2n (2.67 g, 7.8 mmol, 65%) was isolated by FC 
(petroleum ether/AcOEt, 19:1 to 8:2) on silica gel as colorless oil, starting 
from tert-butyl (4-methoxyphenyl)carbamate (2.68 g, 12 mmol, 1 eq) in 
DMF (60 mL, 0.22M), NaH 60 wt. % in mineral oil (600 mg, 14.4 mmol, 1.2 eq) and (3-
Bromoprop-1-yn-1-yl)cyclohexane12 (3.38 g, 21.6 mmol, 1.8 eq). Rf= 0.52 (petroleum 
ether/AcOEt, 9:1). 1H NMR (300 MHz, CDCl3) δ 7.21 (d, J = 8.9 Hz, 2H, Carom-H), 6.85 (d, J = 
8.9 Hz, 2H, Carom-H), 4.29 (bs, 2H, NCH2), 3.79 (s, 3H, OCH3), 2.39-2.29 (m, 1H, CH), 1.78-
1.56 (m, 4H, 2×CH2), 1.56-1.15 (m, 15H, 3×CH3+3×CH2). 13C NMR (75 MHz, CDCl3) δ 157.9 
(Carom-O), 154.7 (C=O), 135.4 (Carom), 128.1 (Carom-H), 113.9 (Carom-H), 85.3 (C≡C), 80.5 
                                                           
10
 Wei, L.-L.; Mulder, J. A.; Xiong, H.; Zificsak, C. A.; Douglas, C. J.; Hsung, R. P. Tetrahedron 2001, 57, 459. 
11
  Robles-Machín, R.; Adrio, J.; Carretero, J. C. J. Org. Chem. 2006, 71, 5023. 
12
  Kleinbeck, F.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 9178. 
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(C(CH3)3), 76.3 (C≡C), 55.5 (OCH3), 40.5 (NCH2), 32.7 (CH2), 29.0 (CH), 28.4 (C(CH3)3), 
26.0, 24.8 (CH2). IR (neat): 2930 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1041 (C-O-C st 
sy) cm-1. HRMS: Calculated for [C21H30NO3]+: 344.2226 [M+H]+; found: 344.2222. 
tert-Butyl (4-methoxyphenyl)(5-phenylpent-2-yn-1-yl)carbamate, SI2o. 
Following GP-A, SI2o (3.65 g, 10 mmol, 75%) was isolated by FC 
(petroleum ether/AcOEt, 19:1 to 8:2) on silica gel as colorless oil, starting 
from tert-butyl (4-methoxyphenyl)carbamate (2.97 g, 13.3 mmol, 1 eq) in 
DMF (66 mL, 0.22M), NaH 60 wt.% in mineral oil (640 mg, 16 mmol, 1.2 eq) and prepared (5-
bromopent-3-yn-1-yl)benzene12 (4.16 g, 18.6 mmol, 1.4 eq). Rf= 0.37 (petroleum ether/AcOEt, 
9:1). 1H NMR (300 MHz, CDCl3) δ 7.37-7.04 (m, 7H, Carom-H), 6.83 (d, J = 8.9 Hz, 2H, Carom-
H), 4.28 (t, J = 2.2 Hz, 2H, NCH2), 3.80 (s, 3H, OCH3), 2.79 (t, J = 7.5 Hz, 2H, Carom-CH2), 2.47 
(tt, J = 7.5, 2.2 Hz, 2H, CH2C≡), 1.44 (s, 9H, 3×CH3).13C NMR (75 MHz, CDCl3) δ 157.9 (Carom-
O), 154.7 (C=O), 140.8 (Carom), 135.4 (Carom), 128.6, 128.5, 128.0, 126.3, 113.9 (Carom-H), 83.3 
(C≡C), 80.6 (C(CH3)3), 77.4 (C≡C), 55.5 (OCH3), 40.4 (NCH2), 35.1 (Carom-CH2), 28.5 
(C(CH3)3), 21.0 (CH2C≡). IR (neat): 2980 (C-H st), 1695 (C=O st), 1245 (C-O-C st as), 1024 (C-
O-C st sy) cm-1. MS (EI) m/z (%): 167 (46), 151 (100), 108 (85). 
tert-Butyl (5-((tert-butyldimethylsilyl)oxy)pent-2-yn-1-yl)(4-
methoxyphenyl)carbamate, SI2p. Following GP-A, SI2p (554 mg, 
1.32 mmol, 64%) was isolated by FC (petroleum ether/AcOEt, 19:1 to 
8:2) on silica gel as colorless oil, starting from tert-butyl (4-
methoxyphenyl)carbamate (460 mg, 2.1 mmol, 1 eq) in DMF (10 mL, 0.22M), NaH 60 wt. % in 
mineral oil (100 mg, 2.5 mmol, 1.2 eq) and ((5-bromopent-3-yn-1-yl)oxy)(tert-
butyl)dimethylsilane13 (800 mg, 2.9 mmol, 1.4 eq). Rf= 0.68 (petroleum ether/AcOEt, 9:1). 1H 
NMR (300 MHz, CDCl3) δ 7.19 (d, J = 8.9 Hz, 2H, Carom-H), 6.84 (d, J = 8.9 Hz, Carom-H), 4.28 
(t, J = 2.2 Hz, 2H, NCH2), 3.78 (s, 3H, OCH3), 3.66 (t, J = 7.3 Hz, 2H, CH2C≡), 2.36 (tt, J = 7.3, 
2.2 Hz, 2H, OCH2), 1.42 (s, 9H, 3×CH3), 0.88 (s, 10H, 3×CH3+CH), 0.05 (s, 6H, 2×CH3). 13C 
NMR (75 MHz, CDCl3) δ 157.9 (Carom-O), 154.6 (C=O), 135.3 (Carom), 128.0, 113.9 (Carom-H), 
80.9 (C≡C), 80.5 (C(CH3)3), 77.4 (C≡C), 62.1 (OCH2), 55.4 (OCH3), 40.3 (NCH2), 28.4 
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  Papahatjis, D. P.; Nahmias, V. R.; Nikas, S. P.; Schimpgen, M.; Makriyannis, A. Chem. Eur. J. 2010, 16, 4091. 
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(C(CH3)3), 26.0 (SiC(CH3)3), 23.3 (CH2C≡), 18.4 (SiC(CH3)3), -5.2 (SiCH3). IR (neat): 2934 (C-
H st), 1701 (C=O st), 1245 (C-O-C st as), 1026 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C23H37NO4SiNa]+: 442.2390 [M+Na]+; found: 442.2386. 
General Procedure B (GP-B) for the Synthesis of Allenes 1a-p. Isomerization step was 
accomplished following a procedure described in the literature:14 SI2a-p (5 mmol, 1 eq) was 
placed in a two-necked round botton flask and dissolved with THF (0.33M). The mixture was 
cooled to 0ºC and tBuOK (1.5 mmol, 30 mol%) was added in three portions and the reaction 
turned dark. The reaction was monitored by TLC after 16 h and more base was added if 
necessary. The catalyst was filtered off and the flask was rinsed with Et2O. After the removal of 
the solvent the residue was purified by FC on silica gel. Spectroscopic data for 1a,10 1b-d,16 1e,15 
1f,16 1g7 and 1h16 were in agreement with those reported in the literature. 
tert-Butyl (4-bromophenyl)(propa-1,2-dien-1-yl)carbamate, 1i. Following GP-
B, 1i (2.7 g, 8.7 mmol, 62%) was isolated by FC (hexanes/AcOEt, 8:2) on silica gel 
as a brown solid, starting from SI2i (4.4 g, 14.1 mmol) in THF (43 mL, 0.33M) 
and tBuOK (0.48 g, 4.2 mmol). 1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 8.6 Hz, 
2H, Carom-H), 7.22 (t, J = 6.4 Hz, 1H, NCH), 7.05 (d, J = 8.6 Hz, 2H, Carom-H), 5.04 (d, J = 6.4 
Hz, 2H, CH2), 1.44 (s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) δ 201.4 (C=C=C), 152.1 
(OC=O), 138.4 (Carom), 131.9 (Carom-H), 129.9 (Carom-H), 120.8 (Carom-Br), 102.0 (NCH), 87.0 
(CH2), 82.0 (C(CH3)3), 28.3 (CH3). IR (CH2Cl2): 2976 (C-H st) 1705 (C=O st), 2976 ((C=C)=C-
H st), 1066 (C=C=C st sy) cm-1. MS (EI) m/z (%): 130 (100). HRMS: Calculated for 
[C14H16NO2BrNa]+: 332.0262 [M+Na]+; found: 332.0266. M.p.: 97-99ºC (hexanes/EtOAc). 
tert-Butyl (4-methoxyphenyl)(propa-1,2-dien-1-yl)carbamate, 1j. Following 
GP-B, 1j (1.36 g, 5.2 mmol, 78%) was isolated by FC (petroleum ether/AcOEt, 
19:1 to 8:2) on silica gel as yellow oil which solidified after standing, starting from 
SI2j (1.7 g, 6.7 mmol) in THF (20 mL, 0.33M) and tBuOK (0.22 g, 2 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.24 (t, J = 6.4 Hz, 1H, NCH), 7.03 (d, J = 8.9 Hz, 2H, Carom-H), 6.80 
                                                           
14
 Ballesteros, A.; Morán-Poladura, P.; González, J. M. Chem. Commun. 2016, 52, 2905. 
15
  Li, X-X; Zhu, L-L; Zhou, W.; Chen, Z. Org. Lett. 2012, 14, 436. 
16
  Yang, X.; Toste, F. D. Chem. Sci. 2016, 7, 2653. 
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(d, J = 8.9 Hz, 2H, Carom-H), 4.95 (d, J = 6.4 Hz, 2H, CH2), 3.71 (s, 3H, OCH3), 1.40 (s, 9H, 
3×CH3). 13C NMR (75 MHz, CDCl3) δ 201.7 (C=C=C), 158.5 (Carom-OCH3), 152.8 (OC=O), 
132.3 (Carom), 129.2 (Carom-H), 113.9 (Carom-H), 102.6 (NCH), 86.5 (CH2), 81.5 (C(CH3)3), 55.5 
(OCH3), 28.3 (CH3). IR (neat): 2980 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1051 (C-O-C 
st sy) cm-1. MS (EI) m/z (%): 160 (100, [M+-C5H9O2]). HRMS: Calculated for [C15H19NO3Na]+: 
264.1263 [M+Na]+; found: 264.1266. M.p.: 55-57ºC (CH2Cl2). 
tert-Butyl propa-1,2-dien-1-yl(3,4,5-trimethoxyphenyl)carbamate, 1k. 
Following GP-B, 1k (2.9 g, 9 mmol, 60%) was isolated by FC (petroleum 
ether/AcOEt, 19:1 to 8:2) on silica gel as yellow oil which solidified after 
standing, starting from SI2k (4.8 g, 15 mmol) in THF (45 mL, 0.33M) and 
tBuOK (500 mg, 4.5 mmol). 1H NMR (300 MHz, CDCl3) δ 7.19 (t, J = 6.4 Hz, 1H, NCH), 6.41 
(s, 2H, Carom-H), 5.05 (d, J = 6.4 Hz, 2H, CH2), 3.83 (s, 3H, OCH3), 3.81 (s, 6H, 2×OCH3), 1.46 
(s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) δ 201.4 (C=C=C), 153.0 (Carom), 152.4 (OC=O), 
137.1 (Carom), 135.0 (Carom), 105.8 (Carom-H), 102.2 (NCH), 86.6 (CH2), 81.8 (C(CH3)3), 61.0 
(OCH3), 56.2 (OCH3), 28.4 (CH3). IR (neat): 2984 (C-H st), 1698 (C=O st), 1257 (C-O-C st as), 
1074 (C-O-C st sy) cm-1. HRMS: Calculated for [C17H23NO5Na]+: 344.1474 [M+Na]+; found: 
344.1475. M.p.: 81-83ºC (CH2Cl2). 
tert-Butyl buta-1,2-dien-1-yl(4-methoxyphenyl)carbamate, 10a. Following GP-
B, 1l (430 mg, 1.56 mmol, 53%) was isolated by FC (petroleum ether/AcOEt, 19:1 
to 8:2) on silica gel as yellow oil, starting from SI3a (810 mmg, 2.9 mmol) in THF 
(9 mL, 0.33M) and tBuOK (99 mg, 0.88 mmol). Rf= 0.61 (petroleum ether/AcOEt, 
9:1). 1H NMR (300 MHz, CDCl3) δ 7.19-7.12 (m, 1H, NCH), 7.05 (d, J = 8.9 Hz, 2H, Carom-H), 
6.83 (d, J = 8.9 Hz, 2H, Carom-H), 5.34 (qd, J = 6.9, 5.9 Hz, 1H, HC=·=CHN), 3.78 (s, 3H, 
OCH3), 1.50 (dd, J = 6.9, 2.8 Hz, 3H, H3CCH), 1.43 (s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) 
δ 196.2 (C=C=C), 158.2 (Carom-O), 152.8 (C=O), 132.5 (Carom), 129.0 (Carom-H), 113.7 (Carom-H), 
101.9 (NCH), 97.4 (HC=·=CN), 81.1 (C(CH3)3), 55.4 (OCH3), 28.3 (C(CH3)3), 15.6 (H3CC=·=). 
IR (CH2Cl2): 2980 (C-H st), 1701 (C=O st), 1257 (C-O-C st as), 1051 (C-O-C st sy) cm-1. MS 
(EI) m/z (%): 275 (15, M+), 174 (47, [M+-C5H9O2]). HRMS: Calculated for [C16H21NO3Na]+: 
298.1421 [M+Na]+; found: 298.1421. 
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tert-Butyl (4-methoxyphenyl)(penta-1,2-dien-1-yl)carbamate, 10b. Following 
GP-B, 1m (162 mg, 0.59 mmol, 51%) was isolated by FC (petroleum 
ether/AcOEt, 19:1 to 8:2) on silica gel as yellow oil, starting from SI3b (318 mmg, 
1.1 mmol) in THF (3.8 mL, 0.33M) and tBuOK (39 mg, 0.34 mmol). Rf= 0.73 
(petroleum ether/AcOEt, 9:1). 1H NMR (300 MHz, CDCl3) δ 7.25-7.18 (m, 1H, NCH), 7.05 (d, J 
= 8.9 Hz, 2H, Carom-H), 6.84 (d, J = 8.9 Hz, 2H, Carom-H), 5.45 (q, J = 6.1 Hz, 1H, HC=·=CN), 
3.79 (s, 3H, OCH3), 1.83 (qdd, J = 7.4, 6.1, 2.9 Hz, 2H, H2CC=·=CN), 1.43 (s, 9H, 3×CH3), 0.79 
(t, J = 7.4 Hz, CH2CH3). 13C NMR (75 MHz, CDCl3) δ 194.7 (C=C=C), 158.4 (Carom-O), 152.9 
(C=O), 132.6 (Carom), 129.3 (Carom-H), 113.8 (Carom-H), 104.3 (NCH), 103.1 (HC=·=CN), 81.2 
(C(CH3)3), 55.5 (OCH3), 28.3 (C(CH3)3), 23.2 (CH2CH3), 12.8 (CH2CH3). IR (neat): 2969 (C-H 
st), 1701 (C=O st), 1245 (C-O-C st as), 1051 (C-O-C st sy) cm-1. MS (EI) m/z (%): 289 (6, M+), 
188 (47, [M+-C5H9O2]). HRMS: Calculated for [C17H23NO3Na]+: 312.1576 [M+Na]+; found: 
312.1580. 
tert-Butyl (3-cyclohexylpropa-1,2-dien-1-yl)(4-methoxyphenyl)carbamate, 
1o. Following the GP-E, 1n (1.1 g, 0.37 mmol, 71%) was isolated by FC 
(petroleum ether/AcOEt, 19:1 to 8:2) on silica gel as yellow oil, starting from 
SI3c (1.5 g, 4.45 mmol) in DMF (15 mL, 0.33M) and tBuOK (150 mg, 1.3 
mmol). Rf= 0.64 (petroleum ether/AcOEt, 9:1). 1H NMR (300 MHz, CDCl3) δ 7.25-7.16 (m, 1H, 
NCH), 7.04 (d, J = 8.9 Hz, 2H, Carom-H), 6.83 (d, J = 8.9 Hz, 2H, Carom-H), 5.37 (t, J = 5.9 Hz, 
1H, HC=·=CN), 3.77 (s, 3H, OCH3), 1.84-1.68 (m, 1H, CcyH), 1.66-1.45 (m, 4H, 2×CcyH2), 1.44 
(s, 9H, 3×CH3), 1.28-0.96 (m, 4H, 2×CcyH2), 0.92-0.69 (m, 2H, CcyH2). 13C NMR (75 MHz, 
CDCl3) δ 193.8 (C=C=C), 158.4 (Carom-O), 152.8 (C=O), 132.5 (Carom), 129.4 (Carom-H), 113.7 
(Carom-H), 108.4 (NCH), 103.2 (HC=·=CN), 81.0 (C(CH3)3), 55.4 (OCH3), 38.4 (CcyH), 32.4 
(CcyH2), 32.2 (CcyH2), 28.3 (C(CH3)3), 26.2 (CcyH2), 25.9 (CH2). IR (neat): 2926 (C-H st), 1964 
(C=C=C st as), 1701 (C=O st), 1245 (C-O-C st as), 1051 (C-O-C st sy) cm-1. MS (EI) m/z (%): 
343 (14, M+), 287 (100), 242 (39, [M+-C5H9O2]). HRMS: Calculated for [C21H29NO3Na]+: 
366.2045 [M+Na]+; found: 366.2039. 
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General Procedure C (GP-C) for the Synthesis of Allenes 1o-p: Corresponding alkyne SI2o-p 
(1.4 mmol, 1 eq) was dissolved in dry THF (0.2 M) and cooled to -78ºC. LiHMDS 1.0 M in THF 
(2.1 mmol, 1.5 eq) was added dropwise to the mixture and stirred at 0ºC for 2 h. The crude was 
quenched with water (5 mL) and aqueous layer extracted with ether (3 × 5 mL). Combined 
organic layers were washed with brine, dried over Na2SO4 and filtered. After the removal of the 
solvent under reduced pressure, the residue was purified by FC (petroleum ether to petroleum 
ether/EtOAc 19:1) on deactivated silica gel (acetone) to obtain 1o-p as an oil. 
tert-Butyl (4-methoxyphenyl)(5-phenylpenta-1,2-dien-1-yl)carbamate, 1o. 
Following GP-C, 1o (295 mg, 0.81 mmol, 58%) was isolated by FC (petroleum 
ether/AcOEt, 19:1) on deactivated silica gel, starting from SI2o (508 mg, 1.4 
mmol) in THF (7 mL, 0.2M) and LiHMDS 1.0M in THF (2.1 mL, 2.1 mmol). 
1H NMR (300 MHz, CDCl3) δ 7.33-7.15 (m, 4H, 3×Carom-H + NCH), 7.15-7.05 (m, 4H, Carom-H), 
6.90 (d, J = 6.9 Hz, 2H, Carom-H), 5.49 (q, J = 6.3 Hz, 1H, HC=·=CN), 3.81 (s, 3H, OCH3), 2.62-
2.38 (m, 2H, H2CC=·=CN), 2,17 (qd, J = 7.9, 2.5 Hz, 2H, H2C-Carom), 1.48 (s, 9H, 3×CH3). 13C 
NMR (75 MHz, CDCl3) δ 195.5 (C=C=C), 158.4 (Carom-O), 152.8 (C=O), 141.6 (Carom), 132.5 
(Carom), 129.2 (Carom-H), 128.4 (Carom-H), 128.3 (Carom-H), 125.9 (Carom-H), 113.8 (Carom-H), 103.1 
(NCH), 102.0 (HC=·=CN), 81.1 (C(CH3)3), 55.4 (OCH3), 35.0 (H2C-Carom), 31.8 (H2CC=·=CN), 
28.3 (C(CH3)3). IR (neat): 2976 (C-H st), 1701 (C=O st), 1245 (C-O-C st as), 1051 (C-O-C st sy) 
cm-1. HRMS: Calculated for [C23H28NO3]+: 366.2069 [M+H]+; found: 366.2068. 
tert-Butyl (5-((tert-butyldimethylsilyl)oxy)penta-1,2-dien-1-yl)(4-
methoxyphenyl)carbamate, 1p. Following GP-C, 1p (333 mg, 0.79 mmol, 
65%) was isolated by FC (petroleum ether/AcOEt, 19:1) on deactivated silica 
gel, starting from SI2p (509 mg, 1.2 mmol) in THF (6 mL, 0.2M) and LiHMDS 
1.0M in THF (1.8 mL, 1.8 mmol). Rf= 0.75 (petroleum ether/AcOEt, 9:1). 1H NMR (300 MHz, 
CDCl3) δ 7.24-7.15 (m, 1H, NCH), 7.04 (d, J = 8.9 Hz, 2H, Carom-H), 6.83 (d, J = 8.9 Hz, Carom-
H), 5.41 (td, J = 6.8, 6.0 Hz, 1H, HC=·=CN), 3.78 (s, 3H, OCH3), 3.49-3.29 (m, 2H, H2C-O), 
2.10-1.98 (m, 2H, H2CC=·=CN), 1.42 (s, 9H, OC(CH3)3), 0.85 (s, 9H, SiC(CH3)3), -0.01 (s, 6H, 
Si(CH3)2). 13C NMR (75 MHz, CDCl3) δ 196.2 (C=C=C), 158.4 (Carom-O), 152.8 (C=O), 132.5 
(Carom), 129.2 (Carom-H), 113.8 (Carom-H), 102.7 (NCH), 99.2 (HC=·=CN), 81.2 (C(CH3)3), 62.5 
N Boc·
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(OCH2), 55.4 (OCH3), 33.7 (H2CC=·=CN), 28.3 (OC(CH3)3), 26.0 (SiC(CH3)3), 18.4 
(SiC(CH3)3), -5.22 (SiCH3), -5.24 (SiCH3). IR (CH2Cl2): 2955 (C-H st), 1705 (C=O st), 1278 
((Si-)CH3 δ sy), 1245 (C-O-C st as), 1099 (Si-O st), 1051 (C-O-C st sy) cm-1. MS (EI) m/z (%): 
167 (100). HRMS: Calculated for [C23H38NO4Si]+: 420.2570 [M+H]+; found: 420.2570. 
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2.2 Synthesis of dienes 2a-x 
Furan (2a), 3-methylfuran (2b), 2-methylfuran (2u), 2,5-dimethylfuran (2v) and 6,6-
dimethylfulvene (2x) are commercially available. 
3-Ethylfuran (2c). 3-Ethylfuran 2c was prepared following the described procedure in the 
literature.17. Spectroscopic data for 2c17 were in agreement with those reported in the literature. 
3-Aryl and 3-Benzyl substituted furans, (2d) and (2h-j) 
 
General Procedure D (GP-D) for the Synthesis of Furans (2d) and (2h-j): Suzuki coupling of 
3-furanboronic acid with p-substituted bromobenzenes or benzyl bromides was prepared 
following the procedure described in the literature.18 To a solution of bromide (4.3 mmol, 1 eq) 
in toluene (9.6 mL, 0.4M) under Ar atmosphere, Pd(PPh3)4 (0.17 mmol, 4 mol%) was added. 
Then, Na2CO3 (aqueous 2M, 4.8 mL) and a solution of 3-furanboronic acid (5.2 mmol, 1.2 eq) in 
MeOH (2.4 mL, 2.2M) were added. The reaction mixture was warmed to 80 ºC for 6h. After 
cooling, CH2Cl2 (10 mL) and Na2CO3 (aqueous 2M, 10 mL) were added. The layers were 
separated and the combined organic phases were dried over Na2SO4, filtered and concentrated. 
Spectroscopic data for 2h-j were in agreement with those reported in the literature.18 
  
                                                           
17
  Wiley, R. A.; Choo, H.-H.; McClellan, D. J. Org. Chem. 1983, 48, 1106. 
18
  Tofi, M.; Georgiou, T.; Montagnon, T.; Vassilikogiannakis, G. Org. Lett. 2005, 7, 3347. 
128  Chapter 5 
 
3-(2-Methylbenzyl)furan (2d). Following GP-D, 2d (592 mg, 3.4 mmol, 80%) 
was obtained as a yellowish oil after purification by FC on silica gel (hexanes to 
hexanes/EtOAc 19:1) starting from 2-methylbenzyl bromide (0.59 mL, 4.3 
mmol) in toluene (9.6 mL, 0.4M), Pd(PPh3)4 (200 mg, 0.17 mmol), Na2CO3 (aqueous 2M, 4.8 
mL) and 3-furanboronic acid (0.6 g, 5.2 mmol) in MeOH (2.4 mL, 2.2M). Rf= 0.55 (2% EtOAc 
in hexanes). 1H NMR (300 MHz, CDCl3) δ 7.42-7.39 (m, 1H, Cheteroarom-H), 7.25-7.18 (m, 4H, 
Carom-H), 7.16 (bs, 1H, Cheteroarom-H), 6.28 (bs, 1H, Cheteroarom-H), 3.80 (s, 2H, CH2), 2.35 (s, 3H, 
CH3). 13C NMR (75 MHz, CDCl3) δ 143.1 (Cheteroarom-H), 139.8 (Cheteroarom-H), 138.5 (Carom), 
136.3 (Carom), 130.3 (Carom-H), 129.3 (Carom-H), 126.6 (Carom-H), 126.2 (Carom-H), 123.8 
(Cheteroarom), 111.4 (Cheteroarom-H), 29.1 (CH2), 19.5 (CH3). IR (neat): 3102 (C-H st) cm-1. MS (EI) 
m/z (%): 172 (M+, 100). 
(Z)-3-Styrylfuran ((Z)-2g), 3-isopentylfuran (2e), 3-Phenetylfuran (2f) 
 
Furans 2g, 2e and 2f were prepared starting from 3-furaldehyde following a Wittig protocol 
described in the literature.18 For (Z)-2g the residue was purified by FC on silica gel 
(hexanes/Et2O 30:1 to 15:1) achieving the separation of E and Z isomers. Spectroscopic data for 
(Z)-2g were in agreement with those reported in the literature.18 In the case of [(E)/(Z)-SI3], the 
residue was not purified by FC and it was used without further purification in the next step with 
traces of solvent. 
 
3-Isopentylfuran (2e). Hydrogenation of [(E)/(Z)-SI3] was prepared following a procedure 
described in the literature with slight modifications.18 The residue was placed in a flask and ~4 
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drops of MeOH were added. H2 bubbled through it 10 min at room temperature and Pd on 
activated carbon in 10%wt (2.5 mol%) was added. The reaction mixture was stirred for 1 day 
under H2 atmosphere. The reaction was monitored by NMR and it was added more catalyst if 
necessary. When the reaction finished, the catalyst was removed by filtration through a pad of 
silica gel eluting with Et2O. After careful removal of the solvent, the residue was purified by FC 
on silica gel (pentane to pentane/Et2O 95:5) to afford 2e as a colorless oil (401 mg, 2.9 mmol, 
20%). Rf= 0.79 (hexanes/EtOAc 19:1). 1H NMR (300 MHz, CDCl3) δ 7.37-7.33 (m, 1H, 
Cheteroarom-H), 7.23-7.20 (m, 1H, Cheteroarom-H), 6.30-6.25 (Cheteroarom-H), 2.48-2.39 (m, 2H, 
Cheteroarom-CH2), 1.73-1.53 (m, 1H, CH), 1.52-1.39 (m, 2H, CHCH2), 0.93 (d, J = 6.6 Hz, 6H, 
2×CH3). 13C NMR (75 MHz, CDCl3) δ 142.7 (Cheteroarom-H), 138.7 (Cheteroarom-H), 125.6 
(Cheteroarom), 111.2 (Cheteroarom-H), 39.3 (CH2), 27.7 (CH), 22.8 (CH2), 22.6 (CH3). IR (neat): 2959 
(C-H st), 1187 (CO-C st) cm-1. MS (EI) m/z (%): 138 (12, M+), 82 (100). 
3-Phenethylfuran (2f). Hydrogenation of (E)-2g and (Z)-2g was prepared following a procedure 
described in the literature.18 Spectroscopic data for 2f were in agreement with those reported in 
the literature.18 
O-based methylenfurans 2k-n and 2o 
 
3-Hydroxymethylfuran 2o was prepared from 3-furaldehyde following a procedure described in 
the literature.19 Spectroscopic data for 2o were in agreement with those reported in the literature. 
                                                           
19
  Xu, P.; Chen, D.-S.; Xi, J.; Yao Z.-J. Chem. Asian J. 2015, 10, 976. 
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3-(Methoxymethyl)furan (2k). 3-(Methoxymethyl)furan 2k was prepared following a procedure 
described in the literature.20 NMR data were in agreement with those reported in the literature. 
3-(Phenoxymethyl)furan (2l). To a solution of 3-hydroxymethylfuran 2o (1 g, 
10.2 mmol, 1 eq) in CH2Cl2 (10 mL, 1M) was added phenol (1.92 g, 20.4 mmol, 2 
eq) and PPh3 (5.3 g, 20.4 mmol, 2 eq) at 0 ºC. Diethyl azodicarboxylate (3.3 mL, 
20.4 mmol, 2 eq) was added dropwise. The mixture was stirred for 16h at room temperature. 
After that, the mixture was concentrated and pentane was added, then the precipitate was filtered 
through Al2O3 and washed with pentane. The solvent was evaporated and the residue was 
purified by FC on silica gel (hexanes to hexanes/EtOAc 9:1) obtaining a colorless oil which 
solidified after standing (355 mg, 2.04 mmol, 20%). Rf= 0.23 (hexanes/EtOAc 19:1). 1H NMR 
(300 MHz, CDCl3) δ 7.55 (bs, 1H, Cheteroarom-H), 7.47 (bs, 1H, Cheteroarom-H), 7.40-7.30 (m, 2H, 
Carom-H), 7.06-6.98 (m, 3H, Carom-H), 6.54(bs, 1H, Cheteroarom-H), 4.97 (s, 2H, CH2). 13C NMR (75 
MHz, CDCl3) δ 158.7 (Carom-O), 143.6 (Cheteroarom-H), 140.9 (Cheteroarom-H), 129.6 (Carom-H), 121.5 
(Cheteroarom), 121.1 (Carom-H), 114.9 (Carom-H), 110.3 (Cheteroarom-H), 61.8 (CH2). IR (neat): 1235 
(C-O-C st as), 1020 (CO-C st) cm-1. MS (EI) m/z (%): 174 (27, M+), 81 (100, [M+-C6H5O]). 
M.p.: 30-32ºC (hexanes/EtOAc). 
General Procedure E (GP-E) for the synthesis of O-Silylated methylenefurans 2m-n: Silane 
derivatives were prepared according to a literature procedure as follows.21 To a stirring solution 
of 3-hydroxymethylfuran 2o (14 mmol, 1 eq) in CH2Cl2 (21 mL, 0.7M) were added imidazole 
(21 mmol, 1.5 eq) and the corresponding chlorosilane (17 mmol, 1.2 eq) at 0ºC. The mixture was 
allowed to warm up to room temperature and stirred for 10 h. After completion, saturated 
aqueous NaHCO3 was added (10 mL) and the aqueous solution was extracted with CH2Cl2 (3×15 
mL). The combined organic extracts were washed with brine (20 mL), dried over Na2SO4 and 
filtered. After the removal of the solvent under reduced pressure the crude was purified by FC on 
silica gel. Spectroscopic data for 2m21 were in agreement with those reported in the literature. 
  
                                                           
20
  Li, N.-N.; Zhang, Y. L.; Mao, S.; Gao, Y.-R.; Guo, D.-D.; Wang, Y.-Q. Org. Lett. 2014, 16, 2732. 
21
  Huang, J.; Hsung, R. P. J. Am. Chem. Soc. 2005, 127, 50. 
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(Furan-3-ylmethoxy)triisopropylsilane (2n). Following GP-E, 2n was 
isolated after FC on silica gel (hexanes to hexanes/CH2Cl2, 95:5) as a colorless 
oil (2.47 g, 9.7 mmol, 95%), using 3-hydroxymethylfuran 2o (1 g, 10.2 mmol) 
in CH2Cl2 (15 mL, 0.7M), imidazole (1.04 g, 15.3 mmol) and triisopropylchlorosilane (2.7 mL, 
12.2 mmol). Rf= 0.91 (5% CH2Cl2 in hexanes). 1H NMR (300 MHz, CDCl3) δ 7.38 (bs, 1H, 
Cheteroarom-H), 6.39 (d, J = 1.5 Hz, 1H, Cheteroarom-H), 4.70 (bs, 1H, Cheteroarom-H), 1.25-1.04 (m, 
21H, 6×CH3 + 3×CH). 13C NMR (75 MHz, CDCl3) δ 143.1 (Cheteroarom-H), 139.2 (Cheteroarom-H), 
126.2 (Cheteroarom), 109.5 (Cheteroarom-H), 58.0 (CH2), 18.1 (CH3), 12.2 (CH). IR (neat): 2944 (C-H 
st), 1095 (Si-O st), cm-1. MS (EI) m/z (%): 254 (1, M+), 211 (100, [M+-C3H7]). HRMS: 
Calculated for [C14H27O2Si]+: 255.1775 [M+H]+; found: 255.1780. 
N-based methylenfurans 2p-s and 2t 
 
N-(Furan-3-ylmethyl)-4-methoxyaniline (2t). It was prepared as follows. Aniline (2.2 g, 17.9 
mmol, 1.1 eq) was dissolved in dry acetonitrile (125 mL, 0.13M) and 3-furaldehyde (1.43 mL, 
16.2 mmol, 1 eq) was added to the reaction mixture and stirred 16 h at room temperature. After 
evaporation, the greenish solid was redissolved in MeOH. NaBH4 (2.7 g, 70 mmol, 4 eq) was 
added in small portions and stirred at room temperature for 5h. After that, the solvent was 
evaporated; 50 mL of water were added and extracted with CH2Cl2 (3×50 mL), dried over 
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Na2SO4, filtered and concentrated. The residue was filtered through a small pad of silica gel 
(petroleum ether/AcOEt 1:1) obtaining 2t as a yellow oil (3.2 g, 15.7 mmol, 97%). Rf= 0.63 
(hexanes/EtOAc 8:2). 1H NMR (300 MHz, CDCl3) δ 7.40-7.35 (m, 2H, Cheteroarom-H), 6.81 (d, J = 
8.9 Hz, 2H, Carom-H), 6.64 (d, J = 8.9 Hz, 2H, Carom-H), 6.42-6.37 (m, 1H, Cheteroarom-H), 4.10 (s, 
2H, CH2), 3.74 (s, 3H, OCH3). 13C NMR (75 MHz, CDCl3) δ 152.5 (Carom-O), 143.3 (Cheteroarom-
H), 142.3 (Carom), 140.0 (Cheteroarom-H), 123.6 (Cheteroarom), 114.9 (Carom-H), 114.6 (Carom-H), 110.3 
(Cheteroarom-H), 55.8 (OCH3), 40.4 (CH2). IR (neat): 3396 (NH st), 1232 (C-O-C st as), 1038 (C-O-
C st sy) cm-1. MS (EI) m/z (%): 203 (M+, 100), 122 (97, [M+-C5H5O]). HRMS: Calculated for 
[C12H14NO2]+: 204.1025 [M+H]+; found: 204.1029. 
tert-Butyl (furan-3-ylmethyl)(4-methoxyphenyl)carbamate (2p). To a 
mixture of (Boc)2O (500 mg, 2.3 mmol, 1 eq) and Amberlyst-15 (75 mg, 15% 
w/w) was added amine 2t (475 mg, 2.3 mmol, 1 eq) and the mixture was 
stirred at room temperature for 1 h. After that, CH2Cl2 was added and the 
catalyst was filtered. The filtrate was collected and concentrated under 
reduced pressure and the residue was isolated by FC on silica gel (petroleum ether/AcOEt 19:1 to 
8:2) as a yellow oil (545 mg, 1.8 mmol, 78%). Rf= 0.6 (hexanes/AcOEt 9:1). 1H NMR (300 
MHz, CDCl3) δ 7.30-7.26 (m, 1H, Cheteroarom-H), 7.21-7.18 (m, 1H, Cheteroarom-H), 6.98 (d, J = 8.4 
Hz, 2H, Carom-H), 6.80-6.72 (m, 2H, Carom-H), 6.31 (bs, 1H, Cheteroarom-H), 4.54 (s, 2H, CH2), 3,69 
(s, 3H, OCH3), 1.40 (s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) δ 157.6 (Carom-O), 154.8 (C=O), 
142.8 (Cheteroarom-H), 140.2 (Cheteroarom-H), 135.1 (Carom), 128.1 (Carom-H), 122.2 (Cheteroarom), 113.7 
(Carom-H), 110.5 (Cheteroarom-H), 79.9 (C(CH3)3), 55.0 (OCH3), 44.9 (CH2), 28.2 (3×CH3). IR 
(neat): 1691 (C=O st) cm-1. MS (EI) m/z (%): 303 (3, M+). HRMS: Calculated for 
[C17H21NO4Na]+: 326.1368 [M+Na]+; found: 326.1376. M.p.: 37-39 ºC (CH2Cl2). 
General Procedure F (GP-F) for the synthesis of furans 2q-s: N-(Furan-3-ylmethyl)-4-
methoxyaniline 2t (1.8 mmol, 1 eq) was dissolved in CH2Cl2 (0.3M) with DMAP (0.18 mmol, 10 
mol%). Triethylamine (2.7 mmol, 1.5 eq) was added and the mixture was cooled to 0ºC. The 
corresponding acyl chloride (2.2 mmol, 1.2 eq) was added slowly. The reaction was stirred for 10 
min at 0ºC and 16h at room temperature. When the reaction has finished, CH2Cl2 was removed 
under vacuum and Et2O and NH4Cl aq. sat. solution was added in the same proportion. The 
O
N
OMe
Boc
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mixture was separated and organic layer was washed with brine, dried over Na2SO4 and filtered. 
Afforded residue was purified through a small plug of silica eluted with petroleum ether/AcOEt 
obtaining 2q-s. 
N-(Furan-3-ylmethyl)-N-(4-methoxyphenyl)acetamide (2q). Following 
GP-F, 2q was isolated after eluting the crude through a small plug of silica 
obtaining a yellow oil (288 mg, 1.24 mmol, 95%), using N-(furan-3-
ylmethyl)-4-methoxyaniline 2t (270 mg, 1.33 mmol) in CH2Cl2 (4.4 mL, 
0.3M), DMAP (16 mg, 0.12 mmol), Et3N (0.28 mL, 2 mmol) and acetyl 
chloride (0.11 mL, 1.6 mmol) were added. Rf= 0.34 (petroleum ether/AcOEt 6:4). 1H NMR (300 
MHz, CDCl3) δ 7.34-7.30 (m, 1H, Cheteroarom-H), 7.22-7.18 (m, 1H, Cheteroarom-H), 6.93 (d, J = 8.9 
Hz, 2H, Carom-H), 6.85 (d, J = 8.9 Hz, 2H, Carom-H), 6.34-6.28 (m, 1H, Cheteroarom-H), 4.64 (s, 2H, 
CH2), 3.80 (s, 3H, OCH3), 1.83 (s, 3H, COCH3). 13C NMR (75 MHz, CDCl3) δ 170.8 (C=O), 
159.1 (Carom-O), 143.1 (Cheteroarom-H), 141.2 (Cheteroarom-H), 135.6 (NCarom), 129.3 (Carom-H), 121.3 
(Cheteroarom), 114.7 (Carom-H), 111.3 (Cheteroarom-H), 55.5 (OCH3), 43.6 (CH2), 22.7 (CH3). IR (neat): 
2937 (C-H st) 1651 (C=O st), 1242 (C-O-C st as), 1020 (C-O-C st sy) cm-1. MS (EI) m/z (%): 
245 (100, M+). HRMS: Calculated for [C14H16NO3]+: 246.1130 [M+H]+; found: 246.1138. 
N-(Furan-3-ylmethyl)-N-(4-methoxyphenyl)propionamide (2r). Following 
GP-F, 2r was isolated after eluting the crude through a small plug of silica 
obtaining a pale yellow oil (610 mg, 2.3 mmol, 95%), using N-(furan-3-
ylmethyl)-4-methoxyaniline 2t (500 mg, 2.46 mmol) in CH2Cl2 (8 mL, 0.3M), 
DMAP (30 mg, 0.25 mmol), Et3N (0.51 mL, 3.7 mmol) and propionyl 
chloride (0.38 mL, 2.9 mmol) were added. Rf= 0.44 (petroleum ether/AcOEt 8:2). 1H NMR (300 
MHz, CDCl3) δ 7.29 (t, J = 1.7 Hz, 1H, Cheteroarom-H), 7.19-7.16 (m, 1H, Cheteroarom-H), 6.90 (d, J = 
8.9 Hz, 2H, Carom-H), 6.82 (d, J = 8.9 Hz, 2H, Carom-H), 6.29 (bs, 1H, Cheteroarom-H), 4.61 (s, 2H, 
NCH2), 3.77 (s, 3H, OCH3), 2.00 (q, J = 7.5 Hz, 2H, CH2CH3), 1.01 (t, J = 7.5 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 174.0 (C=O), 159.0 (Carom-O), 142.9 (Cheteroarom-H), 141.1 
(Cheteroarom-H), 135.0 (NCarom), 129.4 (Carom-H), 121.4 (Cheteroarom), 114.6 (Carom-H), 111.2 
(Cheteroarom-H), 55.4 (OCH3), 43.7 (NCH2), 27.7 (CH2CH3), 9.7 (CH2CH3). IR (neat): 1655 (C=O 
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st), 1245 (C-O-C st as), 1038 (C-O-C st sim) cm-1. MS (EI) m/z (%): 259 (100, M+), 203 
([M+H]+-C3H5O). HRMS: Calculated for [C15H18NO3]+: 260.1287 [M+H]+; found: 260.1297. 
N-(Furan-3-ylmethyl)-N-(4-methoxyphenyl)pivalamide (2s). Following 
GP-F, 2s was isolated after eluting the crude through a small plug of silica 
obtaining a pale yellow oil (485 mg, 1.69 mmol, 97%), using N-(furan-3-
ylmethyl)-4-methoxyaniline 2t (359 mg, 1.76 mmol) in CH2Cl2 (5.9 mL, 
0.3M), DMAP (21.5 mg, 0.18 mmol), Et3N (0.36 mL, 2.6 mmol) and pivaloyl 
chloride (0.26 mL, 2.1 mmol) were added. Rf= 0.72 (petroleum ether/AcOEt 8:2). 1H NMR (300 
MHz, CDCl3) δ 7.33-7.30 (m, 1H, Cheteroarom-H), 7.16 (bs, 1H, Cheteroarom-H), 6.92 (d, J = 8.9 Hz, 
2H, Carom-H), 6.81 (d, J = 8.9 Hz, 2H, Carom-H), 6.32 (bs, 1H, Cheteroarom-H), 4.55 (s, 2H, NCH2), 
3.79 (s, 3H, OCH3), 1.00 (s, 3H, 3×CH3). 13C NMR (75 MHz, CDCl3) δ 177.9 (C=O), 159.1 
(Carom-O), 142.8 (Cheteroarom-H), 141.4 (Cheteroarom-H), 135.8 (NCarom), 131.0 (Carom-H), 121.6 
(Cheteroarom), 114.0 (Carom-H), 111.5 (Cheteroarom-H), 55.5 (OCH3), 47.4 (NCH2), 41.0 (C(CH3)3), 
29.6 (3×CH3). IR (neat): 2951 (C-H st), 1634 (C=O st), 1243 (C-O-C st as), 1020 (C-O-C st sim) 
cm-1. MS (EI) m/z (%): 287 (64, M+), 203 (63, M+-C5H9O). HRMS: Calculated for [C17H22NO3]+: 
288.1600 [M+H]+; found: 288.1601. 
Cyclopentadiene (2w). Compound 2w was prepared following the procedure reported in the 
literature.22 Spectroscopic data were in agreement with those reported in the literature. 
                                                           
22
  Musa, O. M. Ring-Opening Metathesis Polymerization of Norbornene and Oxanorbornene Moieties and Uses 
thereof. U.S. Patent 0065880, March 17, 2011. 
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Ethyl 3-(furan-3-yl)propanoate (2y) 
 
Ethyl (E)-3-(furan-3-yl)acrylate was isolated after a HWE reaction starting from 3-furaldehyde 
following a procedure described in the literature.23 For 2x, we were unable to generate it by 
following literature procedure.23 Ethyl 3-(furan-3-yl)propanoate 2x was prepared as follows. To a 
solution of acetic acid (0.1 mL, 1.8 mmol, 3 eq) in DME (7.4 mL, 0.08M), dipotassium azo-1,2-
dicarboxylate salt24 (0.35 g, 1.8 mmol, 3 eq) and ethyl (E)-3-(furan-3-yl)acrylate (100 mg, 0.6 
mmol, 1 eq) in DME (6 mL, 0.1M) were added dropwise at 50 ºC. The reaction was monitored 
by NMR and more azodicarboxylate was added salt if necessary. Then, it was cooled and filtered 
through a small pad of Celite and the solvent was removed in vacuo. Spectroscopic data for ethyl 
3-(furan-3-yl)propanoate 2x23 were in agreement with those reported in the literature. 
  
                                                           
23
  (a) Davis, C. H.; Hurst, T. E.; Jacob, A. M.; Moody, C. J. J. Org. Chem. 2005, 70, 4414. (b) Weyerstahl, P.; Licha, 
K.; Marschall, H. Liebigs Ann. Chem. 1994, 917. 
24
  (a) Wullschleger, C. W.; Gertsch, J.; Altmann, K.-H. Org. Let. 2010, 12, 1120. (b) Groves, J. T.; Ma, K. W. J. Am. 
Chem. Soc. 1977, 99, 4076. 
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2.3 Synthesis of catalysts 
(3a), (3b), (3c), (3d) and (3e) catalysts are commercially available. Catalysts (3f),25 (3h),26 (3l),25 
(3m),25 (3n),27 (3o)28 and (3p)29 has been previously synthesized and used in the literature. 
2.3.1 Synthesis of precursors 
 
(S)-2,2´-bis(methoxymethoxy)-1,1´-binaphthalene (SI4). (S)-2,2´-Bis(methoxymethoxy)-1,1´-
binaphthalene was prepared following the procedure described in the literature with slight 
modifications, instead of using MOMBr, it was used MOMCl.30 NMR spectral data were in 
agreement with those reported in the literature.30 
Silylated BINOL derivative (SI5a-b) 
SI5a and SI5b were prepared from (S)-2,2´-bis(methoxymethoxy)-1,1´-binaphthalene with the 
corresponding silanol derivative in two steps following a procedure described in the literature.31 
Spectroscopic data for SI5a31 and SI5b32 were in agreement with those reported in the literature. 
                                                           
25
  Rueping, M.; Nachtsheim, B. J.; Koenigs, R. M.; Ieawsuwan, W. Chem. Eur. J. 2010, 16, 13116. 
26
  Sai, M.; Yamamoto, H. J. Am. Chem. Soc. 2015, 137, 7091. 
27
  Kaupmees, K.; Tolstoluzhsky, N.; Raja, S.; Rueping, M.; Leito, I. Angew. Chem. Int. Ed. 2013, 52, 11569. 
28
  Knipe, P. C.; Smith, M. D. Org. Biomol. Chem. 2014, 12, 5094. 
29
  Lalli, C.; van de Weghe, P. Chem. Commun. 2014, 50, 7495. 
30
  Wu, T. R.; Shen, L.; Chong, J. M. Org. Lett. 2004, 6, 2701. 
31
  Storer, R. I.; Diane, E. C., Yike, N.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 84. 
32
  Maruoka, K.; Itoh, T.; Araki, Y.; Shirasaka, T.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1988, 61, 2975. 
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SI5a: 1H NMR (300 MHz, CDCl3) δ 7.98 (s, 2H, Carom-H), 7.80-7.65 (m, 14H, Carom-H), 7.51-
7.28 (m, 24H, Carom-H), 5.36 (s, 2H, OH). 13C NMR (75 MHz, CDCl3) δ 156.5 (Carom-OH), 142.1 
(Carom-H), 136.3 (Carom-H), 134.7 (Carom), 134.2 (Carom), 129.5 (Carom-H), 129.2 (Carom), 129.0 
(Carom-H), 128.2 (Carom-H), 127.8 (Carom-H), 123.9 (Carom-H), 123.8 (Carom-H), 123.6 (Carom), 110.6 
(Carom). 
(S)-3,3´-Dibromo-5,5ʹ,6,6ʹ,7,7ʹ,8,8ʹ-octahydro-[1,1ʹ-binaphthalene]-2,2ʹ-diol (SI6) 
 
(S)-H8-Binol was synthesized following the procedure described in the literature.33 Spectroscopic 
data for (S)-H8-binol were in agreement with those reported in the literature.25,34 
SI6 was prepared following the reported procedure in the literature from (S)-H8-binol by a 
bromination step.25 Spectroscopic data for SI6 were in agreement with those reported in the 
literature.25 
(S)-3,3ʹ-Bis(triphenylsilyl)-5,5ʹ,6,6ʹ,7,7ʹ,8,8ʹ-octahydro-[1,1ʹbinaphthalene]2,2ʹ-diol (SI7) 
 
SI7 was synthesized following a procedure described in the literature with slight modifications as 
follows.35 SI6 (1g, 2.21 mmol, 1 eq) was dissolved in DMF (16 mL, 0.14M), imidazole (0.67 g, 
                                                           
33
  Korostylev, A.; Tararov, V. I.; Fischer, C.; Monsees, A.; Börner, A. J. Org. Chem. 2004, 69, 3220. 
34
  The enantiomeric excess of (S)-H8-Binol was calculated by HPLC analysis on chiral stationary phase using Chiralcel 
OD-H column [n-hexane/ i-PrOH (95:5)]; flow rate 1.0 mL/min; τminor = 13.85 min, τmajor = 16.77 min (99% ee). 
35
  Sewgobind, N. V.; Wanner, M. J.; Ingemann, S.; de Gelder, R.; van Maarseveen, J. H.; Hiemstra, H. J. Org. Chem. 
2008, 73, 6405. 
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9.9 mmol, 4.5 eq) and  corresponding silyl chloride (4.1 g, 13.3 mmol, 6 eq) were added at room 
temperature. The mixture was stirred at room temperature for 72 h until all starting material was 
consumed (reaction monitored by TLC using hexanes/CH2Cl2 2.5:1). The reaction was quenched 
with a saturated solution of Na2CO3 (10 mL). The aqueous layer was extracted with EtOAc 
(3×10 mL) and combined organic extracts were washed with HCl (1M, 20 mL) and brine (20 
mL). Organic layer was dried over Na2SO4 and filtered. After the removal of the solvent, the 
residue was filtered through a small plug of silica gel (hexanes/EtOAc 19:1) obtaining a crude 
wich pure enough to perform the next step. To a solution of bromosilyl ether (1 g, 1.03 mmol, 1 
eq) in dry THF (25 mL, 0.04M) was dropwise added tBuLi (1.6M  in pentane) (3.9 mL, 6.2 
mmol, 6 eq) over 10 min at 0 ºC. The mixture was stirred at room temperature for 5 h. Then, the 
mixture was cooled to 0 ºC and a saturated solution of NH4Cl (15 mL) was added dropwise to 
quench the reaction. The mixture was extracted with CH2Cl2 (3×10 mL) and combined organic 
extracts were washed with brine and dried over Na2SO4, filtered and the solvent was removed 
under reduced pressure. The residue was purified by FC on silica gel (hexanes/EtOAc 19:1 to 
8:2) to obtain SI7 (1.07 g, 1.32 mmol, 60% two steps). 1H NMR (300 MHz, CDCl3) δ 7.61-7.55 
(m, 12H, Carom-H), 7.45-7.29 (m, 18H, Carom-H), 6.93 (s, 2H, Carom-H), 4.87 (s, 2H, 2×OH), 2.58 
(bs, 4H, 2×CH2), 2.45-2.24 (m, 4H, 2×CH2), 1.77-1.61 (m, 8H, 4×CH2). 13C NMR (75 MHz, 
CDCl3) δ 156.3 (Carom-O), 140.2 (Carom), 139.8 (Carom-H), 136.4 (Carom-H), 134.8 (Carom), 130.2 
(Carom), 129.5 (Carom-H), 127.8 (Carom-H), 119.0 (Carom), 117.3 (Carom), 29.3 (CH2), 27.6 (CH2), 
23.1 (CH2). 
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1,1´-Spirobiindane-7,7´-derivatives 
The spiroanalog of BINOL was prepared following the procedure available on the literature with 
some modifications.36 
1,5-bis-m-anisyl-3-pentanone (SI8). A solution of m-anisaldehyde (367.2 mmol, 2.0 eq) and 
acetone (183.6 mmol, 1 eq) in 25 mL of EtOH was added dropwise to a solution of 37.5 g of 
NaOH in 300 mL of 50% aqueous ethanol, stirring in a water bath at room temperature. The 
mixture was stirred for 2 h with mechanic stirring. Then CH2Cl2 was added and the aqueous layer 
was extracted with CH2Cl2. The combined organic layers were washed with water, dried over 
Na2SO4, filtered and the solvent was removed under reduced pressure. A solution of 1,5-bis-m-
anisyl-1,4-pentadien-3-one (53.5 mmol, 1 eq) in the minimum quantity of acetone was stirred 
with Ni Raney (2 eq) under an atmosphere of H2 (1 atm, balloon) at room temperature, 
monitoring the reaction by TLC and adding more catalyst as necessary. After 16 h, the catalyst 
was filtered off, washed with acetone and the filtrate was evaporated under reduced pressure. The 
crude was obtained as a colorless oil wich was purificated by FC on silica (hexanes to 
hexanes/EtOAc 8:2) to obtain SI8 (21.4 mmol, 40%). 1H NMR (300 MHz, CDCl3) δ 7.25-7.19 
(m, 2H, Carom-H), 6.80-6.76 (m, 6H, Carom-H), 3.79 (s, 6H, OCH3), 2.90 (t, J = 7.5 Hz, 4H, CH2), 
2.71 (t, J = 7.5 Hz, 4H, CH2). 13C NMR (75 MHz, CDCl3) δ 209.0 (C=O), 159.7 (Carom-O), 142.6 
(Carom), 129.4 (Carom-H), 120.6 (Carom-H), 114.1 (Carom-H), 111.4 (Carom-H), 55.1 (OCH3), 44.4 
(O=CCH2), 29.7 (CH2). 
4,4´-dibromo-7,7´-dimethoxy-1,1´-spirobiindane (SI9). SI8 (9.8 mmol, 1 eq) was dissolved in 
the minimum quantity of CH2Cl2, pyridine (34.3 mmol, 3.5 eq) was added and the mixture was 
                                                           
36
  Birman, V. B.; Rheingold, A. L.; Lam, K.-C. Tetrahedron: Asymmetry 1999, 10, 125. 
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cooled to -10 ºC. A solution of bromine in CH2Cl2 (24.5 mmol, 2.5 eq, 10% v/v) was added 
dropwise. After that, the reaction mixture was allowed to warm to room temperature and stirred 
until the starting material disappeared (1 day). The mixture was washed with aqueous NaHSO3 to 
remove excess bromine, washed with diluted HCl and water and dried over Na2SO4, filtered and 
concentrate under vacuum. The product solidified on standing and it was used without further 
purification. The crude (5.5 mmol, 1 eq) was stirred with 22 g of H3PO4 (PPA can be used as 
well) at 105 ºC for 5.5 h. Due to the complex workup, low scale reaction is recommended. The 
crude was cooled to 0ºC and quenched with aqueous KOH solution and stirred for 10 minutes. 
The mixture was extracted with Et2O (3×30 mL) and then with CH2Cl2 (3×30 mL), the combined 
organic extracts were dried over Na2SO4, filtered and concentrated under vacuum. The residue 
was purified by FC on silica gel (hexanes/EtOAc 9:1) and SI9 was obtained (6.4 mmol, 65%). 1H 
NMR (300 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 2H, Carom-H), 6.52 (d, J = 8.6 Hz, 2H, Carom-H), 
3.52 (s, 3H, OCH3), 3.12-2.89 (m, 4H, CH2), 2.37-2.27 (m, 2H, CH2), 2.20-2.12 (m, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 155.6 (Carom-O), 144.8 (Carom), 138.2 (Carom), 130.3 (Carom-H), 
110.8 (Carom-H), 110.5 (Carom-Br), 61.9 (Cspiro), 55.4 (OCH3), 37.9 (CH2), 33.2 (CH2). 
rac-1,1´-Spirobiindane-7,7´–diol, (±)-SI10. In a dried flask a solution of SI9 (1.4 mmol, 1 eq) in 
THF (0.12M) was placed under Argon atmosphere. The solution was cooled to -78 ºC and treated 
with tBuLi 1.9M solution in pentane (5.6 mmol, 4 eq). After 1 h, the reaction mixture was 
quenched with EtOH and aqueous layer was extracted with CH2Cl2 (3×10 mL). Combined 
organic layers were washed with water and dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure The residue was used in the next step without further 
purification. In a dried flask a solution of 7,7´-dimethoxy-1,1´-spirobiindane (1.96 mmol, 1 eq) in 
CH2Cl2 (0.22M) was cooled to -78 ºC, treated with BBr3 in CH2Cl2 (4.5 mmol, 2.3 eq) and 
allowed to warm to room temperature for 16 h. The reaction mixture was diluted with CH2Cl2 
and washed with water until washings had neutral pH. Organic layer was dried over Na2SO4, 
filtered and evaporated. The residue was purified by FC on silica gel (hexane/EtOAc, 19:1 to 8:2) 
to give product (±)-SI10 (1.1 mmol, 81%). 1H NMR (300 MHz, CDCl3) δ 7.18 (t, J = 7.7 Hz, 2H, 
Carom-H), 6.90 (d, J = 7.4 Hz, 2H, Carom-H), 6.68 (d, J = 8.0 Hz, 2H, Carom-H), 4.72 (s, 2H, OH), 
3.09-2.98 (m, 4H, CH2), 2.36-2.14 (m, 4H, CH2). 13C NMR (75 MHz, CDCl3) δ 152.9 (Carom-
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OH), 145.8 (Carom), 130.5 (Carom), 129.8 (Carom-H), 117.6 (Carom-H), 114.3 (Carom-H), 57.4 (Cspiro), 
37.4 (CH2), 31.2 (CH2). 
7,7´-Bis-(L-menthyloxy-carbonyloxy)-1,1´-spirobiindane (R)-SI11 and (S)-SI11 
The resolution of rac-1,1´-spirobiindane-7,7´–diol (±)-SI10 was achieved using L-Menthyl 
chloroformate (1.9 mmol, 2.4 eq) which was added to a stirring solution of rac-1,1´-
spirobiindane-7,7´–diol (±)-SI10 (0.8 mmol, 1 eq), Et3N (2.95 mmol, 3.7 eq) and DMAP (0.08 
mmol, 10 mol%) in CH2Cl2 (0.1M) under Ar atmosphere. After stirring for 9 h at room 
temperature the organic layer was washed with water, HCl and brine. The organic layer was 
dried with Na2SO4, evaporated and the residue was purified by FC on silica gel (hexane to 
hexane/EtOAc 95:5) to give (R)-SI11 (0.44 mmol, 40%) and (S)-SI11 (0.46 mmol, 42%). Mixed 
fractions were gotten as well. 
(R)-SI11: 1H NMR (300 MHz, CDCl3) δ 7.20 (t, J = 7.7 Hz, 2H, Carom-H), 7.09 (d, J = 7.7 Hz, 
2H, Carom-H), 6.98 (d, J = 7.7 Hz, 2H, Carom-H), 4.33 (td, J = 10.8, 4.4 Hz, 2H, 2×CcyH), 3.17-
2.99 (m, 4H, 2×CcyH2), 2.46-2.33 (m, 2H, CcyH2), 2.32-2.19 (m, 2H, CcyH2), 1.95-1.20 (m, 14H, 
2×CcyH + 6×CcyH2), 1.07-0.82 (m, 16H, 2×CcyH + 2×CH + 4×CH3), 0.71 (d, J = 6.9 Hz, 6H, 
2×CH3). 13C NMR (75 MHz, CDCl3) δ 152.6 (C=O), 147.6 (Carom), 145.7 (Carom), 138.9 (Carom), 
127.8 (Carom-H), 121.9 (Carom-H), 119.9 (Carom-H), 78.5 (OCH), 59.1 (Cspiro), 46.5 (CH), 40.2 
(CcyH2), 38.8 (CcyH2), 34.0 (CcyH2), 31.2 (CcyH2), 31.1 (CH), 25.4 (CH), 23.0 (CcyH2), 21.9 
(CH3), 20.7 (CH3), 16.1 (CH3). 
(S)-SI11: 1H NMR (300 MHz, CDCl3) δ 7.22 (t, J = 7.7 Hz, 2H, Carom-H), 7.12 (d, J = 7.7 Hz, 
2H, Carom-H), 6.95 (d, J = 7.7 Hz, 2H, Carom-H), 4.39 (td, J = 10.9, 4.4 Hz, 2H, 2×Ccy-H), 3.14-
2.92 (m, 4H, 2×CcyH2), 2.37-1.17 (m, 18H, 4×CcyH + 6×CcyH2 + 2×CH), 1.01-0.83 (m, 12H, 
4×CH3), 0.72 (d, J = 6.9 Hz, 6H, 2×CH3). 13C NMR (75 MHz, CDCl3) δ 153.0 (C=O), 147.4 
(Carom), 145.4 (Carom), 139.0 (Carom), 127.8 (Carom-H), 122.0 (Carom-H), 120.3 (Carom-H), 78.3 
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(OCH), 58.5 (Cspiro), 46.6 (CH), 40.3 (CcyH2), 38.3 (CcyH2), 33.9 (CcyH2), 31.1 (CcyH2), 30.9 
(CH), 25.4 (CH), 22.9 (CcyH2), 21.8 (CH3), 20.6 (CH3), 15.9 (CH3). 
(S)-(−)-1,1´-Spirobiindane-7,7´-diol, (S)-SI12. For the preparation of (S)-SI12, a solution of (S)-
SI11 (0.32 mmol, 1 eq) and hydrazine hydrate (4.4 mmol, 6 eq) in THF (0.15M) were added. The 
mixture was refluxed under Ar atmosphere for 2 h. The crude was diluted with CH2Cl2, washed 
with diluted HCl, water and dried over Na2SO4, filtered and the solvent was removed under 
reduced pressure. FC on silica gel (hexanes/EtOAc 19:1 to 8:2) afforded (S)-SI12 (0.18 mmol, 
56%). 1H NMR (300 MHz, CDCl3) δ 7.18 (t, J = 7.6 Hz, 2H, Carom-H), 6.89 (d, J = 7.6 Hz, 2H, 
Carom-H), 6.68 (d, J = 8.1 Hz, 2H, Carom-H), 4.57 (s, 2H, OH), 3.07-3.01 (m, 4H, CH2), 2.35-2.14 
(m, 4H, CH2). 13C NMR (75 MHz, CDCl3) δ 152.9 (Carom-O), 145.8 (Carom), 130.4 (Carom), 129.9 
(Carom-H), 117.7 (Carom-H), 114.3 (Carom-H), 57.4 (Cspiro), 37.4 (CH2), 31.2 (CH2). [α]D20: -43.9 (c 
= 1.0, CH2Cl2). Literature value [α]D20: -32.7 (c = 1.0, CHCl3). 
The opposite enantiomer was obtained following the same procedure described. 
(S)-6,6´-bis(triphenylsilyl)-2,2´,3,3´-tetrahydro-1,1´-spirobiindane-7,7´-diol, (S)-SI13 
 
(S)-6,6´-bis(triphenylsilyl)-2,2´,3,3´-tetrahydro-1,1´-spirobiindane-7,7´-diol (S)-SI13 was 
prepared through an ortho-bromination step of (S)-SI12 following a patented procedure with 
slight modifications as follows.37 To a solution of (S)-SI12 (0.16 mmol, 1 eq) and KHCO3 (0.32 
mmol, 2 eq) in CH2Cl2 (1.5 mL, 0.11M), N-bromo succinimide (0.33 mmol, 2.05 eq) was added 
slowly at -20ºC. The reaction mixture was stirred for 20 h. The mixture was quenched with HCl 
(2M, 5 mL) and extracted with CH2Cl2 (3×5 mL). Combined organic layers were dried over 
Na2SO4 and filtered. After removal of the solvent, the crude was filtered through a small plug of 
                                                           
37
  Chipa, L.; Zambad, S. P.; Gupta, R.; Tuli, D.; Kasundra, A.; Munshi, S.; Siddiqui, M. A.; Bhattamisra, S. K.; Dutt, 
C.; Chauthaiwale, V. Pyrazole derivatives as thyroid receptor modulators and their preparation, pharmaceutical 
compositions and use in the treatment of diseases. International Patent WO 2008149379, July 02, 2008. 
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silica and it was used in the next step without further purification. NMR spectral data were in 
agreement with those reported in the literature.38 
(S)-SI13. Silylation and rearrangement step were developed following a procedure reported in 
the literature.39. Spectroscopic data for (S)-SI13 were in agreement with those reported in the 
literature.39 1H NMR (300 MHz, CDCl3) δ 7.63-7.60 (m, 12H, Carom-H), 7.43-7.37 (m, 6H, Carom-
H), 7.32-7.27 (m, 12H, Carom-H), 7.12 (d, J = 7.4 Hz, 2H, Carom-H), 6.87 (d, J = 7.4 Hz, 2H, Carom-
H), 5.20 (s, 2H, 2×OH), 3.16-2.96 (m, 4H, 2×CH2), 2.40-2.22 (m, 4H, 2×CH2). 13C NMR (75 
MHz, CDCl3) δ 158.5 (Carom), 149.2 (Carom), 139.0 (Carom-H), 136.3 (Carom-H), 134.5 (Carom), 
131.4 (Carom), 129.6 (Carom-H), 128.0 (Carom-H), 117.9 (Carom-H), 117.6 (Carom), 58.2 (Cspiro), 37.3 
(CH2), 31.2 (CH2). 
  
                                                           
38
  Gonzalez, A. Z.; Benitez, D.; Tkatchouk, E.; Goddard III, W. A.; Toste, F. D. J. Am. Chem. Soc. 2011, 133, 5500. 
39
  Xing, C.-H.; Liao Y.-X.; Zhang, Y.; Sabarova, D.; Bassous, M.; Hu, Q.-S. Eur. J. Org. Chem. 2012, 6, 1115. 
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2.3.2 Synthesis of catalysts 
Catalysts 3g-j 
 
General Procedure G (GP-G) for the synthesis of catalysts 3g-j: Corresponding (S)-diol (0.5 
mmol, 1 eq) was placed in a two-necked flask fitted with a reflux condenser under Argon 
atmosphere and was dissolved in dry CH2Cl2 (0.15M). Freshly distilled and dry Et3N (3.5 mmol, 
7 eq) and POCl3 (0.75 mmol, 1.5 eq) respectively were added at 0ºC and the reaction mixture 
was stirred for 5 min. DMAP (1 mmol, 2 eq) was added into the reaction mixture at 0ºC and it 
was stirred at room temperature for 2 h. Freshly distilled EtCN (0.15M) was added followed by 
corresponding sulfonamide (1.5 mmol, 3 eq) and the reaction was heated to 95ºC for 14 h. The 
mixture was cooled to room temperature and quenched with water (10 mL), stirred for 30 
minutes and diluted with CH2Cl2. The organic layer was separated from the mixture and the 
aqueous phase was extracted with CH2Cl2 (3×10 mL). The combined organic extracts were 
washed with NaHCO3 sat. aq. (5 mL) and 5M HCl (3×5 mL). Combined organic extracts were 
dried with Na2SO4, filtered and solvent was removed under reduced pressure. The residue was 
purified by FC on silica gel (CH2Cl2 to CH2Cl2/MeOH 95:5). After purification, residue must be 
cleaned with 5M HCl (5×5 mL) since no calcium ions are present during the synthetic steps, it is 
likely that N-triflylphosphoramides bound calcium cations from the silica gel used for the final 
column chromatography but they release it upon acidic washing.40 EDX measurements had been 
done to confirm that these highly acidic BrØnsted acids are free from any metal impurities.41 (3h) 
was synthesized following a procedure in the literature.26 
  
                                                           
40
  Hatano, M.; Moriyama, K.; Maki, T.; Ishihara, K. Angew. Chem. Int. Ed. 2010, 122, 3911. 
41
  Rueping, M.; Nachtsheim, B. J.; Koenigs, R. M.; Ieawsuwan, W. Chem. Eur. J. 2010, 16, 13116. 
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1,1,1-trifluoro-N-((11bS)-4-oxido-2,6-bis(triphenylsilyl)dinaphtho[2,1-
d:1´,2´-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide (3g). 
Following GP-G, 3g was isolated as a white solid by FC on silica gel (314 
mg, 0.31 mmol, 63%), starting from SI5a (400 mg, 0.5 mmol) in CH2Cl2 
(2.6 mL) with Et3N (0.49 mL, 3.5 mmol), POCl3 (70 µL, 0.75 mmol), DMAP (122 mg, 1 mmol), 
EtCN (2.6 mL) and NH2Tf (235 mg, 1.5 mmol). Rf= 0.33 (CH2Cl2/MeOH, 98:2). 1H NMR (300 
MHz, CDCl3) δ 8.35 (s, 1H, Carom-H), 8.13 (s, 1H, Carom-H), 7.93 (d, J = 8.1 Hz, 1H, Carom-H), 
7.85-7.78 (m, 7H, Carom-H), 7.78-7.69 (m, 6H, Carom-H), 7.58-7.24 (m, 24H, Carom-H), 4.26 (s, 1H, 
NH). 13C NMR (75 MHz, CDCl3) δ 142.7 (Carom-H), 142.1 (Carom-H), 136.9 (Carom-H), 136.6 
(Carom-H), 134.3 (Carom), 133.3 (Carom), 133.2 (Carom), 131.1 (Carom), 131.0 (Carom), 129.9 (Carom-H), 
129.5 (Carom-H), 128.9 (Carom-H), 128.8 (Carom-H), 128.2 (Carom-H), 127.9 (Carom-H), 127.7 (Carom-
H), 126.8 (Carom-H), 126.0 (Carom-H), 125.9 (Carom-H), 125.1 (Carom), 121.7 (Carom), 120.9 (Carom). 
19F NMR (282 MHz, CDCl3) δ -77.8. IR (CH2Cl2): 1430 (SO2 st as), 1190 (SO2 st sim), 1190 
(P=O st)cm-1. HRMS: Calculated for [C57H40NO5PSF3Si2]–: 994.1855 [M-H]–; found: 994.1848. 
M.p.: 160-162ºC (CH2Cl2). [α]D20: +175.4 (c = 1.0, CH2Cl2). 
N-((11bS)-2,6-bis(tert-butyldimethylsilyl)-4-oxidodinaphtho[2,1-d:1´,2´-
f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide (3h). 
Following GP-G, 3j was isolated as a white solid by FC on silica gel (314 
mg, 0.31 mmol, 52%), starting from SI5b (125 mg, 0.24 mmol) in CH2Cl2 
(0.8 mL) with Et3N (0.23 mL, 1.7 mmol), POCl3 (33 µL, 0.36 mmol), 
DMAP (58.6 mg, 1 mmol), EtCN (0.8 mL) and NH2Tf (111 mg, 0.72 
mmol). Rf= 0.27 (CH2Cl2/MeOH, 92:8). 1H NMR (300 MHz, CDCl3) δ 8.07 (d, J = 8.7 Hz, 2H, 
Carom-H), 7.91 (dd, J = 8.3, 5.1 Hz, 2H, Carom-H), 7.47-7.35 (m, 2H, Carom-H), 7.25-7.17 (m, 2H, 
Carom-H), 7.06-6.97 (m, 2H, Carom-H), 2.49 (s, 1H, NH), 0.81 (s, 9H, 3×CH3), 0.79 (s, 9H, 
3×CH3), 0.61 (s, 3H, CH3), 0.49 (s, 3H, CH3), 0.48 (s, 3H, CH3), 0.39 (s, 3H, CH3). 13C NMR (75 
MHz, CDCl3) δ 151.5 (Carom), 151.4 (Carom), 151.2 (Carom), 151.1 (Carom), 138.6 (Carom-H), 133.8 
(Carom), 133.7 (Carom), 130.8 (Carom), 130.7 (Carom), 129.1 (Carom), 129.0 (Carom), 128.8 (Carom), 
128.7 (Carom), 128.5 (Carom-H), 128.4 (Carom-H), 127.1 (Carom-H), 126.9 (Carom-H), 126.8 (Carom-H), 
126.7 (Carom-H), 125.4 (Carom-H), 125.3 (Carom-H), 121.6 (Carom), 121.0 (Carom), 26.9 (CH3), 26.9 
(CH3), 17.8 (CH3), 17.7 (CH3), -3.3 (CH3), -3.8 (CH3), -4.4 (CH3), -4.8 (CH3). 19F NMR (282 
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MHz, CDCl3) δ -79.4. HRMS: Calculated for [C33H40NO5SPF3Si2] –: 706.1855 [M-H]–; found: 
706.1850. M.p.: 105-107ºC (CH2Cl2). [α]D20: +151.9 (c = 0.6, CH2Cl2). 
1,1,1-trifluoro-N-((11bS)-4-oxido-2,6-bis(triphenylsilyl)-
8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1´,2´-
f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide (3i). Following GP-
G, 3i was isolated as a white solid by FC on silica gel (226 mg, 0.22 mmol, 
55%), starting from SI7 (330 mg, 0.41 mmol) in CH2Cl2 (1.6 mL) with Et3N 
(0.4 mL, 2.9 mmol), POCl3 (57 µL, 0.61 mmol), DMAP (100 mg, 0.82 mmol), EtCN (1.6 mL) 
and NH2Tf (180 mg, 1.2 mmol). Rf= 0.4 (CH2Cl2:MeOH, 96:4). 1H NMR (300 MHz, CDCl3) δ 
7.62 (dd, J = 7.7, 1.7 Hz, 6H, Carom-H), 7.54 (dd, J = 7.7, 1.7 Hz, 6H, Carom-H), 7.46-7.24 (m, 
19H, Carom-H), 7.06 (s, 1H, Carom-H), 3.07 (bs, 1H, NH), 2.83-2.54 (m, 6H, 3×CH2), 2.41-2.20 
(m, 2H, 2×CH2), 1.93-1.56 (m, 8H, 4×CH2). 13C NMR (75 MHz, CDCl3) δ 150.6 (Carom), 150.4 
(Carom), 150.1 (Carom), 150.0 (Carom), 141.7 (Carom), 141.6 (Carom), 140.9 (Carom), 140.9 (Carom), 
140.3 (Carom-H), 139.5 (Carom-H), 136.9 (Carom-H), 136.6 (Carom-H), 135.7 (Carom), 135.7 (Carom), 
135.5 (Carom), 135.1 (Carom), 133.6 (Carom), 133.4 (Carom), 132.1 (q, 1JC-F = 273.8 Hz, CF3), 130.0 
(Carom-H), 129.5 (Carom-H), 128.3 (Carom-H), 127.7 (Carom-H), 126.5 (Carom), 126.5 (Carom), 125.8 
(Carom), 122.9 (Carom), 122.8 (Carom), 121.7 (Carom), 121.6 (Carom), 29.3 (CH2), 28.1 (CH2), 28.1 
(CH2), 22.7 (CH2), 22.7 (CH2), 22.6 (CH2), 22.6 (CH2). 19F NMR (282 MHz, CDCl3) δ -77.9. IR 
(CH2Cl2): 1428 (SO2 st as), 1195 (SO2 st sim), 1109 (P=O st) cm-1. HRMS: Calculated for 
[C57H48NO5SPF3Si2]-: 1002.2481 [M-H]-; found: 1002.2486. M.p.: 158-160ºC (CH2Cl2). [α]D20: 
+87.5 (c = 1.0, CH2Cl2). 
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Following GP-G, 3k was isolated after FC on silica gel (36 mg, 0.04 mmol, 24%), starting from 
(S)-SI13 (120 mg, 0.15 mmol) in CH2Cl2 (0.85 mL) with Et3N (0.15 mL, 1.1 mmol), POCl3 (22 
µL, 0.23 mmol), DMAP (38.1 mg, 0.31 mmol), EtCN (0.85 mL) and NH2Tf (72.7 mg, 0.47 
mmol). Rf= 0.33 (CH2Cl2:MeOH, 96:4). 1H NMR (300 MHz, CDCl3) δ 7.61-7.48 (m, 10H, Carom-
H), 7.44-7.20 (m, 20H, Carom-H), 7.16 (d, J = 7.4 Hz, 1H, Carom-H), 7.08 (d, J = 7.4 Hz, 1H, Carom-
H), 3.23-2.80 (m, 4H, 2×CH2), 2.59 (s, 1H, NH), 2.40-2.14 (m, 3H, CH2+CHaHb), 2.12-1.92 (m, 
1H, CHaHb). 13C NMR (75 MHz, CDCl3) δ 164.8 (q, 1JC-F = 234.1 Hz, CF3), 149.3 (Carom-O), 
139.4 (Carom-H), 138.7 (Carom-H), 136.9 (Carom-H), 136.7 (Carom-H), 135.0 (Carom-H), 133.6 (Carom), 
133.2 (Carom), 129.6 (Carom-H), 129.3 (Carom-H), 128.1 (Carom-H), 127.9 (Carom), 127.7 (Carom-H), 
127.5 (Carom-H), 123.2 (Carom-H), 123.1 (Carom-H), 60.1 (Cspiro), 39.0 (CH2), 38.2 (CH2), 30.1 
(CH2), 30.0 (CH2). 19F NMR (282 MHz, CDCl3) δ -78.4. IR (CH2Cl2): 1278 (SO2 st as), 1260 
(SO2 st sim), 1207 (C-F st) cm-1. HRMS: Calculated for [C54H42NO5SPF3Si2]-: 960.2012 [M-H]-; 
found: 960.2014. M.p.: 114-116ºC (CH2Cl2). [α]D20: -244.0 (c = 0.6, CH2Cl2). 
2.4 Preparation of DMDO 
DMDO was prepared following the procedure reported in the literature.42 Concentration of 
DMDO solution was determined by classical iodometric titration.43 
                                                           
42
  Alberch, L.; Cheng, G.; Seo, S.-K.; Li, X.; Boulineau, F. P.; Wei, A. J. Org. Chem. 2011, 76, 2532. 
43
  Hayes, C. J.; Sherlock, A. E.; Selby, M. D. Org. Biomol. Chem. 2006, 4, 193. 
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2.5 Synthesis of cycloadducts 4a-k 
 
General Procedure H (GP-H) for the synthesis of 4a-k: A test tube equipped with a stirring 
bar was charged with the corresponding catalyst (5 mol%) and cooled to -78 ºC. Then, 
corresponding allene (0.1 mmol, 1 eq) was added followed by a precooled mixture of DMDO in 
toluene (0.2 mmol, 2 eq). Subsequently, furan (0.3 mmol, 3 eq) was added. The mixture was 
stirred for 16 h at -78 ºC. The crude reaction was purified by flash column chromatography on 
silica gel. TLCs were developed in p-anisaldehyde dip. 
The racemic standards for HPLC separation were prepared using diphenyl phosphate or 
diphenyl-N-triflyl phosphoramide catalyst. 
3-((1R,2S,5R)-3-Oxo-8-oxabicyclo[3.2.1]oct-6-en-2-yl)oxazolidin-2-one (4a). 
Following GP-H, 4a (22.2 mg, 44%) was isolated by FC (hexanes/EtOAc 1:1 to 
2:8), as an oil after 16h, starting from catalyst 3g (11.9 mg, 0.01 mmol), allene 
1a (30 mg, 0.24 mmol), DMDO solution in toluene (1.7 mL, 0.48 mmol) and 
furan (52 µL, 0.72 mmol). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 6.40 (dd, J = 6.1, 1.9 Hz, 
1H, H-6), 6.27 (d, J = 6.2 Hz, 1H, H-7), 5.06 (m, 1H, H-5), 5.03 (dd, J = 4.7, 1.8 Hz, 1H, H-1), 
4.51-4.23 (m, 2H, CH2), 3.72-3.61 (m, 1H, CHaHb), 3.33-3.18 (m, 1H, CHaHb), 2.87 (dd, J = 
15.9, 5.2 Hz, 1H, H-4a), 2.44 (d, J = 15.9 Hz, H-4b). 13C NMR (75 MHz, CDCl3) δ 200.7 (C=O), 
158.9 (O-C=O), 136.1 (C-6), 131.2 (C-7), 80.1 (C-5), 78.2 (C-1), 65.9 (C-2), 62.6 (OCH2), 45.9 
(C-4), 42.8 (CH2). IR (CH2Cl2): 1745, 1716 cm-1. MS (EI) m/z (%): 123 (20). HRMS: Calculated 
for [C10H12NO4]+: 210.0766 [M+H]+; found: 210.0766. The ee was determined by HPLC using a 
Chiralcel OD-3 column [n-hexane/i-PrOH (80:20)]; flow rate 0.60 mL/min; τminor =39.1 min, 
τmajor = 45.9 min (20% ee). 
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N,4-Dimethyl-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)benzenesulfonamide (4b). Following GP-H, 4b (14.0 mg, 34%) was isolated 
by FC (hexanes/EtOAc 2:8 to 1:1), as a solid after 16h, starting from catalyst 3g 
(6.6 mg, 0.007 mmol), allene 1b (30 mg, 0.13 mmol), DMDO solution in toluene 
(1.7 mL, 0.27 mmol) and furan (29 µL, 0.4 mmol). Rf= 0.51 (hexanes/EtOAc 1:1). dr: >20:1. 1H 
NMR (300 MHz, CDCl3) δ 7.68 (d, J = 8.2 Hz, 2H, Carom-H), 7.28 (d, J = 8.2 Hz, Carom-H), 6.36-
6.30 (m, 2H, H-6 + H-7), 5.05-4.95 (m, 2H, H-1 + H-5), 4.92 (d, J = 4.8 Hz, 1H, H-2), 2.76 (dd, 
J = 16.3, 5.3 Hz, 1H, H-4a), 2.66 (s, 3H, NCH3), 2.41 (s, 3H, Carom-CH3), 2.34 (dd, J = 16.3, 0.9 
Hz, 1H, H-4b). 13C NMR (75 MHz, CDCl3) δ 200.8 (C=O), 143.5 (Carom), 135.8 (Carom), 135.3 
(C-7), 131.9 (C-6), 129.5 (Carom-H), 127.2 (Carom-H), 81.3 (C-5), 77.5 (C-1), 69.1 (C-2), 45.8 (C-
4), 32.6 (CH3N), 21.5 (CH3-Carom). IR (CH2Cl2): 1724 (C=O st), 1332 (SO2 st as), 1153 (SO2 st 
sy) cm-1. MS (EI) m/z (%): 307 (M+, 1), 152 (100). HRMS: Calculated for [C15H18NO4S]+: 
308.0957 [M+H]+; found: 308.0951. The ee was determined by HPLC using a Chiralpak AD-H 
column [n-hexane/i-PrOH (80:20)]; flow rate 1.00 mL/min; τminor = 26.3 min, τmajor = 39.5 min 
(48% ee). M.p: 91-93ºC (CH2Cl2). [α]D20: +18.0 (c = 1.0, CH2Cl2). 
4-Methyl-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-yl)-N-
phenylbenzenesulfonamide (4c). Following GP-H, 4c (10.4 mg, 27%) was 
isolated by FC (hexanes/EtOAc 9:1 to 6:4), as an oil after 16h, starting from 
catalyst 3g (5.2 mg, 0.005 mmol), allene 1c (30 mg, 0.1 mmol), DMDO solution in toluene (0.75 
mL, 0.21 mmol) and furan (22 µL, 0.3 mmol). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 7.55 (d, 
J = 8.3 Hz, 2H, Carom-H), 7.40-7.13 (m, 7H, Carom-H), 5.93 (dd, J = 6.1, 1.7 Hz, 1H, H-6), 5.45 (d, 
J = 4.4 Hz, 1H, H-2), 5.03 (dd, J = 4.4, 1.7 Hz, 1H, H-1), 4.91 (m, 1H, H-5), 4.61 (dd, J = 6.1, 
1.7 Hz, 1H, H-7), 2.84 (dd, J = 15.7, 5.1 Hz, 1H, H-4a), 2.41 (s, 3H, CH3), 2.33 (d, J = 15.6 Hz, 
1H, H-4b). 13C NMR (75 MHz, CDCl3) δ 202.0 (C=O), 143.4 (Carom), 137.0 (Carom), 136.8 
(Carom), 133.9 (Carom-H), 132.9 (Carom-H), 131.6 (C-6), 129.3 (C-7), 129.1 (Carom-H), 129.0 (Carom-
H), 128.2 (Carom-H), 81.4 (C-5), 78.0 (C-2), 72.2 (C-1), 45.6 (C-4), 21.6 (CH3). IR (CH2Cl2): 
1730 (C=O st), 1339 (SO2 st as), 1156 (SO2 st sy) cm-1. MS (EI) m/z (%): 214 (100), 289 (77). 
HRMS: Calculated for [C20H20NO4S]+: 370.1113 [M+H]+; found: 370.1121. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 
mL/min; τmajor =26.6 min, τminor = 30.1 min (74% ee). [α]D20: +197.9 (c = 0.4, CH2Cl2). 
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N-(4-bromophenyl)-4-methyl-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-
en-2-yl)benzenesulfonamide (4d). Following GP-H, 4d (8.5 mg, 23%) was 
isolated by FC (hexanes/EtOAc 19:1 to 7:3), as a solid after 16h, starting from 
catalyst 3g (4.1 mg, 0.004 mmol), allene 1d (30 mg, 0.08 mmol), DMDO 
solution in toluene (0.7 mL, 0.16 mmol) and furan (18 µL, 0.25 mmol). Rf= 0.34 
(hexanes/EtOAc 7:3). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 8.3 Hz, 2H, Carom-H), 
7.41 (d, J = 8.7 Hz, 2H, Carom-H), 7.24 (d, J = 8.6 Hz, 2H, Carom-H), 7.07 (d, J = 8.7 Hz, 2H, 
Carom-H), 6.0 (dd, J = 6.1 Hz, 1.8 Hz, 1H, H-6), 5.45 (d, J = 4.3 Hz, 1H, H-2), 5.02 (dd, J = 4.3, 
1.7 Hz, 1H, H-1), 4.96-4.90 (m, 1H, H-5), 4.78 (dd, J = 6.1, 1.7 Hz, 1H, H-7), 2.85 (dd, J = 15.7, 
5.1 Hz, 1H, H-4a), 2.42 (s, 3H, CH3), 2.33 (d, J = 15.7 Hz, 1H, H-4b). 13C NMR (75 MHz, 
CDCl3) δ 201.9 (C=O), 143.7 (CaromSO2), 136.4 (Carom), 136.1 (Carom), 134.5 (Carom-H), 134.4 (C-
6), 132.4 (Carom-H), 131.5 (C-7), 129.2 (Carom-H), 128.1 (Carom-H), 123.7 (Carom-Br), 81.3 (C-5), 
78.0 (C-2), 72.2 (C-1), 45.6 (C-4), 21.6 (CH3). IR (CH2Cl2): 1726 (C=O st), 1339 (SO2 st as), 
1159 (SO2 st sy) cm-1. HRMS: Calculated for [C20H19NO4SBr]+: 448.0218 [M+H]+; found: 
448.0222. The ee was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH 
(90:10)]; flow rate 1.00 mL/min; τmajor =39.5 min, τminor = 48.3 min (39% ee). M.p.: 184-186 ºC 
(CH2Cl2, decomp). [α]D20: +98.1 (c = 0.5, CH2Cl2). 
N-Mesityl-4-methyl-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)benzenesulfonamide (4e). Following GP-H, 4e (6.8 mg, 18%) was isolated 
by FC (hexanes/EtOAc 19:1 to 7:3), as solid after 16h, starting from 3f (3.4 mg, 
0.005 mmol), allene 1e (30 mg, 0.09 mmol), DMDO solution in toluene (0.63 
mL, 0.18 mmol) and furan (20 µL, 0.28 mmol). Rf= 0.38 (hexanes/EtOAc 7:3). dr: >20:1. 1H 
NMR (300 MHz, CDCl3) δ 7.57 (d, J = 8.3 Hz, 2H, Carom-H), 7.21 (d, J = 8.1 Hz, 2H, Carom-H), 
6.92 (d, J = 2.1 Hz, 1H, Carom-H), 6.77 (d, J = 2.2 Hz, 1H, Carom-H), 6.11 (dd, J = 6.1, 1.7 Hz, 1H, 
H-6), 5.22 (d, J = 4.5 Hz, 1H, H-2), 5.09 (dd, J = 6.1, 1.7 Hz, 1H, H-7), 4.94 (app d, J = 5.4 Hz, 
1H, H-5), 4.81 (dd, J = 4.5, 1.8 Hz, 1H, H-1), 2.90 (dd, J = 15.4, 5.0 Hz, 1H, H-4a), 2.44-2.34 
(m, 4H, H-4b+CH3), 2.30 (s, 3H, CH3), 2.27 (s, 3H, CH3), 1.67 (s, 3H, CH3). 13C NMR (75 MHz, 
CDCl3) δ 201.2 (C=O), 143.1 (Carom), 140.9 (Carom), 140.4 (Carom), 139.0 (Carom), 137.7 (Carom), 
134.6 (C-6), 132.7 (Carom), 131.5 (C-7), 130.0 (Carom-H), 129.9 (Carom-H), 128.9 (Carom-H), 128.6 
(Carom-H), 79.9 (C-5), 78.2 (C-2), 72.9 (C-1), 45.2 (C-4), 21.5 (CH3), 20.9 (CH3), 20.1 (CH3), 
19.1 (CH3). IR (ATR): 1734 (C=O st), 1336 (SO2 st as), 1159 (SO2 st sy) cm-1. HRMS: 
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Calculated for [C23H25NO4SNa]+: 434.1402 [M+Na]+; found: 434.1407. The ee was determined 
by HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; 
τmajor =13.1 min, τminor = 17.3 min (50% ee). M.p.: 165-167 ºC (hexanes/EtOAc). [α]D20: +116.6 (c 
= 1.0, CH2Cl2). 
N-(4-methoxyphenyl)-4-methyl-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)benzenesulfonamide (4f). Following GP-H, 4f (5.0 mg, 50%) was 
isolated by FC (hexanes/EtOAc 9:1 to 6:4), as a solid after 16h reaction time, 
starting from catalyst 3g (4.7 mg, 0.005 mmol), allene 1f (30 mg, 0.09 mmol), 
DMDO solution in toluene (1.2 mL, 0.2 mmol) and furan (21 µL, 0.28 mmol). 
Rf= 0.33 (hexanes/EtOAc 6:4). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 8.3 Hz, 2H, 
Carom-H), 7.21 (d, J = 8.1 Hz, 2H, Carom-H), 7.07 (d, J = 9.0 Hz, 2H, Carom-H), 6.76 (d, J = 9.0 Hz, 
2H, Carom-H), 5.95 (dd, J = 6.1, 1.8 Hz, 1H, H-6), 5.43 (d, J = 4.4 Hz, 1H, H-2), 5.02 (dd, J = 4.4, 
1.7 Hz, 1H, H-1), 4.91 (m, 1H, H-5), 4.73 (dd, J = 6.1, 1.7 Hz, 1H, H-7), 3.79 (s, 3H, OCH3), 
2.83 (dd, J = 15.6, 5.0 Hz, 1H, H-4a), 2.41 (s, 3H, CaromCH3), 2.32 (d, J = 15.8 Hz, 1H, H-4b). 
13C NMR (75 MHz, CDCl3) δ 202.1 (C=O), 159.9 (CaromOCH3), 143.3 (CaromSO2), 136.8 
(CaromCH3), 133.9 (C-7), 133.8 (Carom-H), 131.7 (Carom-H), 129.2 (Carom-N), 129.0 (Carom-H), 
128.1 (Carom-H), 114.1 (C-6), 81.4 (C-1), 78.0 (C-5), 72.2 (C-2), 55.3 (OCH3), 45.5 (C-4), 21.5 
(CH3). IR (CH2Cl2): 1730 (C=O st), 1339 (SO2 st as), 1253(C-O-C st as), 1156 (SO2 st sy) cm-1. 
MS (EI) m/z: 332 (100), 244 (2). HRMS: Calculated for [C21H22NO5S]+: 400.1219 [M+H]+; 
found: 400.1216. The ee was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-
PrOH (90:10)]; flow rate 1.00 mL/min; τmajor =56.5 min, τminor = 78.2 min (60% ee). M.p.: 176-
178 ºC (CH2Cl2, decomp). [α]D20: +57.4 (c = 1.0, CH2Cl2). 
N-(4-Methoxyphenyl)-N-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)acetamide (4g). Following GP-H, 4g (21.7 mg, 50%) was isolated by FC 
(hexanes/EtOAc 9:1 to 6:4), as a solid after 16h reaction time, starting from 
catalyst 3g (7.5 mg, 0.007 mmol), allene 1g (30 mg, 0.15 mmol), DMDO 
solution in toluene (0.8 mL, 0.3 mmol) and furan (33 µL, 0.45 mmol). Rf= 0.24 
(hexanes/EtOAc 4:6). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 7.18 (bs, 2H, Carom-H), 6.90 (d, J 
= 8.5 Hz, 2H, Carom-H), 6.0 (dd, J = 6.1, 1.8 Hz, 1H, H-6), 5.70 (d, J = 4.3 Hz, 1H, H-2), 5.00-
4.91 (m, 2H, H-1 + H-5), 4.69 (dd, J = 6.1, 1.7 Hz, 1H, H-7), 3.84 (s, 3H, OCH3), 2.90 (dd, J = 
15.5, 5.0 Hz, 1H, H-4a), 2.37 (d, J = 15.5 Hz, 1H, H-4b), 1.87 (s, 3H, CH3). 13C NMR (75 MHz, 
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CDCl3) δ 201.4 (C-3), 171.9 (C=O), 159.9 (OC=O), 133.8 (Carom), 133.6 (C-6), 132.2 (C-7), 
114.9 (Carom-H), 80.7 (C-1), 78.4 (C-5), 69.6 (C-2), 55.6 (OCH3), 45.3 (C-4), 22.7 (CH3). IR 
(CH2Cl2): 2962 (C-H st), 1659 (C=O st), 1242 (C-O-C st as), 1034 (C-O-C st sy) cm-1. HRMS: 
Calculated for [C16H18NO4]+: 288.1236 [M+H]+; found: 288.1243. The ee was determined by 
HPLC using a Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τmajor = 
33.7 min, τminor = 46.4 min (22% ee). M.p.: 134-136ºC (CH2Cl2). 
tert-Butyl-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(phenyl)carbamate (4h). Following GP-H, 4h (15.3 mg, 37%) was isolated 
by FC (hexanes/EtOAc 19:1 to 8:2), as an oil after 16h, starting from catalyst 3g 
(6.4 mg, 0.06 mmol), allene 1h (30 mg, 0.13 mmol), DMDO solution in toluene 
(0.9 mL, 0.26 mmol) and furan (28 µL, 0.39 mmol). Rf= 0.46 (hexanes/EtOAc 
7:3). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 7.38-7.27 (m, 3H, Carom-H), 7.25-7.15 (m, 2H, 
Carom-H), 5.98 (dd, J =6.1, 1.8 Hz, 1H, H-6), 5.26 (bs, 1H, H-2), 5.00 (dd, J = 4.4, 1.7 Hz, 1H, H-
1), 4.93 (m, 1H, H-5), 4.67 (d, J = 6.1 Hz, 1H, H-7), 2.85 (dd, J = 15.6, 5.1 Hz, 1H, H-4a), 2.38 
(d, J = 15.6 Hz, 1H, H-4b), 1.36 (s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) δ 201.7 (C=O), 
155.2 (O-C=O), 140.4 (Carom), 133.2 (Carom-H), 132.2 (Carom-H), 130.2 (C-6), 128.9 (C-7), 127.9 
(Carom-H), 80.6 (C-1), 78.2 (C-5), 77.2 (C(CH3)3), 71.1 (C-2), 45.2 (C-4), 28.1 (CH3). IR (ATR): 
1726 (C=O st) cm-1. MS (EI) m/z (%): 259 (22), 215 (39). HRMS: Calculated for 
[C18H21NO4Na]+: 338.1368 [M+Na]+; found: 338.1367. The ee was determined by HPLC using a 
Chiralcel OZ-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor =10.3 min, τminor 
= 22.5 min (64% ee). 
tert-Butyl (4-bromophenyl)-((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-
2-yl)carbamate (4i). Following GP-H, 4i (8.1 mg, 21%) was isolated by FC 
(hexanes/EtOAc 19:1 to 8:2), as a solid after 16h, starting from catalyst 3g (4.8 
mg, 0.005 mmol), allene 1i (30 mg, 0.1 mmol), DMDO solution in toluene (0.7 
mL, 0.2 mmol) and furan (21 µL, 0.3 mmol). Rf= 0.38 (hexanes/EtOAc 8:2). dr: 
>20:1. 1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 8.6 Hz, 2H, Carom-H), 7.09 (d, J = 8.6 Hz, 2H, 
Carom-H), 6.03 (dd, J = 6.1, 1.8 Hz, 1H, H-6), 5.24 (bs, 1H, H-2), 4.98 (dd, J = 4.4, 1.8 Hz, 1H, 
H-1), 4.95 (dd, J = 5.2, 1.2 Hz, 1H, H-5), 4.83 (d, J = 5.6 Hz, 1H, H-7), 2.85 (dd, J = 15.6, 5.2 
Hz, 1H, H-4a), 2.39 (d, J = 15.6 Hz, 1H, H-4b), 1.36 (s, 9H, 3×CH3). 13C NMR (75 MHz, CDCl3) 
δ 201.6 (C=O), 154.8 (O-C=O), 139.5 (Carom-N), 133.7 (C-6), 132.1 (C-5), 132.0 (Carom-H), 121.7 
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(Carom-Br), 81.2 (C(CH3)3), 80.5 (C-1), 78.2 (C-5), 71.0 (C-2), 45.2 (C-4), 28.1 (CH3). IR (ATR): 
1730 (C=O st), 1701 (C=O st) cm-1. MS (EI) m/z (%): 184 (100), 155 (54). HRMS: Calculated 
for [C18H20NO4BrNa]+: 416.0473 [M+Na]+; found: 416.0478. The ee was determined by HPLC 
using a Chiralpak AD-H column [n-hexane/i-PrOH (93:7)]; flow rate 1.00 mL/min; τmajor =11.0 
min, τminor = 14.3 min (71% ee). M.p.: 106-108 ºC (CH2Cl2). [α]D20: +121.8 (c = 0.7, CH2Cl2). 
tert-Butyl ((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-yl)(3,4,5-
trimethoxyphenyl) carbamate (4k). Following GP-H, 4k (14.2 mg, 
38%) was isolated by FC (hexanes/EtOAc 8:2 to 1:1) as an oil after 16h, 
starting from catalyst 3g (4.6 mg, 0.005 mmol), allene 1k (30 mg, 0.09 
mmol), DMDO solution in toluene (1.0 mL, 0.19 mmol) and furan (20.3 
µL, 0.28 mmol). dr: >20:1. 1H NMR (300 MHz, CDCl3) δ 6.46 (s, 2H, Carom-H), 6.04 (dd, J = 6.1, 
1.8 Hz, 1H, H-6), 5.32-5.04 (m, 1H, H-2), 5.01 (dd, J = 4.5, 1.7 Hz, 1H, H-1), 4.99-4.93 (m, 1H, 
H-5), 4.84 (bs, 1H, H-7), 3.85 (s, 3H, OCH3), 3.81 (s, 6H, 2×OCH3), 2.85 (dd, J = 15.5, 5.0 Hz, 
1H, H-4a), 2.39 (d, J = 15.5 Hz, 1H, H-4b), 1.40 (bs, 9H, C(CH3)3). 13C NMR (75 MHz, CDCl3) 
δ 202.0 (C=O), 155.3 (OC=O), 153.2 (Carom), 138.0 (Carom), 133.4 (C-6), 132.5 (C-7), 107.7 
(Carom-H), 80.8 (C-1 + C(CH3)3), 78.5 (C-5), 77.4 (C-2), 61.2 (OCH3), 56.4 (OCH3), 45.4 (C-4), 
28.4 (C(CH3)3). IR (CH2Cl2): 2976 (C-H st), 1701 (C=O st) cm-1. HRMS: Calculated for 
[C21H27NO7Na]+: 428.1685 [M+Na]+; found: 428.1681. The ee was determined by HPLC using a 
Chiralpak AD-H column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τmajor = 19.7 min, 
τminor = 33.0 min (73% ee). 
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2.6 Synthesis of cycloadducts 4j, 5a-s and 6a-y 
 
General Procedure I (GP-I): A test tube with a stirring bar was charged with 3g catalyst (0.003 
mmol, 5 mol%) and it was cooled to -78 ºC. Then, corresponding allene (0.05 mmol, 0.33 eq) 
was added followed by a precooled mixture of DMDO in toluene (0.11 mmol, 2.1 eq) and EtOAc 
(0.2M). Subsequently, corresponding diene (0.05 mmol, 1 eq) was added. After 1 h, another 
addition of allene (0.05 mmol, 0.33 eq) was made with the corresponding mixture of DMDO 
solution (0.11 mmol, 2.1 eq) and EtOAc (0.2M). After 1 h, a third addition was repeated. The 
mixture was stirred for 16 h at -78 ºC. After that, the reaction was quenched with NaHCO3 (sat. 
aqueous, 2 mL) and extracted with Et2O (3×5 mL). Combined organic layers were dried over 
Na2SO4 and after the removal of the solvent under reduced pressure the crude was purified by FC 
on silica gel (petroleum ether/EtOAc). For 14c and 15b-d: 5 equivalents of allene, 12.5 eq of 
DMDO in toluene were portionwise added in 5 adittions (30 minutes each) under [0.015M]. 
General Procedure J (GP-J): A test tube equipped with a stirring bar was charged with 3g 
catalyst (0.005 mmol, 5 mol%) and it was cooled to -78 ºC. Then, corresponding allene44 (0.11 
mmol, 1 eq) was added followed by a precooled mixture of DMDO in toluene (0.27 mmol, 2.5 
eq) and EtOAc (0.05M). Subsequently, corresponding furan (0.22 mmol, 2 eq) was added.45 The 
mixture was stirred for 16 h at -78 ºC. After that, the reaction was quenched with NaHCO3 (sat. 
aqueous, 2 mL) and extracted with Et2O (3×5 mL). Combined organic layers were dried over 
Na2SO4 and after the removal of the solvent under reduced pressure the crude was purified by FC 
on silica gel (petroleum ether/EtOAc). 
                                                           
44
  For oily allenes: it was dissolved in the corresponding quantity of EtOAc and precooled before the addition. Then, 
DMDO solution and furan were added sequentially. 
45
  When furan is used 13 equivalents are needed. 
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The racemic standards for HPLC analysis were prepared using diphenyl phosphoric acid or its N-
triflyl phosphoramide analog. In some cases it was needed the use of (R)-3g+(S)-3g to get the 
racemic standards. TLCs were developed in p-anisaldehyde dip. 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)carbamate 4j. Following GP-J, 4j (29.6 mg, 78%) was isolated 
by FC (hexanes/EtOAc 9:1 to 6:4) as a solid after 16h, starting from 
catalyst 3g (5.5 mg, 0.005 mmol), allene 1j (30 mg, 0.11 mmol), DMDO 
solution in toluene (1.2 mL, 0.27 mmol), EtOAc (1 mL) and furan (0.1 mL, 1.43 mmol, 13 eq). 
Rf= 0.40 (hexanes/EtOAc 7:3). dr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100ºC) δ 7.11 (d, J = 
8.9 Hz, 2H, Carom-H), 6.89 (d, J = 8.9 Hz, 2H, Carom-H), 6.12 (dd, J = 6.1, 1.9 Hz, 1H, H-6), 5.07 
(dd, J = 4.4, 1.7 Hz, 1H, H-1), 5.04 (d, J = 4.4 Hz, 1H, H-2), 4.92 (d, J = 5.1 Hz, H-5), 4.77 (d, J 
= 6.1 Hz, 1H, H-7), 3.78 (s, 3H, OCH3), 2.82 (dd, J = 15.7, 5.1 Hz, 1H, H-4a), 2.28 (d, J = 15.7 
Hz, 1H, H-4b), 1.32 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 201.1 (C=O), 
158.2 (Carom), 154.1 (OC=O), 133.5 (C-6), 132.7 (Carom), 131.0 (C-7), 130.5 (Carom-H), 113.5 
(Carom-H), 79.4 (C-1), 79.1 (C(CH3)3), 77.3 (C-5), 70.7 (C-2), 54.3 (OCH3), 44.4 (C-4), 27.4 
(C(CH3)3). IR (CH2Cl2): 2972 (C-H st), 1698 (C=O st), 1242 (C-O-C st as), 1038 (C-O-C st sy) 
cm-1. MS (EI) m/z (%): 246 (100). HRMS: Calculated for [C19H24NO5H]+: 346.1654 [M+H]+; 
found: 346.1657. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.00 mL/min; τmajor = 34.3 min, τmajor = 44.9 min (82% ee). [α]D20: +147.5 
(c = 1.0, CH2Cl2). M.p.: 144-146ºC (CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-7-methyl-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)carbamate, 5a. Following GP-I, 5a (16 
mg, 78%) was isolated by FC (hexanes/EtOAc 2:8 to 1:1), as a solid after 
16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j (45 mg, 
0.17 mmol), DMDO solution in toluene (1.56 mL, 0.36 mmol), EtOAc (0.72 mL, 0.025M) and 3-
methylfuran 2a (5.2 µL, 0.05 mmol). Rf= 0.62 (hexanes/EtOAc 7:3). rr: 14:1. 1H NMR (500 
MHz, DMSO-d6, 100ºC) δ 7.17 (d, J = 8.9 Hz, 2H, Carom-H), 6.91 (d, J = 8.9 Hz, Carom-H), 5.96-
5.93 (m, 1H, H-6), 4.83 (d, J = 5.7 Hz, 1H, H-5), 4.74 (d, J = 5.0 Hz, 1H, H-1), 4.44 (d, J = 5.0 
Hz, 1H, H-2), 3.77 (s, 3H, OCH3), 2.79 (dd, J = 17.1, 5.7 Hz, 1H, H-4a), 2.42 (d, J = 17.1 Hz, 
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1H, H-4b), 1.52 (s, 3H, CH3), 1.30 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 
200.2 (C=O), 157.8 (Carom), 153.2 (OC=O), 142.3 (C-7), 135.6 (Carom), 129.0 (C-6), 128.7 (Carom-
H), 113.9 (Carom-H), 81.1 (C-1), 79.6 (C(CH3)3), 76.9 (C-5), 71.7 (C-2), 55.0 (OCH3), 44.0 (C-4), 
27.4 (C(CH3)3), 13.1 (CH3). IR (CH2Cl2): 2976 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 
1030 (C-O-C st sy) cm-1. MS (EI) m/z (%): 260 (100), 222 (12), 178 (22), 137 (8). HRMS: 
Calculated for [C20H25NO5Na]+: 382.1630 [M+Na]+; found: 382.1624. The ee was determined by 
HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor 
= 14.5 min, τmajor = 16.4 min (83% ee). [α]D20: -115.8 (c = 1.0, CH2Cl2). 
tert-Butyl ((1R,2S,5R)-7-ethyl-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(4-methoxyphenyl) carbamate, 5b. Following GP-I, 5b (14.1 mg, 
66%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), as an oil 
after 16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j (45 
mg, 0.17 mmol), DMDO solution in toluene (1.6 mL, 0.36 mmol), EtOAc (0.69 mL) and furan 
2c (20.4 µL, 0.06 mmol). Rf= 0.52 (petroleum ether/EtOAc 7:3). rr 10:1. 1H NMR (500 MHz, 
DMSO-d6, 100 ºC) δ 7.13 (d, J = 8.9 Hz, 2H, Carom-H), 6.90 (d, J = 8.9 Hz, 2H, Carom-H), 5.93-
5.91 (m, 1H, H-6), 4.84 (d, J = 5.9 Hz, 1H, H-5), 4.77 (d, J = 5.1 Hz, 1H, H-1), 4.34 (d, J = 5.1 
Hz, 1H, H-2), 3.76 (s, 3H, OCH3), 2.77 (dd, J = 17.4, 5.9 Hz, 1H, H-4a), 2.41 (d, J = 17.4 Hz, 
1H, H-4b), 1.87-1.74 (m, 2H, CH2CH3), 1.27 (s, 9H, C(CH3)3), 0.97 (t, J = 7.3 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 201.1 (C=O), 158.6 (Carom), 154.1 (OC=O), 149.8 (C-
7), 136.7 (Carom), 131.5 (Carom), 129.4 (Carom-H), 127.5 (C-6), 114.8 (Carom-H), 80.8 (C-1), 80.4 
(C(CH3)3), 77.7 (C-5), 72.5 (C-2), 56.0 (OCH3), 44.8 (C-4), 28.3 (C(CH3)3), 21.5 (CH2CH3), 
12.3 (CH2CH3). IR (CH2Cl2): 2969 (C-H st), 1701 (C=O st), 1245 (C-O-C st as), 1030 (C-O-C st 
sy) cm-1. HRMS: Calculated for [C21H27NO5Na]+: 396.1787 [M+Na]+; found: 396.1780. The ee 
was determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 
mL/min; τminor = 12.2 min, τmajor = 13.7 min (71% ee). [α]D20: +69.6 (c = 1.0, CH2Cl2). 
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tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-7-(2-methylbenzyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5c. Following GP-I, 5c 
(11.5 mg, 45%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), 
as a solid after 16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), 
allene 1j (45 mg, 0.17 mmol), DMDO solution in toluene (1.56 mL, 0.36 
mmol), EtOAc (0.72 mL) and furan 2d (8.5 µL, 0.06 mmol). Rf= 0.38 (petroleum ether/EtOAc 
7:3). rr: 10:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.18 (d, J = 8.6 Hz, 2H, Carom-H), 7.15-
7.10 (m, 3H, Carom-H), 7.07-7.04 (m, 1H, Carom-H), 6.92 (d, J = 8.6 Hz, 2H, Carom-H), 5.75 (app s, 
1H, H-6), 4.84 (d, J = 5.9 Hz, 1H, H-5), 4.80 (d, J = 4.9 Hz, 1H, H-1), 4.48 (d, J = 4.9 Hz, 1H, 
H-2), 3.76 (s, 3H, OCH3), 3.13 (d, J = 16.6 Hz, 1H, CHaHb), 3.03 (d, J = 16.6 Hz, 1H, CHaHb), 
2.81 (dd, J = 17.1, 5.9 Hz, 1H, H-4a), 2.43 (d, J = 17.1 Hz, 1H, H-4b), 2.19 (s, 3H, CH3), 1.34 (s, 
9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 200.0 (C=O), 157.7 (Carom), 153.3 
(OC=O), 145.7 (C-7), 136.6 (Carom), 135.7 (Carom), 135.4 (Carom), 129.9 (C-6), 129.6 (Carom-H), 
128.6 (Carom-H), 128.5 (Carom-H), 125.8 (Carom-H), 125.3 (Carom-H), 113.9 (Carom-H), 80.2 (C-1), 
79.6 (OC(CH3)3), 76.8 (C-5), 72.0 (C-2), 55.0 (OCH3), 43.9 (C-4), 31.1 (CH2), 27.5 (C(CH3)3), 
18.3 (CH3). IR (CH2Cl2): 2972 (C-H st), 1698 (C-H st), 1245 (C-O-C st as), 1030 (C-O-C st sy) 
cm-1. HRMS: Calculated for [C27H31NO5Na]+: 472.2100 [M+Na]+; found: 472.2099. The ee was 
determined by HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 
mL/min; τminor = 12.8 min, τmajor = 17.4 min (85% ee). M.p.: 115-117 ºC (CH2Cl2). [α]D20: -66.6 (c 
= 1.1, CH2Cl2). 
tert-Butyl ((1R,2S,5R)-7-isopentyl-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(4-methoxyphenyl)carbamate, 5d. Following GP-J, 5d (17.8 mg, 
40%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), as an oil 
after 16 h, starting from catalyst 3g (5.5 mg, 0.005 mmol), allene 1j (30 
mg, 0.11 mmol), DMDO solution in toluene (1.25 mL, 0.27 mmol), EtOAc 
(0.95 mL) and furan 2e (29.8 µL, 0.22 mmol). Rf= 0.5 (petroleum ether/EtOAc 7:3). rr: 15:1. 1H 
NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.15 (d, J = 8.8 Hz, 2H, Carom-H), 6.91 (d, J = 8.8 Hz, 2H, 
Carom-H), 5.94-5.92 (m, 1H, H-6), 4.84 (d, J = 5.8 Hz, 1H, H-5), 4.80 (d, J = 5.0 Hz, 1H, H-1), 
4.48 (d, J = 5.0 Hz, 1H, H-2), 3.77 (s, 3H, OCH3), 2.80 (dd, J = 17.1, 5.8 Hz, 1H, H-4a), 2.41 (d, 
J = 17.1 Hz, 1H, H-4b), 1.69 (bs, 2H, CH2), 1.51-1.41 (m, 1H, CH(CH3)2), 1.29 (s, 11H, CH2 + 
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C(CH3)3), 0.85 (d, J = 6.0 Hz, 6H, 2×CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 200.3 
(C=O), 157.7 (Carom), 153.2 (OC=O), 147.5 (C-7), 135.4 (Carom), 128.7 (Carom-H), 127.3 (C-6), 
113.8 (Carom-H), 80.1 (C-1), 79.4 (OC(CH3)3), 76.8 (C-5), 71.7 (C-2), 54.9 (OCH3), 44.0 (C-4), 
36.1 (CHCH2), 27.4 (C(CH3)3), 26.8 (CH), 25.1 (C7CH2), 21.8 (CH3), 21.5 (CH3). IR (CH2Cl2): 
2959 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated 
for [C24H33NO5Na]+: 438.2256 [M+Na]+; found: 438.2257. The ee was determined by HPLC 
using a Chiralcel OD-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 6.7 
min, τmajor = 7.9 min (76% ee). [α]D20: -41.5 (c = 0.9, CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-phenethyl-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5e. Following GP-I, 5e (7.8 
mg, 30%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), as a 
solid after 16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j 
(45 mg, 0.17 mmol), DMDO solution in toluene (1.35 mL, 0.36 mmol), 
EtOAc (0.93 mL) and furan 2f (7.8 µL, 0.06 mmol). Rf= 0.5 (petroleum 
ether/EtOAc 7:3). rr 18:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.29-7.23 (m, 2H, Carom-H), 
7.20-7.10 (m, 5H, Carom-H), 6.87 (d, J = 8.9 Hz, 2H, Carom-H), 6.03-6.00 (m, 1H, H-6), 4.86 (d, J 
= 5.8 Hz, 1H, H-5), 4.82 (d, J = 5.0 Hz, 1H, H-1), 4.48 (d, J = 5.0 Hz, 1H, H-2), 3.71 (s, 3H, 
OCH3), 2.81 (dd, J = 17.1, 5.8 Hz, 1H, H-4a), 2.76-2.71 (m, 2H, CH2CH2Ph), 2.43 (d, J = 17.1 
Hz, 1H, H-4b), 2.07-1.94 (m, 2H, CH2CH2Ph), 1.27 (s, 9H, C(CH3)3). 13C NMR (125 MHz, 
DMSO-d6, 100 ºC) δ 200.3 (C=O), 157.7 (Carom), 153.3 (OC=O), 146.8 (C-7), 140.8 (Carom), 
135.4 (Carom), 128.7 (Carom-H), 128.0 (C-6), 127.6 (Carom-H), 127.5 (Carom-H), 125.2 (Carom-H), 
113.8 (Carom-H), 80.1 (C-1), 79.5 (OC(CH3)3), 76.8 (C-5), 71.8 (C-2), 54.8 (OCH3), 44.0 (C-4), 
33.1 (CH2CH2Ph), 28.7 (CH2CH2Ph), 27.4 (C(CH3)3). IR (CH2Cl2): 2934 (C-H st), 1698 (C=O 
st), 1242 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for [C27H31NO5Na]+: 
472.2100 [M+Na]+; found: 472.2100. The ee was determined by HPLC using a Chiralpak AD-H 
column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 19.3 min, τminor= 21.4 min 
(62% ee). M.p.: 108-110 ºC (CH2Cl2). [α]D20: -110.7 (c = 0.2, CH2Cl2). 
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tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-((Z)-styryl)-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5f. Following GP-I, 5f 
(3.1 mg, 12%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), 
as a solid after 16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), 
allene 1j (45 mg, 0.17 mmol), DMDO solution in toluene (1.56 mL, 
0.36 mmol), EtOAc (0.72 mL) and furan 2g (8.2 µL, 0.06 mmol). Rf= 0.52 (petroleum 
ether/EtOAc 7:3). rr 20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.38-7.31 (m, 4H, Carom-H), 
7.30-7.25 (m, 1H, Carom-H), 6.90 (d, J = 8.8 Hz, 2H, Carom-H), 6.79 (d, J = 8.8 Hz, 2H, Carom-H), 
6.38 (d, J = 12.2 Hz, 1H, HC=CHPh), 6.23-6.20 (m, 1H, H-6), 5.93 (d, J = 12.2 Hz, 1H, 
HC=CHPh), 4.97-4.93 (m, 1H, H-5), 4.90 (d, J = 5.2 Hz, 1H, H-1), 4.22 (bs, 1H, H-2), 3.74 (s, 
3H, OCH3), 2.82 (dd, J = 17.5, 5.9 Hz, 1H, H-4a), 2.45 (d, J = 17.5 Hz, 1H, H-4b), 1.30 (s, 9H, 
3×CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 200.7 (C=O), 158.5 (Carom), 156.7 (OC=O), 
142.5 (C-7), 137.5 (Carom), 136.5 (Carom), 132.6 (C-6), 131.3 (HC=CHPh), 129.4 (Carom-H), 129.0 
(Carom-H), 128.7 (Carom-H), 127.9 (Carom-H), 122.9 (HC=CHPh), 114.8 (Carom-H), 114.6 (Carom-H), 
81.0 (C(CH3)3), 79.9 (C-1), 78.1 (C-5), 72.2 (C-2), 55.9 (OCH3), 44.4 (C-4), 28.4 (C(CH3)3). IR 
(CH2Cl2): 2976 (C-H st), 1705 (C=O st), 1242 (C-O-C st as) cm-1. HRMS: Calculated for 
[C27H29NO5Na]+: 470.1943 [M+Na]+; found: 470.1951. The ee was determined by HPLC using a 
Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 0.70 mL/min; τminor = 16.9 min, τmajor= 
18.3 min (85% ee). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-phenyl-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)carbamate, 5f. Following GP-I, 5f (8.2 
mg, 34%) was isolated by FC (hexanes/EtOAc 2:8 to 1:1), as a solid after 
16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j (45 mg, 
0.17 mmol), DMDO solution in toluene (1.56 mL, 0.36 mmol), EtOAc 
(0.72 mL) and 3-phenylfuran 2h (8.2 mg, 0.06 mmol). Rf= 0.27 (hexanes/EtOAc 7:3). rr: >20:1. 
1H NMR (500 MHz, DMSO-d6, 100ºC) δ 7.56 (d, J = 7.2 Hz, 2H, Carom-H), 7.35 (t, J = 7.6 Hz, 
2H, Carom-H), 7.28-7.22 (m, 1H, Carom-H), 7.18 (d, J = 8.4 Hz, 2H, Carom-H), 6.89 (d, J = 8.9 Hz, 
2H, Carom-H), 6.79 (bs, 1H, H-6), 5.56 (d, J = 5.4 Hz, 1H, H-1), 5.09 (dd, J = 6.0, 2.4 Hz, 1H, H-
5), 4.31 (d, J = 5.4 Hz, 1H, H-2), 3.77 (s, 3H, OCH3), 2.92 (dd, J = 18.0, 6.2 Hz, 1H, H-4a), 2.58 
(d, J = 18.0 Hz, 1H, H-4b), 0.92 (s, 9H, 3×CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 
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199.9 (C=O), 157.1 (Carom-O), 152.3 (O-C=O), 144.9 (C-7), 136.8 (Carom-N), 132.9 (Carom), 127.8 
(C-6), 127.7 (Carom-H), 127.5 (Carom-H), 127.1 (Carom-H), 125.6 (Carom-H), 113.7 (Carom-H), 79.4 
(C(CH3)3), 78.3 (C-1), 77.4 (C-5), 71.8 (C-2), 54.9 (OCH3), 43.5 (C-4), 26.9 (C(CH3)3). IR 
(CH2Cl2): 2972 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1034 (C-O-C st sy) cm-1. HRMS: 
Calculated for [C25H27NO5Na]+: 444.1787 [M+Na]+; found: 444.1786. The ee was determined by 
HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 
27.9 min, τminor = 33.1 min (76% ee). M.p: 122-124ºC (CH2Cl2). [α]D20: -93.6 (c = 1.0, CH2Cl2). 
tert-Butyl (4-Methoxyphenyl)((1R,2S,5R)-7-(4-methoxyphenyl)-3-oxo-
8-oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5h. Following GP-I, 5h (4 
mg, 17%) was isolated by FC (petroleum ether/EtOAc 9:1 to 4:6), as an 
oil after 16 h, starting from catalyst 3g (2.5 mg, 0.002 mmol), allene 1j 
(40 mg, 0.15 mmol), DMDO solution in toluene (1.3 mL, 0.32 mmol), 
EtOAc (1.0 mL) and furan 2i (8.9 mg, 0.05 mmol). Rf= 0.24 (petroleum ether/EtOAc 7:3). rr 
>20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.47 (d, J = 8.4 Hz, 2H, Carom-H), 7.17 (d, J = 
8.3 Hz, 2H, Carom-H), 6.91 (d, J = 8.3 Hz, 2H, Carom-H), 6.88 (d, J = 8.4 Hz, 2H, Carom-H), 6.61 (d, 
J =2.4 Hz, 1H, H-6), 5.51 (d, J = 5.4 Hz, 1H, H-1), 5.05 (dd, J = 6.0, 2.4 Hz, 1H, H-5), 4.31 (d, J 
= 5.4 Hz, 1H, H-2), 3.77 (s, 6H, 2×OCH3), 2.90 (dd, J = 17.9, 6.0 Hz, 1H, H-4a), 2.55 (d, J = 
17.9 Hz, 1H, H-4b), 0.95 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 200.0 
(C=O), 158.8 (Carom), 157.1 (Carom), 155.6 (OC=O), 144.5 (C-7), 127.6 (Carom-H), 127.0 (Carom-
H), 125.8 (Carom), 125.5 (C-6), 113.7 (Carom-H), 113.5 (Carom-H), 79.1 (C(CH3)3), 78.4 (C-5), 77.4 
(C-1), 71.8 (C-2), 54.9 (OCH3), 54.9 (OCH3), 43.6 (C-4), 26.9 (C(CH3)3). IR (CH2Cl2): 2972 (C-
H st), 1701 (C=O st), 1245 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C26H29NO6Na]+: 474.1893 [M+Na]+; found: 474.1890. The ee was determined by HPLC using a 
Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 60.8 min, 
τmajor = 96.2 min (63% ee). 
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tert-Butyl ((1R,2S,5R)-7-(4-fluorophenyl)-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)(4-methoxyphenyl)carbamate, 5i. Following GP-I, 5i (8.4 mg, 
34%) was isolated by FC (hexanes/EtOAc 2:8 to 1:1), as a solid after 16h 
reaction time, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j 
(45 mg, 0.17 mmol), DMDO solution in toluene (1.63 mL, 0.36 mmol), 
EtOAc (0.65 mL) and furan 2j (9.2 mg, 0.06 mmol). Rf= 0.29 
(hexanes/EtOAc 7:3). rr: >20:1. 1H-NMR (500 MHz, DMSO-d6, 100ºC) δ 7.61-7.54 (m, 2H, 
Carom-H), 7.20-7.09 (m, 4H, Carom-H), 6.87 (d, J = 8.9 Hz, 2H, Carom-H), 6.75 (d, J = 2.4 Hz, 1H, 
H-6), 5.56 (d, J = 5.4 Hz, 1H, H-1), 5.08 (dd, J = 6.0, 2.4 Hz, 1H, H-5), 4.33 (d, J = 5.4 Hz, 1H, 
H-2), 3.77 (s, 3H, OCH3), 2.92 (dd, J = 17.9, 6.2 Hz, 1H, H-4a), 2.57 (d, J = 18.0 Hz, 1H, H-4b), 
0.96 (s, 9H, 3×CH3). 13C-NMR (125 MHz, DMSO-d6, 100 ºC) δ 199.9 (C=O), 161.3 (d, 1JC-F = 
245.5 Hz, Carom-F), 157.2 (CaromOCH3), 152.3 (OC=O), 144.0 (C-7), 136.7 (Carom), 129.6 (d, 3JC-F 
= 7.6 Hz, Carom-H), 127.8 (Carom), 127.8 (C-6), 127.7 (Carom-H), 127.6 (Carom-H), 114.5 (d, 2JC-F = 
21.9 Hz, Carom-H), 113.7 (Carom-H), 79.7 (C(CH3)3), 78.4 (C-1), 77.5 (C-5), 71.8 (C-2), 54.9 
(OCH3), 43.5 (C-4), 26.9 (CH3). IR (CH2Cl2): 2972 (C-H st), 1709 (C=O st), 1245 (C-O-C st as), 
1159 (C-F st), 1038 (C-O-C st sy) cm-1. HRMS: Calculated for [C25H26NO5FNa]+: 462.1693 
[M+Na]+; found: 462.1690. The ee was determined by HPLC using a Chiralpak AD-H column 
[n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 28.0 min, τmajor = 30.4 min (57% ee). 
tert-Butyl ((1R,2S,5R)-7-(methoxymethyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate 5j. 
Following GP-J, 5j (24.3 mg, 57%) was isolated by FC (petroleum 
ether/EtOAc 8:2 to 1:1), as an oil after 16 h, starting from catalyst 3g (5.5 
mg, 0.005 mmol), allene 1j (30 mg, 0.11 mmol), DMDO solution in toluene (1.2 mL, 0.27 
mmol), EtOAc (1.0 mL) and furan 2k (20.5 µL, 0.22 mmol). Rf= 0.45 (petroleum ether/EtOAc 
1:1). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100ºC) δ 7.14 (d, J = 8.8 Hz, 2H, Carom-H), 6.93 
(d, J = 8.8 Hz, 2H, Carom-H), 6.21-6.19 (m, 1H, H-6), 4.93-4.88 (m, 2H, H-5+H-1), 4.42 (d, J = 
5.0 Hz, 1H, H-2), 3.78 (s, 3H, CaromOCH3), 3.67 (d, J = 13.7 Hz, 1H, CHaHb), 3.56 (d, J = 13.7 
Hz, CHaHb), 3.21 (s, 3H, OCH3), 2.83 (dd, J = 17.3, 5.9 Hz, H-4a), 2.44 (d, J = 17.3 Hz, 1H, H-
4b), 1.30 (s, 9H, 3×CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 199.9 (C=O), 157.8 
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(CaromOCH3), 153.2 (C-7), 144.0 (OC=O), 135.5 (CaromN), 130.3 (C-6), 128.6 (Carom-H), 113.9 
(Carom-H), 79.6 (C(CH3)3), 78.3 (C-1), 76.7 (C-5), 71.5 (C-2), 67.7 (CH2OCH3), 57.0 
(CH2OCH3), 55.0 (CaromOCH3), 43.6 (C-4), 27.4 (C(CH3)3). IR (CH2Cl2): 2972 (C-H st), 1698 
(C=O st), 1242 (C-O-C st as), 1034 (C-O-C st sy) cm-1. MS (EI) m/z (%): 290 (100), 258 (20), 
178 (62). HRMS: Calculated for [C21H27NO6Na]+: 412.1736 [M+Na]+; found: 412.1740. The ee 
was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 
1.00 mL/min; τminor = 18.4 min, τmajor = 22.2 min (82% ee). [α]D20: -146.3 (c = 1.0, CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-(phenoxymethyl)-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)carbamate, 5k. Following GP-I, 5k (14 
mg, 54%) was isolated by FC (petroleum ether/EtOAc 9:1 to 7:3), as a 
solid after 16 h, starting from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j 
(45 mg, 0.17 mmol), DMDO solution in toluene (1.42 mL, 0.35 mmol), EtOAc (0.86 mL) and 
furan 2l (9.9 mg, 0.06 mmol). Rf= 0.39 (petroleum ether/EtOAc 7:3). rr: >20:1. 1H NMR (500 
MHz, DMSO-d6, 100 ºC) δ 7.31-7.25 (m, 2H, Carom-H), 7.16 (d, J = 8.9 Hz, 2H, Carom-H), 6.97-
6.92 (m, 1H, Carom-H), 6.89-6.83 (m, 4H, Carom-H), 6.37-6.35 (m, 1H, H-6), 5.07 (d, J = 4.9 Hz, 
1H, H-1), 4.96 (d, J = 5.9 Hz, 1H, H-5), 4.56 (d, J = 4.9 Hz, 1H, H-2), 4.27-4.11 (m, 2H, 
CHaHbOPh), 3.73 (s, 3H, OCH3), 2.87 (dd, J = 17.1, 5.9 Hz, 1H, H-4a), 2.47 (app s, 1H, H-4b), 
1.27 (s, 9H, 3×CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 200.9 (C=O), 158.8 (CaromO), 
158.7 (CaromO), 154.3 (OC=O), 143.9 (C-7), 136.2 (Carom), 132.1 (C-6), 129.8 (Carom-H), 129.8 
(Carom-H), 121.3 (Carom-H), 115.3 (Carom-H), 114.9 (Carom-H), 80.7 (C(CH3)3), 79.6 (C-1), 77.9 (C-
5), 72.6 (C-2), 64.8 (CH2OPh), 55.8 (OCH3), 44.7 (C-4), 28.3 (C(CH3)3). IR (CH2Cl2): 2976 (C-
H st), 1698 (C=O st), 1243 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C26H29NO6Na]+: 474.1893 [M+Na]+; found: 474.1901. The ee was determined by HPLC using a 
Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 26.3 min, 
τmajor = 28.8 min (89% ee). M.p.: 80-82 ºC (CH2Cl2). [α]D20: -119.3 (c = 1.0, CH2Cl2). 
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tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-
(((triphenylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)carbamate, 5l. Following GP-I, 5l (25.4 mg, 68%) was isolated by 
FC (petroleum ether/EtOAc 9:1 to 7:3), as a solid after 16 h, starting 
from catalyst 3g (2.8 mg, 0.003 mmol), allene 1j (45 mg, 0.17 mmol), 
DMDO solution in toluene (1.35 mL, 0.36 mmol), EtOAc (0.93 mL) and furan 2m (20.3 mg, 
0.06 mmol). Rf= 0.37 (petroleum ether/EtOAc 7:3). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 
100ºC) δ 7.54 (m, 6H, Carom-H), 7.48 (m, 3H, Carom-H), 7.43 (m, 6H, Carom-H), 7.05 (d, J = 8.9 
Hz, 2H, Carom-H), 6.76 (d, J = 8.9 Hz, 2H, Carom-H), 6.24-6.22 (m, 1H, H-6), 4.99 (d, J = 5.0 Hz, 
1H, H-1), 4.91 (d, J = 5.9 Hz, 1H, H-5), 4.43 (d, J = 4.8 Hz, 1H, H-2), 4.15 (d, J = 14.1 Hz, 1H, 
CHaHb), 4.02 (d, J = 14.1 Hz, 1H, CHaHb), 3.69 (s, 3H, OCH3), 2.83 (dd, J = 17.2, 5.9 Hz, 1H, 
H-4a), 2.44 (d, J = 17.2 Hz, 1H, H-4b), 1.19 (s, 9H, 3×CH3). 13C NMR (125 MHz, DMSO-d6, 50 
ºC) δ 200.5 (C=O), 157.8 (Carom-O), 153.4 (OC=O), 146.1 (C-7), 135.2 (Carom), 134.6 (Carom-H), 
133.3 (Carom-H), 130.2 (C-6), 130.1 (Carom-H), 129.0 (Carom-H), 127.9 (Carom-H), 113.9 (Carom-H), 
79.8 (C(CH3)3), 78.4 (C-1), 77.0 (C-5), 71.7 (C-2), 60.1 (OCH2), 55.0 (OCH3), 43.9 (C-4), 27.5 
(C(CH3)3). IR (CH2Cl2): 2976 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1026 (C-O-C st sy) 
cm-1. MS (EI) m/z (%): 259 (30), 199 (100). HRMS: Calculated for [C38H39NO6Si]+: 656.2444 
[M+H]+; found: 656.2440. The ee was determined by HPLC using a Chiralcel OD-3 column [n-
hexane/i-PrOH (98:2)]; flow rate 1.00 mL/min; τminor = 17.5 min, τmajor = 20.7 min (90% ee). 
M.p.: 61-63 ºC (CH2Cl2). [α]D20: +121.9 (c = 1.0, CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxo-7-
(((triisopropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)carbamate, 5m. Following GP-I, 5m (21.3 mg, 70%) was isolated by 
FC (petroleum ether/EtOAc 9:1 to 4:6), as an oil after 16 h, starting from 
catalyst 3g (2.8 mg, 0.003 mmol), allene 1j (45 mg, 0.17 mmol), DMDO solution in toluene (1.5 
mL, 0.36 mmol), EtOAc (0.78 mL) and furan 2n (15.3 µL, 0.06 mmol). Rf= 0.53 (petroleum 
ether/EtOAc 7:3). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.9 Hz, 2H, 
Carom-H), 6.89 (d, J = 8.9 Hz, 2H, Carom-H), 6.20-6.18 (m, 1H, H-6), 4.97 (d, J = 4.8 Hz, 1H, H-
1), 4.91 (d, J = 5.8 Hz, 1H, H-5), 4.56 (d, J = 4.8 Hz, 1H, H-2), 4.03 (d, J = 14.6 Hz, 1H, 
CHaHb), 3.77 (s, 3H, OCH3), 3.71 (bs, 1H, CHaHb), 2.84 (dd, J = 17.0, 5.8 Hz, 1H, H-4a), 2.43 
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(d, J = 17.0 Hz, 1H, H-4b), 1.29 (s, 9H, OC(CH3)3), 1.03 (s, 21H, 6×CH3 + 3×CH). 13C NMR 
(125 MHz, DMSO-d6, 100 ºC) δ 200.1 (C=O), 157.8 (Carom-O), 153.4 (OC=O), 147.0 (C-7), 
135.0 (Carom), 129.0 (C-6), 128.9 (Carom-H), 113.7 (Carom-H), 79.6 (C(CH3)3), 78.5 (C-1), 76.7 (C-
5), 71.5 (C-2), 59.3 (OCH2), 54.8 (OCH3), 43.9 (C-4), 27.3 (C(CH3)3), 17.2 (SiCH), 11.1 
(SiCH(CH3)2). IR (CH2Cl2): 2926 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1030 (C-O-C st 
sy) cm-1. MS (EI) m/z (%): 356 (49), 199 (100). HRMS: Calculated for [C29H45NO6SiNa]+: 
554.2916 [M+Na]+; found: 554.2914. The ee was determined by HPLC using a Chiralcel OZ-3 
column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 9.7 min, τminor = 132 min (91% 
ee). [α]D20: -95.5 (c = 1.0, CH2Cl2). 
tert-Butyl ((1R,2S,5R)-7-(((tert-
butoxycarbonyl)amino)methyl)-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)(4-methoxyphenyl) carbamate, 5n. Following GP-J, 
5n (31.9 mg, 50%) was isolated by FC (petroleum ether/EtOAc 
8:2 to 1:1), as a solid after 16 h, starting from catalyst 3g (5.5 
mg, 0.005 mmol), allene 1j (30 mg, 0.11 mmol), DMDO solution in toluene (1.1 mL, 0.27 
mmol), EtOAc (0.66 mL) and furan 2o (66.7 mg, 0.22 mmol). rr >20:1. 1H NMR (500 MHz, 
DMSO-d6, 100 ºC) δ 7.11 (d, J = 8.8 Hz, 2H, Carom-H), 7.05 (d, J = 8.9 Hz, 2H, Carom-H), 6.89 (d, 
J = 8.9 Hz, 2H, Carom-H), 6.84 (d, J = 8.8 Hz, 2H, Carom-H), 6.06 (app s, 1H, H-6), 4.83 (d, J = 5.9 
Hz, 1H, H-5), 4.80 (d, J = 5.0 Hz, 1H, H-1), 4.32 (d, J = 5.0 Hz, 1H, H-2), 4.28 (d, J = 16.3 Hz, 
1H, CHaHb), 3.78 (s, 3H, OCH3), 3.77-3.70 (m, 4H, OCH3 + CHaHb), 2.79 (dd, J = 17.4, 5.9 Hz, 
1H, H-4a), 2.41 (d, J = 17.4 Hz, H-4b), 1.38 (s, 9H, C(CH3)3), 1.28 (s, 9H, C(CH3)3). 13C NMR 
(125 MHz, DMSO-d6, 100 ºC) δ 199.7 (C=O), 157.6 (Carom), 156.9 (Carom), 153.6 (OC=O), 153.1 
(OC=O), 143.7 (C-7), 135.9 (Carom), 134.8 (Carom), 131.3 (C-6), 128.5 (Carom-H), 127.5 (Carom-H), 
113.7 (Carom-H), 113.5 (Carom-H), 79.5 (C(CH3)3), 79.0 (C-1), 78.8 (C(CH3)3), 76.5 (C-5), 72.0 
(C-2), 54.9 (OCH3), 54.9 (OCH3), 47.2 (CH2N), 43.6 (C-4), 27.5 (C(CH3)3), 27.4 (C(CH3)3). IR 
(CH2Cl2): 2930 (C-H st), 1698 (C=O st), 1242 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: 
Calculated for [C32H41N2O8]+: 581.2863 [M+H]+; found: 581.2863. The ee was determined by 
HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 
20.8 min, τminor = 29.3 min (60% ee). M.p.: 54-56 ºC (CH2Cl2). 
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tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-7-((N-(4-
methoxyphenyl)acetamido)methyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5o. Following GP-
I, 5o (23.2 mg, 78%) was isolated by FC (petroleum ether/EtOAc 
8:2 to 4:6), as a solid after 16 h, starting from catalyst 3g (2.8 
mg, 0.003 mmol), allene 1j (45 mg, 0.17 mmol), DMDO solution in toluene (1.5 mL, 0.36 
mmol), EtOAc (0.78 mL) and furan 2p (14 mg, 0.06 mmol). Rf= 0.2 (petroleum ether/EtOAc 
1:1). rr >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.8 Hz, 2H, Carom-H), 7.12 
(d, J = 8.6 Hz, 2H, Carom-H), 6.97 (d, J = 8.6 Hz, 2H, Carom-H), 6.86 (d, J = 8.8 Hz, 2H, Carom-H), 
6.03-5.98 (m, 1H, H-6), 4.83-4.78 (m, 2H, H-1 + H-5), 4.61 (d, J = 15.0 Hz, 1H, CHaHb), 4.22 
(d, J = 5.0 Hz, 1H, H-2), 3.81 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.75 (bs, 1H, CHaHb), 2.78 
(dd, J = 17.6, 5.9 Hz, 1H, H-4a), 2.40 (d, J = 17.6 Hz, H-4b), 1.78 (s, 3H, CH3), 1.28 (s, 9H, 
C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 199.6 (C=O), 168.8 (NC=O), 158.1 (Carom), 
157.5 (Carom), 153.0 (OC=O), 143.0 (C-7), 136.2 (Carom), 135.2 (Carom), 131.8 (C-6), 128.7 (Carom-
H), 128.4 (Carom-H), 114.2 (Carom-H), 113.7 (Carom-H), 79.5 (C(CH3)3), 78.6 (C-1), 76.4 (C-5), 
72.0 (C-2), 55.0 (OCH3), 54.9 (OCH3), 46.1 (CH2N), 43.4 (C-4), 27.4 (C(CH3)3), 21.6 (CH3). IR 
(CH2Cl2): 2934 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1034 (C-O-C st sy) cm-1. MS (EI) 
m/z (%): 245 (73), 203 (62), 81 (100). HRMS: Calculated for [C29H35N2O7]+: 523.2444 [M+H]+; 
found: 523.2443. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (80:20)]; flow rate 1.00 mL/min; τmajor = 11.2 min, τminor = 17.3 min (69% ee). M.p.: 153-
155 ºC (CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-7-((N-(4-
methoxyphenyl)propionamido)methyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5p. Following GP-
J, 5p (44.8 mg, 76%) was isolated by FC (petroleum 
ether/EtOAc 8:2 to 1:1), as an oil after 16 h, starting from 
catalyst 3g (5.5 mg, 0.005 mmol), allene 1j (30 mg, 0.11 mmol), DMDO solution in toluene (1.2 
mL, 0.27 mmol), EtOAc (0.78 mL) and furan 2q (57 mg, 0.22 mmol). Rf= 0.34 (petroleum 
ether/EtOAc 1:1). rr >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.4 Hz, 2H, 
Carom-H), 7.11 (d, J = 8.4 Hz, 2H, Carom-H), 6.97 (d, J = 8.4 Hz, 2H, Carom-H), 6.86 (d, J = 8.4 Hz, 
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2H, Carom-H), 6.01 (app s, 1H, H-6), 4.81 (d, J = 5.9 Hz, 1H, H-5), 4.79 (d, J = 5.2 Hz, 1H, H-1), 
4.63 (d, J = 14.8 Hz, 1H, CHaHb), 4.22 (d, J = 5.2 Hz, 1H, H-2), 3.80 (s, 3H, OCH3), 3.78-3.71 
(m, 4H, OCH3 + CHaHb), 2.78 (dd, J = 17.5, 5.9 Hz, 1H, H-4a), 2.40 (d, J = 17.5 Hz, H-4b), 
2.10-1.96 (m, 2H, CH2CH3), 1.28 (s, 9H, C(CH3)3), 0.96 (t, J = 7.4 Hz, 3H, CH2CH3). 13C NMR 
(125 MHz, DMSO-d6, 100 ºC) δ 199.6 (C=O), 172.2 (NC=O), 158.1 (Carom), 157.5 (Carom), 153.0 
(OC=O), 143.0 (C-7), 136.3 (Carom), 134.7 (Carom), 131.8 (C-6), 128.8 (Carom-H), 128.4 (Carom-H), 
79.5 (C(CH3)3), 78.6 (C-1), 76.4 (C-5), 72.1 (C-2), 55.0 (OCH3), 54.9 (OCH3), 46.3 (CH2N), 
43.4 (C-4), 27.5 (C(CH3)3), 26.4 (CH2CH3), 8.9 (CH2CH3). IR (CH2Cl2): 2976 (C-H st), 1701 
(C=O st), 1245 (C-O-C st as), 1034 (C-O-C st sy) cm-1. HRMS: Calculated for [C30H37N2O7]+: 
537.2601 [M+H]+; found: 537.2610. The ee was determined by HPLC using a Chiralpak IA 
column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 39.5 min, τminor = 45.8 min 
(71% ee). [α]D20: -31.1 (c = 1.5, CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-7-((N-(4-
methoxyphenyl)pivalamido)methyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 5q. Following GP-
I, 5q (24.3 mg, 75%) was isolated by FC (petroleum ether/EtOAc 
8:2 to 1:1), as an oil after 16 h, starting from catalyst 3g (2.8 mg, 
0.003 mmol), allene 1j (45 mg, 0.17 mmol), DMDO solution in 
toluene (1.56 mL, 0.36 mmol), EtOAc (0.72 mL) and furan 2r (16.4 mg, 0.06 mmol). rr >20:1. 
1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.19 (d, J = 8.5 Hz, 2H, Carom-H), 7.10 (d, J = 8.4 Hz, 
2H, Carom-H), 6.95 (d, J = 8.4 Hz, 2H, Carom-H), 6.85 (d, J = 8.5 Hz, 2H, Carom-H), 5.96 (app s, 
1H, H-6), 4.82 (d, J = 5.9 Hz, 1H, H-5), 4.77 (d, J = 5.1 Hz, 1H, H-1), 4.66 (d, J = 14.5 Hz, 1H, 
CHaHb), 4.22 (d, J = 5.0 Hz, 1H, H-2), 3.81 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.58 (d, J = 14.5 
Hz, 1H, CHaHb), 2.78 (dd, J = 17.5, 5.9 Hz, 1H, H-4a), 2.40 (d, J = 17.5 Hz, H-4b), 1.27 (s, 9H, 
C(CH3)3), 0.99 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 199.7 (C=O), 176.1 
(NC=O), 158.3 (Carom), 157.5 (Carom), 153.0 (OC=O), 143.1 (C-7), 136.3 (Carom), 135.3 (Carom), 
131.9 (C-6), 130.3 (Carom-H), 128.5 (Carom-H), 113.7 (Carom-H), 79.4 (OC(CH3)3), 78.7 (C-1), 76.4 
(C-5), 72.1 (C-2), 55.0 (OCH3), 54.9 (OCH3), 49.6 (CH2N), 43.5 (C-4), 39.3 (C(CH3)3), 28.8 
(C(CH3)3), 27.5 (C(CH3)3). IR (CH2Cl2): 2962 (C-H st), 1698 (C=O st), 1242(C-O-C st as), 1030 
(C-O-C st sy) cm-1. MS (EI) m/z (%): 287 (40). HRMS: Calculated for [C32H41N2O7]+: 565.2914 
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[M+H]+; found: 565.2921. The ee was determined by HPLC using a Chiralpak IA column [n-
hexane/i-PrOH (97:3)]; flow rate 1.00 mL/min; τmajor = 31.0 min, τminor = 33.6 min (54% ee). 
tert-Butyl (4-methoxyphenyl)((1R,2S,5R)-3-oxobicyclo[3.2.1]oct-6-en-
2-yl)carbamate, 5r. Following GP-J, 5r (16.7 mg, 44%) was isolated by 
FC (n-hexane/EtOAc, 9:1 to 7:3), as a solid after 16h, starting from 
catalyst 3g (5.5 mg, 0.005 mmol), allene 1j (30 mg, 0.11 mmol), DMDO 
solution in toluene (1.5 mL, 0.27 mmol), EtOAc (0.7 mL) and cyclopentadiene 2w (0.12 mL, 
1.43 mmol, 13 eq). 1H NMR (500 MHz, CDCl3) δ 7.10 (d, J = 8.4 Hz, 2H, Carom-H), 6.80 (d, J = 
8.4 Hz, 2H, Carom-H), 5.72 (m, 1H, H-6), 5.19 (bs, 1H, H-2), 4.46 (dd, J = 6.0, 2.6 Hz, 1H, H-7), 
3.80 (s, 3H, OCH3), 2.95 (m, 1H, H-1), 2.81 (m, 1H, H-5), 2.54 (dd, J = 15.9, 3.4 Hz, 1H, H-4a), 
2.36 (d, J = 15.9 Hz, 1H, H-4b), 2.16 (m, 1H, H-8a), 2.00 (d, J = 11.1 Hz, 1H, H-8b), 1.32 (s, 9H, 
3×CH3). 13C NMR (125 MHz, CDCl3) δ 205.4 (C=O), 158.8 (CaromOCH3), 156.2 (OC=O), 135.5 
(C-6), 134.3 (C-7), 133.2 (Carom-N), 131.7 (Carom-H), 113.7 (Carom-H), 80.2 (C(CH3)3), 71.3 (C-2), 
55.5 (OCH3), 44.9 (C-4), 44.9 (C-8), 44.7 (C-1), 39.5 (C-5), 28.4 (C(CH3)3). IR (CH2Cl2): 2970 
(C-H st), 1701 (C=O st), 1240 (C-O-C st as), 1035 (C-O-C st sy) cm-1. MS (EI) m/z (%): 343 (2, 
M+), 243 (38), 149 (100). HRMS: Calculated for [C20H25NO4Na]+: 366.1681 [M+Na]+; found: 
366.1684. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH 
(97:3)]; flow rate 1.00 mL/min; τminor = 11.5 min, τmajor = 15.0 min (27% ee). M.p.: 132-134 ºC 
(CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1S,5R)-3-oxo-8-(propan-2-ylidene) 
bicyclo[3.2.1]oct-6-en-2-yl)carbamate, 5s. Following GP-J, 5s (9.5 mg, 
22%) was isolated by FC (hexanes/EtOAc 2:8 to 1:1), as a solid after 16 
h, starting from catalyst 3g (5.5 mg, 0.005 mmol), allene 1j (30 mg, 0.11 
mmol), DMDO solution in toluene (0.84 mL, 0.27 mmol), EtOAc (1.4 mL) and 6,6-
dimethylfulvene 2x (40 µL, 0.33 mmol, 3 eq). 1H NMR (500 MHz, CDCl3) δ 7.14 (d, J = 8.3 Hz, 
2H, Carom-H), 6.85-6.78 (m, 2H, Carom-H), 5.83 (dd, J = 6.3, 2.9 Hz, 1H, H-6), 5.04 (bs, 1H, H-2), 
4.64-4.52 (m, 1H, H-7), 3.81 (s, 3H, OCH3), 3.53 (bs, 1H, H-1), 3.42-3.37 (m, 1H, H-5), 2.51-
2.39 (m, 2H, H-4a + H-4b), 1.78 (s, 3H, CH3), 1.70 (s, 3H, CH3), 1.33 (s, 9H, C(CH3)3). 13C 
NMR (125 MHz, CDCl3) δ 205.2 (C=O), 158.8 (Carom), 156.0 (OC=O), 141.4 (C-8), 135.5 (C-6), 
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134.4 (C-7), 133.5 (Carom), 131.7 (Carom-H), 118.0 (C(CH3)2), 113.8 (Carom-H), 80.1 (C(CH3)3), 
72.1 (C-2), 55.5 (OCH3), 46.6 (C-1), 45.6 (C-4), 41.3 (C-5), 28.4 (C(CH3)3), 19.7 (CH3), 19.4 
(CH3). IR (CH2Cl2): 2980 (C-H st), 1724 (C=O st), 1242 (C-O-C st as), 1049 (C-O-C st sy) cm-1. 
MS (ESI) m/z (%): 284 (100). HRMS: Calculated for [C23H29NO4Na]+: 406.1994 [M+Na]+; 
found: 406.2000. The ee was determined by HPLC using a Chiralpak IC column [n-hexane/i-
PrOH (95:05)]; flow rate 1.00 mL/min; τ1 = 32.9 min, τ2 = 48.9 min (0% ee). M.p: 139-141ºC 
(CH2Cl2). 
tert-Butyl (4-methoxyphenyl) ((1R,2S,4S,5S)-4-methyl-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 6a. Following GP-J, 6a 
(26.4 mg, 67%) was isolated by FC (petroleum ether/EtOAc 9:1 to 7:3), 
as a solid after 16h, starting from catalyst 3g (5.5 mg, 0.005 mmol), 
allene 1l (30 mg, 0.11 mmol, 1 eq), DMDO solution in toluene (1.2 mL, 0.27 mmol), EtOAc (1.0 
mL) and furan 2a (0.1 mL, 1.43 mmol, 13 eq). Rf= 0.42 (petroleum ether/EtOAc 7:3). dr: >20:1. 
1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.10 (d, J = 8.8 Hz, 2H, Carom-H), 6.89 (d, J = 8.8 Hz, 
2H, Carom-H), 6.13 (dd, J = 6.0, 1.7 Hz, 1H, H-6), 5.18 (d, J = 4.3 Hz, 1H, H-2), 5.03 (dd, J = 4.3, 
1.7 Hz, 1H, H-1), 4.75 (d, J = 6.0 Hz, 1H, H-7), 4.61-4.570 (m, 1H, H-5), 3.78 (s, 3H, OCH3), 
2.41-2.35 (m, 1H, H-4), 1.33 (s, 9H, C(CH3)3), 1.30 (q, J = 7.3 Hz, 3H, CH3). 13C NMR (125 
MHz, DMSO-d6, 100 ºC) δ 204.9 (C=O), 158.2 (Carom), 154.1 (OC=O), 133.6 (C-6), 132.5 
(Carom), 131.2 (C-7), 130.6 (Carom-H), 113.5 (Carom-H), 82.2 (C-5), 79.7 (C-1), 79.1 (C(CH3)3), 
68.1 (C-2), 54.9 (OCH3), 48.5 (C-4), 27.4 (C(CH3)3), 14.9 (CH3). IR (CH2Cl2): 2972 (C-H st), 
1691 (C=O st), 1245 (C-O-C st as), 1045 (C-O-C st sy) cm-1. MS (EI) m/z (%): 359 (1, M+). 
HRMS: Calculated for [C20H26NO5]+: 360.1811 [M+H]+; found: 360.1811. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 
mL/min; τmajor = 11.9 min, τminor = 14.5 min (35% ee). M.p.: 101-103 ºC (CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4,7-dimethyl-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)(4-methoxyphenyl)carbamate, 6b. Following GP-I, 6b (17.3 
mg, 86%) was isolated by FC (petroleum ether/EtOAc 9:1 to 7:3), as a 
solid after 16 h, starting from catalyst 3g (2.7 mg, 0.003 mmol), allene 1l 
(45 mg, 0.16 mmol), DMDO solution in toluene (1.36 mL, 0.34 mmol), EtOAc (0.81 mL) and 3-
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methylfuran 2b (4.9 µL, 0.05 mmol). Rf= 0.42 (petroleum ether/EtOAc 7:3). rr: 15:1. 1H NMR 
(500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.7 Hz, 2H, Carom-H), 6.91 (d, J = 8.7 Hz, 2H, Carom-
H), 5.97-5.94 (m, 1H, H-6), 4.73 (d, J = 4.9 Hz, 1H, H-1), 4.54 (bs, 1H, H-2), 4.51-4.46 (m, 1H, 
H-5), 3.77 (s, 3H, OCH3), 2.46 (q, J = 7.5 Hz, 1H, H-4), 1.45 (bs, 3H, CH3), 1.30 (s, 9H, 
C(CH3)3), 1.27 (d, J = 7.5 Hz, 3H, C-4CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 204.5 
(C=O), 157.8 (Carom), 153.2 (OC=O), 142.4 (C-7), 135.5 (Carom), 128.9 (C-6), 128.9 (Carom-H), 
113.9 (Carom-H), 82.4 (C-5), 81.4 (C-1), 79.5 (C(CH3)3), 69.8 (C-2), 55.0 (OCH3), 48.1 (C-4), 
27.4 (C(CH3)3), 16.5 (CH3). IR (CH2Cl2): 2976 (C-H st), 1720 (C=O st), 1245 (C-O-C st as), 
1043 (C-O-C st sy) cm-1. HRMS: Calculated for [C21H27NO5Na]+: 396.1787 [M+Na]+; found: 
396.1785. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH 
(95:5)]; flow rate 1.00 mL/min; τmajor = 10.5 min, τminor = 11.2 min (81% ee). M.p.: 122-124 ºC 
(CH2Cl2). [α]D20: +35.7 (c = 0.8, CH2Cl2). 
tert-Butyl (4-methoxyphenyl) ((1R,2S,4S,5S)-4-methyl-7-(2-
methylbenzyl)-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-yl) carbamate, 6c. 
Following GP-I, 6c (13.3 mg, 53%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from catalyst 3g 
(2.7 mg, 0.003 mmol), allene 1l (45 mg, 0.16 mmol), DMDO solution in 
toluene (1.35 mL, 0.34 mmol), EtOAc (0.81 mL) and furan 2d (8 µL, 0.05 mmol). Rf= 0.40 
(petroleum ether/EtOAc 8:2). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.18 (d, J = 
8.9 Hz, 2H, Carom-H), 7.16-7.09 (m, 3H, Carom-H), 7.05-7.01 (m, 1H, Carom-H), 6.92 (d, J = 8.9 
Hz, 2H, Carom-H), 5.78-5.72 (m, 1H, H-6), 4.79 (d, J = 4.9 Hz, 1H, H-1), 4.60 (d, J = 4.9 Hz, 1H, 
H-2), 4.52-4.48 (m, 1H, H-5), 3.75 (s, 3H, OCH3), 3.06 (d, J = 16.6 Hz, 1H, CHaHb), 2.97-2.89 
(m, 1H, CHaHb), 2.48-2.44 (m, 1H, H-4), 2.17 (s, 3H, CH3), 1.34 (s, 9H C(CH3)3), 1.28 (d, J = 
7.3 Hz, 3H, C-4CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 204.3 (C=O), 157.8 (Carom), 
153.4 (OC=O), 145.9 (Carom), 129.8 (C-6), 129.6 (Carom-H), 128.8 (Carom-H), 128.5 (Carom-H), 
125.8 (Carom-H), 125.3 (Carom), 114.0 (Carom-H), 82.4 (C-5), 80.6 (C-1), 79.6 (C(CH3)3), 70.1 (C-
2), 55.0 (OCH3), 48.0 (C-4), 31.1 (CH2), 27.5 (C(CH3)3), 18.3 (CH3), 16.5 (C-4CH3). IR 
(CH2Cl2): 2980 (C-H st), 1716 (C=O st), 1242 (C-O-C st as), 1035 (C-O-C st sy) cm-1. HRMS: 
Calculated for [C28H33NO5Na]+: 486.2256 [M+Na]+; found: 486.2262. The ee was determined by 
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HPLC using a Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τminor = 
6.7 min, τmajor = 8.0 min (73% ee). [α]D20: +121.3 (c = 0.6, CH2Cl2). 
tert-Butyl (4-methoxyphenyl) ((1R,2S,4S,5S)-4-methyl-3-oxo-7-
(((triphenylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-yl) 
carbamate, 6d. Following GP-I, 6d (15 mg, 64%) was isolated by FC 
(petroleum ether/EtOAc 9:1 to 7:3), as a solid after 16 h, starting from 
catalyst 3g (1.8 mg, 0.002 mmol), allene 1l (30 mg, 0.11 mmol), DMDO 
solution in toluene (0.93 mL, 0.23 mmol), EtOAc (0.51 mL) and furan 2m (12.8 mg, 0.04 mmol). 
rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.56-7.51 (m, 6H, Carom-H), 7.51-7.46 (m, 
3H, Carom-H), 7.46-7.39 (m, 6H, Carom-H), 7.04 (d, J = 8.9 Hz, 2H, Carom-H), 6.75 (d, J = 8.9 Hz, 
2H, Carom-H), 6.24-6.21 (m, 1H, H-6), 4.96 (d, J = 4.9 Hz, 1H, H-1), 4.59-4.51 (m, 2H, H-2 + H-
5), 4.08 (d, J = 13.8 Hz, 1H, CHaHb), 3.92 (bs, 1H, CHaHb), 3.67 (s, 3H, OCH3), 2.48-2.44 (m, 
1H, H-4), 1.28 (d, J = 7.4 Hz, 3H, CH3), 1.20 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 
75 ºC) δ 204.3 (C=O), 157.8 (Carom), 153.3 (OC=O), 146.1 (C-7), 134.4 (Carom-H), 134.2 (Carom), 
133.3 (Carom-H), 130.0 (C-6), 129.8 (Carom-H), 128.9 (Carom-H), 113.8 (Carom-H), 82.3 (C-5), 79.6 
(C-1), 78.8 (C(CH3)3), 69.7 (C-2), 59.9 (CH2O), 54.9 (OCH3), 47.9 (C-4), 27.4 (C(CH3)3), 16.7 
(CH3). IR (ATR): 2934 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1059 (C-O-C st sy) cm-1. 
MS (EI) m/z (%): 356 (36), 199 (100). HRMS: Calculated for [C39H41NO6SiNa]+: 670.2601 
[M+Na]+; found: 670.2603. The ee was determined by HPLC using a Chiralpak IC column [n-
hexane/i-PrOH (99:1)]; flow rate 1.00 mL/min; τmajor = 39.4 min, τminor = 47.4 min (90% ee). 
M.p.: 125-127 ºC (CH2Cl2). [α]D20: +55.2 (c = 1.0, CH2Cl2). 
tert-Butyl (4-methoxyphenyl) ((1R,2S,4S,5S)-4-methyl-3-oxo-7-
(((triisopropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-yl) 
carbamate, 6e. Following GP-I, 6e (14.8 mg, 75%) was isolated by FC 
(petroleum ether/EtOAc 9:1 to 7:3), as a solid after 16 h, starting from 
catalyst 3g (1.8 mg, 0.002 mmol), allene 1l (30 mg, 0.11 mmol), DMDO 
solution in toluene (0.93 mL, 0.23 mmol), EtOAc (0.51 mL) and furan 2n (9.7 µL, 0.04 mmol). 
Rf= 0.47 (petroleum ether/Et2O 7:3). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.15 (d, 
J = 7.9 Hz, 2H, Carom-H), 6.89 (d, J = 7.9 Hz, 2H, Carom-H), 6.20-6.17 (m, 1H, H-6), 4.95 (d, J = 
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4.8 Hz, 1H, H-1), 4.69 (app s, 1H, H-2), 4.58-4.55 (m, 1H, H-5), 3.95 (d, J = 14.6 Hz, 1H, 
CHaHb), 3.77 (s, 3H, OCH3), 3.60 (app s, 1H, CHaHb), 2.44-2.49 (m, 1H, H-4), 1.29 (s, 12H, 
C(CH3)3 + C-4CH3), 1.03 (m, 21H, Si(CH(CH3)2)3. 13C NMR (125 MHz, DMSO-d6, 75 ºC) δ 
204.6 (C=O), 157.9 (Carom), 153.5 (OC=O), 147.3 (C-7), 134.7 (Carom), 129.4 (Carom-H), 129.0 (C-
6), 113.8 (Carom-H), 82.2 (C-5), 79.6 (C-1), 79.0 (C(CH3)3), 69.5 (C-2), 59.3 (CH2O), 54.9 
(OCH3), 48.2 (C-4), 27.4 (C(CH3)3), 17.4 (Si(CH(CH3)2)3), 11.1 (CH3). IR (CH2Cl2): 2944 (C-H 
st), 1701 (C=O st), 1245 (C-O-C st as), 1063 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C30H47NO6SiNa]+: 568.3070 [M+Na]+; found: 568.3078. The ee was determined by HPLC using 
a Chiralcel OZ-3 column [n-hexane/i-PrOH (99:1)]; flow rate 0.70 mL/min; τminor = 16.9 min, 
τmajor = 212 min (85% ee). M.p.: 118-120 ºC (CH2Cl2). [α]D20: +54.3 (c = 1.3, CH2Cl2). 
tert-Butyl ((1S,2R,4R,5R)-4-ethyl-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(4-methoxyphenyl)carbamate, 6f. Following GP-J, 6f (25 mg, 64%) 
was isolated by FC (petroleum ether/EtOAc 9:1 to 7:3), as a solid after 16 
h, starting from catalyst ent-3g (5.2 mg, 0.005 mmol), allene 1m (30 mg, 0.1 mmol, 1 eq), 
DMDO solution in toluene (0.98 mL, 0.26 mmol), EtOAc (1.1 mL) and furan 2a (98 µL, 1.35 
mmol, 13 eq). Rf= 0.33 (petroleum ether/EtOAc 8:2). dr: >20:1. 1H NMR (500 MHz, DMSO-d6, 
100 ºC) δ 7.11 (d, J = 8.5 Hz, 2H, Carom-H), 6.89 (d, J = 8.5 Hz, 2H, Carom-H), 6.13-6.09 (m, 1H, 
H-6), 5.14 (d, J = 4.3 Hz, 1H, H-2), 5.03 (d, J = 4.3 Hz, 1H, H-1), 4.72-4.70 (m, 1H, H-5), 4.68 
(d, J = 6.3 Hz, 1H, H-7), 3.78 (s, 3H, OCH3), 2.22-2.16 (m, 1H, H-4), 1.84-1.73 (m, 2H, CH2), 
1.33 (s, 9H, C(CH3)3), 0.98 (t, J = 7.5 Hz, 3H, CH2CH3). 13C NMR (125 MHz, DMSO-d6, 100 
ºC) δ 204.0 (C=O), 158.2 (Carom), 154.1 (OC=O), 133.5 (C-7), 132.4 (Carom), 131.3 (C-6), 130.7 
(Carom-H), 113.5 (Carom-H), 80.5 (C-5), 79.8 (C-1), 79.1 (C(CH3)3), 68.7 (C-2), 55.8 (C-4), 54.9 
(OCH3), 27.4 (C(CH3)3), 22.8 (CH2), 11.2 (CH2CH3). IR (CH2Cl2): 2969 (C-H st), 1724 (C=O 
st), 1242 (C-O-C st as), 1049 (C-O-C st sy) cm-1. MS (EI) m/z (%): 373 (1, M+), 317 (21), 244 
(100). HRMS: Calculated for [C21H27NO5Na]+: 396.1787 [M+Na]+; found: 396.1792. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 
mL/min; τminor = 11.4 min, τmajor = 13.9 min (35% ee). M.p.: 89-91 ºC (CH2Cl2). 
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tert-Butyl ((1S,2R,4R,5R)-4-ethyl-7-methyl-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 6g. 
Following GP-I, 6g (15.3 mg, 76%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from catalyst ent-3g 
(2.6 mg, 0.003 mmol), allene 1m (45 mg, 0.16 mmol), DMDO solution in toluene (1.4 mL, 0.33 
mmol), EtOAc (0.66 mL) and 3-methylfuran 2b (4.7 µL, 0.05 mmol). Rf= 0.50 (petroleum 
ether/EtOAc 8:2). rr: 10:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.17 (d, J = 8.4 Hz, 2H, 
Carom-H), 6.91 (d, J = 8.4 Hz, 2H, Carom-H), 5.96-5.90 (m, 1H, H-6), 4.74 (d, J = 4.7 Hz, 1H, H-
1), 4.66-4.59 (m, 2H, H-2 + H5), 3.77 (s, 3H, OCH3), 2.29-2.23 (m, 1H, H-4), 1.75 (p, J = 7.4 
Hz, 2H, CH2CH3), 1.31 (m, 12H, C(CH3)3 + CH3), 0.98 (t, J = 7.4 Hz, 3H, CH2CH3). 13C NMR 
(125 MHz, DMSO-d6, 100 ºC) δ 203.7 (C=O), 157.9 (Carom), 153.4 (OC=O), 142.5 (C-7), 135.2 
(Carom), 129.2 (C-6), 129.1 (Carom-H), 113.9 (Carom-H), 81.7 (C-1), 80.4 (C-5), 79.4 (C(CH3)3), 
70.6 (C-2), 55.3 (C-4), 55.0 (OCH3), 27.4 (C(CH3)3), 23.9 (CH2), 12.8 (CH3), 11.1 (CH2CH3). IR 
(CH2Cl2): 2972 (C-H st), 1724 (C=O st), 1245 (C-O-C st as), 1040 (C-O-C st sy) cm-1. MS (EI) 
m/z (%): 258 (93), 134 (100). HRMS: Calculated for [C22H29NO5Na]+: 410.1943 [M+Na]+; 
found: 410.1947. The ee was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-
PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 10.7 min, τmajor = 12.4 min (92% ee). [α]D20: -107.8 
(c = 1.0, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-ethyl-7-(2-methylbenzyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 6h. 
Following GP-I, 6h (14.9 mg, 60%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from catalyst 3g 
(2.6 mg, 0.003 mmol), allene 1m (45 mg, 0.16 mmol), DMDO solution 
in toluene (1.38 mL, 0.33 mmol), EtOAc (0.69 mL) and furan 2d (7.8 µL, 0.05 mmol). Rf= 0.61 
(petroleum ether/EtOAc 7:3). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.19 (d, J = 
8.8 Hz, 2H, Carom-H), 7.14-7.07 (m, 3H, Carom-H), 7.01-6.97 (m, 1H, Carom-H), 6.92 (d, J = 8.8 
Hz, 2H, Carom-H), 5.72-5.65 (m, 1H, H-6), 4.82 (d, J = 4.7 Hz, 1H, H-1), 4.67 (d, J = 4.7 Hz, 1H, 
H-2), 4.64-4.61 (m, 1H, H-5), 3.75 (s, 3H, OCH3), 2.94 (d, J = 16.9 Hz, 1H, CHaHb), 2.76 (d, J = 
16.9 Hz, 1H, CHaHb), 2.30-2.25 (m, 1H, H-4), 2.14 (s, 3H, CH3), 1.80-1.70 (m, 2H, CH2CH3), 
1.34 (s, 9H, C(CH3)3), 0.97 (t, J = 7.5 Hz, 3H, CH2CH3). 13C NMR (125 MHz, DMSO-d6, 100 
Experimental  173 
 
ºC) δ 203.5 (C=O), 157.9 (Carom), 153.5 (OC=O), 146.0 (C-7), 136.7 (Carom), 135.4 (Carom), 129.9 
(C-6), 129.5 (Carom-H), 129.1 (Carom-H), 128.4 (Carom-H), 125.8 (Carom-H), 125.3 (Carom-H), 114.0 
(Carom-H), 80.9 (C-1), 80.4 (C-5), 79.5 (C(CH3)3), 70.8 (C-2), 55.2 (C-4), 55.0 (OCH3), 30.9 
(CH2), 27.5 (C(CH3)3), 24.0 (CH2CH3), 18.2 (CH3), 11.1 (CH2CH3). IR (CH2Cl2): 2972 (C-H st), 
1724 (C=O st), 1242 (C-O-C st as), 1034 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C29H35NO5Na]+: 500.2413 [M+Na]+; found: 500.2416. The ee was determined by HPLC using a 
Chiralpak AD-H column [n-hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τminor = 8.2 min, τmajor 
= 13.3 min (87% ee). 
tert-Butyl ((1R,2S,4S,5S)-4-ethyl-3-oxo-7-
(((triisopropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-yl)(4-
methoxyphenyl)carbamate, 6i. Following GP-I, 6i (23.9 mg, 82%) was 
isolated by FC (petroleum ether/EtOAc 19:1 to 8:2), as an oil after 16 h, 
starting from catalyst 3g (2.6 mg, 0.003 mmol), allene 1m (45 mg, 0.16 
mmol), DMDO solution in toluene (1.23 mL, 0.33 mmol) with EtOAc (0.85 mL) and furan 2n 
(14 µL, 0.05 mmol). Rf= 0.42 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR (500 MHz, 
DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.8 Hz, 2H, Carom-H), 6.89 (d, J = 8.8 Hz, 2H, Carom-H), 6.19-
6.17 (m, 1H, H-6), 4.95 (d, J = 4.6 Hz, 1H, H-1), 4.77 (app s, 1H, H-2), 4.71-4.69 (m, 1H, H-5), 
3.83 (d, J = 13.7 Hz, 1H, CHaHb), 3.77 (s, 3H, OCH3), 3.40 (app s, 1H, CHaHb), 2.29 (t, J = 7.2 
Hz, 1H, H-4), 1.78 (p, J = 7.4 Hz, 2H, CH2CH3), 1.30 (s, 9H, C(CH3)3), 1.01 (m, 24H, 
Si(CH(CH3)2)3 + CH2CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.5 (C=O), 157.9 
(Carom), 153.5 (OC=O), 147.3 (C-7), 134.4 (Carom), 129.4 (Carom-H), 129.1 (C-6), 113.7 (Carom-H), 
80.2 (C-5), 79.4 (C-1), 79.3 (C(CH3)3), 70.2 (C-2), 59.1 (CH2O), 55.3 (C-4), 54.7 (OCH3), 27.4 
(C(CH3)3), 23.9 (CH2CH3), 17.2 (Si(CH(CH3)2)3), 11.1 (CH2CH3). IR (CH2Cl2): 2962 (C-H st), 
1701 (C=O st), 1245 (C-O-C st as), 1066 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C31H49NO6SiNa]+: 582.3227 [M+Na]+; found: 582.3229. The ee was determined by HPLC using 
a Chiralcel OZ-3 column [n-hexane/i-PrOH (99:1)]; flow rate 0.70 mL/min; τminor = 11.2 min, 
τmajor = 14.8 min (93% ee). [α]D20: +79.4 (c = 1.7, CH2Cl2). 
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tert-Butyl ((1R,2S,4S,5S)-4-ethyl-3-oxo-7-phenethyl-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 6j. 
Following GP-I, 6j (18.1 mg, 73%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from catalyst 3g (2.6 
mg, 0.003 mmol), allene 1m (45 mg, 0.16 mmol), DMDO solution in 
toluene (1.38 mL, 0.33 mmol), EtOAc (0.69 mL) and furan 2f (7.2 µL, 0.05 mmol). Rf= 0.38 
(petroleum ether/EtOAc 8:2). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.28-7.22 (m, 
2H, Carom-H), 7.19-7.12 (m, 3H, Carom-H), 7.09 (d, J = 7.3 Hz, 2H, Carom-H), 6.86 (d, J = 8.8 Hz, 
2H, Carom-H), 6.02-5.98 (m, 1H, H-6), 4.82 (d, J = 4.6 Hz, 1H, H-1), 4.69 (bs, 1H, H-2), 4.66-
4.63 (m, 1H, H-5), 3.68 (s, 3H, OCH3), 2.69-2.53 (m, 2H, CH2Ph), 2.32-2.26 (m, 1H, H-4), 1.82-
1.73 (m, 4H, C-7CH2 +CH2CH3), 1.29 (s, 9H, C(CH3)3), 0.99 (t, J = 7.4 Hz, 3H, CH2CH3). 13C 
NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.6 (C=O), 157.9 (Carom), 153.5 (OC=O), 147.1 (C-7), 
140.8 (Carom), 135.0 (Carom), 129.1 (Carom-H), 128.1 (C-6), 127.6 (Carom-H), 127.5 (Carom-H), 125.2 
(Carom-H), 113.8 (Carom-H), 80.8 (C-1), 80.3 (C-5), 79.4 (C(CH3)3), 70.5 (C-2), 55.3 (C-4), 54.8 
(OCH3), 33.2 (CH2Ph), 28.4 (C-7CH2), 27.4 (C(CH3)3), 23.9 (CH2CH3), 11.1 (CH2CH3). IR 
(CH2Cl2): 2980 (C-H st), 1701 (C=O st), 1242 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: 
Calculated for [C29H35NO5Na]+: 500.2413 [M+Na]+; found: 500.2406. The ee was determined by 
HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (95:05)]; flow rate 1.0 mL/min; τmajor 
= 17.3 min, τminor = 20.1 min (77% ee). [α]D20: +24.1 (c = 0.5, CH2Cl2). 
Ethyl 3-((1S,2S,4S,5R)-4-((tert-butoxycarbonyl)(4-
methoxyphenyl)amino)-2-ethyl-3-oxo-8-oxabicyclo[3.2.1]oct-6-en-6-
yl)propanoate, 6k. Following GP-I, 6k (18.5 mg, 70%) was isolated by 
FC (petroleum ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from 
catalyst 3g (2.8 mg, 0.003 mmol), allene 1m (48.5 mg, 0.17 mmol), 
DMDO solution in toluene (1.32 mL, 0.35 mmol), EtOAc (0.9 mL) and furan 2y (9.4 mg, 0.06 
mmol). Rf= 0.42 (petroleum ether/EtOAc 7:3). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) 
δ 7.16 (d, J = 9.0 Hz, 2H, Carom-H), 6.90 (d, J = 9.0 Hz, 2H, Carom-H), 5.99-5.95 (m, 1H, H-6), 
4.83 (d, J = 4.9 Hz, 1H, H-1), 4.66-4.63 (m, 1H, H-5), 4.53 (bs, 1H, H-2), 4.06 (q, J = 7.1 Hz, 
2H, COCH2CH3), 3.77 (s, 3H, OCH3), 2.43-2.24 (m, 3H, H-4 + CH2COOEt), 1.87 (bs, 2H, C-
7CH2), 1.78-1.70 (m, 2H, C-4CH2), 1.29 (s, 9H, C(CH3)3), 1.19 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 
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0.97 (t, J = 7.4 Hz, 3H, C-4CH2CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.4 (C=O), 
171.3 (EtOC=O), 157.9 (Carom), 153.3 (OC=O), 146.1 (C-7), 135.3 (Carom), 128.8 (Carom-H), 128.0 
(C-6), 113.9 (Carom-H), 80.5 (C-1), 80.3 (C-5), 79.4 (C(CH3)3), 70.6 (C-2), 59.2 (CO2CH2CH3), 
55.0 (C-4), 54.9 (OCH3), 32.0 (C-7CH2), 27.4 (C(CH3)3), 24.0 (C-4CH2), 22.7 (CH2CO2Et), 13.5 
(C-4CH2CH3), 11.1 (C-4CH2CH3). IR (CH2Cl2): 2980 (C-H st), 1701 (C=O st), 1245 (C-O-C st 
as), 1034 (C-O-C st sy) cm-1. HRMS: Calculated for [C26H35NO7Na]+: 496.2311 [M+Na]+; 
found: 496.2296. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 10.1 min, τminor = 15.7 min (85% ee). [α]D20: +50.6 
(c = 0.8, CH2Cl2). 
tert-Butyl ((1S,2R,4R,5R)-4-ethyl-7-((N-(4-
methoxyphenyl)propionamido)methyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 
6l. Following GP-J, 6l (35.3 mg, 60%) was isolated by FC 
(petroleum ether/EtOAc 8:2 to 1:1), as an oil after 16 h, starting 
from catalyst ent-3g (5.2 mg, 0.005 mmol), allene 1m (30 mg, 0.10 mmol), DMDO solution in 
toluene (1.13 mL, 0.26 mmol), EtOAc (0.94 mL) and furan 2r (53.7 mg, 0.2 mmol). Rf= 0.23 
(petroleum ether/EtOAc 6:4). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.15 (d, J = 
8.8 Hz, 2H, Carom-H), 7.08 (d, J = 8.6 Hz, 2H, Carom-H), 696 (d, J = 8.6 Hz, 2H, Carom-H), 6.84 (d, 
J = 8.8 Hz, 2H, Carom-H), 6.02-5.99 (m, 1H, H-6), 4.77 (d, J = 4.9 Hz, 1H, H-1), 4.63-4.60 (m, 
1H, H-5), 4.46 (bs, 1H, CHaHb), 4.32 (bs, 1H, H-2), 3.81 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 
3.59 (bs, 1H, CHaHb), 2.28-2.22 (m, 1H, H-4), 2.07-1.95 (m, 2H, COCH2CH3), 1.72 (p, J = 7.4 
Hz, 2H, C-4CH2CH3), 1.29 (s, 9H, C(CH3)3), 0.99-0.92 (m, 6H, COCH2CH3 + C-4CH2CH3). 13C 
NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.0 (C=O), 172.2 (COEt), 158.1 (Carom), 157.6 (Carom), 
153.1 (OC=O), 143.3 (C-7), 135.9 (Carom), 134.7 (Carom), 131.6 (C-6), 128.8 (Carom-H), 128.7 
(Carom-H), 114.2 (Carom-H), 113.8 (Carom-H), 80.0 (C-5), 79.4 (C(CH3)3), 79.2 (C-1), 71.0 (C-2), 
55.0 (OCH3), 54.9 (OCH3), 54.5 (C-4), 46.1 (C-7CH2), 27.4 (C(CH3)3), 26.4 (COCH2CH3), 24.2 
(C-4CH2), 11.0 (CH2CH3), 8.9 (CH2CH3). IR (CH2Cl2): 2980 (C-H st), 1698 (C=O st), 1245 (C-
O-C st as), 1034 (C-O-C st sy) cm-1. MS (EI) m/z (%): 259 (90), 203 (100). HRMS: Calculated 
for [C32H41N2O7]+: 565.2914 [M+H]+; found: 565.2908. The ee was determined by HPLC using a 
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Chiralpak IA column [n-hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τminor = 7.2 min, τmajor = 
13.9 min (68% ee). [α]D20: -26.2 (c = 1.2, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-cyclohexyl-3-oxo-8-oxabicyclo[3.2.1]oct-
6-en-2-yl)(4-methoxyphenyl) carbamate, 6m. Following GP-J, 6m 
(16.5 mg, 44%) was isolated by FC (petroleum ether/EtOAc 9:1 to 
7:3), as an oil after 16 h, starting from catalyst 3g (4.3 mg, 0.004 
mmol), allene 1n (30 mg, 0.09 mmol, 1 eq), DMDO solution in toluene 
(0.9 mL, 0.22 mmol), EtOAc (0.84 mL) and furan 2a (82 µL, 1.13 mmol, 13 eq). Rf= 0.61 
(petroleum ether/EtOAc 8:2). dr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.12 (d, J = 
8.9 Hz, 2H, Carom-H), 6.89 (d, J = 8.9 Hz, 2H, Carom-H), 6.11-6.05 (m, 1H, H-6), 5.09 (d, J = 4.3 
Hz, 1H, H-2), 5.01 (d, J = 4.3 Hz, 1H, H-1), 4.88-4.84 (m, 1H, H-5), 4.58 (d, J = 6.0 Hz, 1H, H-
7), 3.78 (s, 3H, OCH3), 2.06-2.02 (m, 1H, H-4), 1.97-1.91 (m, 1H, CcyH), 1.91-1.84 (m, 1H, 
CcyH), 1.78-1.69 (m, 3H, 3×CcyH), 1.69-1.60 (m, 2H, 2×CcyH), 1.34 (s, 9H, C(CH3)3), 1.25-1.15 
(m, 2H, 2×CcyH), 1.12-1.01 (m, 2H, 2×CcyH). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.4 
(C=O), 158.3 (Carom), 154.1 (OC=O), 133.5 (C-6), 132.1 (Carom), 131.5 (C-7), 130.9 (Carom-H), 
113.5 (Carom-H), 79.8 (C-1), 79.1 (C(CH3)3), 78.9 (C-5), 70.0 (C-2), 60.0 (C-4), 54.9 (OCH3), 
37.2 (CcyH), 30.9 (CcyH2), 30.2 (CcyH2), 27.5 (C(CH3)3), 25.3 (CcyH2), 25.2 (CcyH2), 25.2 (CcyH2). 
IR (CH2Cl2): 2962 (C-H st), 1701 (C=O st), 1257 (C-O-C st as), 1020 (C-O-C st sy) cm-1. 
HRMS: Calculated for [C25H33NO5Na]+: 450.2256 [M+Na]+; found: 450.2253. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (95:05)]; flow rate 1.00 
mL/min; τmajor = 11.6 min, τminor = 22.6 min (80% ee). [α]D20: +147.4 (c = 0.4, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-cyclohexyl-7-methyl-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl) carbamate, 6n. 
Following GP-I, 6n (10.3 mg, 40%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as a solid after 16 h, starting from catalyst 3g 
(2.9 mg, 0.003 mmol), allene 1n (60 mg, 0.17 mmol), DMDO solution 
in toluene (1.62 mL, 0.38 mmol), EtOAc (0.45 mL) and 3-methylfuran 2b (5.3 µL, 0.06 mmol). 
Rf= 0.42 (petroleum ether/EtOAc 8:2). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.18 
(d, J = 8.7 Hz, 2H, Carom-H), 6.90 (d, J = 8.7 Hz, 2H, Carom-H), 5.91-5.87 (m, 1H, H-6), 4.77-4.73 
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(m, 2H, H-1 + H-5), 4.72 (bs, 1H, H-2), 3.77 (s, 3H, OCH3), 2.15 (d, J = 6.9 Hz, 1H, H-4), 1.93-
1.82 (m, 1H, CcyH), 1.82-1.75 (m, 1H, CcyH), 1.75-1.66 (m, 3H, 3×CcyH), 1.66-1.59 (m, 1H, 
CcyH), 1.31 (s, 9H, C(CH3)3), 1.26-1.08 (m, 8H, CH3 + 5× CcyH). 13C NMR (125 MHz, DMSO-
d6, 100 ºC) δ 203.3 (C=O), 158.0 (Carom), 153.6 (OC=O), 142.6 (C-7), 134.8 (Carom), 129.6 (C-6), 
129.5 (Carom-H), 113.9 (Carom-H), 81.9 (C-1), 79.4 (C(CH3)3), 78.7 (C-5), 71.8 (C-2), 59.9 (C-4), 
55.0 (OCH3), 38.6 (CcyH), 30.6 (CcyH2), 30.0 (CcyH2), 27.4 (C(CH3)3), 25.4 (CcyH2), 25.4 (CcyH2), 
25.3 (CcyH2), 12.5 (CH3). IR (CH2Cl2): 2922 (C-H st), 1698 (C=O st), 1260 (C-O-C st as), 1030 
(C-O-C st sy) cm-1. HRMS: Calculated for [C26H35NO5Na]+: 464.2413 [M+Na]+; found: 
464.2411. The ee was determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH 
(95:05)]; flow rate 1.00 mL/min; τmajor = 9.1 min, τminor = 23.6 min (94% ee). M.p.: 97-99 ºC 
(CH2Cl2). [α]D20: +211.8 (c = 0.2, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-cyclohexyl-7-(2-methylbenzyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl) carbamate, 6o. 
Following GP-I, 6o (17.8 mg, 76%) was isolated by FC (petroleum 
ether/EtOAc 19:1 to 8:2), as an oil after 16 h, starting from catalyst 3g 
(2.2 mg, 0.002 mmol), allene 1n (45 mg, 0.13 mmol), DMDO solution 
in toluene (1.1 mL, 0.28 mmol), EtOAc (0.70 mL) and furan 2d (6.6 
µL, 0.04 mmol). Rf= 0.33 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR (500 MHz, DMSO-
d6, 100 ºC) δ 7.22 (d, J = 8.9 Hz, 2H, Carom-H), 7.12-7.05 (m, 3H, Carom-H), 6.95-6.90 (m, 3H, 
Carom-H), 5.62-5.58 (m, 1H, H-6), 4.86 (d, J = 4.6 Hz, 1H, H-1), 4.78-4.74 (m, 2H, H-2 + H-5), 
3.74 (s, 3H, OCH3), 2.76 (d, J = 16.8 Hz, 1H, CHaHb), 2.55-2.51 (m, 1H, CHaHb), 2.16 (d, J = 
6.9 Hz, 1H, H-4), 2.10 (s, 3H, CH3), 1.93-1.82 (m, 1H, CcyH), 1.81-1.66 (m, 4H, 4×CcyH), 1.66-
1.58 (m, 1H, CcyH), 1.34 (s, 9H, C(CH3)3), 1.25-1.06 (m, 5H, CcyH). 13C NMR (125 MHz, 
DMSO-d6, 100 ºC) δ 203.1 (C=O), 158.0 (Carom), 153.7 (OC=O), 146.2 (C-7), 136.7 (Carom), 
135.4 (Carom), 134.9 (Carom), 130.3 (C-6), 129.6 (Carom-H), 129.5 (Carom-H), 128.4 (Carom-H), 125.7 
(Carom-H), 125.2 (Carom-H), 114.0 (Carom-H), 81.2 (C-1), 79.4 (C(CH3)3), 78.7 (C-5), 72.0 (C-2), 
59.7 (C-4), 55.0 (OCH3), 38.6 (CcyH), 30.7 (CH2), 30.5 (CcyH2), 29.9 (CcyH2), 27.5 (C(CH3)3), 
25.4 (CcyH2), 25.4 (CcyH2), 25.3 (CcyH2), 18.2 (CH3). IR (CH2Cl2): 2926 (C-H st), 1698 (C=O st), 
1245 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for [C33H41NO5Na]+: 554.2882 
[M+Na]+; found: 554.2879. The ee was determined by HPLC using a Chiralpak IA column [n-
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hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τminor = 11.8 min, τmajor = 12.8 min (97% ee). 
[α]D20: +82.9 (c = 1.0, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-cyclohexyl-3-oxo-7-
(((triisopropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-yl)(4-
methoxyphenyl) carbamate, 6p. Following GP-I, 6p (23.6 mg, 87%) 
was isolated by FC (petroleum ether/EtOAc 19:1 to 8:2), as an oil after 
16 h, starting from catalyst 3g (2.2 mg, 0.002 mmol), allene 1n (45 mg, 
0.13 mmol), DMDO solution in toluene (1.1 mL, 0.28 mmol), EtOAc (0.70 mL) and furan 2n 
(11.7 µL, 0.04 mmol). Rf= 0.45 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR (500 MHz, 
DMSO-d6, 100 ºC) δ 7.17 (d, J = 8.8 Hz, 2H, Carom-H), 6.88 (d, J = 8.8 Hz, 2H, Carom-H), 6.16-
6.13 (m, 1H, H-6), 4.96 (d, J = 4.5 Hz, 1H, H-1), 4.90-4.81 (m, 2H, H-2 + H-5), 3.76 (s, 3H, 
OCH3), 3.65 (d, J = 14.8 Hz, 1H, CHaHb), 3.12 (bs, 1H, CHaHb), 2.17 (d, J = 7.2 Hz, 1H, H-4), 
1.94-1.86 (m, 1H, CcyH), 1.86-1.79 (m, 1H, CcyH), 1.77-1.67 (m, 3H, 3×CcyH), 1.66-1.59 (m, 1H, 
CcyH), 1.30 (s, 9H, C(CH3)3), 1.26-1.09 (m, 5H, 5× CcyH), 0.99 (s, 21H, 3×CH(CH3)2). 13C NMR 
(125 MHz, DMSO-d6, 100 ºC) δ 203.1 (C=O), 158.1 (Carom), 153.7 (OC=O), 147.5 (C-7), 133.9 
(Carom), 129.9 (Carom-H), 129.5 (C-6), 113.7 (Carom-H), 79.5 (C-1), 79.4 (C(CH3)3), 78.5 (C-5), 
71.3 (C-2), 59.9 (C-4), 58.8 (CH2), 54.7 (OCH3), 38.4 (CcyH), 30.6 (CcyH2), 30.0 (CcyH2), 27.4 
(C(CH3)3), 25.4 (CcyH2), 25.3 (CcyH2), 25.3 (CcyH2), 17.2 (Si(CH(CH3)2)3), 11.0 (C(CH3)3). IR 
(CH2Cl2): 2926 (C-H st), 1698 (C=O st) cm-1. HRMS: Calculated for [C35H55NO6SiNa]+: 
636.3696 [M+Na]+; found: 636.3704. The ee was determined by HPLC using a Chiralpak IA 
column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τmajor = 3.9 min, τminor = 7.7 min 
(99% ee). [α]D20: +83.8 (c = 1.5, CH2Cl2). 
tert-Butyl ((1R,2S,4R,5S)-4-cyclohexyl-3-oxo-7-phenethyl-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl) carbamate, 6q. 
Following GP-I, 6q (17.6 mg, 70%) was isolated by FC (petroleum 
ether/EtOAc 9:1 to 7:3), as an oil after 16 h, starting from catalyst 3g 
(2.2 mg, 0.002 mmol), allene 1n (45 mg, 0.13 mmol), DMDO solution 
in toluene (1.1 mL, 0.28 mmol), EtOAc (0.72 mL) and furan 2f (6.7 µL, 0.04 mmol). Rf= 0.51 
(petroleum ether/EtOAc 8:2). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.26-7.21 (m, 
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2H, Carom-H), 7.18-7.13 (m, 3H, Carom-H), 7.05 (d, J = 7.5 Hz, 2H, Carom-H), 6.84 (d, J = 8.9 Hz, 
2H, Carom-H), 5.98-5.95 (m, 1H, H-6), 4.83 (d, J = 4.5 Hz, 1H, H-1), 4.80-4.75 (m, 2H, H-2 + H-
5), 3.65 (s, 3H, OCH3), 2.64-2.52 (m, 1H, CcyH), 2.17 (d, J = 7.0 Hz, 1H, H-4), 1.93-1.85 (m, 1H, 
Ccy-H), 1.84-1.77 (m, 1H, CHaHb), 1.75-1.67 (m, 3H, 3×CcyH), 1.67-1.60 (m, CHaHb), 1.60-1.51 
(m, 2H, CH2), 1.29 (s, 9H, C(CH3)3), 1.27-1.07 (m, 6H, 6×CcyH). 13C NMR (125 MHz, DMSO-
d6, 100 ºC) δ 203.3 (C=O), 158.0 (Carom), 153.6 (OC=O), 147.2 (C-7), 140.7 (Carom), 134.6 
(Carom), 129.6 (Carom-H), 128.5 (C-6), 127.5 (Carom-H), 127.4 (Carom-H), 125.1 (Carom-H), 113.8 
(Carom-H), 81.0 (C-1), 79.3 (C(CH3)3), 78.7 (C-5), 71.8 (C-2), 59.9 (C-4), 54.8 (OCH3), 38.6 
(CH), 33.2 (CH2), 30.6 (CH2), 30.0 (CH2), 28.0 (CH2), 27.4 (C(CH3)3), 25.4 (CH2), 25.4 (CH2), 
25.3 (CH2). IR (CH2Cl2): 2926 (C-H st), 1698 (C=O st), 1245 (C-O-C st as), 1030 (C-O-C st sy) 
cm-1. HRMS: Calculated for [C33H41NO5Na]+: 554.2882 [M+Na]+; found: 554.2877. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 
mL/min; τmajor = 7.9 min, τminor = 14.7 min (96% ee). [α]D20: +72.0 (c = 1.0, CH2Cl2). 
tert-Butyl ((1R,2S,4R,5S)-4-cyclohexyl-7-((N-(4-
methoxyphenyl)propionamido)methyl)-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 
6r. Following GP-J, 6r (27.7 mg, 51%) was isolated by FC 
(petroleum ether/EtOAc 7:3 to 4:6), as a solid after 16 h, starting 
from catalyst 3g (4.3 mg, 0.004 mmol), allene 1n (30 mg, 0.09 
mmol), DMDO solution in toluene (0.82 mL, 0.22 mmol), EtOAc (0.93 mL) and furan 2r (45.1 
mg, 0.17 mmol). Rf= 0.5 (petroleum ether/EtOAc 1:1). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 
100 ºC) δ 7.14 (d, J = 8.6 Hz, 2H, Carom-H), 7.04 (d, J = 8.6 Hz, 2H, Carom-H), 6.96 (d, J = 8.6 Hz, 
2H, Carom-H), 6.82 (d, J = 8.5 Hz, 2H, Carom-H), 5.99 (app s, 1H, H-6), 4.79-4.73 (m, 2H, H-1 + 
H-5), 4.37 (bs, 1H, H-2), 4.24 (bs, 1H, CHaHb), 3.81 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.39 
(bs, 1H, CHaHb), 2.18-2.14 (m, 1H, H-4), 2.03-1.95 (m, 2H, CH2CH3), 1.89-1.80 (m, 1H, CcyH), 
1.75-1.57 (m, 5H, 5×CcyH), 1.29 (s, 9H, C(CH3)3), 1.24-1.08 (m, 4H, 4×CcyH), 1.07 (d, J = 6.1 
Hz, 1H, CcyH), 0.93 (t, J = 7.4 Hz, 3H, CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 202.6 
(C=O), 172.1 (COEt), 158.1 (Carom), 157.7 (Carom), 153.2 (OC=O), 143.5 (C-7), 134.8 (Carom), 
131.8 (C-6), 129.0 (Carom-H), 128.7 (Carom-H), 114.2 (Carom-H), 113.8 (Carom-H), 79.5 (C-1), 79.4 
(C(CH3)3), 78.6 (C-2), 72.2 (C-5), 59.0 (C-4), 55.0 (OCH3), 54.9 (OCH3), 45.9 (CH2N), 30.4 
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(CcyH2), 29.9 (CcyH2), 27.5 (C(CH3)3), 26.3 (CH2CH3), 25.5 (CcyH2), 25.4 (CcyH2), 25.2 (CcyH2), 
8.9 (CH2CH3). IR (CH2Cl2): 2976 (C-H st), 1698 (C=O st), 1242 (C-O-C st as), 1034 (C-O-C st 
sy) cm-1. HRMS: Calculated for [C36H47N2O7]+: 619.3383 [M+H]+; found: 619.3384. The ee was 
determined by HPLC using a Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 
mL/min; τmajor = 12.2 min, τminor = 15.2 min (96% ee). M.p.: 83-85 ºC (CH2Cl2). [α]D20: +58.2 (c = 
1.5, CH2Cl2). 
tert-Butyl (4-methoxyphenyl) ((1R,2S,4S,5S)-3-oxo-4-phenethyl-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)carbamate, 6s. Following GP-J, 6s 
(7.4 mg, 30%) was isolated by FC (petroleum ether/EtOAc 9:1 to 
7:3), as an oil after 16 h, starting from catalyst 3g (2.7 mg, 0.003 
mmol), allene 1o (20 mg, 0.05 mmol, 1 eq), DMDO solution in toluene (0.6 mL, 0.14 mmol), 
EtOAc (0.5 mL) and furan 2a (52 µL, 0.71 mmol, 13 eq). Rf= 0.63 (petroleum ether/EtOAc 7:3). 
dr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.32-7.27 (m, 2H, Carom-H), 7.25-7.22 (m, 
2H, Carom-H), 7.21-7.17 (m, 1H, Carom-H), 7.12 (d, J = 8.9 Hz, 2H, Carom-H), 6.89 (d, J = 8.9 Hz, 
2H, Carom-H), 6.10 (dd, J = 6.1, 1.8 Hz, 1H, H-6), 5.19 (d, J = 4.4 Hz, 1H, H-2), 5.06-5.03 (m, 
1H, H-1), 4.76-4.74 (m, 1H, H-5), 4.70 (d, J = 6.1 Hz, 1H, H-7), 3.78 (s, 3H, OCH3), 2.69 (t, J = 
7.9 Hz, 2H, CH2Ph), 2.34-2.29 (m, 1H, H-4), 2.13-1.98 (m, 2H, C-4CH2), 1.33 (s, 9H, C(CH3)3). 
13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 204.0 (C=O), 158.2 (Carom), 154.1 (OC=O), 140.7 
(Carom), 133.4 (Carom), 132.4 (C-6), 131.4 (C-7), 130.7 (Carom-H), 127.8 (Carom-H), 127.7 (Carom-H), 
125.4 (Carom-H), 113.5 (Carom-H), 80.6 (C-5), 79.8 (C-1), 79.1 (C(CH3)3), 68.8 (C-2), 54.9 
(OCH3), 53.6 (C-4), 32.3 (CH2Ph), 31.2 (C-4CH2), 27.5 (C(CH3)3). IR (CH2Cl2): 2986 (C-H st), 
1701 (C=O st), 1240 (C-O-C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for 
[C27H31NO5Na]+: 472.2100 [M+Na]+; found: 472.2099. The ee was determined by HPLC using a 
Chiralpak IA column [n-hexane/i-PrOH (90:10)]; flow rate 1.00 mL/min; τminor = 11.5 min, τmajor 
= 14.1 min (13% ee). 
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tert-Butyl (4-methoxyphenyl)((1R,2S,4S,5S)-7-methyl-3-oxo-4-
phenethyl-8-oxabicyclo[3.2.1]oct-6-en-2-yl)carbamate, 6t. 
Following GP-J, 6t (15.3 mg, 60%) was isolated by FC (petroleum 
ether/EtOAc 19:1 to 8:2), as an oil after 16 h, starting from catalyst 
3g (2.7 mg, 0.003 mmol), allene 1o (20 mg, 0.05 mmol), DMDO solution in toluene (0.58 mL, 
0.14 mmol), EtOAc (0.52 mL) and 3-methylfuran 2b (10 µL, 0.11 mmol). Rf= 0.29 (petroleum 
ether/EtOAc 7:3). rr: 10:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.31-7.25 (m, 2H, Carom-H), 
7.25-7.21 (m, 2H, Carom-H), 7.20-7.15 (m, 2H, Carom-H), 6.91 (d, J = 8.6 Hz, 2H, Carom-H), 5.94-
5.90 (m, 1H, H-6), 4.75 (d, J = 4.8 Hz, 1H, H-1), 4.70-4.67 (m, 2H, H-5), 4.63 (bs, 1H, H-2), 
3.77 (s, 3H, OCH3), 2.78-2.68 (m, 2H, CH2Ph), 2.40-2.36 (m, 1H, H-4), 2.06-1.99 (m, 2H, C-
4CH2), 1.33 (s, 3H, CH3), 1.29 (s, 9H, C(CH3)3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 
203.7 (C=O), 157.9 (Carom), 153.3 (OC=O), 142.6 (C-7), 141.0 (Carom), 135.2 (Carom), 129.1 
(Carom-H), 128.9 (C-6), 127.8 (Carom-H), 127.7 (Carom-H), 125.3 (Carom-H), 113.9 (Carom-H), 81.6 
(C-1), 80.5 (C-5), 79.5 (C(CH3)3), 70.4 (C-2), 55.0 (OCH3), 53.1 (C-4), 32.4 (CH2Ph), 32.2 (C-
4CH2), 27.5 (CH3), 27.4 (C(CH3)3). IR (CH2Cl2): 2980 (C-H st), 1698 (C=O st), 1257 (C-O-C st 
as), 1032 (C-O-C st sy) cm-1. HRMS: Calculated for [C28H33NO5Na]+: 486.2256 [M+Na]+; 
found: 486.2255. The ee was determined by HPLC using a Chiralpak IC column [n-hexane/i-
PrOH (90:10)]; flow rate 1.00 mL/min; τminor = 16.5 min, τmajor = 19.5 min (84% ee). [α]D20: +34.6 
(c = 1.0, CH2Cl2). 
tert-Butyl (4-methoxyphenyl)((1R,2S,4S,5S)-3-oxo-4-phenethyl-7-
(((triisopropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)carbamate, 6u. Following GP-I, 6u (16.3 mg, 62%) was isolated 
by FC (petroleum ether/EtOAc 19:1 to 8:2), as an oil after 16 h, 
starting from catalyst 3g (2.04 mg, 0.002 mmol), allene 1o (75 mg, 0.2 mmol, 5 eq), DMDO 
solution in toluene (2.05 mL, 0.51 mmol, 12.5 eq), EtOAc (0.70 mL) and furan 2n (11 µL, 0.04 
mmol, 1 eq). Allene, DMDO and EtOAc were added in 5 portions (30 minutes per portion). Rf= 
0.32 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.32-7.26 
(m, 2H, Carom-H), 7.23 (d, J = 7.5 Hz, 2H, Carom-H), 7.21-7.13 (m, 3H, Carom-H), 6.89 (d, J = 8.5 
Hz, 2H, Carom-H), 6.18-6.15 (m, 1H, H-6), 4.97 (d, J = 4.7 Hz, 1H, H-1), 4.82-4.73 (m, 2H, H-1 + 
H-5), 3.87 (d, J = 14.8 Hz, 1H, CHaHb), 3.77 (s, 3H, OCH3), 3.47 (bs, 1H, CHaHb), 2.73 (t, J = 
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7.9 Hz, 2H, CH2Ph), 2.44-2.38 (m, 1H, H-4), 2.09-2.01 (m, 2H, C-4CH2), 1.29 (s, 9H, C(CH3)3), 
1.02 (s, 21H, 3×CH(CH3)2). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 203.5 (C=O), 157.9 
(Carom), 153.5 (OC=O), 147.4 (C-7), 140.9 (Carom), 134.5 (Carom), 129.3 (Carom-H), 128.9 (C-6), 
127.7 (Carom-H), 125.3 (Carom-H), 113.7 (Carom-H), 80.3 (C-5), 79.5 (C(CH3)3), 79.2 (C-1), 70.1 
(C-2), 59.1 (C-7CH2), 54.7 (OCH3), 53.2 (C-4), 32.3 (CH2Ph), 32.1 (C-4CH2), 27.4 (C(CH3)3), 
17.2 (Si(CH(CH3)2)3), 11.1 (SiC(CH3)3). IR (CH2Cl2): 2937 (C-H st), 1716 (C=O st), 1257 (C-O-
C st as), 1030 (C-O-C st sy) cm-1. HRMS: Calculated for [C37H53NO6SiNa]+: 658.3540 [M+Na]+; 
found: 658.3531. The ee was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-
PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 6.4 min, τminor = 7.9 min (82% ee). [α]D20: +37.3 (c 
= 0.48, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-(2-((tert-
butyldimethylsilyl)oxy)ethyl)-3-oxo-8-oxabicyclo[3.2.1]oct-6-
en-2-yl)(4-methoxyphenyl)carbamate, 6v. Following GP-J, 6v 
(13.3 mg, 37%) was isolated by FC (petroleum ether/EtOAc 
19:1 to 8:2), as an oil after 16 h, starting from catalyst 3g (3.6 mg, 0.003 mmol), allene 1p (30 
mg, 0.07 mmol, 1 eq), DMDO solution in toluene (0.72 mL, 0.18 mmol), EtOAc (0.71 mL) and 
furan 2a (70 µL, 0.93 mmol, 13 eq). dr: >20:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.11 (d, 
J = 8.8 Hz, 2H, Carom-H), 6.89 (d, J = 8.8 Hz, 2H, Carom-H), 6.11 (dd, J = 6.1, 1.8 Hz, 1H, H-6), 
5.15 (d, J = 4.3 Hz, H-2), 5.05-5.01 (m, 1H, H-1), 4.76-4.74 (m, 1H, H-5), 4.74-4.70 (m, 1H, H-
7), 3.78 (s, 3H, OCH3), 3.75-3.64 (m, 2H, OCH2), 2.44-2.38 (m, 1H, H-4), 1.98 (dt, J = 13.8, 6.8 
Hz, 1H, C-4CHaHb), 1.88 (dt, J = 13.8, 6.8 Hz, 1H, C-4CHaHb), 1.33 (s, 9H, C(CH3)3), 0.90 (s, 
9H, SiC(CH3)3), 0.07 (s, 3H, Si(CH3)2), 0.07 (s, 3H, Si(CH3)2). 13C NMR (125 MHz, DMSO-d6, 
100 ºC) δ 203.9 (C=O), 158.2 (Carom), 154.1 (OC=O), 133.3 (C-6), 132.4 (Carom), 131.5 (C-7), 
130.6 (Carom-H), 113.5 (Carom-H), 80.6 (C-5), 79.7 (C-1), 79.1 (C(CH3)3), 68.7 (C-2), 59.9 
(CH2O), 54.9 (OCH3), 51.1 (C-4), 32.6 (C-4CH2), 27.4 (C(CH3)3), 25.3 (SiC(CH3)3), 17.3 
(SiC(CH3)3), -5.9 (SiCH3). IR (CH2Cl2): 2930 (C-H st), 1726 (C=O st), 1245 (C-O-C st as), 1049 
(C-O-C st sy) cm-1. HRMS: Calculated for [C27H42NO6Si]+: 504.2781 [M+H]+; found: 504.2784. 
The ee was determined by HPLC using a Chiralpak IC column [n-hexane/i-PrOH (98:2)]; flow 
rate 1.00 mL/min; τminor = 19.8 min, τmajor = 33.1 min (10% ee). 
Experimental  183 
 
tert-Butyl ((1S,2R,4R,5R)-4-(2-((tert-
butyldimethylsilyl)oxy)ethyl)-7-methyl-3-oxo-8-
oxabicyclo[3.2.1]oct-6-en-2-yl)(4-methoxyphenyl)carbamate, 
6w. Following GP-I, 6w (15.1 mg, 82%) was isolated by FC 
(petroleum ether/EtOAc 19:1 to 8:2), as an oil after 16 h, starting from catalyst ent-3g (1.8 mg, 
0.002 mmol), allene 1p (75 mg, 0.18 mmol, 5 eq), DMDO solution in toluene (1.85 mL, 0.45 
mmol, 12.5 eq), EtOAc (0.5 mL, 0.015M) and 3-methylfuran 2a (3.2 µL, 0.04 mmol, 1 eq). 
Allene, DMDO and EtOAc were added in 5 portions (30 minutes per portion). Rf= 0.25 
(petroleum ether/EtOAc 9:1). rr: 15:1. 1H NMR (500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.9 
Hz, 2H, Carom-H), 6.91 (d, J = 8.9 Hz, 2H, Carom-H), 5.94-5.90 (m, 1H, H-6), 4.74 (d, J = 4.9 Hz, 
1H, H-1), 4.69-4.64 (m, 1H, H-5), 4.62-4.54 (m, 1H, H-2), 3.77 (s, 3H, OCH3), 3.75-3.69 (m, 2H, 
CH2CH2OTBS), 2.49-2.46 (m, 1H, H-4), 1.93-1.87 (m, 2H, CH2CH2OTBS), 1.30 (s, 9H, 
3×CH3), 0.89 (s, 9H, 3× CH3), 0.06 (s, 6H, 2× CH3). 13C NMR (125 MHz, DMSO-d6, 100 ºC) δ 
203.9 (C=O), 157.8 (Carom), 146.0 (OC=O), 142.6 (C-7), 136.9 (Carom), 129.1 (Carom-H), 128.9 (C-
6), 113.9 (Carom-H), 81.6 (C-1), 80.5 (C-5), 79.5 (C(CH3)3), 70.4 (C-2), 58.1 (CH2CH2OTBS), 
55.0 (OCH3), 50.8 (C-4), 34.0 (CH2CH2OTBS), 27.4 (C(CH3)3), 25.3 (SiC(CH3)3), 17.5 
(SiC(CH3)3), 17.2 (CH3), -3.8 (SiCH3). IR (CH2Cl2): 3009 (C-H st), 1698 (C=O st), 1242 (C-O-C 
st as), 1038 (C-O-C st sy) cm-1. HRMS: Calculated for [C28H44NO6Si]+: 518.2938 [M+H]+; 
found: 518.2945. The ee was determined by HPLC using a Chiralpak AD-H column [n-hexane/i-
PrOH (95:5)]; flow rate 1.00 mL/min; τmajor = 8.0 min, τminor = 10.7 min (75% ee). [α]D20: -33.9 (c 
= 1.2, CH2Cl2). 
tert-Butyl ((1R,2S,4S,5S)-4-(2-((tert-
butyldimethylsilyl)oxy)ethyl)-3-oxo-7-
(((tripropylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(4-methoxyphenyl)carbamate, 6x. Following GP-I, 6x (8.4 
mg, 34%) was isolated by FC (petroleum ether/EtOAc 19:1 to 
8:2) as an oil after 16 h, starting from catalyst 3g (1.8 mg, 0.002 mmol), allene 1p (75 mg, 0.18 
mmol, 5 eq), DMDO solution in toluene (1.80 mL, 0.45 mmol, 12.5 eq), EtOAc (0.60 mL, 
0.015M) and furan 2n (9.2 mg, 0.04 mmol, 1 eq). Allene, DMDO and EtOAc were added in 5 
portions (30 minutes per portion). Rf= 0.43 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR 
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(500 MHz, DMSO-d6, 100 ºC) δ 7.16 (d, J = 8.6 Hz, 2H, Carom-H), 6.89 (d, J = 8.6 Hz, 2H, Carom-
H), 6.18-6.14 (m, 1H, H-6), 4.96 (d, J = 4.8 Hz, 1H, H-1), 4.78-4.67 (m, 2H, H-5 + H-2), 3.91 
(bs, 1H, CHaHb), 3.77 (s, 3H, OCH3), 3.73 (q, J = 6.3 Hz, 2H, CH2OTBDMS), 3.53 (bs, 1H, 
CHaHb), 2.53-2.50 (m, 1H, H-4), 1.98-1.86 (m, 2H, C-4CH2), 1.29 (s, 9H, C(CH3)3), 1.02 (s, 
21H, Si(CH(CH3)2)3), 0.89 (s, 9H, SiC(CH3)3), 0.06 (s, 6H, Si(CH3)2). 13C NMR (125 MHz, 
DMSO-d6, 100 ºC) δ 203.4 (C=O), 157.9 (Carom), 153.4 (OC=O), 147.4 (C-7), 134.6 (Carom), 
129.3 (Carom-H), 128.7 (C-6), 113.7 (Carom-H), 80.4 (C-5), 79.5 (C(CH3)3), 79.0 (C-1), 70.0 (C-2), 
59.9 (CH2OTBDMS), 59.2 (C-7CH2), 54.8 (OCH3), 50.6 (C-4), 33.8 (C-4CH2), 27.3 (C(CH3)3), 
25.3 (SiC(CH3)3), 17.3 (SiC(CH3)3), 17.2 (Si(CH(CH3)2)3), 11.1 (Si(CH(CH3)2)3), -5.9 
(Si(CH3)2). IR (CH2Cl2): 2922 (C-H st), 1716 (C=O st), cm-1. HRMS: Calculated for 
[C37H64NO7Si2]+: 690.4221 [M+H]+; found: 690.4222. The ee was determined by HPLC using a 
Chiralpak IA column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 mL/min; τminor = 4.3 min, τmajor = 
4.9 min (83% ee). [α]D20: -56.1 (c = 0.38, CH2Cl2). 
tert-Butyl ((1S,2R,4R,5R)-4-(2-((tert-
butyldimethylsilyl)oxy)ethyl)-3-oxo-7-
(((triphenylsilyl)oxy)methyl)-8-oxabicyclo[3.2.1]oct-6-en-2-
yl)(4-methoxyphenyl)carbamate, 6y. Following GP-I, 6y 
(13.7 mg, 73%) was isolated by FC (petroleum ether/EtOAc 
19:1 to 8:2) as an oil after 16 h, starting from catalyst ent-3b (1.2 mg, 0.001 mmol), allene 1p (50 
mg, 0.12 mmol, 5 eq), DMDO solution in toluene (1.25 mL, 0.30 mmol, 12.5 eq), EtOAc (0.33 
mL, ) and furan 2m (8.5 mg, 0.02 mmol, 1 eq). Allene, DMDO and EtOAc were added in 5 
portions (30 minutes per portion). Rf= 0.35 (petroleum ether/EtOAc 9:1). rr: >20:1. 1H NMR 
(500 MHz, DMSO-d6, 100 ºC) δ 7.55-7.35 (m, 15H, Carom-H), 7.05 (d, J = 8.8 Hz, 2H, Carom-H), 
6.74 (d, J = 8.8 Hz, 2H, Carom-H), 6.21-6.18 (m, 1H, H-6), 4.97 (d, J = 4.8 Hz, H-1), 4.76-4.72 
(m, 1H, H-5), 4.62-4.53 (m, 1H, H-2), 4.03 (d, J = 14.2 Hz, CHaHb), 3.91-3.81 (m, 1H, CHaHb), 
3.78-3.68 (m, 2H, CH2OTBDMS), 3.67 (s, 3H, OCH3), 2.52 (bs, 1H, H-4), 1.97-1.85 (m, 2H, C-
4CH2), 1.21 (s, 9H, C(CH3)3), 0.89 (s, 9H, SiC(CH3)3), 0.06 (s, 6H, Si(CH3)2). 13C NMR (125 
MHz, DMSO-d6, 100 ºC) δ 203.2 (C=O), 157.7 (Carom), 153.2 (OC=O), 146.3 (C-7), 136.3 
(Carom), 134.3 (Carom-H), 134.1 (Carom-H), 134.0 (Carom-H), 133.2 (Carom), 129.7 (C-6), 129.6 
(Carom-H), 129.5 (Carom), 129.0 (Carom), 128.9 (Carom-H), 127.4 (Carom-H), 127.3 (Carom-H), 127.1 
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(Carom-H), 113.7 (Carom-H), 80.4 (C-5), 79.5 (C(CH3)3), 78.8 (C-1), 70.2 (C-2), 59.9 
(CH2OTBDMS), 59.8 (C-7CH2), 54.8 (OCH3), 50.4 (C-4), 33.9 (C-4CH2), 27.3 (C(CH3)3), 25.3 
(SiC(CH3)3), 17.3 (SiC(CH3)3), -5.9 (SiCH3). IR (CH2Cl2): 2930 (C-H st), 1698 (C=O st), cm-1. 
HRMS: Calculated for [C46H58NO7Si2]+: 792.3752 [M+H]+; found: 792.3752. The ee was 
determined by HPLC using a Chiralpak AD-H column [n-hexane/i-PrOH (95:5)]; flow rate 1.00 
mL/min; τmajor = 6.0 min, τminor = 7.5 min (86% ee). [α]D20: -48.9 (c = 0.98, CH2Cl2).  
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3. ALLYLATION OF IMINES USING ENANTIOPURE BORONATES 
3.1 Synthesis of starting materials 
 
3,4-Diethylhexane-3,4-diol (SI14): Diol SI14 was prepared following a procedure described in a 
PhD dissertation and NMR spectral information are consistent with given data.46 A round bottom 
flask was charged with magnesium powder (9.7g, 400 mmol, 8 eq) under Ar atmosphere. After 
that, SmI2 0.1M solution in THF (50 mL, 5 mmol, 10 mol%) and TMSCl (3.15 mL, 25 mmol, 0.5 
eq) were added at room temperature. A mixture of 3-pentanone (5.4 mL, 50 mmol, 1 eq) and 
TMSCl (6.3 mL, 50 mmol, 1 eq) was added dropwise to the reaction at the rate to maintain the 
blue colour. After 48h the reactions turned in grey colour and aqueous HCl 1M was added 
dropwise and extracted with Et2O (3×20 mL), dried over Na2SO4, filtered and solvent was 
removed under reduced pressure. Residue was purified by FC (petroleum ether to petroleum 
ether/EtOAc 8:2) to afford a colorless oil (4 g, 22.9 mmol, 46%). 1H NMR (300 MHz, CDCl3) δ 
1.98 (s, 2H, 2×OH), 1.61 (q, J = 7.5, 8H, 4×CH2), 0.94 (t, J = 7.5 Hz, 12H, 4×CH3). 13C NMR 
(75 MHz, CDCl3) δ 79.0 (C), 27.5 (CH2), 9.2 (CH3). 
Allylboronates (±)-7a and (±)-7b 
 
General Procedure K (GP-K): (±)-7a and (±)-7b were synthesized following a procedure 
described in the literature with slight modifications.47 A dried round bottom flask was charged 
with the corresponding diol (19.3 mmol, 1 eq) in dry THF (5.2 mL, 3.7M). The solution was 
cooled to 0ºC and BH3·DMS 2M in THF (9.65 mL, 1 eq) was added dropwise to the mixture. 
                                                           
46
  Incerti-Pradillos, Celia A. Asymmetric allylation of carbonyl compounds: kinetic resolution of sec-allylboronates and 
total synthesis of natural products, Loughborough University, 2014. 
47
  Incerti-Pradillos, C. A.; Kabeshov, M. A.; Malkov, A. V. Angew. Chem. Int. Ed. 2013, 52, 5338. 
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Then the reaction was stirred at 0ºC for 30 min and then at room temperature for 90 min. The 
resulting borane SI15a-b (1.3M in THF) was used in the next step in a without further 
purification when required. A two-necked round bottom flask fitted with a condenser was 
charged with magnesium powder (23.2 mmol, 1.2 eq). Dry THF (9.3 mL, 0.8M) was added to the 
flask followed by borane solution SI15a-b (1.3 M in THF) via cannula with vigorous stirring. 
Crotyl bromide (19.3 mmol, 1 eq) was added dropwise at room temperature to the solution 
(exotermic!) and let stirred for 30 minutes. Afterwards, crotyl bromide (19.3 mmol, 1 eq) was 
added to the reaction and the mixture was stirred for 90 minutes. The reaction was quenched 
carefully with aqueous HCl (0.1M) until the excess of magnesium was fully consumed. The 
mixture was extracted with EtOAc (3×15 mL) and dried over Na2SO4. After filtration, the solvent 
was removed under reduced pressure. The crude mixture was purified by FC on silica gel 
(petroleum ether/CH2Cl2 10:0 to 5:5). 
(±)-2-(But-3-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, (±)-7a. Following 
GP-K, pinacol (4 g, 33.8 mmol, 1 eq) was used as starting material obtaining a 
colorless oil (4.3 g, 23.6 mmol, 70%) after purification by FC on silica gel 
(petroleum ether to 1:1 petroleum ether/CH2Cl2). Rf= 0.48 (petroleum ether/CH2Cl2 
4.2:0.8). NMR spectral data are consistent with literature values.47 1H NMR (300 MHz, CDCl3) δ 
6.01-5.87 (m, 1H, CH=CH2), 5.02-4.89 (m, 2H, CH=CH2), 1.90 (t, J = 7.4 Hz, 1H, BCH), 1.24 
(s, 12H, 4×CH3), 1.10 (d, J = 7.3 Hz, 3H, CHCH3). 13C NMR (75 MHz, CDCl3) δ 140.9 
(CH=CH2), 111.9 (CH=CH2), 83.2 (C(CH3)2), 27.4 (CH3), 27.6 (CH3), 14.1 (CH3). HC-B 
resonance was not observed due to quadrupolar effect of Boron. 
(±)-2-(But-3-en-2-yl)-4,4,5,5-tetraethyl-1,3,2-dioxaborolane, (±)-7b. (±)-7b was 
synthesized following GP-K using diol SI14 (3.4 g, 19.3 mmol, 1 eq) as starting 
material obtaining a colorless oil (2.9 g, 12.2 mmol, 65%) after purification by FC on 
silica gel (petroleum ether to 1:1 petroleum ether:CH2Cl2). Rf= 0.40 (petroleum 
ether/CH2Cl2 4.8:0.2). NMR spectral data are consistent with literature values.47 1H NMR (300 
MHz, CDCl3) δ 5.96 (ddd, J = 17.3, 10.3, 7.1 Hz, 1H, CH=CH2), 5.00-4.86 (m, 2H, CH=CH2), 
1.90 (t, J = 7.3 Hz, 1H, BCH), 1.71-1.58 (m, 8H, 4×CH2), 1.10 (d, J = 7.3 Hz, 3H,CHCH3), 0.90 
(t, J = 7.4 Hz, 12H, 4×CH3). 13C NMR (75 MHz, CDCl3) δ 141.6 (CH=CH2), 111.6 (CH=CH2), 
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88.2 (C(CH2CH3)2), 26.50 (CH2), 26.44 (CH2), 14.4 (CH3), 8.93 (CH3), 8.87 (CH3). HC-B 
resonance was not observed due to quadrupolar effect of Boron. 
3.2 Kinetic Resolution of racemic allylboronate (±)-7b 
 
General Procedure for the Kinetic Resolution: A round bottom flask was charged with (R)-
TRIP (40.5 mg, 0.05 mmol, 5 mol%) in dry toluene (1.56 mL, 0.03M). The reaction was cooled 
to -42 ºC and freshly distilled benzaldehyde (0.1 mL, 1.05 mmol, 1 eq) in dry toluene (1.54 mL, 
0.68M) and boronate (±)-7b (500 mg, 2.1 mmol, 2 eq) in toluene (1.25 mL, 1.68M) was 
sequentially added dropwise to the mixture. After 22h, the reaction was quenched with NaHCO3 
aq. sat. (20 mL) and stirred at room temperature for 1h. The mixture was extracted with EtOAc 
(3×20 mL), dried over Na2SO4 and filtered. After the removal of the solvent under reduced 
pressure the oily residue was purified by FC on silica gel (petroleum ether to petroleum 
ether/CH2Cl2 2:8) to afford (S)-7b (91%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ 5.97 
(ddd, J = 17.3, 10.3, 7.1 Hz, 1H, HC=CH2), 4.96 (ddd, J = 17.3, 1.9, 1.8 Hz, 1H, Hb), 4.90 (ddd, 
J = 10.3, 1.7, 1.6 Hz, 1H, Ha), 1.92 (t, J = 7.3 Hz, 1H, BCH), 1.72-1.59 (m, 8H, 4×CH2), 1.10 (d, 
J = 7.3 Hz, 3H, CH3), 0.90 (t, J = 7.5 Hz, 12H, 4×CH3). 13C NMR (75 MHz, CDCl3) δ 141.6 
(CH=CH2), 111.6 (CH=CH2), 88.3 (C(CH2CH3)2), 26.51 (CH2), 26.45 (CH2), 14.4 (CH3), 8.94 
(CH3), 8.89 (CH3). HC-B resonance was not observed due to quadrupolar effect of Boron. [α]Drt: 
-4.7 (c = 0.4, CH2Cl2). 
The enantiomeric excess of the enantiopure boronate (S)-7b was checked by HPLC analysis on 
chiral stationary phase at the corresponding alcohol 8 reproducing a reaction developed by 
Hoffmann.48 
                                                           
48
  Hoffmann, R. W. Pure & Appl. Chem. 1988, 60, 123. 
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(S)-7b (25 mg, 0.11 mmol, 1 eq) was placed in a vial equipped with a stirring bar and toluene 
(0.5 mL, 0.22M) was added. After that, benzaldehyde (12 µL, 0.12 mmol, 1.1 eq) was added. 
After 16h, toluene was evaporated under reduced pressure and it was purified by FC (petroleum 
ether to petroleum ether/CH2Cl2 4:6) obtaining oily alcohol 8 as a mixture of diastereoisomers 
(12.7 mg, 0.08 mmol, 72%). E:Z ratio 1:5.3. 1H NMR (300 MHz, CDCl3) δ (*denotes minor 
isomer) 7.42-7.23 (m, 5H, Carom-H), 5.73-5.54 (m, 1H, HC=CH), 5.51-5.37 (m, 1H, HC=CH), 
4.77-4.64(m, 1H, HCOH), 2.65-2.33 (m, 2H, CH2), 2.08* (bs, 1H, OH), 2.04 (bs, 1H, OH), 1.73-
1.66* (m, 3H, CH3), 1.66-1.56 (m, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor 
isomer) 144.2 (Carom), 129.6* (Carom-H), 128.5 (Carom-H), 127.8 (HC=CH), 127.6 (HC=CH), 
127.6* (HC=CH), 126.9* (HC=CH), 126.0 (Carom-H), 125.9* (Carom-H), 125.8 (Carom-H), 74.0, 
73.6* (HCOH), 43.0* (CH2), 37.1 (CH2), 18.2* (CH3), 13.1 (CH3). The ee was determined by 
HPLC analysis using a Chiralcel OD-3 column [n-hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min 
at 21 ºC; Z isomer τminor = 14.28 min, τmajor = 16.79 min (99% ee); E isomer τmajor = 12.18 min, 
τminor = 15.22 min (99% ee). 
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3.3 Synthesis of primary amines 9a-l 
 
General Procedure for the Synthesis of Primary Amines (GP-L): Aldehyde (0.14 mmol, 1 
eq) was placed in a vial equipped with a stirring bar. EtOH (0.28 mL, 0.5M) and aqueous 
ammonia (4.2 mmol, ~30 eq, 32% wt.) were added and the mixture was stirred for 1 h. (S)-7b 
(0.17 mmol, 1.2 eq) was added to the solution and the vial was rinsed with EtOH (0.14 mL). The 
mixture was stirred at room temperature for 2-6 h, until white precipitate appeared. The cap of 
the vial was removed to vaporize most of ammonia and HCl (5M aqueous, 2 mL) was added to 
acidify the solution (pH=1). Traces of alcohol were extracted with Et2O (3×5 mL) and organic 
layer was washed with HCl (5M aqueous, 3×5 mL). Aqueous layer was alkalized with NaOH 
(6M aqueous, until pH=12-14) and extracted with CH2Cl2 (3×5 mL). Combined dichloromethane 
layers were washed with water, dried over anhydrous Na2SO4 and filtered. The removal of the 
solvent gave an oily residue that was purified by FC on silica gel with CHCl3:NH3 aq. (99:1) to 
CHCl3:MeOH:NH3 aq. (98:1:1) affording primary amine 9a-l. TLCs were developed in PMA. 
The racemic standards for HPLC analysis were prepared using boronate (±)-7a. 
(S,Z)-1-Phenylpent-3-en-1-amine, 9a. Following GP-L, 9a (14.9 mg, 0.09 
mmol, 76%) was isolated by FC as pure oil after 2 h, starting from 
benzaldehyde (12.4 µL, 0.12 mmol), aqueous ammonia (0.22 mL, 3.67 mmol) 
in EtOH (0.24 mL) and adding boronate (S)-7b (35 mg, 0.15 mmol) diluted in 
EtOH (0.12 mL). E:Z ratio 1:8.3 (measured on the crude by quantitative 13C-NMR spectra). Rf= 
0.43 (EtOAc). 1H NMR (300 MHz, CD3OD) δ (*denotes minor isomer) 7.38-7.18 (m, 5H, Carom-
H), 5.59-5.44 (m, 1H, HC=CH), 5.39-5.25 (m, 1H, HC=CH), 3.86 (t, J = 6.9 Hz, 1H, HCNH2), 
2.59-2.30 (m, 2H, CH2), 1.62* (dd, J =6.2, 1.1 Hz, 3H, CH3), 1.55 (dd, J = 6.9, 0.7 Hz, 3H, CH3). 
13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 146.4 (Carom), 129.4 (Carom-H), 129.2* 
(HC=CH), 128.8* (HC=CH), 128.0 (HC=CH), 127.7 (Carom-H), 127.6 (Carom-H), 127.6* (Carom-
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H), 127.3 (HC=CH), 57.2 (HCNH2), 57.1* (HCNH2), 43.5* (CH2), 37.6 (CH2), 18.1* (CH3), 
13.0 (CH3). IR (CH2Cl2): 3019, 2922 (NH2 st), 2780 (C-H st), 1597 (NH2 δ) cm-1. MS (EI) m/z 
(%): 106 (100, [M+-C4H7]). HRMS: Calculated for [C11H16N]+: 162.1283 [M+H]+; found: 
162.1280. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10a. 
(S,Z)-1-(p-Tolyl)pent-3-en-1-amine, 9b. Following GP-L, 9b (15.2 mg, 
0.09 mmol, 62%) was isolated by FC as pure oil after 3 h, starting from p-
tolualdehyde (16.5 µL, 0.14 mmol), aqueous ammonia (0.25 mL, 4.2 
mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in EtOH (0.14 
mL). E:Z ratio 1:6.0. Rf= 0.62 (CHCl3:MeOH 5%). 1H NMR (300 MHz, CD3OD) δ (*denotes 
minor isomer) 7.23-7.16 (d, J = 8.1 Hz, 2H. Carom-H), 7.12 (d, J = 8.1 Hz, 2H, Carom-H), 5.57-5.43 
(m, 1H, HC=CH), 5.38-5.23 (m, 1H, HC=CH), 3.82 (t, J = 6.9 Hz, 1H, HCNH2), 2.54-2.32 (m, 
2H, CH2), 2.30 (s, 3H, Carom-CH3), 1.62* (dd, J = 6.3, 1.3 Hz, 3H, CH3), 1.55 (dd, J = 6.7, 0.7 
Hz, 3H, CH3). 13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 143.3 (Carom), 137.6 
(Carom-CH3), 130.0 (Carom-H), 129.1* (HC=CH), 128.9* (HC=CH), 127.8 (HC=CH), 127.51 
(Carom-H), 127.46* (Carom-H), 127.2 (HC=CH), 56.9 (HCNH2), 56.7* (HCNH2), 43.5* (CH2), 
37.6 (CH2), 21.1 (Carom-CH3), 18.1* (CH3), 13.0 (CH3). IR (CH2Cl2): 3019, 2922 (NH2 st), 2831 
(C-H st), 1512 (NH2 δ) cm-1. MS (EI) m/z (%): 120 (100, [M+-C4H7]). HRMS: Calculated for 
[C12H15]+: 159.1171 [M-NH3+H]+; found: 159.1174. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10b. 
(S,Z)-1-(4-Methoxyphenyl)pent-3-en-1-amine, 9c. Following GP-L, 9c 
(19.8 mg, 0.10 mmol, 74%) was isolated by FC as pure oil after 2 h, 
starting from p-anisaldehyde (17.0 µL, 0.14 mmol), aqueous ammonia 
(0.25 mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 
mg, 0.17 mmol) diluted in EtOH (0.14 mL). E:Z ratio 1:5.7. Rf= 0.32 (EtOAc). 1H NMR (300 
MHz, CD3OD) δ (*denotes minor isomer) 7.28-7.20 (d, J =8.7 Hz, 2H, Carom-H), 6.90-6.83 (d, J 
=8.7 Hz, 2H, Carom-H), 5.57-5.43 (m, 1H, HC=CH), 5.39-5.23 (m, 1H, HC=CH), 3.82 (t, J = 7.0 
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Hz, 1H, HCNH2), 3.77 (s, 3H, OCH3), 2.54-2.29 (m, 2H, CH2), 1.62* (dd, J = 6.3, 1.3 Hz, 3H, 
CH3), 1.55 (dd, J = 6.8, 0.9 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor 
isomer) 158.64 (Carom-OCH3), 158.60* (Carom-OCH3), 138.4 (Carom), 128.3* (HC=CH), 128.1* 
(HC=CH), 127.5 (Carom-H), 127.2 (HC=CH), 126.6 (HC=CH), 113.8 (Carom-H), 55.5* (OCH3), 
55.4 (OCH3), 55.2 (HCNH2), 43.2* (CH2), 37.3 (CH2), 18.2* (CH3), 13.1 (CH3). IR (CH2Cl2): 
3011, 2937 (NH2 st), 2932 (C-H st), 1609, 1243 (C-O-C st), 1609 (NH2 δ), 1242 (C-O-C st as), 
1034 (C-OC st sy) cm-1. MS (EI) m/z (%): 136 (100, [M+-C4H7]). HRMS: Calculated for 
[C12H15O]+: 175.1123 [M-NH3+H]+; found: 175.1127. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10c. 
(S,Z)-1-(2-Methoxyphenyl)pent-3-en-1-amine, 9d. Following GP-L, 9d 
(16.4 mg, 0.09 mmol, 61%) was isolated by FC as pure oil after 6 h, starting 
from o-anisaldehyde (19.4 mg, 0.14 mmol), aqueous ammonia (0.25 mL, 4.2 
mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in EtOH (0.14 
mL). E:Z ratio 1:9.0. Rf= 0.14 (EtOAc). 1H NMR (300 MHz, CD3OD) δ (*denotes minor isomer) 
7.29-7.17 (m, 2H, Carom-H), 6.99-6.87 (m, 2H, Carom-H), 5.57-5.43 (m, 1H, HC=CH), 5.40-5.28 
(m, 1H, HC=CH), 4.15 (t, J = 6.9 Hz, 1H, HCNH2), 3.85 (s, 3H, OCH3), 2.60-2.26 (m, 2H, CH2), 
1.62* (dd, J = 6.2, 1.3 Hz, 3H, CH3), 1.55 (dd, J = 6.7, 0.8 Hz, 3H, CH3). 13C NMR (75 MHz, 
CD3OD) δ (*denotes minor isomer) 158.3 (Carom-O), 133.8 (Carom), 129.0 (Carom-H), 128.14 
(HC=CH), 128.11 (HC=CH), 127.0 (Carom-H), 121.5 (Carom-H), 111.7 (Carom-H), 55.8 (OCH3), 
52.2 (HCNH2), 51.7* (HCNH2), 41.5* (CH2), 35.6 (CH2), 18.2* (CH3), 13.0 (CH3). IR (CH2Cl2): 
3012, 2919 (NH2 st), 2818 (C-H st), 1601, 1583 (NH2 δ), 1235 (C-O-C st as), 1051 (C-O-C st sy) 
cm-1. MS (EI) m/z (%): 136 (100, [M+-C4H7]). HRMS: Calculated for [C12H17NONa]+: 214.1208 
[M+Na]+; found: 214.1208. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10d. 
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(S,Z)-1-(3-Methoxyphenyl)pent-3-en-1-amine, 9e. Following GP-L, 9e 
(15.7 mg, 0.08 mmol, 59%) was isolated by FC as pure oil after 6 h, 
starting from m-anisaldehyde (17.1 µL, 0.14 mmol), aqueous ammonia 
(0.25 mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.168 mmol) 
diluted in EtOH (0.14 mL). E:Z ratio 1:5.6. Rf= 0.32 (EtOAc). 1H NMR (300 MHz, CD3OD) δ 
(*denotes minor isomer) 7.22 (t, J = 7.7 Hz, 1H, Carom-H), 6.94-6.85 (m, 2H, Carom-H), 6.82-6.76 
(m, 1H, Carom-H), 5.59-5.44 (m, 1H, HC=CH), 5.40-5.25 (m, 1H, HC=CH), 3.84 (t, J = 7.0 Hz, 
1H, HCNH2), 3.79 (s, 3H, OCH3), 2.56-2.30 (m, 2H, CH2), 1.63* (dd, J = 6.2, 1.2 Hz, 3H, CH3), 
1.55 (dd, J = 6.7, 0.9 Hz, 3H, CH3). 13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 
161.3 (Carom-O), 148.0 (Carom), 130.3 (Carom-H), 129.2* (HC=CH), 128.8* (HC=CH), 127.7 
(HC=CH), 127.3 (HC=CH), 119.93 (Carom-H), 119.86* (Carom-H), 113.4 (Carom-H), 113.22 (Carom-
H), 113.16* (Carom-H), 57.2 (OCH3), 57.0* (OCH3), 55.6 (HCNH2), 43.5* (CH2), 37.5 (CH2), 
18.1 (CH3), 13.0* (CH3). IR (CH2Cl2): 3012, 2940 (NH2 st), 2840 (C-H st), 1601, 1583 (NH2 δ), 
1260 (C-O-C st as), 1049 (C-O-C st sy) cm-1. MS (EI) m/z (%): 136 (100, [M+-C4H7]). HRMS: 
Calculated for [C12H18NO]+: 192.1388 [M+H]+; found: 192.1392. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10e. 
(S,Z)-1-(4-Bromophenyl)pent-3-en-1-amine, 9f. Following GP-L, 9f 
(24.5 mg, 0.10 mmol, 73%) was isolated by FC as pure oil after 3 h, 
starting from 4-bromobenzaldehyde (25.9 mg, 0.14 mmol), aqueous 
ammonia (0.25 mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 
mmol) diluted in EtOH (0.12 mL). E:Z ratio 1:5.7. Rf= 0.34 (EtOAc). 1H NMR (300 MHz, 
CD3OD) δ (*denotes minor isomer) 7.49-7.41 (d, J = 8.4 Hz, 2H, Carom-H), 7.30-7.21 (d, J = 8.4 
Hz, 2H, Carom-H), 5.59-5.42 (m, 1H, HC=CH), 5.38-5.23 (m, 1H, HC=CH), 3.86 (t, J = 6.9 Hz, 
1H, HCNH2), 2.54-2.28 (m, 2H, CH2), 1.62* (dd, J = 6.3, 1.4 Hz, 3H, CH3), 1.53 (dd, J = 6.8, 1.0 
Hz, 3H, CH3). 13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 145.7 (Carom), 132.4 
(Carom-H), 129.7 (Carom-H), 129.6* (Carom-H), 129.5* (HC=CH), 128.4* (HC=CH), 127.6 
(HC=CH), 127.4 (HC=CH), 121.53 (Carom-Br), 121.51* (Carom-Br), 56.6 (HCNH2), 56.5* 
(HCNH2), 43.4* (CH2), 37.5 (CH2), 18.1* (CH3), 13.0 (CH3). IR (CH2Cl2): 3019, 2919 (NH2 st), 
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2850 (C-H st), 1590 (NH2 δ) cm-1. MS (EI) m/z (%): 184 (100, [M+-C4H7]). HRMS: Calculated 
for [C11H15NBr]+: 240.0388 [M+H]+; found: 240.0394. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10f. 
(S,Z)-1-(4-Chlorophenyl)pent-3-en-1-amine, 9g. Following GP-L, 9g 
(22.5 mg, 0.11 mmol, 82%) was isolated by FC as pure oil after 5 h, 
starting from 4-chlorobenzaldehyde (20 mg, 0.14 mmol), aqueous 
ammonia (0.25 mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 
mmol) diluted in EtOH (0.14 mL). E:Z ratio 1:5.5. Rf= 0.51 (petroleum ether/EtOAc 2:8). 1H 
NMR (300 MHz, CD3OD) δ (*denotes minor isomer) 7.36-7.27 (s, 4H. Carom-H), 5.60-5.42 (m, 
1H, HC=CH), 5.39-5.24 (m, 1H, HC=CH), 3.87 (t, J = 6.9 Hz, 1H, HCNH2), 2.55-2.29 (m, 2H, 
CH2), 1.62* (dd, J = 6.2, 1.3 Hz, 3H, CH3), 1.53 (dd, J = 6.8, 0.8 Hz, 3H, CH3). 13C NMR (75 
MHz, CD3OD) δ (*denotes minor isomer) 145.3 (Carom), 133.6 (Carom-Cl), 129.5* (HC=CH), 
129.4 (Carom-H), 129.3 (Carom-H), 129.3* (Carom-H), 128.5* (HC=CH), 127.5 (HC=CH), 127.4 
(HC=CH), 56.6 (HCNH2), 56.5* (HCNH2), 43.4* (CH2), 37.5 (CH2), 18.1* (CH3), 13.0 (CH3). 
IR (CH2Cl2): 3012, 2926 (NH2 st), 2851 (C-H st), 1591 (NH2 δ), 1088 (C-Cl st) cm-1. MS (EI) 
m/z (%): 140 (100, [M+-C4H7]). HRMS: Calculated for [C11H15NCl]+: 196.0893 [M+H]+; found: 
196.0895. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10g. 
(S,Z)-1-(4-Fluorophenyl)pent-3-en-1-amine, 9h. Following GP-L, 9h 
(15.2 mg, 0.08 mmol, 61%) was isolated by FC as pure oil after 5 h, 
starting from 4-fluorobenzaldehyde (15.1 µL, 0.14 mmol), aqueous 
ammonia (0.25 mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 
mmol) diluted in EtOH (0.14 mL). E:Z ratio 1:5.4. Rf= 0.33 (petroleum ether/EtOAc 2:8). 1H 
NMR (300 MHz, CD3OD) δ (*denotes minor isomer) 7.39-7.28 (m, 2H, Carom-H), 7.08-6.97 (m, 
2H, Carom-H), 5.58-5.43 (m, 1H, HC=CH), 5.39-5.23 (m, 1H, HC=CH), 3.88 (t, J = 6.9 Hz, 1H, 
HCNH2), 2.54-2.28 (m, 2H, CH2), 1.62* (dd, J = 6.3, 1.4 Hz, 3H, CH3), 1.53 (dd, J = 6.8, 1.8 Hz, 
3H, CH3). 13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 163.3 (d, 1JC-F = 243.3 Hz, 
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Carom-F), 142.4 (d, 4JC-F = 3.3 Hz, Carom-C), 129.4 (d, 3JC-F = 7.9 Hz, Carom-H), 129.4* (d, 3JC-F = 
8.0 Hz, Carom-H), 128.6* (HC=CH), 127.5 (HC=CH), 127.4 (HC=CH), 115.9 (d, 2JC-F = 21.4 Hz, 
Carom-H), 56.5 (HCNH2), 56.4* (HCNH2), 43.6* (CH2), 37.6 (CH2), 18.1* (CH3), 13.0 (CH3). IR 
(CH2Cl2): 3010, 2985 (NH2 st), 2930 (C-H st), 1217 (C-F st) cm-1. MS (EI) m/z (%): 124 (100, 
[M+-C4H7]). HRMS: Calculated for [C11H15NF]+: 180.1189 [M+H]+; found: 180.1188. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10h. 
(R,Z)-1-Phenylhept-5-en-3-amine, 9i. Following GP-L, 9i (19.3 mg, 0.1 
mmol, 73%) was isolated by FC as pure oil after 4 h, starting from 
hydrocinnamaldehyde (18.8 µL, 0.14 mmol), aqueous ammonia (0.25 mL, 
4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in EtOH 
(0.14 mL). E:Z ratio nd. Rf= 0.23 (petroleum ether/EtOAc 2:8). 1H NMR (300 MHz, CD3OD) δ 
(*denotes minor isomer) 7.29-7.10 (m, 5H, Carom-H), 5.68-5.50 (m, 1H, HC=CH), 5.49-5.35 (m, 
1H, HC=CH), 2.83-2.55 (m, 3H, 2×H-1+H-3), 2.29-2.08 (m, 2H, H-4ab), 2.07-1.94* (m, 2H, H-
4ab), 1.84-1.52 (m, 5H, 2×H-2+CH3). 13C NMR (75 MHz, CD3OD) δ (*denotes minor isomer) 
143.5 (Carom), 129.39 (Carom-H), 129.35 (Carom-H), 129.2* (HC=CH), 128.8* (HC=CH), 127.9 
(HC=CH), 127.4 (HC=CH), 126.8 (Carom-H), 51.9 (C-3), 51.5* (C-3), 41.2* (C-2), 39.8 (C-2), 
35.3 (C-4), 33.5 (C-1), 33.4* (C-1), 18.2* (CH3), 13,2 (CH3). IR (CH2Cl2): 3026, 2919 (NH2 st), 
2857 (C-H st), 1605, 1583 (NH2 δ) cm-1. MS (EI) m/z (%): 134 (81, [M+-C4H7]), 91 (100, [M+-
C6H12N]). HRMS: Calculated for [C13H20N]+: 190.1596 [M+H]+; found: 190.1599. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10i. 
(R,Z)-Dodec-2-en-5-amine, 9j. Following GP-L, 9j (15.5 mg, 0.08 
mmol, 60%) was isolated by FC as pure oil after 3 h, starting from 
octanal (21.9 µL, 0.14 mmol), aqueous ammonia (0.25 mL, 4.2 
mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in EtOH (0.14 
mL). E:Z ratio 1:5.6. Rf= 0.25 (EtOAc). 1H NMR (300 MHz, CD3OD) δ (*denotes minor isomer) 
5.67-5.49 (m, 1H, HC=CH), 5.49-5.36 (m, 1H, HC=CH), 2.80-2.65 (m, 1H, H-5), 2.25-2.03 (m, 
2H, H-4ab), 2.02-1.89* (m, 2H, H-4ab), 1.68* (dd, J = 6.0, 1.2 Hz, 3H, 3×H-1), 1.64 (dd, J = 6.8, 
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0.8 Hz, 3H, 3×H-1), 1.46-1.25 (m, 12H, 6×CH2), 0.95-0.86 (m, 3H, CH2CH3). 13C NMR (75 
MHz, CD3OD) δ (*denotes minor isomer) 129.1* (HC=CH), 128.9* (HC=CH), 128.0 (HC=CH), 
127.3 (HC=CH), 52.3 (C-5), 51.9* (C-5), 41.2* (C-4), 37.74 (C-4), 37.67* (CH2), 35.3 (CH2), 
33.0 (CH2), 30.9 (CH2), 30.4 (CH2), 27.2 (CH2), 27.1* (CH2), 23.7 (CH2), 18.2* (CH3), 14.4 
(CH3), 13.2 (CH3). IR (CH2Cl2): 2959, 2930 (NH2 st), 2851 (C-H st), 1454 (NH2 δ) cm-1. MS (EI) 
m/z (%): 128 (100, [M+-C4H7]). 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding benzoylated product 10j. 
(S,Z)-1-Cyclohexylpent-3-en-1-amine, 9k. Following GP-L, 9k (8.0 mg, 0.05 
mmol, 34%) was isolated by FC as pure oil after 3 h, starting from 
cyclohexanecarboxaldehyde (17.0 µL, 0.14 mmol), aqueous ammonia (0.25 
mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in 
EtOH (0.14 mL). E:Z ratio 1:6.3. Rf= 0.25 (EtOAc). 1H NMR (300 MHz, CD3OD) δ (*denotes 
minor isomer). 5.67-5.49 (m, 1H, H-4), 5.47-5.35 (m, 1H, H-3), 2.58-2.51 (m, 1H, H-1), 2.31-
2.17 (m, 1H, H-2a), 2.15-2.02 (m, 1H, H-2b), 1.99-1.86* (m, 1H, H-2b), 1.85-1.59 (m, 8H, 
2×CcyH2+CcyH+CH3), 1.39-0.96 (m, 6H, 3×CcyH2). 13C NMR (75 MHz, CDCl3) δ (*denotes 
minor isomer) 129.5* (HC=CH), 129.0* (HC=CH), 128.6 (HC=CH), 127.2 (HC=CH), 57.2 (C-
1), 56.7* (C-1), 44.1 (CcyH), 44.0* (CcyH), 38.2* (C-2), 32.4 (C-2), 30.7 (CcyH2), 30.6* (CcyH2), 
29.5* (CcyH2), 29.5 (CcyH2), 27.7 (CcyH2), 27.6 (CcyH2), 27.6* (CcyH2), 27.5 (CcyH2), 18.2* (CH3), 
13.1 (CH3). IR (CH2Cl2): 2922, 2851 (NH2 st), 1451 (NH2 δ) cm-1. MS (EI) m/z (%):126 (100, 
[M+-C4H7]). HRMS: Calculated for [C11H22N]+: 168.1752 [M+H]+; found: 168.1749. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding benzoylated product 10k. 
(S,1E,5Z)-1-Phenylhepta-1,5-dien-3-amine, 9l. Following GP-L, 9l (17.3 
mg, 0.14 mmol, 66%) was isolated by FC as pure oil after 3 h, starting 
from trans-cinnamaldehyde (17.6 µL, 0.14 mmol), aqueous ammonia (0.25 
mL, 4.2 mmol) in EtOH (0.28 mL) and adding boronate (S)-7b (40 mg, 0.17 mmol) diluted in 
EtOH (0.14 mL). E:Z ratio 1:6.0. Rf= 0.44 (CHCl3:MeOH 5%). 1H NMR (300 MHz, CDCl3) δ 
(*denotes minor isomer) 7.41-7.18 (m, 5H, Carom-H), 6.51 (dd, J = 15.9, 1.2 Hz, 1H, H-1), 6.21 
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(dd, J = 15.9, 6.8 Hz, 1H, H-2), 5.69-5.52 (m, 1H, H-6), 5.51-5.38 (m, 1H, H-5), 3.56 (qd, J = 
6.6, 1.2 Hz, 1H, H-3), 2.30 (t, J = 6.9 Hz, 2H, H-4), 2.22-2.08* (m, 2H, H-4), 1.68 (dd, J = 6.7, 
0.9 Hz, 3H, CH3), 1.48 (brs, 2H, NH2). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 
137.34* (Carom), 137.30 (Carom), 134.7* (C-6), 134.6 (C-6), 128.9 (Carom-H), 128.9* (Carom-H), 
128.65 (Carom-H), 128.56* (Carom-H), 127.5* (Carom-H), 127.4 (Carom-H), 126.9 (C-1), 126.6 (C-2), 
126.4 (C-5), 54.0 (C-3), 53.7* (C-3), 41.4* (C-4), 35.5 (C-4), 18.2* (CH3), 13.2 (CH3). IR 
(CH2Cl2): 3019, 2915 (NH2 st), 2830 (C-H st), 1490 (NH2 δ) cm-1. MS (EI) m/z (%): 186 (1, [M+-
H]), 132 (100, [M+-C4H7]). HRMS: Calculated for [C13H18N]+: 188.1439 [M+H]+; found: 
188.1444. 
The enantiomeric excess of the product was measured by HPLC analysis on chiral stationary 
phase at the corresponding acetylated product 10l. 
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3.4 Synthesis of protected amines 10a-l 
 
General Procedure for acetylation: A vial equipped with a magnetic stirring bar was charged 
with the amine 9a-h, 9j and 9l (0.09 mmol, 1 eq), CH2Cl2 (0.25M), DMAP (0.009 mmol, 10 
mol%), Et3N (0.28 mmol, 3 eq) and Ac2O (0.14 mmol, 1.5 eq). The crude mixture was stirred at 
room temperature until completion (30-60 min). The residue was concentrated in vacuo and 
purified by FC on silica gel (petroleum ether/EtOAc 8:2 to 6:4) affording the corresponding 
acetylated product as white solid. TLCs were developed in PMA. 
The racemic standards for HPLC analysis were prepared through an acetylation reaction of 
racemic amines 9a-h, 9j and 9l, which were previously synthesized using boronate (±)-7a. 
General Procedure for benzoylation: A vial equipped with a magnetic stirring bar was charged 
with the primary amine 9i or 9k (0.03 mmol, 1 eq), CH2Cl2 (0.25M), Et3N (0.05 mmol, 1.5 eq) 
and benzoyl chloride (0.04 mmol, 1.2 eq). The crude mixture was stirred at room temperature 
until completion (60 min). The mixture was concentrated in vacuo and purified by FC on silica 
gel (petroleum ether/EtOAc 19:1 to 7:3) affording the corresponding benzoylated product as a 
white solid. TLC was developed in PMA. 
The racemic standards for HPLC analysis were prepared through a benzoylation reaction of 
racemic amines 9i and 9k, which were previously synthesized using boronate (±)-7a. 
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(S,Z)-N-(1-Phenylpent-3-en-1-yl)acetamide, 10a. Following GP for 
acetylation, 10a (9.9 mg, 0.05 mmol, 89%) was isolated by FC, starting from 
primary amine 9a (8.8 mg, 0.05 mmol) in CH2Cl2 (0.22 mL), Et3N (22.3 µL, 
0.16 mmol), DMAP (1.1 mg, 0.009 mmol) and acetic anhydride (7.8 µL, 0.08 mmol). E:Z ratio 
1:6.3 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.37-7.21 (m, 5H, Carom-H), 5.80 
(d, J = 7.0 Hz, 1H, NH), 5.63-5.45 (m, 1H, HC=CH), 5.35-5.23 (m, 1H, HC=CH), 5.11-4.99 (m, 
1H, HCNH), 2.57 (tdd, J = 7.0, 1.7, 0.9 Hz, 2H, CH2), 2.52-2.45* (m, 2H, CH2), 1.99 (s, 3H, 
COCH3), 1.63* (dd, J = 6.4, 1.4 Hz, 3H, CH3), 1.59 (dd, J = 6.8, 0.8 Hz, 3H, CH3). 13C NMR (75 
MHz, CDCl3) δ (*denotes minor isomer) 169.4 (C=O), 142.0* (Carom), 141.9 (Carom), 128.9* 
(Carom-H), 128.7 (Carom-H), 127.4 (HC=CH), 127.3* (HC=CH), 127.2 (Carom-H), 126.6 (Carom-H), 
126.6* (Carom-H), 126.4* (HC=CH), 125.5 (HC=CH), 53.1 (HCNH), 53.0* (HCNH), 39.4* 
(CH2), 33.5 (CH2), 23.5 (COCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3282 (NH st), 1645 
(C=O st) cm-1. MS (EI) m/z (%): 148 (64, [M+-C4H7]). HRMS: Calculated for [C13H18NO]+: 
204.1388 [M+H]+; found: 204.1396. The ee was determined by HPLC using a Chiralpak IA 
column [n-hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min; Z isomer τminor = 44.24 min, τmajor = 
51.01 min (97% ee); E isomer τmajor = 47.61 min, τminor = 56.93 min (96% ee). 
(S,Z)-N-(1-(p-tolyl)pent-3-en-1-yl)acetamide, 10b. Following GP for 
acetylation, 10b (16.1 mg, 0.07 mmol, 80%) was isolated by FC, starting 
from primary amine 9b (16.4 mg, 0.09 mmol) in CH2Cl2 (0.37 mL), Et3N 
(39 µL, 0.28 mmol), DMAP (1.1 mg, 0.009 mmol) and acetic anhydride (13.2 µL, 0.14 mmol). 
E:Z ratio 1:6.0. 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.23-7.10 (m, 4H, Carom-
H), 5.82 (d, J = 8.1 Hz, 1H, NH), 5.64-5.47 (m, 1H, HC=CH), 5.36-5.23 (m, 1H, HC=CH), 5.07-
4.93 (m, 1H, HCNH), 2.60-2.52 (m, 2H, CH2), 2.53-2.40* (m, 2H, CH2), 2.32 (s, 3H, CaromCH3), 
1.97 (s, 3H, COCH3), 1.59 (dd, J = 6.7, 0.8 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ 
(*denotes minor isomer) 169.3 (C=O), 139.0* (Carom), 138.9 (Carom), 137.1 (Carom-CH3), 137.0* 
(Carom-CH3), 129.4 (Carom-H), 128.8* (HC=CH), 127.1 (HC=CH), 126.6 (Carom-H), 126.5* 
(HC=CH), 125.7 (HC=CH), 52.9 (HCNH), 52.7* (HCNH), 39.4* (CH2), 33.4 (CH2), 23.6 
(COCH3), 21.2 (CaromCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3289 (NH st), 2926 (C-H st), 
1644 (C=O st) cm-1. MS (EI) m/z (%):162 (92, [M+-C4H7]). HRMS: Calculated for [C14H20NO]+: 
218.1545 [M+H]+; found: 218.1549. The ee was determined by HPLC using a Chiralpak AY-3 
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column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; Z isomer τminor = 25.78 min, τmajor = 
41.14 min (>99% ee); E isomer τminor = 38.28 min, τmajor = 55.80 min (95% ee). 
(S,Z)-N-(1-(4-Methoxyphenyl)pent-3-en-1-yl)acetamide, 10c. 
Following GP for acetylation, 10c (17.8 mg, 0.08 mmol, 90%) was 
isolated by FC, starting from primary amine 9c (16.2 mg, 0.08 mmol) in 
CH2Cl2 (0.34 mL), Et3N (38.5 µL, 0.28 mmol), DMAP (1.0 mg, 0.008 mmol) and acetic 
anhydride (7.8 µL, 0.08 mmol). E:Z ratio 1:5.7. 1H NMR (300 MHz, CDCl3) δ (*denotes minor 
isomer) 7.20 (d, J = 8.7 Hz, 2H, Carom-H), 6.86 (d, J = 8.6 Hz, 2H, Carom-H), 5.75 (d, J = 8.2 Hz, 
1H, NH), 5.62-5.44 (m, 1H, HC=CH), 5.35-5.22 (m, 1H, HC=CH), 5.06-4.91 (m, 1H, HCNH), 
3.79 (s, 3H, OCH3), 2.60-2.51 (m, 2H, CH2), 2.50-2.42* (m, 2H, CH2), 1.97 (s, 3H, COCH3), 
1.63* (dd, J = 6.4, 1.0 Hz, 3H, CH3), 1.59 (dd, J = 6.8, 0.9 Hz, 3H, CH3). 13C NMR (75 MHz, 
CDCl3) δ (*denotes minor isomer) 169.3 (C=O), 158.9 (Carom-O), 134.2* (Carom), 134.0 (Carom), 
128.8* (HC=CH), 127.8 (Carom-H), 127.7* (Carom-H), 127.1 (HC=CH), 126.6* (HC=CH), 125.7 
(HC=CH), 114.1* (Carom-H), 55.4 (HCNH), 52.6 (OCH3), 52.5* (OCH3), 39.3* (CH2), 33.4 
(CH2), 23.6 (COCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3282 (NH st), 1644 (C=O st), 1245 
(C-O-C st as), 1020 (C-O-C st sy) cm-1. MS (EI) m/z (%): 178 (98, [M+-C4H7]). HRMS: 
Calculated for [C14H20NO2]+: 234.1494 [M+H]+; found: 234.1499. The ee was determined by 
HPLC using a Chiralpak AY-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; Z isomer 
τminor = 55.28 min, τmajor = 124.25 min (98% ee); E isomer τmajor = 99.91 min, τminor = 106.38 min 
(95% ee). 
(S,Z)-N-(1-(2-Methoxyphenyl)pent-3-en-1-yl)acetamide, 10d. Following GP 
for acetylation, 10d (14.9 mg, 0.06 mmol, 68%) was isolated by FC, starting 
from primary amine 9d (18 mg, 0.09 mmol) in CH2Cl2 (0.38 mL), Et3N (39.3 
µL, 0.28 mmol), DMAP (1.1 mg, 0.009 mmol) and acetic anhydride (13.3 µL, 0.14 mmol). E:Z 
ratio 1:9.0. 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.25-7.19 (m, 1H, Carom-H), 
7.15 (dd, J = 7.6, 1.8 Hz, 1H, Carom-H), 6.95-6.86 (m, 2H, Carom-H), 6.43 (d, J = 8.7 Hz 1H, NH), 
5.55-5.41 (m, 1H, HC=CH), 5.35-5.23 (m, 1H, HC=CH), 5.22-5.10 (m, 1H, HCNH), 3.89 (s, 
3H, OCH3), 2.63-2.42 (m, 2H, CH2), 1.97 (s, 3H, COCH3), 1.65-1.56* (m, 3H, CH3), 1.51 (dd, J 
= 6.7, 0.9 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.0 (C=O), 
157.2 (Carom-O), 129.3 (Carom), 129.2 (Carom-H), 128.6 (HC=CH), 126.5 (Carom-H), 126.4 
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(HC=CH), 120.8 (Carom-H), 111.1 (Carom-H), 55.5 (OCH3), 51.8 (HCNH), 32.6 (CH2), 23.8 
(COCH3), 18.1* (CH3), 12.9 (CH3). IR (CH2Cl2): 3307 (NH st), 2930 (C-H st), 1641 (C=O st), 
1245 (C-OC st as), 1027 (C-O-C st sy) cm-1. MS (EI) m/z (%): 178 (100, [M+-C4H7]). HRMS: 
Calculated for [C14H20NO2]+: 234.1494 [M+H]+; found: 234.1498. The ee was determined by 
HPLC using a Chiralcel OD-3 column [n-hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min; Z isomer 
τminor = 35.75 min, τmajor = 106.07 min (85% ee); E isomer τmajor = 33.85 min, τminor = 97.60 min 
(73% ee). 
(S,Z)-N-(1-(3-Methoxyphenyl)pent-3-en-1-yl)acetamide, 10e. Following GP 
for acetylation, 10e (14.4 mg, 0.06 mmol, 89%) was isolated by FC as an oil, 
starting from primary amine 9e (13.3 mg, 0.07 mmol) in CH2Cl2 (0.28 mL), 
Et3N (29 µL, 0.21 mmol), DMAP (0.8 mg, 0.007 mmol) and acetic anhydride 
(9.8 µL, 0.1 mmol). E:Z ratio 1:5.6. 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.31-
7.20 (m, 1H, Carom-H), 6.93-6.75 (m, 3H, Carom-H), 5.78 (d, J = 6.8 Hz, 1H, NH), 5.65-5.48 (m, 
1H, HC=CH), 5.36-5.23 (m, 1H, HC=CH), 5.09-4.92 (m, 1H, HCNH), 3.80 (s, 3H, OCH3), 2.62-
2.51 (m, 2H, CH2), 2.51-2.42* (m, 2H, CH2), 1.99 (s, COCH3), 1.60 (dd, J = 6.8, 0.9 Hz, 3H, 
CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.4 (C=O), 159.9 (Carom-O), 
143.6 (Carom), 129.8 (Carom-H), 129.7* (Carom-H), 129.0* (HC=CH), 127.3 (HC=CH), 126.4* 
(HC=CH), 125.5 (HC=CH), 118.9 (Carom-H), 118.8* (Carom-H), 112.8 (Carom-H), 112.7* (Carom-
H), 112.5 (Carom-H), 112.4* (Carom-H), 55.4 (OCH3), 53.1 (HCNH), 52.9* (HCNH), 39.4* (CH2), 
33.5 (CH2), 23.6 (COCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3285 (NH st), 2940 (C-H st), 
1648 (C=O st), 1260 (C-O-C st as), 1045 (C-O-C st sy) cm-1. MS (EI) m/z (%): 178 (100, [M+-
C4H7]). HRMS: Calculated for [C14H20NO2]+: 234.1494 [M+H]+; found: 234.1498. The ee was 
determined by HPLC using a Chiralpak IC column [n-hexane/i-PrOH (98:2)]; flow rate 0.7 
mL/min; Z isomer τminor = 139.35 min, τmajor = 172.43 min (>99% ee); E isomer τmajor = 134.51 
min, τminor = 192.95 min (96% ee). 
(S,Z)-N-(1-(4-Bromophenyl)pent-3-en-1-yl)acetamide, 10f. Following 
GP for acetylation, 10f (20.8 mg, 0.07 mmol, 83%) was isolated by FC, 
starting from primary amine 5c (21.4 mg, 0.09 mmol) in CH2Cl2 (0.36 mL), 
Et3N (37.2 µL, 0.27 mmol), DMAP (1.1 mg, 0.009 mmol) and acetic anhydride (12.6 µL, 0.13 
mmol). E:Z ratio 1:5.7 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.43 (d, J = 8.4 
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Hz, 2H, Carom-H), 7.14 (d, J = 8.4 Hz, 2H, Carom-H), 5.87 (d, J = 7.3 Hz, 1H, NH), 5.67-5.47 (m, 
1H, HC=CH), 5.31-5.19 (m, 1H, HC=CH), 5.03-4.89 (m, 1H, HCNH), 2.56-2.48 (m, 2H, CH2), 
2.47-2.39* (m, 2H, CH2), 1.98 (s, 3H, COCH3), 1.63* (dd, J = 6.4, 1.4 Hz, 3H, CH3), 1.58 (dd, J 
= 6.8, 0.8 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.5 (C=O), 
141.2* (Carom), 141.1 (Carom), 131.7 (Carom-H), 129.5* (HC=CH), 128.4 (Carom-H), 128.3* (Carom-
H), 127.7 (HC=CH), 125.9* (HC=CH), 125.0 (HC=CH), 121.2 (Carom-Br), 52.7 (HCNH), 52.5* 
(HCNH), 39.3* (CH2), 33.3 (CH2), 23.5 (COCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3282 
(NH st), 1648 (C=O st) cm-1. MS (EI) m/z (%): 226 (44, [M+-C4H7]). HRMS: Calculated for 
[C13H17NOBr]+: 282.0494 [M+H]+; found: 282.0504. The ee was determined by HPLC using a 
Chiralpak AY-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; Z isomer τminor = 27.18 
min, τmajor = 51.42 min (98% ee); E isomer τminor = 44.41 min, τmajor = 54.08 min (98% ee). 
(S,Z)-N-(1-(4-Chlorophenyl)pent-3-en-1-yl)acetamide, 10g. Following 
GP for acetylation, 10g (13.6 mg, 0.06 mmol, 84%) was isolated by FC, 
starting from primary amine 9g (13.4 mg, 0.07 mmol) in CH2Cl2 (0.27 mL), 
Et3N (28.4 µL, 0.2 mmol), DMAP (1.0 mg, 0.008 mmol) and acetic anhydride (9.6 µL, 0.1 
mmol). E:Z ratio 1:5.5. 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.29 (d, J = 8.5 
Hz, 2H, Carom-H), 7.20 (d, J = 8.5 Hz, 2H, Carom-H), 5.81 (d, J = 7.1 Hz, 1H, NH), 5.66-5.47 (m, 
1H, HC=CH), 5.33-5.18 (m, 1H, HC=CH), 5.07-4.90 (m, 1H, HCNH), 2.58-2.49 (m, 2H, CH2), 
2.47-2.40* (m, 2H, CH2), 1.98 (s, 3H, COCH3), 1.64* (dd, J = 6.4, 1.4 Hz, 3H, CH3), 1.58 (dd, J 
= 6.8, 0.9 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.4 (C=O), 
140.7* (Carom), 140.5 (Carom), 133.1 (Carom-Cl), 133.0* (Carom-Cl), 129.5* (HC=CH), 128.8 (Carom-
H), 128.0 (Carom-H), 127.9* (Carom-H), 127.8 (HC=CH), 126.0* (HC=CH), 125.0 (HC=CH), 52.6 
(HCNH), 52.4* (HCNH), 39.3* (CH2), 33.4 (CH2), 25.5* (COCH3), 23.6 (COCH3), 18.1* (CH3), 
13.2 (CH3). IR (CH2Cl2): 3285 (NH st), 1648 (C=O st) cm-1. MS (EI) m/z (%): 182 (49, [M+-
C4H7]). HRMS: Calculated for [C13H17NOCl]+: 238.1001 [M+H]+; found: 238.0999. The ee was 
determined by HPLC using a Chiralpak AY-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 
mL/min; Z isomer τminor = 23.02 min, τmajor = 44.60 min (>99% ee); E isomer τminor = 38.71 min, 
τmajor = 41.73 min (>99% ee). 
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 (S,Z)-N-(1-(4-Fluorophenyl)pent-3-en-1-yl)acetamide, 10h. Following 
GP for acetylation, 10h (5.5 mg, 0.02 mmol, 61%) was isolated by FC, 
starting from primary amine 9h (7.4 mg, 0.04 mmol) in CH2Cl2 (0.16 mL), 
Et3N (16.7 µL, 0.12 mmol), DMAP (0.5 mg, 0.004 mmol) and acetic 
anhydride (5.8 µL, 0.06 mmol). E:Z ratio 1:5.4. 1H NMR (300 MHz, CDCl3) δ (*denotes minor 
isomer) 7.31-7.20 (m, 2H, Carom-H), 7.06-6.96 (m, 2H, Carom-H), 5.74 (d, J = 6.0 Hz, 1H, NH), 
5.66-5.48 (m, 1H, HC=CH), 5.35-5.19 (m, 1H, HC=CH), 5.07-4.93 (m, 1H, HCNH), 2.59-2.50 
(m, 2H, CH2), 2.49-2.41* (m, 2H, CH2), 1.99 (s, 3H, COCH3), 1.59 (dd, J = 6.7, 0.8 Hz, 3H, 
CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.4 (C=O), 162.1 (d, 1JC-F = 
245.2 Hz, Carom-F), 162.0* (d, 1JC-F = 245.2 Hz, Carom-F), 137.9* (d, 4JC-F = 2.9 Hz, Carom), 137.8 
(d, 4JC-F = 3.3 Hz, Carom), 129.3* (HC=CH), 128.2 (d, 3JC-F = 7.8 Hz, Carom-H), 128.1* (d, 3JC-F = 
7.2 Hz, Carom-H), 127.6 (HC=CH), 126.1* (HC=CH), 125.2 (HC=CH), 115.5 (d, 2JC-F = 21.4 Hz, 
Carom-H), 115.4* (d, 2JC-F = 21.4 Hz, Carom-H), 52.6 (HCNH), 52.4* (HCNH), 39.5* (CH2), 33.5 
(CH2), 23.5 (COCH3), 18.1* (CH3), 13.1 (CH3). IR (CH2Cl2): 3289 (NH st), 2927 (C-H st), 1644 
(C=O st), 1220 (C-F st). MS (EI) m/z (%): 166 (49, [M+-C4H7]), 124 (100, [M+-C6H4F]). HRMS: 
Calculated for [C13H17NOF]+: 222.1294 [M+H]+; found: 222.1292. The ee was determined by 
HPLC using a Chiralpak AY-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; Z isomer 
τminor = 17.30 min, τmajor = 34.12 min (>99% ee); E isomer τmajor = 24.23 min, τminor = 30.90 min 
(99% ee). 
10h was crystallized in vapour diffusion conditions with Et2O:n-hexane at -20 ºC. 
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(R,Z)-N-(1-Phenylhept-5-en-3-yl)benzamide, 10i. Following GP for 
benzoylation, 10i (9.3 mg, 0.03 mmol, 96%) was isolated by FC, starting 
from primary amine 9i (6.3 mg, 0.03 mmol) in CH2Cl2 (0.13 mL), Et3N (7 
µL, 0.05 mmol) and benzoyl chloride (4.6 µL, 0.04 mmol). E:Z ratio nd. Rf= 0.51 (petroleum 
ether/EtOAc 8:2). 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 7.72-7.65 (m, 2H, 
Carom-H), 7.53-7.38 (m, 3H, Carom-H), 7.32-7.23 (m, 2H, Carom-H), 7.24-7.14 (m, 3H, Carom-H), 
5.94 (d, J = 8.8 Hz, 1H, NH), 5.71-5.56 (m, 1H, HC=CH), 5.56-5.40 (m, 1H, HC=CH), 4.38-
4.18 (m, 1H, H-3), 2.74 (t, J = 8.0 Hz, 2H, 2×H-1), 2.54-2.41 (m, 1H, H-4a), 2.40-2.25 (m, 1H, 
H-4b), 2.07-1.78 (m, 2H, 2×H-2), 1.67* (dd, J = 5.9, 0.9 Hz, 3H, CH3), 1.63 (dd, J = 6.7, 0.7 Hz, 
3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 167.1 (C=O), 142.0* (Carom), 
141.9 (Carom), 135.1* (Carom), 135.0 (Carom), 131.4 (Carom-H), 129.0* (HC=CH), 128.7 (HC=CH), 
128.6 (HC=CH), 128.5 (Carom-H), 127.4 (Carom-H), 126.9 (Carom-H), 126.5* (HC=CH), 126.1 
(Carom-H), 125.6 (Carom-H), 49.7 (C-3), 49.5* (C-3), 38.1* (C-2), 36.3* (C-4), 36.2 (C-2), 32.75 
(C-4), 32.67* (C-1), 32.1 (C-1), 18.2* (CH3), 13.2 (CH3). IR (CH2Cl2): 3303 (NH st), 2926 (C-H 
st), 1630 (C=O st) cm-1. MS (EI) m/z (%): 238 (38, [M+- C4H7]), 105 (100, [M+-C13H18N]). 
HRMS: Calculated for [C20H24NO]+: 294.1858 [M+H]+; found: 294.1859. The ee was determined 
by HPLC using a Chiralpak AY-3 column [n-hexane/i-PrOH (97:3)]; flow rate 1.0 mL/min; E 
isomer τminor = 61.18 min, τmajor = 129.93 min (93% ee); Z isomer τmajorr = 83.30 min, τminor = 
87.76 min (93% ee). 
(R,Z)-N-(Dodec-2-en-5-yl)acetamide, 10j. Following GP for 
acetylation, 10j (10.2 mg, 0.04 mmol, 81%) was isolated by FC, 
starting from primary amine 9j (10.2 mg, 0.06 mmol) in CH2Cl2 
(0.22 mL), Et3N (23.4 µL, 0.17 mmol), DMAP (1.0 mg, 0.008 mmol) and acetic anhydride (8 
µL, 0.08 mmol). E:Z ratio 1:5.6. 1H NMR (300 MHz, CDCl3) δ (*denotes minor isomer) 5.66-
5.52 (m, 1H, HC=CH), 5.47-5.31 (m, 1H, HC=CH), 5.24 (d, J = 8.4 Hz, 1H, NH), 4.07-3.86 (m, 
1H, HCNH), 2.36-2.23 (m, 1H, H-4a), 2.21-2.07 (m, 1H, H-4b), 1.95 (s, 3H, COCH3), 1.66* (dd, 
J = 6.0, 1.3 Hz, 3H, CH3), 1.61 (dd, J = 6.7, 1.1 Hz, 3H, CH3), 1.41-1.16 (m, 13H, 6×CH2), 0.91-
0.83 (m, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.64 (C=O), 
169.59* (C=O), 128.4* (HC=CH), 126.9 (HC=CH), 126.8* (HC=CH), 125.9 (HC=CH), 49.4 
(HCNH), 49.1* (HCNH), 37.9* (CH2), 34.4 (CH2), 32.0 (CH2), 31.9 (CH2), 29.7 (CH2), 29.4 
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(CH2), 26.2 (CH2), 26.1* (CH2), 23.7 (COCH3), 18.2* (CH3), 14.2 (CH3), 13.1 (CH3). IR 
(CH2Cl2): 3278 (NH st), 2926 (C-H st), 1645 (C=O st) cm-1. MS (EI) m/z (%):170 (35, [M+-
C4H7]). HRMS: Calculated for [C14H28NO]+: 226.2171 [M+H]+; found: 226.2177. The ee was 
determined by HPLC using a Chiralpak AY-3 column [n-hexane/i-PrOH (95:5)]; flow rate 1.0 
mL/min; Z isomer τminor = 12.85 min, τmajor = 22.86 min (96% ee); E isomer τmajor = 19.99 min, 
τminor = 26.17 min (99% ee). 
(S,Z)-N-(1-Cyclohexylpent-3-en-1-yl)benzamide, 10k. Following GP for 
benzoylation, 10k (3.9 mg, 0.01 mmol, 96%) was isolated by FC, starting from 
primary amine 9k (2.5 mg, 0.01 mmol) in CH2Cl2 (0.1 mL), Et3N (3.2 µL, 0.02 
mmol) and benzoyl chloride (2.1 µL, 0.02 mmol). Rf= 0.5 (petroleum ether/EtOAc 8:2). E:Z ratio 
1:6.3 1H NMR (300 MHz, CDCl3) δ 7.77-7.70 (m, 2H, Carom-H), 7.53-7.38 (m, 3H, Carom-H), 5.91 
(d, J = 9.3 Hz, 1H, NH), 5.66-5.52 (m, 1H, HC=CH), 5.51-5.37 (m, 1H, HC=CH), 4.14-4.01 (m, 
1H, H-1), 2.50-2.37 (m, 1H, H-2a), 2.34-2.15 (m, 1H, H-2b), 1.88-1.71 (m, 4H, 2×CcyH2), 1.71-
1.42 (m, 4H, CcyH+CH3), 1.36-0.98 (m, 6H, 3×CcyH2). 13C NMR (75 MHz, CDCl3) δ (*denotes 
minor isomer) 167.3 (C=O), 135.4* (Carom), 135.3 (Carom), 131.4* (Carom-H), 128.7 (Carom-H), 
128.4* (HC=CH), 127.1* (HC=CH), 126.9 (Carom-H), 126.8 (HC=CH), 126.3 (HC=CH), 54.1 
(C-1), 53.8* (C-1), 41.4 (CcyH), 35.2* (C-2), 30.1 (C-2), 29.9* (CcyH2), 29.8* (CcyH2), 29.3 
(CcyH2), 29.0 (CcyH2), 26.5 (CcyH2), 26.3 (CcyH2), 18.2* (CH3), 13.2 (CH3). IR (CH2Cl2): 3310 
(NH st), 2851 (C-H st), 1630 (C=O st) cm-1. MS (EI) m/z (%): 216 (59, [M+-C4H7]), 105 (100, 
[M+-C11H20N]). HRMS: Calculated for [C18H26NO]+: 272.2018 [M+H]+; found: 272.2014. The ee 
was determined by HPLC using a Chiralcel OD-3 column [n-hexane/i-PrOH (98:2)]; flow rate 
1.0 mL/min; E isomer τmajor = 13.05 min, τminor = 16.15 min (94% ee), Z isomer τminor = 14.19 
min, τmajor = 18.47 min (91% ee). 
N-((S,1E,5Z)-1-Phenylhepta-1,5-dien-3-yl)acetamide, 10l. Following GP 
for acetylation, 10l (17.3 mg, 0.07 mmol, 97%) was isolated by FC, 
starting from primary amine 9l (14.6 mg, 0.08 mmol) in CH2Cl2 (0.31 mL), 
Et3N (32.6 µL, 0.23 mmol), DMAP (1.0 mg, 0.008 mmol) and acetic anhydride (11 µL, 0.12 
mmol). E:Z ratio 1:6.0 1H NMR (300 MHz, CDCl3) δ 7.41-7.18 (m, 4H, Carom-H), 6.51 (dd, J = 
16.0, 1.5 Hz, 1H, H-1), 6.14 (dd, J = 16.0, 6.0 Hz, 1H, H-2), 5.72-5.49 (m, 2H, H-6+NH), 5.49-
5.35 (m, 1H, H-5), 4.80-4.64 (m, 1H, H-3), 2.56-2.29 (m, 2H, CH2), 2.03 (s, 3H, COCH3), 1.73-
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1.60 (m, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (*denotes minor isomer) 169.4 (C=O), 136.8 
(Carom), 130.6 (C-1), 130.5* (C-1), 129.5 (C-6), 128.7 (Carom-H), 127.7 (C-2), 127.6 (Carom-H), 
126.5 (Carom-H), 126.1*(C-5), 125.2 (C-5), 50.7 (C-3), 50.5* (C-3), 38.3* (C-4), 32.5 (C-4), 23.7 
(COCH3), 18.2* (CH3), 13.2 (CH3). IR (CH2Cl2): 3289 (NH st), 2926 (C-H st), 1644 (C=O st) 
cm-1. MS (EI) m/z (%): 229 (1, M+), 174 (72, [M+-C4H7]). HRMS: Calculated for [C15H20NO]+: 
230.1545 [M+H]+; found: 230.1546. The ee was determined by HPLC using a Chiralpak IC 
column [n-hexane/EtOH (97:3)]; flow rate 1.0 mL/min; Z isomer τminor = 32.04 min, τmajor = 34.47 
min (94% ee). 
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ABBREVIATIONS, ACRONYMS AND SYMBOLS1 
Ac  Acetyl 
acac Acetylacetonate 
ACDC Asymmetric Counterion Directed Catalysis 
Ac2O Acetic anhydride 
aq.  Aqueous 
Ar  Aryl 
BINOL 1,1´-Bi-2-naphthol 
Bn  Benzyl 
Boc tert-Butoxycarbonyl 
bs  broad signal 
c  Concentrarion (measured in g/100 mL) 
Carom Aromatic carbon 
CBA Chiral Brønsted Acid 
CPA Chiral Phosphoric Acid 
D-A Diels-Alder 
DFT Densitiy Functional Theory 
DMDO Dimethyldioxirane 
DMSO Dimethylsulfoxide 
dpp diphenyl phosphate 
d.r. diastereomeric ratio 
EDG Electron-donating group 
e.e. enantiomeric excess 
et al. Et alii (and others) 
eV  Electron volt 
EWG Electron-withdeawing group 
FC  Flash chromatography 
GC Gas chromatography 
GP General Procedure 
HOMO Highest Occupied Molecular Orbital 
HPLC High Performance Liquid Chromatography 
HRMS High Resolution Mass Spectrometry 
J  Coupling constant 
LUMO Lowest Unoccupied Molecular Orbital 
Mes mesityl 
M.p. Melting point 
MS molecular sieves or Mass Spectrometry 
                                                          
1  For standard Abbreviations and Acronyms, see: “Guidelines for Authors” J. Org. Chem. 2017. 
n.d. not determined 
NHC N-heterocyclic carbene 
n.r. no reaction 
PMP para-methoxyphenyl 
PTC Phase Transfer Catalysis 
R  alkyl group or substituent 
r.r. regioisomeric ratio 
r.t.  room temperature 
SOMO Single Occupied Molecular Orbital 
SPINOL 1,1´-spirobiindane-7,7´-diol 
SI  Supporting Information 
TADDOL (α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanol) 
Tf  Trifluoromethanesulfonyl 
Ts  Tosyl 
TS  transition state 
X  halogen, heteroatom or leaving group 
δ  chemical shift 
τmajor Retention time for major enantiomer 
τminor Retention time for minor enantiomer 
Resumen extendido 
El empleo de catalizadores quirales que contienen enlaces de hidrógeno dadores 
ha abierto una estrategia muy útil para la afinidad entre el catalizador y el sustrato ya 
que confiere una mejor organización y estados de transición más rígidos que otorgan 
mejores estereoselectividades. En este sentido, los ácidos de Brønsted han demostrado 
ser catalizadores altamente eficaces y versátiles para un gran número de 
transformaciones sintéticas relevantes. Debido a la necesidad de activar un mayor rango 
de sustratos mediante la utilización de ácidos más fuertes, Terada y Akiyama 
desarrollaron un nuevo grupo de ácidos fosfóricos quirales basados en la estructura del 
BINOL capaces de actuar de forma bifuncional en un gran número de reacciones. 
Siguiendo la línea de investigación del grupo en el área de la organocatálisis 
asimétrica, la presente memoria recoge el estudio y desarrollo de varias metodologías 
bajo catálisis de ácidos de Brønsted quirales los cuales participan generando especies 
reactivas y a su vez proporcionando un entorno asimétrico conduciendo a la formación 
de productos de forma enantioenriquecida. 
En un primer capítulo, se ha expuesto un breve resumen con perspectiva histórica 
de las características más generales de la organocatálisis asimétrica, haciendo especial 
mención a los avances en los diferentes modos de activación de compuestos carbonílicos 
e iminas empleando catalizadores de ácidos de Brønsted tipo ácidos fosfóricos o 
triflamidas. Se detallan los modos de activación con recientes ejemplos bibliográficos 
aclarando el mecanismo de cada uno de ellos. 
El principal proyecto de la tesis doctoral consiste en el estudio del 
comportamiento de compuestos con estructura 1,3-dipolo frente a dienos ricos en 
electrones en un caso típico de cicloadición (4+3). Pretendemos explorar el uso de 
cationes alílicos estabilizados por heteroátomos como fuente de la unidad que aporta tres 
átomos de carbono, los cuales son conocidos por reaccionar de manera eficaz con dienos  
  
via cicloadición (4+3) rindiendo una estructura carbocatiónica cíclica de siete eslabones 
que posteriormente evoluciona hasta el producto final (ver Esquema 1). 
 
Esquema 1 
Inicialmente se trabajó en la síntesis de los diferentes precursores de catión 
oxaalílico como son los metilidenoxiranos. De esta forma, la formación in situ de los 
cationes oxaalílicos mediante la epoxidación de alenos estabilizados por nitrógeno con 
la consiguiente apertura del metilidenoxirano resultó ser la estrategia más viable. La 
primera aproximación se basó en la apertura de alquilidenoxiranos mediante catálisis 
por ácidos de Brønsted fuertes que se fundamenta en la protonación o activación del 
sustrato mediante enlaces de hidrógeno por el catalizador ácido, la base conjugada 
obtenida, que contiene el entorno quiral, se mantiene próxima al protón por 
interacciones iónicas o electrostáticas. La posterior transformación sobre este intermedio 
asimétrico da lugar al producto final enantioenriquecido. Se realizó un estudio con los 
reactivos epoxidantes clásicos como pueden ser mCPBA, CH3COOH, 
t
BuOOH o H2O2 
sin observar el producto de cicloadición en ninguno de los casos. Al acudir a la 
bibliografía se observó la utilización del dimetildioxirano (DMDO) en reacciones de 
epoxidación de alenos. Asimismo, se decidió preparar dicho compuesto y ensayarlo en 
la reacción obteniendo el cicloaducto con un rendimiento del 35% en presencia de 
furano y un ácido fosfórico (Esquema 2). 
 
Esquema 2 
En 2004, para compensar las limitaciones observadas hasta la fecha con el empleo 
de tioureas quirales, Akiyama y Terada presentaron los ácidos fosfóricos derivados del 
BINOL. Estas especies presentan la acidez adecuada para generar interacciones 
electrostáticas más estables, y una situación más restringida del grupo ácido gracias a su 
entorno quiral. Además, el grupo fosfato es a la vez ácido y base, confiriendo un 
carácter bifuncional al catalizador. De esta forma, se procedió a verificar la viabilidad de 
la reacción variando la acidez de los catalizadores empleados para promover la reacción 
entre una alenamida conocida y furano como dieno rico en electrones. Se observó que 
una mayor acidez en el sistema catalítico promovía la reacción de manera más eficaz en 
términos de rendimiento y estereocontrol. 
De esta forma, se evaluaron diferentes alenos con grupos dadores y electron-
atractores modulando de esta forma la electrofilia del catión oxaalílico con el fin de 
lograr los mejores resultados encontrando necesaria la incorporación tanto de un grupo 
electron-atractor tipo alcoxicarbonilo como un sustituyente aromático sobre el átomo de 
nitrógeno. A continuación se realizaron estudios de temperatura, diversos modos de 
adición, variaciones en la concentración, estudio de equivalentes, disolventes y co-
disolventes observando una mejora significativa bajo el empleo de acetato de etilo como 
co-disolvente en el sistema de reacción. De esta forma, también se estudió el empleo de 
otros acetatos sin observar ninguna mejora. 
Con el fin de mejorar los resultados, se reevaluaron diferentes catalizadores bajo 
las condiciones óptimas de reacción incluyendo sistemas tipo SPINOL o bifosfóricos 
que han demostrado buenos resultados en otras reacciones descritas en la bibliografía sin 
lograr una mejora en los resultados. 
Tras un extenso proceso de exploración de las variables de reacción, se determina 
que el empleo de triflamida sustituida por triphenylsilyl en posiciones 3,3´del BINOL 
como catalizador en DMDO en tolueno y acetato de etilo como disolvente a -78 ºC 
conducen a la formación de 8-oxabiciclo[3.2.1]-octano (Esquema 3). 
 
Esquema 3 
A continuación se decidió estudiar la influencia de la sustitución y naturaleza 
electrónica del dieno, observando que la reacción es muy dependiente de este parámetro, 
estando limitada al uso de furanos como dienos ricos en electrones capaces de 
proporcionar resultados aceptables en cuanto a rendimiento y estereocontrol. Se realizó 
el alcance de la reacción con buenos rendimientos y enantioselectividades bajo una 
absoluta diastereoselectividad y casi completa regioselectividad. Sin embargo, la 
reacción queda limitada al uso de furanos sustituidos en posición 3. 
Con el fin de completar el trabajo se utilizaron los furanos que mejores resultados 
aportaron al estudio de alenos sustituidos en posición γ con sustituyentes de diferente 
naturaleza como grupos alquilo o funcionalizados obteniendo excelentes resultados 
(Esquema 4). 
 
Esquema 4 
Finalmente, el tercer capítulo trata sobre el trabajo realizado en la Universidad de 
Loughborough (UK) bajo la supervisión del Prof. Andrei V. Malkov y la posterior 
colaboración con nuestro grupo en la UPV/EHU trabajando con el objetivo de establecer 
las condiciones óptimas para la resolución cinética de mezclas racémicas de 
alilboronatos secundarios mediante la alilación selectiva facial de aldehídos empleando 
condiciones de ácidos de Brønsted quirales (Esquema 5) para posteriormente utilizarlos 
como productos de partida en la alilación de iminas. 
 
Esquema 5 
Los boronatos resueltos serán utilizados para la síntesis de aminas quirales 
homoalílicas. Desarrollaremos la alilación asimétrica de iminas primarias mediante el 
empleo de alilboronatos enantioenriquecidos con el objetivo de lograr un proceso de 
absoluta transferencia de quiralidad al producto final. Los boronatos resueltos se 
añadirán tras la condensación del correspondiente aldehído en imina bajo amoniaco en 
disolución de etanol a temperatura ambiente (Esquema 6). 
 
Esquema 6 
  
 
